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Letters 
Relationship 
1 Medicine 
What the needles said 
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COMMUNICATION STILL 
DOESN’T COME EASY 
I read with interest your article 
entitled "A DramaticTurn" [Spring 
2001] regarding the physician- 
patient relationship. I suspect my 
experience during my tenure at 
Yale in the early 1980s was fairly 
typical. I certainly received the 
message that truly caring about the 
patient as an individual was very 
important, but I did not receive any 
training regarding how to make 
that "caring” experience happen on 
any consistent basis. 
This article tells me that Yale still 
cares very much about the patient. 
But I was disappointed to note its 
suggestion that Yale still does not 
know how to teach the student 
how to make the physician-patient 
relationship happen within the 
short appointment reality of pri¬ 
mary care today. 
I am now one of the chiefs of 
ophthalmology with Kaiser and The 
Permanente Medical Group (tpmg) 
in California. I have also just been 
recruited to be the local "communi¬ 
cation consultant” in our facility. 
Communication consultants like 
myself are given training on the 
essential ingredients of an effective 
patient-provider interaction. These 
evidence-based elements have been 
dubbed the"Four Habits of the 
Highly Effective Clinician.”They 
form the backbone of an eight-hour 
curriculum which teaches the 
participants four key skills that 
allow the physician to make a sat¬ 
isfying human connection with 
the patient—even within a 15- 
minute interaction. 
Awareness-building presen¬ 
tations like those of Ms. Smith’s are 
highly valuable. I think the next 
step might be offering our physi- 
cians-in-training a program similar 
to tpmg's, one that teaches specific 
and achievable techniques to im¬ 
prove communication. 
ELLEN KOLARIK, M.D. '85 
PETALUMA, CALIF. 
TAKING THE PULSE 
OF HEALTH INTERACTIONS 
In the Spring 2001 issue, the article 
“A DramaticTurn” provided a 
thought-provoking look at the physi¬ 
cian-patient relationship. We want 
to call your attention to another 
Yale-based initiative that examines 
the clinician-patient relationship. 
The Program for the Study of 
Health Care Relationships,funded 
by the Patrick and Catherine Wel¬ 
don Donaghue Medical Research 
Foundation, is a collaborative pro¬ 
ject between Yale University and the 
University of Connecticut. The pro¬ 
gram's mission is to bring issues 
surrounding the relational aspects 
of care to the forefront of the ongo¬ 
ing discourse about health care in 
Connecticut and the nation. It seeks 
to enable patients, health-care 
professionals, providers, health 
policymakers and other interested 
individuals to engage in successful 
partnerships, with the shared goal 
of improving patient outcomes, 
especially in the context of adher¬ 
ence to therapeutic regimes. 
A multidisciplinary team has 
been working for a year to study the 
relational aspects of care and their 
effects on adherence.The interdis¬ 
ciplinary program provides a forum 
for a range of issues, including health 
education; the role of the Internet 
and technology; the influence of 
organizations, insurance and poli¬ 
cy; and the relationships among 
professions, as well as with patients. 
The group consists of physicians, 
nurses, social workers, consumers, 
academics and others, and has 
a website: info.med.yale.edu/ 
nursing/hcr/. 
SALLY COHEN, R.N., PH.D., DIRECTOR, 
PROGRAM FOR THE STUDY OF HEALTH 
CARE RELATIONSHIPS; ASSOCIATE 
PROFESSOR, YALE SCHOOL OF NURSING 
THANK YOU FOR AN 
OUTSTANDING MAGAZINE 
May I take this opportunity to com¬ 
mend you on the excellent quality 
and caliber of Yale Medicine. It is 
outstanding, informative, insight¬ 
ful and pleasurable to read. Thank 
you for your superior effort. 
LEE H. STROHL, M.D. '68 
LAKESIDE, MICH. 
The current format of Yale Medi¬ 
cine is terrific. It is global in its per¬ 
spective, clearly informative and 
upbeat. Your accomplishment as 
well as the accomplishments of 
those featured rekindles the pride 
we all shared in ysm when we 
fledged various decades ago.Thank 
you for your efforts. I have begun 
looking forward greatly to succes¬ 
sive issues. 
GLENN L. KELLY, M.D. ’62, HS '66 
ENGLEWOOD, COLO. 
WHAT THE STORY SAID 
ABOUT NEEDLE EXCHANGE 
I was very much impressed by 
“What the Needles Said” [Summer 
2001]. This very positive and accu¬ 
rate reporting of the events that 
led to the creation and successful 
implementation of New Haven's 
Needle Exchange Program is per¬ 
haps the best summary of the pro¬ 
gram that I have seen. 
The Yale medical community 
deserves a great deal of gratitude 
for its support of needle exchange 
at a time when the entire nation 
was still very much in a "black 
death/bubonic plague” panic in 
regard to aids. I'm proud that my 
city and my police department 
proved positive in rising to the chal¬ 
lenges which were thrust upon us 
at that moment in history. 
NICHOLAS PASTORE, DIRECTOR, CRIMINAL 
JUSTICE POLICY FELLOWSHIP; FORMER 
CHIEF OF POLICE, NEW HAVEN, CONN. 
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FROM THE EDITOR 
Walking a fine line 
Every so often someone will offer an idea for an article or a comment about 
a piece they read in “the journal,” meaning Yale Medicine. Along with 
my thanks, I usually note that Yale Medicine is more journalism than jour¬ 
nal, a magazine rather than a medical tome. This is an important dis¬ 
tinction in academia, where the peer-reviewed scrutiny and serious aims 
of scientific publishing reflect one set of core values. 
We’re a slightly different animal. Our primary goal is to keep 
alumni in touch with each other and informed about the work and schol¬ 
arship that goes on here. Our objective is to be intriguing to a wide 
audience and still relevant to each of our readers, whose interests run the 
gamut from structural biology to the history of medicine. As cartoonist 
Sidney Harris observes below, what one subspecialist finds hopelessly gen¬ 
eral may be incomprehensible to another learned person. It is our intent 
to bridge that gap in a way that readers will find engaging. 
We hope you’ll let us know how we’re doing. As this issue went to 
press, we received some welcome feedback from the Association of 
American Medical Colleges, which honored Yale Medicine with its highest 
level of recognition, the Award of Excellence. Also this issue, we are 
completing the final phase of the magazine’s redesign. I appreciate the 
suggestions we’ve received along the way and hope you like the result. 
Michael Fitzsousa 
michael.fitzsousa@yale.edu 
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chronicle news from cedar street 
Students placed candles around the rim of 
the Women’s Table on Cross Campus 
during a vigil the evening of September 11. 
Hundreds of people from throughout 
the Yale community gathered to honor the 
victims of the day’s tragedies. 
“THE STRANGEST KIND 
OF LETDOWN” 
On September’s day of terror, 
Yale geared up to treat 
survivors who never came. 
On September n, a day of death and 
panic elsewhere, there was an odd 
sort of quiet in New Haven. In the med¬ 
ical school’s clinics and classrooms, the 
day’s routine activities fell by the way- 
side, overwhelmed by the horror of what 
was happening in New York, Virginia 
and Pennsylvania. The medical center 
geared up for an onslaught of trauma 
cases that never materialized. For 24 
hours, Yale-New Haven Hospital was on 
disaster alert for survivors who might 
have been pulled from the wreckage of 
the collapsed World Trade Center only 90 
miles away. But, said a hospital spokes¬ 
woman, “It was the strangest kind of let¬ 
down. There were no patients to help.” 
Medical school faculty and alumni 
who provided aid in Lower Manhattan 
experienced a similar disappointment. 
Emergency physician Scott Weir, m.d., 
a veteran of search-and-rescue efforts 
including the 1998 bombing of the U.S. 
embassy in Nairobi, had never seen any¬ 
thing like the devastation at the World 
Trade Center. During a week on the 
scene he treated no survivors, only res¬ 
cuers with minor injuries. Kenneth C. 
Rondello, m.p.h. ’94, m.d., spent four 
days at the blast site and Chelsea Piers, 
where an ice rink became a morgue 
and the set of television’s “Spin City” a 
trauma center. “No news footage you’ve 
seen or descriptions you’ve heard can 
truly do it justice,” he said. “The air was 
permeated with the nauseating, acrid 
smell of burning jet fuel. Everything was 
covered in inches of gray ash, as if a 
volcano had erupted.” 
Life went on at Yale but the tragedy 
haunted everything that followed. 
No gathering could begin without some 
acknowledgement of “the events of 
September n.” The day of the attacks, 
classes were canceled for first- and 
second-year medical students, some of 
whom traveled to New York to volunteer 
in the Office of the Chief Medical Exam¬ 
iner. That first night, hundreds of stu¬ 
dents and faculty members carried can¬ 
dles down College Street to a vigil at 
Cross Campus. 
In the days that followed, the Univer¬ 
sity responded with drives for blood and 
donations, along with lectures and dis¬ 
cussions on terrorism, foreign policy and 
Islam. Students at the School of Public 
Health held a teach-in. Medical and pub¬ 
lic health students visited local mer¬ 
chants of Middle Eastern descent to reas¬ 
sure them at a time when they might 
fear discrimination. On September 28, 
speakers invited by the Department of 
Psychiatry and the Child Study Center 
explored the ways in which people cope 
with a world turned upside down. 
Among those determined to get 
on with their lives were Edwin Thrower, 
ph.d., a postdoctoral associate in the 
Department of Pharmacology, and his 
fiancee, Bozena Sakowska. They decided 
to go ahead with their wedding Sep¬ 
tember 15, even though his parents 
and friends in England could attend 
only via a conference call. The ceremony 
included a prayer for victims of the 
attacks, and ended on an upbeat note. 
“We had friends come from Manhattan,” 
Thrower said. “They said this was very 
much needed—a celebration of joy, 
love and life.” 
STEM CELL SCIENTIST 
URGES CONGRESS TO FUND 
EMBRYONIC RESEARCH 
When Diane Krause, m.d., ph.d., pub¬ 
lished findings this spring from her 
work on adult-derived stem cells in mice, 
she didn’t expect to become a player 
in a national political debate. “I thought 
it would be important for those of us 
in the field,” she said in July, adding “I 
didn’t realize it was going to get such 
press attention.” 
Krause, an associate professor of lab¬ 
oratory medicine and pathology, identified 
adult stem cells in bone marrow that can 
also create new liver, lung, gastrointestinal 
and skin cells. Working with collabora¬ 
tors at Johns Hopkins and New York 
University, she found the first evidence 
that these progenitor cells are capable 
of creating up to 15 different mature cell 
types (See Findings, page 13). 
Since the publication of her work in 
the May issue of Cell, Krause has been 
besieged by media inquiries from around 
the world. In early summer, she was 
asked to testify on Capitol Hill. 
Her conclusions were published as 
the national debate over embryonic stem 
cell research was heating up and, to her 
dismay, have provided fodder to oppo¬ 
nents of such work, which requires the 
destruction of human embryos. Those 
who oppose embryonic stem cell research 
for moral reasons argue that it is unnec¬ 
essary because adult stem cell research 
shows such promise. Krause insists that 
research down both avenues is vital. 
In July she had a chance to make her 
point before the U.S. Senate Appropria¬ 
tions Subcommittee on Labor, Health and 
Human Services and Education, which 
held hearings on the federal government’s 
role in funding future embryonic stem 
cell research. 
Embryonic stem cell research needs 
to be funded for three reasons, Krause 
told the subcommittee. First, these cells 
can be grown in vitro, unlike adult stem 
cells. Second, because they are the most 
versatile cells available, embryonic stem 
cells yield far more information on how 
they maintain that versatility than adult- 
derived cells. And third, she said, “No 
one can predict which lines of investiga¬ 
tion will lead to effective and safe treat¬ 
ments for human disease.” 
On August g President Bush out¬ 
lined his plan for funding embryonic 
stem cell research: only existing lines of 
embryonic stem cells, left over from in 
vitro fertilization, could be used in fed¬ 
erally funded research. Research using 
embryonic stem cell lines developed 
after August 9 would be ineligible for 
funding. On August 27, the National 
Institutes of Health released a hst of 64 
eligible embryonic stem cell fines. 
Scientists have questioned that list, 
noting that many cell lines are unavailable 
or inappropriate for a variety of reasons. 
“The president’s plan is not well 
thought out,” Krause said. “It doesn’t give 
federally funded scientists the freedom 
to pursue scientific questions.” 
On September 5, Secretary of Health 
and Human Services Tommy Thompson 
told a Senate committee that only about 
24 of the 64 cell lines were ready for use 
in experiments. The usefulness of the 
remaining cell fines, he said, remains to 
be proven. 
In testimony before a Senate subcommittee, 
Diane Krause urged that federal funding be pro¬ 
vided to support embryonic stem cell research. 
Krause also took exception to the use of her 
findings on adult stem cells to argue for restric¬ 
tions on embryonic stem cell funding. 
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6 chronicle 
FROM THE AUTOPSY SUITE, 
A TREASURE TROVE 
OF “POST-MORTEMISM” 
A.2948 GLOMERULUS OF NEWBORN INFANT 
Armin Hemberger had “an incredible ability to 
summarize the essence of the anatomical find¬ 
ings of a given condition in a single illustration.” 
Before photography became the standard 
for capturing images of important ana¬ 
tomical findings, pathology departments 
hired specially trained illustrators to 
create visual materials for teaching and 
recording medical knowledge. One of 
the most gifted among them was Armin 
Bismark Hemberger, whose career at 
Yale spanned six decades. 
Hemberger, who lived from 1896 to 
1974, is the subject of new interest and 
may someday be featured in a documen¬ 
tary film and traveling exhibit. 
A student of Max Brodel, who is widely 
regarded as the father of American med¬ 
ical illustration, Hemberger worked in 
the tradition of Vesalius, da Vinci and 
Dtirer, combining artistic skill with a re¬ 
markable level of scientific accuracy to 
produce brilliant images in pen and ink, 
pencil, gouache and watercolor. Approxi¬ 
mately 700 of these drawings are pre¬ 
served in the illustration collection of the 
Department of Pathology. 
“Hemberger was one of the best,” 
said Ranice W. Crosby, director emerita 
of the Department of Art as Applied 
to Medicine at Johns Hopkins, where 
Brodel’s papers are archived. 
Bom in Scranton, Pa., on April 1,1896, 
Hemberger graduated from the Mary¬ 
land Institute of Art and Design in Balti¬ 
more. In 1917, he was recruited by Mil- 
ton C. Winternitz, m.d., as a medical 
illustrator for the New Haven Station of 
the Army Chemical Warfare Service. His 
drawings are in two classic monographs 
edited by Winternitz, Collected Studies on 
the Pathology of War Gas Poisoning and 
The Pathology of Influenza. Hemberger 
returned to Baltimore in 1920 for a year 
of study with Brodel before spending the 
remainder of his career at Yale. He 
retired in 1962. 
In addition to his medical work, 
Hemberger painted landscapes and is 
represented in the collection of the Met¬ 
ropolitan Museum of Art in New York. 
In 1987, during the construction of 
a new autopsy suite, faculty member 
Raymond Yesner, m.d., noticed two large 
filing cabinets that had been pushed into 
the old dissection room. “I was absolutely 
knocked over by what I saw—hundreds 
of Hemberger’s paintings and drawings 
stacked one on top of the other.” An 
effort to catalog the images began in 
earnest and steps to preserve the origi¬ 
nal works followed. Five years ago, Jon 
S. Morrow, ph.d. '74, m.d. '76, hs ’77, 
chair of the Department of Pathology, 
asked Katherine Henderson, the depart¬ 
ment’s photography and graphics man¬ 
ager, to begin digitizing the illustrations 
and transferring the original works into 
acid-free, archival containers. Working 
with Deborah Dillon, m.d. ’92, a faculty 
member who provided annotation for 
many of the drawings, this task has now 
been largely completed. 
Last year, Judith Hokanson Barbeau, 
a public relations consultant hired by the 
department, saw a stack of Hemberger’s 
art on a shelf and became interested in 
his life and career. She located the artist’s 
son in New Hampshire, where she 
examined Hemberger’s original water- 
colors, oils, woodcarvings and engrav¬ 
ings. She later located and interviewed 
Hemberger’s former students and col¬ 
leagues, recording information and per¬ 
sonal remembrances. 
Hemberger’s work has guided gen¬ 
erations of medical students and physi- 
cians-in-training. One of them was 
Morrow, who said that the artist “had an 
incredible ability to summarize the 
essence of the anatomical findings of a 
given condition in a single illustration. 
Hemberger conveys more information 
about a disease process in a single draw¬ 
ing than a pathologist can assimilate by 
seeing a dozen examples in dissection.” 
With the support of Yesner and Mor¬ 
row, Barbeau hopes to make a film about 
Hemberger, as well as organize an accom¬ 
panying touring exhibition of his work. 
GRADUATE PROGRAM FOSTERS 
AN INTERDISCIPLINARY SPIRIT 
AND A JUMP IN APPLICATIONS 
How does an academic program go 
from newborn to campus fixture in only 
five years? 
Yale’s Combined Program in the Bio¬ 
logical and Biomedical Sciences (bbs) 
has accomplished this feat by uniting n 
academic departments and fostering a 
sense of community that’s evident from 
the lab bench to the pages of its irrever¬ 
ent student magazine. 
Founded on the principle that re¬ 
search is inherently interdisciplinary and 
no longer conforms to traditional depart¬ 
mental boundaries, bbs provides grad¬ 
uate students with flexible opportunities 
to study with more than 200 faculty 
members from across Yale. “There’s a lot 
more interchange than there ever was 
before bbs,” said Lynn Cooley, ph.d., the 
program’s new director and a professor of 
genetics and cell biology. “There's more 
communication, more coordination, and 
fewer territorial disputes over resources.” 
The program is divided into eight 
interest-based tracks: Biological Sci¬ 
ences, Cell Biology and Molecular Physi¬ 
ology, Genetics and Development, 
et cetera. 
APPLICATIONS HIT AN ONLINE SNAG 
Every alum knows about the Yale System of 
Medical Education and its emphasis on inde¬ 
pendent scholarship over class rankings, 
grades and exams. This summer, applicants 
to the medical school became familiar with 
a different kind of Yale system, created after 
the failure of a Web-based application pro¬ 
cess introduced by the American Medical 
College Application Service (amcas). Techni¬ 
cal glitches made it difficult for many appli¬ 
cants to file online, and the system for trans¬ 
mitting application data to medical schools 
has been crippled by software problems. 
Unfortunately, the old amcas paper-based 
system had already been dismantled, and 
medical schools found themselves scram¬ 
bling to devise new procedures. 
The transition system developed by the 
Admissions Office and the school’s informa¬ 
Immunology, Microbiology, Molecular 
Biophysics and Biochemistry, Neuro¬ 
science, and Pharmacological Sciences 
and Molecular Medicine, each of which 
draws its faculty from multiple depart¬ 
ments. While students affiliate with a 
single track, they have almost unlimited 
research opportunities at Yale, including 
access to faculty in departments such as 
Computer Science, Engineering, Psy¬ 
chology and Chemistry, bbs students 
“can rotate anywhere and settle into the 
lab that’s most suited to their interests,” 
said BBS Administrative Director John 
Alvaro, ph.d. “They have a nice home 
base and yet they have access to all the 
labs on campus.” 
bbs, which streamlined the admis¬ 
sions process and administrative 
structure for graduate students in the 
life sciences, has also succeeded in 
recruiting students. Applications jumped 
nearly 20 percent in the past year. 
One cornerstone of the program’s 
strength has been its partnership with 
Bristol-Myers Squibb (bms), which helped 
establish bbs with a multimillion-dollar 
grant in 1996. bms funds graduate study 
and provides opportunities for students 
to gain experience in pharmaceutical 
research at its Wallingford, Conn., facility. 
One of Cooley’s priorities is to expand 
partnerships between life sciences com¬ 
panies and bbs. She also plans to embark 
on a major fund-raising effort to estab¬ 
lish an endowment supporting graduate 
education. And she wants to continue 
to encourage collaborative research in 
emerging disciplines such as bioinfor¬ 
matics. The bbs program, says Cooley, 
provides “a way for the campus to nur¬ 
ture new emerging scientific disciplines.” 
John Alvaro and Lynn Cooley 
tion technology staff has worked so well 
that it has been adapted for use by other 
medical schools. Despite the problems with 
amcas and a downward trend in medical 
school applications nationally, applications 
to Yale have remained steady, according to 
Director of Admissions Richard A. Silverman. 
Meanwhile, amcas has developed an interim 
system of its own, sending printed copies 
of its applications to medical schools via 
overnight mail, amcas has also announced 
changes in leadership and is devoting sub¬ 
stantial resources to evaluating this year’s 
problems while working on a solution for 
next year. 
CONTRIBUTIONS REACH NEW HIGH 
For the second year in a row, gifts to the 
medical school have soared. At the close of 
fiscal year 2001, philanthropy from all 
sources totaled nearly $77 million, compared 
to $63.5 million for the previous year and 
$40 million in fiscal 1999. Gifts from individ¬ 
uals more than doubled over the past year, 
from $15.5 million to $33 million. Of particu¬ 
lar note was record-breaking giving by 
reunion classes that celebrated last June. 
Donations from professional foundations 
totaled $21 million; private agencies gave 
just under $16 million and corporations 
gave $6 million. “These totals are not only 
a reflection of the generosity of the many 
friends of the School of Medicine,” said Dean 
David A. Kessler, M.D.,“but also a continu¬ 
ing commitment and support for faculty 
research and clinical excellence.” 
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Rounds CLINICAL MEDICINE AT YALE 
Marc Potenza has used functional magnetic 
resonance imaging to localize brain activity 
associated with pathological gambling to the 
anterior cingulate cortex. 
SLOT MACHINES AND 
THE CINGULATE CORTEX 
The neurobiology of pathological 
gambling bears striking similarities 
to that of drug craving. 
From the green towers of the world’s 
largest casino rising up from the Con¬ 
necticut farmland to the smash-hit 
television program Who Wants to Be a 
Millionaire, a culture that promotes and 
glorifies gambling is all around us. 
But until recently, little has been done 
to investigate gambling addiction, a sig¬ 
nificant health problem that may be as 
prevalent as some other major psychi¬ 
atric illnesses such as schizophrenia, 
according to Marc N. Potenza, ph.d. ’93, 
m.d. ’94, an assistant professor of psychi¬ 
atry and director of the Problem Gam¬ 
bling Clinic at Yale. 
Research suggests a rise in the rate 
of pathological gambling during the explo¬ 
sive growth of legalized gambling in the 
United States, which began with state lot¬ 
tery systems in the 1960s, proliferated 
with riverboat gambling and casinos on 
Native American reservations two decades 
later, and now continues to expand with 
Internet gambling and video poker. 
While historically viewed simply as a 
sin or vice, pathological gambling has 
symptoms similar to those of drug addic¬ 
tion, said Potenza, who is using brain 
imaging and drug trials to better under¬ 
stand its causes and to develop more 
effective treatments. 
“The gambling industry is huge,” he 
said. The $51 billion generated from casi¬ 
nos, lotteries and horse race betting 
exceeds the revenues of the movie, theme 
park and music industries combined. 
One estimate pegs the societal cost of 
problem gambling — including legal fees 
for divorces and incarceration, as well as 
health bills — at $5 billion a year. Potenza 
believes the price could run far higher. 
While it is estimated that 86 percent 
of adults have gambled at some point in 
their lives, fewer than 10 percent develop 
a problem and fewer than 3 percent of 
those become pathological gamblers, he 
said. Still, many compulsive gamblers 
report devastating troubles—their lives 
torn apart by bankruptcy, divorce and 
criminal activity. About a fifth of patho¬ 
logical gamblers attempt suicide. 
Problem and pathological gamblers, 
though, have had few treatment options 
available. For example, about 85 percent 
of callers to the Connecticut Council on 
Problem Gambling’s hotline reported 
never having received any prior help for 
a gambling problem. Potenza is working 
to change that. 
The Problem Gambling Clinic, a col¬ 
laboration between Yale’s Department of 
Psychiatry and the Connecticut Mental 
Heath Center, is one of only four sites in 
the U.S. to participate in the first multi¬ 
center trial of a drug to treat compulsive 
gambling. Initial data from the trial eval¬ 
uating the effects of paroxetine (Paxil) 
are encouraging, said Potenza. He is 
also using functional magnetic reso¬ 
nance imaging to monitor the brain 
activity of both gamblers and healthy sub¬ 
jects who have viewed videotaped cues 
intended to spark the urge to gamble. 
Only in the pathological gamblers did 
viewing the cues lead to lower activity in 
the anterior cingulate cortex, a brain 
region which has been repeatedly impli¬ 
cated in previous studies of drug craving 
and mood states. While further study is 
needed, the neuroimaging study may help 
identify a possible intervention point for 
patients with the addiction. 
9 
MULTIPLE SCLEROSIS THE TARGET 
OF EXPERIMENTAL SCHWANN CELL 
TRANSPLANT 
Physicians and researchers are hoping 
that cells from a nerve in a patient’s ankle 
will stem the degeneration of the nervous 
system caused by multiple sclerosis. 
In July a Yale team transplanted 
Schwann cells from the sural nerve into 
a patient’s brain in an effort to reverse 
the stripping away of myelin, the protec¬ 
tive sheath that surrounds nerve fibers 
in the spinal cord and brain. It was the 
first central nervous system transplan¬ 
tation to repair the myelin-forming cells 
in a patient with multiple sclerosis. 
“The purpose of this experiment 
was to determine whether the procedure 
is safe and has enough promise to jus¬ 
tify future research,” said Timothy 
Vollmer, m.d., associate professor of 
neurology and principal investigator on 
the experiment. 
Animal studies have found that 
Schwann cells, which make myelin in 
peripheral nerves, can replace oligo¬ 
dendrocytes, which make myelin in the 
brain and spinal cord. Vollmer and 
his team wanted to determine whether 
Schwann cells can not only survive 
in the human brain, but also wrap 
myelin around nerve fibers and restore 
normal function. 
Over two days in July Vollmer’s team 
first isolated Schwann cells from the 
sural nerve in the patient’s ankle. Then, 
a neurosurgery team led by Dennis D. 
Spencer, m.d., hs ’76, used a magnetic 
resonance imaging machine to guide 
a needle through the patient’s frontal 
lobe and inject the cells into a previously 
identified multiple sclerosis lesion. 
For the next six months researchers will 
monitor the patient with both neuro¬ 
imaging and functional assessments. 
Then surgeons will perform a biopsy to 
see whether the cells survived and 
made myelin. 
The team included Jeffrey D. Kocsis, 
ph.d., Stephen G. Waxman, m.d., ph.d., 
and others. The research is funded by 
The Myelin Project in Washington, D.C. 
HOME MONITORS DEEMED 
INADEQUATE FOR SPOTTING SIDS 
Events that home monitors routinely 
detect as warning signs for sudden 
infant death syndrome (sids), such as a 
prolonged cessation of breathing or a 
slow heart rate, may be common even 
in healthy infants, according to Yale 
researchers. “This study calls into ques¬ 
tion the utility of home monitoring for 
sids,” said George Lister, m.d. ’73, hs 
’75, professor of pediatrics and anesthe¬ 
siology. The findings were published in 
March in jama: The Journal of the Ameri¬ 
can Medical Association. 
A study group made up of physicians 
at institutions around the country moni¬ 
tored 1,079 infants, some healthy and 
others considered at high risk for sids, 
for periods ranging from 16 to 66 weeks. 
Infants who were born prematurely, 
had a sibling who died of sids or had 
experienced a life-threatening event that 
required intervention were classified as 
high risk. “The threshold for an ‘event’ 
conventionally used for home monitoring 
picked up so many infants that it would 
be hard to separate those who are normal 
and not normal,” said Lister, who chaired 
the study group. Researchers then used 
special monitors to record breathing and 
heart rate patterns around the time of 
an “event.” 
The most extreme events, those that 
lasted a very long time by usual medical 
standards, were common only in infants 
born prematurely, but occurred before the 
age when sids was prevalent. The study 
group concluded, therefore, that extreme 
events are not immediate precursors to 
sids. “These early events might be mark¬ 
ers of vulnerability to sids,” said Lister, 
“but are unlikely to be events that 
directly evolve into sids.” 
Y
a
le
 
M
e
d
ic
in
e
 
a
u
tu
m
n
 
20
01
 
IO Rounds 
An algorithm developed by Ray Bahado-Singh 
and Joshua Copel uses data from ultrasounds 
and other measurements to gauge the risk of 
Down syndrome. 
INSTEAD OF A NEEDLE, 
SIMPLE MEASUREMENTS RULE 
OUT DOWN SYNDROME 
Yale researchers have developed an 
algorithm that allows physicians to gauge 
the risk of Down syndrome in fetuses 
without resorting to amniocentesis, an 
invasive procedure that could cause a 
miscarriage. Instead, physicians rely on 
what is called an ultrasonic biometry 
algorithm, which measures risk based 
on a number of factors, including infor¬ 
mation gathered by ultrasound— 
measurements of the fetus’s upper arm 
and skin at the back of the neck. 
In a study published in the May issue 
of the American Journal of Obstetrics and 
Gynecology, Ray O. Bahado-Singh, m.d., 
associate professor of obstetrics and 
gynecology, reported that the algorithm 
proved accurate in almost 80 percent of 
cases. Having this assessment allows 
parents to determine whether to proceed 
with amniocentesis. 
Down syndrome is a congenital dis¬ 
order caused by an extra chromosome 21. 
Children affected have mild to moderate 
mental retardation, shorter stature and 
flattened facial features. Women over 35 
have a higher risk of giving birth to a child 
with Down syndrome, but using age 
alone physicians detect only about one in 
five cases, said co-author Joshua A. Copel, 
m.d.. professor of obstetrics and gynecol¬ 
ogy and pediatrics. “Using blood tests 
and ultrasound we apply adjustments to 
the mother’s age-related risk,” Copel said. 
“This would mean fewer amniocenteses 
and a higher percentage of abnormal 
babies identified.” 
PATHOLOGISTS SET 
NEW CRITERIA 
FOR CANCER PRECURSOR 
Pathologists tracking the progression 
of disease from acid reflux to esophageal 
inflammation to Barrett’s esophagus, 
a precursor of cancer, can’t always agree 
on how to evaluate biopsies. Now, a 
national group of gastrointestinal pathol¬ 
ogists founded by a Yale professor has 
developed new criteria for grading pre- 
malignant changes in cells, also referred 
to as dysplasia. 
Criteria for grading dysplasia were 
established in 1988, but still led to 
inconsistent results among pathologists. 
“That grading decision,” said Marie E. 
Robert, m.d., associate professor of 
pathology, “is made by looking through 
a microscope at a slide of a biopsy. It 
is very subjective.” 
Using their new criteria, Robert 
and 11 other gastrointestinal pathologists 
found that they agreed more often on 
categorizing dysplasia. Among the revi¬ 
sions they suggested was more attention 
to the location of atypical cells. Atypical 
epithelial cells on the surface of the 
mucosa are more predictive of future 
cancer than cells in the deep mucosa. 
The new criteria also sought to clarify 
the difference between low-grade dyspla¬ 
sia, which requires routine follow-up, 
and high-grade dysplasia, which usually 
prompts surgical resection, Robert said. 
A follow-up study of patients found 
a correlation between diagnoses with the 
new criteria and cancer risk. “When we 
modified and discussed the criteria, the 
risk of developing cancer went up in a 
linear fashion, after earlier biopsy diag¬ 
noses of negative, low-grade and high- 
grade dsyplasia,” Robert said. “That would 
argue that our new criteria are valid and 
can guide clinicians and patients on how 
they ought to be followed once these 
diagnoses are made.” 
The Gastrointestinal Pathology Study 
Group, which included pathologists from 
Johns Hopkins University, the University 
of Michigan, Vanderbilt University and 
others, published their findings in April 
in Human Pathology. 
JOBS AND BRAIN CANCER MAY BE LINKED 
Farm workers, waitresses and people who work with rubber or 
cleaning chemicals are at a higher risk for brain cancer, according 
to a study by Yale scientists published this spring in the journal 
Occupational and Environmental Medicine. Tongzhang Zheng, sc.d., 
associate professor of epidemiology and environmental health, 
found that an increased risk of brain cancer was associated with 
a variety of jobs involving gasoline, solvents, agriculture, rubber 
and plastic production, textiles, electric services, electronic equip¬ 
ment, plumbing and sheet metal. The higher risk, Zheng said, 
could be due to exposure to pesticides, solvents, dyes, metal fumes 
and other carcinogens. “More studies are needed, however,” he 
said, “because it could also be due to chance.” 
et cetera. 
TARGETING MACULAR DEGENERATION 
Macular degeneration, caused by the deteri¬ 
oration of the central portion of the retina 
called the macula, affects an estimated one- 
third of the over-65 population. Now, with 
a $1 million gift from Foresight Inc. and $i 
million in matching funds raised by Yale, the 
Department of Ophthalmology and Visual 
Science is on its way to establishing a center 
to address problems in retinal functioning. 
The funding will be put toward the $5 million 
cost of establishing a center to study the 
cellular and molecular biology and physiol¬ 
ogy of the development of the retina. 
Foresight Inc. is a Connecticut-based char¬ 
itable foundation. It was founded in 1968 
by patients treated by Yale ophthalmologists. 
SLEEP APNEA AND STROKE 
People who snore, sleep restlessly and feel 
tired during the day are at higher risk of suf¬ 
fering a stroke, according to a study by a 
Yale researcher published in the June issue of 
the journal Stroke. “Sleep-related breathing 
disorders are strongly associated with in¬ 
creased risk of stroke independent of known 
risk factors,” said Vahid Mohsenin, m.d., 
director of the Yale Center for Sleep Disorders 
and principal investigator of the study. "Since 
sleep-related breathing disorders are treat¬ 
able, patients with stroke and transient 
ischemic attacks should be investigated for 
these conditions.” 
LESSONS IN GERIATRIC MEDICINE 
The care of elderly patients is far more 
complex than treatment of younger people, 
yet clinicians too often ignore this differ¬ 
ence. The medical school has received a 
$2 million grant from the Donald W. Reynolds 
Foundation to teach medical students how 
to care for the aging population. “With the 
elderly, any problem has many causes and 
consequences that need to be understood,” 
said Margaret A. Drickamer, m.d., associate 
professor of internal medicine and geri¬ 
atrics at Yale, and lead investigator on the 
project.“It means asking more questions 
and asking different questions.” Drickamer 
hopes to integrate geriatric medicine into 
existing curricula. “We don’t want to take 
away from existing programs,” she said. 
“We just want to make sure the concepts 
are taught.” 
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Findings from the bench 
In their first collaboration, Nina and John Rose 
mixed a common livestock virus with hiv 
proteins to produce a vaccine that has kept 
infected monkeys aids free. 
AIDS VACCINE 
CLEARS FIRST HURDLE 
Livestock virus is the vector 
for agent that works in monkeys; 
nasal administration seen as plus. 
A vaccine that uses an attenuated live¬ 
stock virus as a vector for two hiv pro¬ 
teins has kept infected monkeys free of 
aids for more than a year, according 
to a team led by Yale scientists. The vac¬ 
cinated monkeys, some infected with 
a highly pathogenic simian aids virus 
for as long as 14 months, have not 
developed full-blown aids and their viral 
loads have remained low. The vaccine 
shows promise in another area; it can be 
administered through nasal drops 
rather than by injection, making it more 
affordable and practical for use in 
developing countries, where aids is 
taking its heaviest toll. 
“Based on our results we think it is 
likely that this vaccine could be an effec¬ 
tive aids vaccine in humans,” said John 
K. Rose, ph.d., professor of pathology 
and of cell biology. Rose and his wife, 
Nina F. Rose, ph.d., an associate research 
scientist, led a team that included 
scientists at Yale, the Aaron Diamond 
aids Research Center, Tulane Univer¬ 
sity, Duke University and the Gladstone 
Institute of Virology and Immunology. 
Their results were published in the Sep¬ 
tember 7 issue of Cell and presented at 
the aids Vaccine 2001 Conference in 
Philadelphia in September. 
The virus, vesicular stomatitis virus 
(vsv), is a preferred vector for vaccines 
because it provokes a strong immune 
response. Although never tested in 
humans, vsv has proved effective in ani¬ 
mal models as a vector for influenza 
and measles vaccines. The combination 
of the virus and two hiv proteins called 
Env and Gag put the monkeys’ immune 
systems on high alert, making them more 
effective against hiv, John Rose said. 
“It is a very strong stimulator in both 
arms of the immune system—the 
antibodies and the cellular immune sys¬ 
tem,” he said. “This holds down the 
spread of the infection in the animals. 
There are fewer infected cells. It is less 
of a task for the immune system to hold 
the virus in check and the viral loads 
go down to very low or below detection.” 
The ability to deliver the vaccine in 
drops rather than through needles, said 
Rose, is crucial in developing countries. 
“It would be impractical and very expen¬ 
sive to inject millions of people with 
dna vaccines,” he said. “The vsv-based 
vaccine would be a cost-effective and 
equally successful alternative to other 
vaccines that have been tested.” In addi¬ 
tion, the vaccine proved far more effec¬ 
tive when administered nasally than 
when injected intramuscularly. 
In two studies carried out over the 
past four years, the team vaccinated 
seven monkeys and left eight monkeys 
in a control group with no vaccination. 
All 15 monkeys were then infected with 
a hybrid of human and simian aids 
viruses. “We found that seven out of the 
eight unvaccinated monkeys developed 
aids in an average of five months, while 
vaccinated monkeys have been aids free 
for up to 14 months,” Rose said. 
Wyeth Lederle Products Corp. has 
licensed rights to the vector and is 
conducting further animal tests in col¬ 
laboration with Yale scientists before 
proceeding to clinical trials. 
IN A STUDY IN MICE, ADULT STEM 
CELLS REVEAL THEIR VERSATILITY 
Stem cells derived from the bone mar¬ 
row of adult mice, a Yale researcher 
and her colleagues have found, can cre¬ 
ate not only new bone marrow cells, 
but liver, lung, gastrointestinal and skin 
cells. “Thus far, this is the closest adult- 
derived stem cell to the embryonic stem 
cell, which can transform into any 
cell type in the body,” said Diane Krause, 
m.d., ph.d., associate professor of labo¬ 
ratory medicine and pathology. Krause 
was lead author of the study, which was 
carried out by scientists from three insti¬ 
tutions. Their study was published in 
the journal Cell in May. 
The research built on the same 
group’s earlier experiments in mouse 
models that showed that bone marrow 
cells could generate new liver cells, 
including hepatocytes and cholangio- 
cytes (Findings, Fall 2000 | Winter 
2001). Krause and her colleagues then 
showed that this regeneration also 
occurs in humans. "However, we didn’t 
know if the bone marrow cell that 
could make liver was the same cell that 
could make blood,” Krause said. 
“We wanted to know what cell it was.” 
et cetera. 
NEW GENES FOR HYPERTENSION 
A team of Yale scientists has identified muta¬ 
tions in two genes that cause a rare form of 
hypertension. The finding has also uncovered 
a previously unknown metabolic pathway 
governing blood pressure that could offer 
new targets for medications. 
The finding, reported in the August 10 
issue of Science, identifies genes on chromo¬ 
somes 12 and 17. In their mutated form they 
can cause increased reabsorption of salt by 
the kidneys and impaired secretion of potas¬ 
sium and hydrogen ions. This leads to a rare 
form of hypertension called pseudohypoal- 
dosteronism type II. 
The principal investigator on the study 
was Richard P. Lifton, m.d., ph.d., professor of 
genetics, medicine, and molecular biophysics 
and biochemistry and an investigator for the 
Howard Hughes Medical Institute. 
In their most recent experiment, 
Krause and her collaborators irradiated 
female mice, then transplanted a single 
male-derived cell. Using the Y chromo¬ 
some as a marker, they identified the 
progeny of that cell. To their surprise, 
they found the male chromosome not 
only in the blood and bone marrow, as 
expected, but also in 15 different cell 
types. “The adult bone marrow cell, we 
have found,” said Krause, “has remark¬ 
able plasticity. ” 
The other principal investigator on 
the project was Neil Theise, m.d., associ¬ 
ate professor at New York University 
School of Medicine. Saul Sharkis, ph.d., 
of the Oncology Center at Johns Hop¬ 
kins School of Medicine, was the senior 
author. Other collaborators were from 
the Department of Genetics at Yale and 
the Department of Pathology at the nyu 
School of Medicine. 
AN HERBAL CLUE TO INFLAMMATION 
An herb commonly used to treat migraines 
inhibits a protein that causes inflammation, 
Yale pharmacologists have found. In an arti¬ 
cle published in the August issue of Chem¬ 
istry & Biology, a team led by Craig Crews, 
ph.d., associate professor of chemistry, phar¬ 
macology, and molecular, cellular and devel¬ 
opmental biology, showed that a component 
of the herb feverfew targets a protein called 
IkappaB Kinase, which is responsible for 
inflammation. “Now that we have identified 
an inhibitor of this protein,” said Crews, 
“that information can be used to develop 
additional inhibitors.” 
After a female mouse received bone marrow 
from a male mouse, the transplanted stem cells 
generated up to 15 different tissue types, includ¬ 
ing lung tissue (above). A team led by Diane 
Krause used the male’s Y chromosomes, shown 
in pink, as markers. 
CASE OF HIDE AND SEEK? 
Treated early, Lyme disease is usually cured 
with antibiotics, but the prolonged form of 
the disease can be more troublesome. Yale sci¬ 
entists have observed that while the Lyme 
spirochete is easily digested by immune cells 
in vitro, rare bacteria within the body can 
withstand the onslaught of the immune sys¬ 
tem, perhaps explaining the spirochete’s 
ability to survive long-term. Ruth R. Mont¬ 
gomery, ph.d., set out with colleague Stephen 
Malawista, m.d., to determine whether the 
spirochete somehow weakened the immune 
system. Results of a study of mice published 
last June in the Journal of Infectious Diseases 
strongly suggested that this was not the case. 
With defects in leukocyte function all but 
ruled out, the team will look next at the other 
side of the equation: how the spirochete may 
be masking itself from immune surveillance. 
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'4 BOOKS 
Health Networks 
Con They Be the Solution? 
Health Networks: 
Can They Be the Solution? 
by Thomas P. Weil, ph.d., 
m.p.h. ’58 
The University of Michigan Press 
(Ann Arbor, Mich.), 2001 
This book evaluates whether re¬ 
cently formed health networks can 
generate enough fiscal savings to 
provide greater access to and qual¬ 
ity of health care despite the current 
trend of cutbacks in reimbursement 
from Medicare and managed-care 
plans. It concludes with a very 
timely and much needed discussion 
of how U.S. health networks might 
divest certain programs, services and 
facilities in the case of an almost 
inevitable economic turndown. 
Quantitative Evaluation 
of HIV Prevention Programs 
edited by Edward H. Kaplan, ph.d.. 
the William N. and Marie A. Beach 
Professor of Management Sciences 
and professor of public health, and 
Ron Brookmeyer 
Yale University Press 
(New Haven), 2002 
How successful are hiv prevention 
programs? Which hiv prevention 
programs are most cost effective? 
Which programs are worth expand¬ 
ing and which should be abandoned 
altogether? This book addresses the 
quantitative evaluation of hiv pre¬ 
vention programs, assessing for the 
first time several different quanti¬ 
tative methods of evaluation. 
How to Have Magnificent 
Sex:The 7 Dimensions of a 
Vital Sexual Connection 
by Lana L. Holstein, m.d. '75 
Crown Publishers (New York), 2001 
Holstein has been helping men and 
women find their vital sexual con¬ 
nection for 25 years. By experiment¬ 
ing with all dimensions—under¬ 
standing the body, exploring the 
senses, recharging desire, opening 
the heart, boosting intimacy, bar¬ 
ing the soul and embracing the 
spirit—Holstein says couples can 
achieve a more perfect union. 
Adolescent Medicine: 
Adolescent Cardiology 
edited by Christine A. Walsh, m.d. 
'73, and Robin W. Doroshow, m.d. 
Hanley el Belfus, Inc. 
(Philadelphia), 2001 
The purpose of this volume from 
the Adolescent Medicine: State of 
the Art Reviews series is to discuss 
practical and important topics 
concerning heart disease — both 
suspected and confirmed—in the 
adolescent. 
Skeletal Injury in the Child, 
3rd Edition 
by John A. Ogden, m.d. ’68 
Springer-Verlag (New York), 2000 
For clinicians and residents, this 
comprehensive text includes new 
chapters covering the subjects of 
polytrauma, growth plate disorders 
and their treatment, the pediatric 
athlete and an overview of non¬ 
operative and operative approaches 
to children’s fracture care. 
The Stranger in the Mirror: 
Dissociation— 
The Hidden Epidemic 
by Marlene Steinberg, M.D., for¬ 
mer research affiliate in psychiatry, 
and Maxine Schnall 
Cliff Street Books (New York), 2000 
Based on Steinberg’s 18 years of 
research, this book debunks the 
myths associated with dissociative 
disorder, presents her own revolu¬ 
tionary test which allows readers 
to assess the severity of their own 
problems and introduces the inno¬ 
vative therapy known as the "Four 
C’s”to cure dissociation. 
The Yale Management Guide 
for Physicians 
by Stephen Rimar, m.d., 
hs ’87, M.B.A. 
John Wiley e[ Sons 
(New York), 2001 
From health care policy and health 
economics to health care market¬ 
ing and negotiating, this compre¬ 
hensive guide addresses all of the 
major issues affecting the delivery 
of health care services in the 21st 
century. This manual helps doctors 
acquire skills they need to expand 
their practices; to develop, articu¬ 
late, and advocate ideas; discuss 
and manage the decision-making 
process and assume a leadership 
role in the health care industry. 
Alternative Medicine and 
Multiple Sclerosis 
by Allen C. Bowling, m.d. 
'88, PH.D. 
Demos Medical Publishing 
(New York), 2001 
In a handy, practical format, this 
book offers reliable information on 
the relevance, safety and effective¬ 
ness of various complementary 
and alternative therapies that are 
not typically considered in discus¬ 
sions of ms management but are 
in widespread use. 
Parenthood Lost: Healing 
the Pain after Miscarriage, 
Stillbirth, and Infant Death 
written and edited by Michael R. 
Berman, m.d., hs ’76, clinical pro¬ 
fessor of obstetrics and gynecology 
Bergin el Garvey 
(Westport, Conn.), 2001 
Berman is the creator of Hygeia 
(www.hygeia.org), an online com¬ 
munity for bereaved parents who 
have lost a pregnancy or newborn 
child. Here he shares insights from 
his experiences helping parents 
deal with their grief and unravels 
the confusing genetic and medical 
causes of miscarriage, stillbirth and 
infant death.Through original 
poetry, firsthand stories told by par¬ 
ents and articles describing genetic 
and medical disorders, this book 
offers clarification and hope for par¬ 
ents who have suffered this tragedy. 
The descriptions above are taken 
from the book jackets. 
send notices of new books to 
Cheryl Violante, Yale Medicine, 
P.O. Box 7612, New Haven, CT 
06519-0612, or via e-mail 
to cheryl.violante@yale.edu. 
on campus 
A hub for health care 
Schools can provide access to health 
care for children who might not 
otherwise see a doctor, former U.S. 
Surgeon General Joycelyn Elders, 
m.d., said during a visit to New 
Haven in early July. Speaking to 
teachers, principals, program 
directors and policymakers at the 
12th annual conference of the 
School of the 21st Century (21C) 
initiative, Elders urged schools to 
establish clinics focusing on pre¬ 
vention. “You can’t educate people 
who are not healthy, and you cer¬ 
tainly can’t keep people healthy if 
they’re not educated,” said Elders. 
Established in 1988, the 21C initia¬ 
tive was founded by Edward F. 
Zigler, ph.d., one of the principal 
architects of the federal Head Start 
Program, Sterling Professor of 
Psychology and a faculty member 
in the Child Study Center. More 
than 1,300 schools in 20 states have 
adopted the program, which 
transforms schools into multiser¬ 
vice centers providing a variety of 
resources for children, parents, 
teachers and child-care providers. 
Guarding against 
germ warfare 
When federal officials simulated a 
bioterrorist attack on Denver, Colo., 
last year,“the city was lost,” said 
Alan S. Rudolph, ph.d., m.b.a., a 
program manager at the Defense 
Advanced Research Projects Agency. 
“They had to close the borders of 
the state of Colorado and they still 
couldn’t contain the pathogen they 
were modeling, a strain of plague.” 
In remarks that seem prescient 
today after the terror attacks on the 
East Coast, Rudolph discussed the 
Colorado simulation exercise dur¬ 
ing a talk at surgical grand rounds 
in May. His topic? “Technological 
Challenges in Defending the U.S. 
against Biological and Chemical 
Warfare.”The simulation, Rudolph 
said,“taught us that we are ill- 
prepared to deal with this prob- 
lem.”The military, he continued, 
must rethink its traditional 
mission of defending against a 
nuclear threat from a large adver¬ 
sary. “It is clear that a small num¬ 
ber of people can perpetrate a 
fairly large effect,” he said. Protec¬ 
tion efforts require the coordina¬ 
tion of different agencies, he said. 
On September 20, President Bush 
announced a new cabinet position 
for homeland security to unify the 
government’s anti-terror efforts. 
Racial disparities and 
community health 
“The driving force behind racial 
inequality in health,” said David 
R. Williams, ph.d.,"is the economic 
circumstances of social groups.” 
Williams, a sociology professor at 
the University of Michigan and 
former Yale faculty member, was 
a keynote speaker in May at a con¬ 
ference titled “The Impact of 
Poverty on Individual and Com¬ 
munity Health,” sponsored by the 
Department of Psychiatry’s Divi¬ 
sion for Prevention and Commu¬ 
nity Research. “Economic status is 
accounting for most of the racial 
difference in health, but not all of 
it,” Williams said.“Poor white men 
still live longer than poor black 
men. The racial differences in eco¬ 
nomic status are not an act of 
God, but reflect the implementa¬ 
tion of racial policies in society 
that have predictable outcomes.” 
Healing outside the box 
When Rachel Naomi Remen, m.d., 
spoke about the will to live at 
the Yale Cancer Center in May, she 
touched more than once on medi¬ 
cine’s preoccupation with control. 
“We may be so deeply into the 
pursuit of mastery,” said the author 
of the national bestseller Kitchen 
Table Wisdom, “that we may 
not see mystery when it happens 
directly in front of us.” Remen 
told of a patient she treated as 
an intern at Memorial Sloan- 
Kettering whose bones and lungs 
were riddled with cancer. During 
a two-week hospitalization, his 
lesions disappeared for no appar¬ 
ent reason. “Were we in awe?” said 
Remen.“Certainly not. We were 
frustrated. It was obvious we had 
misdiagnosed this man.” Patholo¬ 
gists consulted for a second opin¬ 
ion concurred with the original 
diagnosis of osteogenic sarcoma. 
When the patient was presented 
at grand rounds, the 250 physicians 
there concluded that the chemo¬ 
therapy that had been stopped 
11 months before had suddenly 
worked. “I sometimes wonder if 
too great a scientific objectivity 
can actually make you blind,” said 
Remen.“It was 15 years before 
I began to question this conclu¬ 
sion. When everyone is thinking 
inside of the box.it is hard to 
think anything new, but outside 
the box is often where life is.” 
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Flexner, a new start 
In 1910, the medical school’s fate 
hung by a thread. The deep 
criticisms it weathered in a land- 
mark report ultimately made 
it a much stronger institution. 
by Pem McNerney 
The Flexner Report of 1910 prompted Yale and 
many other medical schools in the United 
States to make fundamental changes. Author 
Abraham Flexner, above, recommended that 
Yale School of Medicine remain open but that 
it bolster its fund-raising and hire full-time 
faculty, among other improvements. 
The release of the Flexner Report in 1910 
was bad news for most of the nation’s 
medical schools. Commissioned by the 
Carnegie Foundation for the Advance¬ 
ment of Teaching to evaluate the ability 
of U.S. medical schools to train new doc¬ 
tors, consultant Abraham Flexner’s ver¬ 
dict was that most weren’t up to the task. 
He recommended that the vast majority 
of schools be shut down; in New England, 
he said, the only two worth saving were 
Yale and Harvard. And despite the tacit 
endorsement, the report singled out Yale’s 
thinly stretched faculty as a weak point. 
“The instructors ... are overworked, being 
called on to carry the routine work of 
extensive subjects in all their parts with¬ 
out adequate assistance. Under such cir¬ 
cumstances, the work, however conscien¬ 
tious, is bound to be limited.” The report 
also recommended that the school obtain 
a larger permanent endowment. 
The School of Medicine’s bleak con¬ 
dition at the turn of the century and its 
successful efforts to rehabilitate itself are 
the subject of Medicine at Yale, 1901-1951, 
the second in a series of exhibits at the 
Cushing/Whitney Medical Library mark¬ 
ing the University’s Tercentennial this 
year. The exhibit, which has been adapted 
for the Web, shows how, in the 1920s, 
the school transformed itself from a 
mediocre institution with part-time fac¬ 
ulty and limited resources into one of the 
nation’s top medical schools. With a full¬ 
time staff, new facilities and many new 
departments, including the innovative 
and controversial Institute of Human 
Relations, the school generated enough 
momentum in the ’20s to survive both the 
Depression and World War II intact. 
The Flexner Report’s grim assessment 
of Yale’s resources and facilities came as 
no great surprise to the school, which had 
been struggling for its survival since the 
1880s. Herbert E. Smith, dean from 1885 
to 1910, had made some improvements. 
He tightened entrance requirements, ex¬ 
panded the curriculum and made efforts 
to establish closer ties with New Haven 
Hospital. His successor, George Blumer, 
dean from 1910 to 1920, was able to estab¬ 
lish a sorely needed, more functional sys¬ 
tem for key faculty, providing them with 
a full-time salary for teaching and research. 
He also oversaw the growth of the endow¬ 
ment fund and forged an agreement 
with New Haven Hospital that allowed 
the school to take charge of the wards and 
use them for medical education. One of 
Blumer’s proudest achievements was the 
establishment of the Department of Pub¬ 
lic Health in 1915, with Charles-Edward 
Amory Winslow as its founding chair. 
In 1920, Milton C. Wintemitz became 
dean. He oversaw the construction of 
the Sterling Hall of Medicine, the expan¬ 
sion of clinical facilities and the estab¬ 
lishment of several departments, includ¬ 
ing the Department of Pediatrics (1921), 
the Department of Obstetrics and Gyne¬ 
cology (1921) and the Psychiatry Group 
(1935). During his tenure, the Department 
of Surgery was moved to a full-time basis 
and the Yale System of Medical Educa¬ 
tion was established. Under the Yale Sys¬ 
tem, medical students were treated like 
graduate students, required course exams 
were eliminated and electives were en¬ 
couraged. The Institute of Human Rela¬ 
tions, specializing in interdisciplinary 
research in medicine, law and the social 
sciences, was created in 1931. According 
to the exhibit text, “Winternitz evoked 
strong emotions in his colleagues. To 
some he was brilliant, bold, and a ‘steam 
engine in pants,’ and to others he was an 
insufferable ‘martinet,’ a Napoleon, and 
an anti-Semite” though he was Jewish 
himself. In 1935 he was forced to step 
down from his post as dean, continuing 
on as chair of pathology until his retire¬ 
ment in 1950. 
Yale had three more deans during the T 
first half of the century: Stanhope Bayne- “ 
Jones (1935-1940), Francis Gilman Blake ; 
(1941-1947) and Cyril Norman Hugh g 
Long (1947-1952). Among other notable > 
accomplishments, they succeeded in get- \ 
ting the medical school on solid finan¬ 
cial ground so that it could continue to \ 
grow following World War II. 
More on the Web 
info.med.yale.edu/ymm 
To view the online exhibit 
Medicine at Yale, 1901-1951, 
please visit our website and 
select EXTRAS. 
FROM TOP 
George Blumer, dean of the medical school 
from 1910 to 1920, started making many of 
the reforms that were needed to improve the 
school’s operations. When Blumer stepped 
down as dean in 1920, he became the David 
Paige Smith Clinical Professor of Medicine until 
he retired in 1940. 
Harvey Cushing was enormously fond of Yale 
College, his alma mater. But when the Univer¬ 
sity invited him to become a professor of surgery 
in 1907, he declined the offer because he felt 
Yale did not have adequate control of clinical 
facilities at New Haven Hospital. He went on to 
have a distinguished career as a neurosurgeon 
at Johns Hopkins and Harvard, Then, upon his 
retirement from Harvard, he came to Yale as 
a professor of neurology in 1932. His rare book 
collection was bequeathed to Yale in 1939. 
Milton Winternitz, dean from 1920 to 1935, 
presided over the boom years of the medical 
school following World War I, when it emerged 
as one of the top medical schools in the coun¬ 
try. Winternitz embarked on a campaign of 
building buildings, hiring faculty, organizing 
departments and raising money to finance it 
all. The son of an immigrant doctor, Winternitz 
was controversial and evoked strong feelings 
among his colleagues. He was forced to step 
down as dean in 1935, but continued on as chair 
of pathology until his retirement in 1950. 
In 1916, the Yale School of Medicine admitted 
women students for the first time. Louise Farnam 
was one of two women to graduate in 1920. 
She won the Campbell Gold Medal for scholastic 
achievement. Her classmate, Helen May Scoville, 
was later hired by Yale as an instructor. 
background During World War I,the medical 
school organized a mobile hospital unit. It 
arrived in France in early 1918, Spent the winter 
in Limoges and moved to the front during a 
major German offensive. The group improved 
its efficiency to the point where it could 
operate on one badly wounded patient every 
45 minutes. 
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18 
(and a taste of lobster) 
An intensive week at the bench in Maine 
introduces students to modern lab strategies and techniques, 
ancient DNA and a clambake to write home about. 
A slice of a shark’s rectal gland 
captures the attention of Jenny 
Blair, Vicash Dindwall and Dena 
Springer as Ignacio Gimenez, a 
postdoctoral fellow in physiology, 
guides them through an experi¬ 
ment at the Mt, Desert Island 
Biological Laboratory in June. The 
Yale students isolated a protein 
in the gland, then measured its 
response to phosphorylation. 
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20 Sharks, salt (and a taste of lobster) 
Few medical students can say that, as part of their education, they 
plucked a writhing dogfish shark from a pool of water. Or that 
they ended their first year by seeking clues to human disease in 
the organs of a fish that reached its evolutionary peak more 
than 300 million years ago. 
This past June that pool of sharks lured about two dozen 
Yale students to Salisbury Cove, Maine, just a few miles from Bar 
Harbor. For more than a century, scientists at the Mt. Desert 
Island Biological Laboratory here have explored the genes shared 
by fish and humans. For about half its lifetime, the labora¬ 
tory has had strong ties to the School of Medicine, a relation¬ 
ship that began in the 1950s, when Franklin Epstein, m.d. 
’47, hs ’49, professor of medicine, began bringing residents 
and fellows to Maine. In June 2000, for the first time, med¬ 
ical students arrived for a week’s training in bench research. 
This year another group of students repeated the Intensive 
Pedagogical Experience, a program designed to introduce them 
to the strategies and techniques of laboratory science and to 
encourage them in careers as physician-scientists. Most of the 
students arriving in June had just completed their first year 
of medical school; the group also included a student who began 
med school this fall. 
In the course of their week on Mt. Desert Island, the 
students cloned genes, learned to synthesize dna by means 
of polymerase chain reaction and generated copies of pro¬ 
teins by inserting rna into frog eggs. They also learned the 
difference between Western blots, used to find specific 
proteins, and Southern and Northern blots, used to find the 
rna and dna for specific genes. 
Rupali Gandhi, who is beginning her second year at Yale 
this fall, majored in biology as an undergraduate, then 
went on to get a law degree at Yale before taking up medicine. 
“I hope to come away from this course with a better under¬ 
standing of a lot of research methods so that the next time 
I read a journal article my eyes won’t glaze over the methods 
section,” she said, sitting on a porch outside one of the many 
laboratory buildings scattered throughout the forest. Under¬ 
standing research strategies and gaining familiarity with the 
scientific method are among the goals of the course, accord¬ 
ing to its director. 
“The idea of rigorous pursuit of a question and a clear 
hypothesis is applicable to all that students do in research at 
Yale,” said John N. Forrest, m.d., hs ’67, who heads the 
Office of Student Research at the medical school and is director 
of the Mt. Desert Island Biological Laboratory, where he has 
spent the last 32 summers. 
Long before the first group of Yale students traveled to Maine, 
the notion of an intensive laboratory experience was brewing 
in the mind of Dean David A. Kessler, m.d. As an undergradu¬ 
ate at Amherst College, he spent four weeks one summer at the 
Woods Hole Marine Biological Laboratory. The time he spent 
studying macrophage inhibition factors in sea urchins served as 
a model for the program in Maine. Kessler wanted to provide 
students with both hands-on laboratory experience and a chance 
to interact closely with faculty. “You get to see things you just 
don’t see sitting in a lecture hall,” he said. “This is what educa¬ 
tion should be.” And holding the course on Mt. Desert Island 
freed students and faculty from the day-to-day distractions of 
being on campus. 
21 
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Nestled amidst hundreds of 
acres of woodlands, the buildings 
at the Mt. Desert Island Biological 
Laboratory belie their true pur¬ 
pose. Although it resembles a rus¬ 
tic fishing camp, the laboratory 
is the summer home to scientists 
from around the world. 
The view from the laboratory’s 
dock on Mt. Desert Island’s north¬ 
ern shore takes in evergreen 
forests and rocky shores typical 
of the Maine coast. 
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22 Sharks, salt (and a taste of lobster) 
Lab assistant Sarah Decker 
extracts the rectal gland from a 
spiny dogfish shark just plucked 
from the laboratory’s pool. 
Local fishermen provide a steady 
supply of the spiny dogfish, 
the only shark species found in 
these waters. 
Forrest scheduled the course for early )une, after students have 
completed their medical school course work and before the lab’s 
high season in July and August, when its year-round population 
of 17 staff members swells to more than 200 principal investiga¬ 
tors, postdocs, graduate students and laboratory technicians. 
Amidst the laboratory’s 350 acres of poplar, pine, spruce and 
cedar forest, the hierarchy that typically rules academia takes a 
sabbatical. First of all, the laboratory, with its shingled and weath¬ 
ered buildings in the woods, looks more like a fishing camp than 
a research center for top scientists from more than 50 institu¬ 
tions. But enter those buildings and you’ll see they’re filled not 
with lobster pots and fishnets, but with beakers, pipettes, com¬ 
puters, centrifuges and a gene sequencer. Dress is informal. As 
often as not, students and faculty wear T-shirts, shorts and san¬ 
dals. They spend most of their waking hours together. And, most 
troubling for some students, only first names are used. "We all 
know him as Dr. Forrest because he’s the head of research,” 
said student Dena Springer. “We come here and he’s John.” 
At the heart of the students’ experiments is the rectal gland, 
an organ unique to sharks and other fish. Local fishermen pro¬ 
vide a regular supply of spiny dogfish sharks, also known as 
Squalus acanthias, a relatively benign member of the shark order. 
Between 16 and 20 inches long, they are decidedly passive com¬ 
pared to their great-white cousins. Students say these fish will 
bite, but only if you stick a finger in their mouths. Their rectal 
gland is a highly specialized organ whose only function is to 
pump salt. Among the gland’s virtues is its relatively large size, 
about an inch long, making it easier to manipulate for neo¬ 
phyte researchers than cells or molecules. 
Examining a fish’s ability to control its salt may seem a highly 
esoteric field of study. Yet the rectal gland offers clues to under¬ 
standing cystic fibrosis, the most common fatal childhood dis¬ 
ease and one that is also concerned with salt imbalance. It is 
caused by a genetic disorder, the malfunction of a protein called 
the cftr chloride channel, which renders the body unable to 
regulate chloride transport. Without the proper functioning of 
this protein, a sticky mucous secretion develops, clogging 
lungs, sinuses and the digestive system. 
Working in four groups of six, the students approach the 
gland from various perspectives. Over the course of a week 
they try to answer these and other questions: What is the func¬ 
tion of the rectal gland in the shark? How is secretion by 
the gland regulated by known agents and second messengers? 
What is the function of cftr? Can we determine Na-K-Cl 
cotransporter activation in an isolated cell preparation? What is 
23 
the importance of single nucleotide polymorphisms in the 
post-genome era? 
Students may look at the entire organ, measuring its func¬ 
tion with agents such as barium, forskolin or ibmx, which 
inhibit or stimulate chloride transport. For another experiment, 
working with tissue from the gland, they isolate a protein and 
try to turn on and off its capacity to transport sodium, potas¬ 
sium and chloride. They may phosphorylate the protein and 
look for signs of activity. When they look through a confocal 
microscope, the students expect to see a lot of green, a sign that 
phosphorylation has activated the cotransporter protein. They 
also take the cftr chloride channels they’ve generated in frog 
eggs and measure their electrical activity. Continuing that exper¬ 
iment, they add hormones to open and close tire channels. 
The science behind the experiments was complex, and at 
times the mechanics could be demanding and repetitive. 
One rainy afternoon medical student Jenny Blair watched as a 
shark’s salt gland excreted liquid into a narrow-bore pipette 
several inches long. When the pipette filled, every few minutes 
or every few seconds, depending on whether chemical agents 
were involved, she inserted a new pipette into tubing coming 
from the gland, while others on her team measured the 
amount of liquid, then determined how much chloride it con¬ 
tained. Upon completing the experiment, they calculated the 
gland’s ability to excrete chloride under the conditions studied. 
Part of the students’ fascination comes from knowing that 
another team in another lab or rotation will pick up on their 
experiments. “We took the body parts of a shark and extracted 
rna from them,” said student Benjamin Negin, describing a 
typical research sequence. “Then we passed the baton on to 
the next group. They’re turning the rna into dna. The final 
group is using polymerase chain reaction of the dna to identify 
what it is.” 
Niya Jones and Bao Duong were part of the second team in 
the sequence Negin described. They learned how to manipulate 
a pipette to insert shark dna into an agarose gel. They were 
filtering the dna by size, looking for the genes related to a family 
of proteins that regulate chloride transport. Steve After, a doctoral 
candidate at Yale, guided them through the process, teaching 
them how to hold the pipette so the dna slips into a well in the 
gel without smearing. 
When, at the end of their experiment, they found a set of small 
genes they could not identify, Jones and Duong passed them off 
for further research to the next team in the rotation. “If it’s a sub¬ 
unit of the cftr channel or an unrelated protein, it would be 
top At the bench in his lab, John 
Forrest instructs a group of 
students in the experiment they 
will undertake, which involves 
manipulations of the rectal gland’s 
ability to excrete salt. 
bottom Steve Aller, a doctoral 
candidate at Yale, instructs 
medical student Niya Jones in the 
use of a pipette for an experi¬ 
ment with shark dna. 
v
a
le
 
M
ed
ic
in
e 
a
u
tu
m
n
 
20
01
 
24 Sharks, salt (and a taste of lobster) 
The week in Maine ends with 
a clambake, campfire and 
sing-along at a park on the 
island’s “quiet side." 
interesting to see,” said Spencer Epps, who planned to compare 
the genes to those in an online database at the National Insti¬ 
tutes of Health. 
Not all the experiments yield clear results. In presenting 
their findings students were refreshingly honest about the suc¬ 
cesses and failures of their experiments, as well as the unan¬ 
swered questions. “We don’t have wild-type data,” said one stu¬ 
dent whose team explored mutations in ion channels, “because 
it got messed up.” “The sequencing did not work,” said a mem¬ 
ber of Epps's group, which had hoped to identify unknown 
genes, “and we’re not sure why.” Most experiments proved suc¬ 
cessful, insofar as the students noted patterns of behavior in 
the way cells responded to stimulants and inhibitors. For exam¬ 
ple, John Koethe explained the slopes and valleys on a graph 
that tracked the rectal gland's response to different agents. 
“They show barium inhibition, recovery, then inhibition,” he 
said. Another group working with rectal gland slices and 
tubules found that forskolin and ibmx activated the chloride 
channel, leading to chloride excretion. Working with the whole 
gland, one team reported inconclusive results of their experi¬ 
ment; a high dose of potassium inhibited chloride secretion but 
a low dose yielded mixed results that offered no firm conclu¬ 
sions as to its effect. 
The experiments conducted here are a natural outgrowth of 
the laboratory’s focus on the physiology of marine and human 
organisms. Sharks, for example, reached evolutionary perfec¬ 
tion between 300 million and 400 million years ago and have 
changed little since. Their genome is about 70 percent iden¬ 
tical to that of humans. “Humans adopted many of the success¬ 
ful systems they evolved,” said James L. Boyer, m.d., hs ’67, 
Ensign Professor of Medicine and director of the Yale Liver 
Center, who lieads tJie Mt. Desert Island Biological Laboratory’s 
board. “That is why we are able to use those marine creatures 
for relevant research on human systems. The differences are 
far fewer than the similarities.” 
Since its founding as a summer school for Tufts University 
students in 1898 in South Harpswell, Maine, the biological 
laboratory's focus has shifted between education and research. 
It first taught marine biology to undergraduates, but quickly 
became a center for marine research as well. In 1921 a land-hold¬ 
ing organization, Wild Gardens of Acadia, offered the lab 100 
acres on Mt. Desert Island. George B. Dorr, one of Wild Gar¬ 
den's leaders, was instrumental in founding Acadia National 
Park and had a vision for Mt. Desert Island. “He believed this 
pristine setting would be an ideal circumstance for the study 
More on the Web 
info.med.yale.edu/ymm 
To explore the Mt. Desert 
Island Marine Biological 
Laboratory online, please 
visit our website and 
select EXTRAS. 
of nature,” said Jerilyn Bowers, director of development and 
public affairs at Mt. Desert Island Biological Laboratory. “He 
wanted this to be a very cultural, artistic society.” 
The laboratory was founded at a time when scientists had 
embraced Darwinian thought and looked for answers to human 
biology in the sea, where life began. Dozens of marine biology 
labs sprang up, but only three in New England have lasted: Woods 
Hole, Cold Spring Harbor Laboratory in New York and the Mt. 
Desert Island Biological Laboratory. Of the three, only the Mt. 
Desert Island laboratory continues to study links between fish 
and humans. Among its neighbors on Mt. Desert Island is The 
Jackson Laboratory, the world’s largest mammalian genetic 
research facility, which specializes in breeding genetically engi¬ 
neered mice for research. As a research center the Mt. Desert 
Island Biological Laboratory has brought forth significant dis¬ 
coveries, said Bowers. “Much of what we know today about how 
the kidney functions came from early research conducted here,” 
she said. The cdna of several sodium chloride transporters was 
first cloned here by two scientists now at Yale, Steven C. Hebert, 
M.D., chair of the Department of Cellular and Molecular Physi¬ 
ology, and Biff Forbush, ph.d., professor of cellular and molec¬ 
ular physiology. 
A quarter-century ago the laboratory renewed its educational 
focus by offering programs for both graduate and high school 
students, along with conferences and symposia for scientists 
from around the world. Still going strong is an eight- to io-week 
summer science program for high school students from sur¬ 
rounding Hancock County. (One of those alumni, Aller, is now 
a ph.d. candidate in molecular biophysics and biochemistry at 
Yale and an instructor in the summer program for Yale medical 
students.) It is also strengthening its research component with 
a five-year plan to recruit three scientists who will be the labora¬ 
tory’s first year-round researchers. 
Throughout the years, according to those who know it well, 
the lab worked its magic through an informal environment 
that brought together biologists, physicians, basic scientists and 
students and, by its remoteness, encouraged cross-fertilization 
of ideas. “It is more conducive to learning and picking up dif¬ 
ferent approaches than if you just stay with your own groups,” 
said Boyer. “At Yale,” he added, “you have to go out of your way 
to make those interactions. Here, you can’t help but do that.” 
For medical students, it is these interactions that make the 
experience worthwhile. In their evaluations of the program’s 
first year, students said that the opportunity to work in small 
groups with faculty was one of its most attractive features. 
Rupali Gandhi, the student now starting her second year of 
medical school, agreed. “You can ask as many questions as you 
want as many times as you want,” she said, “and get very 
clear explanations.” 
Joining Forrest on the faculty this year were Forbush and 
Raymond Frizzell, ph.d., chair of the Department of Cell Biol¬ 
ogy and Physiology at the University of Pittsburgh. (Frizzell 
arranged a similar program this year for medical students from 
Pittsburgh, who arrived a week before the Yale students.) 
If the first year of the Intensive Pedagogical Experience 
offered any lessons, it was that the schedule left students little 
time to enjoy Mt. Desert Island. This year, students had a free 
afternoon and evening every other day. During those free hours 
Forrest and Forbush led bicycle and hiking tours of the island. 
On Friday, the last day of the course, students made their 
final presentations after lunch and had the rest of the day to 
themselves. That evening Forrest organized a clambake at Sea¬ 
wall, a picnic area and campground at Acadia National Park in a 
section of the island the locals call the “quiet side.” Forrest arrived 
early to stoke a bonfire for cooking. Before long, lobsters and 
bags of vegetables and mussels were steaming in huge pots of 
seawater as the sun set over the rocky shore. 
Earlier in tine week Forrest sat on a wooden chair outside his 
lab on a bluff overlooking Mt. Desert Island’s Eastern Bay and 
mused about the course. One of its virtues, he said, is a “confer¬ 
ence room” like this, in the shade of a tree with the ocean below. 
“It’s asking a lot,” he said, “to say you’re going to change peo¬ 
ple’s lives in a week, that people are to change their career goals 
based on a week’s experience. But this course has the potential 
to encourage people who otherwise might not think about a 
research career. Some of these students have never run a gel, 
ground up tissue or looked at cells under a microscope in a 
research mode before. Here we have very bright students learn¬ 
ing all this medicine from lectures, books, videos and the Inter¬ 
net. Unless they are looking inside a cell, thinking about how to 
study some component of how that cell functions, unless they 
are striving to interpret what really exists, from their own ques¬ 
tions, they are going to be passive recipients. The idea of hands- 
on work is often so illuminating that it leads people to say, 'This 
is what I want to do for the rest of my life.’” ym 
john curtis is the associate 
editor of Yale Medicine. 
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Yale’s International Health Program sends young doctors around the globe 
to provide needed care—and learn the basics of a simpler medicine. 
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28 A world of difference 
Ramona Farid, m.d., knew she wasn’t in New Haven anymore 
the night she found herself on a hospital patio pouring a patient’s 
urine on an anthill. She was testing for glucose. 
If she’d been at Yale, Farid wouldn’t have had to think twice 
about how to follow the progress of a 16-year-old girl in diabetic 
ketoacidosis, or dka; she would simply have ordered finger 
sticks at two-hour intervals and checked the patient’s blood for 
glucose using a glucose monitor. But this was rural Haiti, where 
the second-year resident was working for a month with Yale’s 
International Health Program (ihp). It was 2 a.m., and there 
wasn’t a test strip to be found at Hopital Albert Schweitzer. 
“I said, 'How the heck am I supposed to manage dka with¬ 
out Chemstrips?’” recalled Farid. 
Finding low-tech (or no-tech) strategies for diagnosing and 
treating patients is one of the challenges for residents like Farid 
who take part in the Yale ihp. Since 1981, the popular program 
has sent residents in internal and emergency medicine to serve 
more than 300 rotations overseas or in Indian Health Service 
hospitals in the United States. This year, 40 of the 100 resi¬ 
dents in internal medicine will spend four to eight weeks in 
locales ranging from Alaska to Zimbabwe. They will be the first 
to be sponsored by a grant from Johnson & Johnson that will 
fund the 20-year-old program and allow it to expand. 
That night in Haiti, Farid realized she understood enough 
about diabetes to monitor her patient’s ketoacidosis without 
Chemstrips. Talking on the phone with the Haitian attending, she 
saw the logic behind the anthill approach. In a patient in dka, 
glucose levels would be high not only in blood, but also in 
urine. By observing how many ants were attracted by the sugar 
in the girl’s urine compared to urine from someone without 
diabetes, Farid could track the decline in the patient’s glucose 
levels. And so, for the rest of the night, she went out to the 
anthill with urine samples every two hours. At 8 a.m., the ants 
stopped coming. Farid took the girl off the insulin drip and 
sent her home with injectable insulin. 
The insight that Farid gained in Haiti—recognizing that she 
had useful knowledge of a disease independent of expensive 
technology—is one of the goals of the ihp, according to Frank J. 
Bia, m.d., its co-founder with Michele Barry, m.d., hs ’77. With 
the extensive use of diagnostic radiology and laboratory testing, 
said Bia, young doctors today “often are not allowed to think 
through a diagnosis. The diagnosis might be handed to them on 
a silver platter, or an mri scan.” Overseas, residents “have to go 
back to actually listening and touching. We feel these are very 
important skills to bring back to the art of being a doctor.” 
In a retrospective study of the program, residents reported 
that by practicing back-to-basics medicine they gained confi¬ 
dence in their ability to do physical examinations and came to 
value them more. The study by Robert Wood Johnson Clinical 
Scholar Anu J. Gupta, m.d. ’94, hs ’00, was published recently 
in The American Journal of Tropical Medicine and Hygiene. 
Residents in the program also have the chance to try proce¬ 
dures they rarely get to practice at home. At the Alaska Native 
Medical Center in Anchorage, second-year resident Walter Lin, 
m.d., helped with a bone marrow biopsy and saw internists take 
on other tasks usually reserved for specialists. In South Africa 
and in Cuba, resident Delia Radovich, m.d., hs ’01, found that 
practicing medicine where care is free and resources are limited 
was liberating. She did not have to document every move she 
made, haggle with insurers or track myriad confirmatory tests. 
Working in a medically underserved area, she said, “makes 
you a better doctor just by realizing the whole world doesn’t 
work the same way the United States works. It makes you more 
human. It pulls you out of your daily grind, and it brings 
you back to the real reason you chose medicine, or should have 
chosen medicine: taking care of patients.” 
The physician’s obligation to care for patients provides the 
motive for the International Health Program, said Bia. “It’s a pro¬ 
fessional ethic that guides the program. You have a social con¬ 
tract that extends beyond the walls of the hospital, and which oth¬ 
ers do not have. You have taken the Hippocratic Oath.” 
Barry, who is president-elect this year of the American Soci¬ 
ety of Tropical Medicine and Hygiene, said the goal of the pro¬ 
gram is “not to train tropical disease doctors but to instill a sense 
of global responsibility. Our philosophy is opening people’s minds 
to underserved areas around the world, not only overseas but 
also in New Haven.” 
Alumni of the program have chosen careers reflecting this 
vision. Gupta’s study found that the 130 Yale residents who went 
abroad between 1982 and 1996 were more likely than their coun¬ 
terparts to practice in public health settings and more likely to 
care for indigent patients, immigrants, substance abusers and 
patients with hiv. For instance, among the doctors in the study 
who now practice in public health settings, 10 had participated 
in the International Health Program, while two had not. Among 
those in the study with a substantial number of Hiv-positive 
patients (more than 20 percent), 30 had gone abroad, while 13 
had not. 
Joel E. Gallant, m.d., m.p.h., hs ’89, fits this profile. Having 
elected a rotation in Haiti in 1987 and one in Tanzania and 
More on the Web 
info.med.yale.edu/ymm 
Travel online with the 
International Health 
Program by visiting our 
website and selecting 
EXTRAS. 
Zimbabwe in 1988, he now serves as associate director of the 
Johns Hopkins aids Service. “It was always my goal to be work¬ 
ing with underserved populations in developing countries,” said 
Gallant. “However, my training at Yale and at Hopkins showed 
me that there were underserved populations on our doorstep, 
and that was especially true with aids.” 
The fact that many participants in the program go on to care 
for marginalized patients appealed to the contributions com¬ 
mittee at Johnson & Johnson, according to Conrad Person, its 
director of international programs. The New Jersey company’s 
credo calls for community and global responsibility. “This pro¬ 
gram fit,” said Person. “Yale was able to demonstrate that people 
who participated in this program were more likely to develop 
compassion in the practices they developed years later. This is an 
exciting program that expands the perspectives of people who are 
very likely to be leaders in the world of health care in the years 
to come.” 
This year’s grant from Johnson & Johnson will send 40 resi¬ 
dents to Indian Health Service hospitals in Arizona, New Mexico 
and Alaska and to 12 countries including Fiji, India, Russia, Israel, 
Brazil, China and Nepal. Next year, the gift will allow the program 
to expand to include residents from other medical schools as well 
as physicians with established practices. Bia estimates that the 
grant will come to about $350,000 annually, covering expenses 
formerly paid for by the Department of Medicine and income 
from a travelers’ clinic run by Barry and Bia. Yale-New Haven Hos¬ 
pital will continue to pay residents’ salaries while they are away. 
For Radovich, now a fellow in hematology/oncology at Memo¬ 
rial Sloan-Kettering Cancer Center, the experience of working 
abroad was invaluable. “I chose Yale for Yale, not even knowing 
that this program was in place. But I think people should come 
to Yale in droves, knowing this is an option.” 
September 11 hasn’t diminished the program’s ambitions; 
if anything, it has set the bar higher, Barry told a group of 
students attending the poster session for the Downs Interna¬ 
tional Health Student Travel Fellowship Program in October. 
“There is a whole world out there that is going to need you even 
more,” she said to the students, who had conducted research 
abroad. “As America becomes more xenophobic, and as more 
health care workers hunker down and stay in the United States, 
I just hope you keep your global vision.” ym 
Michele Barry, top, and Frank Bia, 
middle, established the International 
Health Program in 1981. Anu Gupta, 
bottom, found in a retrospective 
study published last year that alumni 
of the program are more likely to 
practice in public health settings and 
care for indigent patients, immi¬ 
grants, substance abusers and 
patients with hiv. 
cathy shufro isa contributing 
editor of Yale Medicine and a tutor in 
the Bass Writing Program at Yale. 
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Type 2 diabetes poses alarming health risks as obesity soars and exercise 
is crowded from modern life. Yale investigators are seeking better 
ways to prevent and treat the disease and to understand the science of fat. 
Dries from Fat 160 
% Daily Value* 
Story by Randi Hutter Epstein, M.D. ’90 
Photographs by Gale Zucker 
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32 An epidemic in the making 
We are seeing obesity running rampant, particularly in 
young adults. It’s a major health problem that has gotten 
increasingly worse in the past five years. 
Robert Sherwin 
For a nation obsessed with fitness, it's a small wonder that so 
many Americans manage to keep gaining weight. Despite an ever¬ 
growing choice of diet products and weight-loss programs, more 
and more Americans are losing die struggle against an expanding 
girth—or not fighting it at all. According to the Centers for Dis¬ 
ease Control and Prevention, rates of obesity surged 60 percent 
during the past decade and, today, one in five Americans is con¬ 
sidered obese, or 30 percent above his or her ideal weight. 
People who are serious about effectively battling obesity 
have generally turned to fitness instructors or nutritionists. But 
at Yale, fat is also the stuff of serious science, pursued by nearly 
100 epidemiologists, pediatricians, endocrinologists, biologists, 
nurses, biochemists and psychologists, among others. They are 
all part of the Yale Diabetes Endocrinology Research Center, led 
by Robert S. Sherwin, m.d., the C.N.H. Long Professor of Med¬ 
icine and past president of the American Diabetes Association. 
Founded in 1993 with a grant from the National Institute of Dia¬ 
betes and Digestive and Kidney Diseases, the Yale diabetes center 
provides the infrastructure for an active interdisciplinary team 
representing 16 departments. Its mission is not to trim the 
American waistline but to find ways to prevent and treat an 
often-serious consequence of obesity, type 2 diabetes mellitus. 
Type 2 diabetes occurs when beta cells in the pancreas lose 
their ability to produce enough insulin to compensate for 
defects in glucose metabolism. Unlike type 1 diabetes, an 
autoimmune disease that destroys the beta cells and all of the 
body’s insulin-making ability, type 2 diabetes leaves patients 
capable of producing insulin but unable to use it effectively. 
This can residt in kidney and heart disease, stroke, blindness, 
nerve damage and loss of limbs. In 1997, the American Dia¬ 
betes Association (ada) estimated that 16 million Americans 
had diabetes. According to Sherwin, the number has increased 
by at least 6 percent a year since then, largely in tandem with 
the rise in obesity. 
Worse, type 2 diabetes, long thought of as an adults-only 
illness, is now striking increasing numbers of young people, 
particularly Native Americans, African-Americans, Asians and 
Latinos. “We are seeing obesity running rampant, particularly 
in young adults,” says Sherwin. “It’s a major health problem 
that has gotten increasingly worse in the past five years.” 
The Yale group has focused its efforts on understanding the 
biology of type 2 diabetes and on crafting strategies to prevent 
its occurrence in key groups of patients at risk for the disease. 
These approaches draw in a diverse group of investigators who 
are interested in everything from the biochemical pathways of 
glucose metabolism to the best ways to encourage at-risk chil¬ 
dren and older adults to exercise and follow a healthy diet. 
IN VIVO BIOCHEMISTRY 
Gerald 1. Shulman, m.d., ph.d., has spent the past 15 years explor¬ 
ing the cellular mechanisms of insulin resistance, the defect in 
the body’s ability to use insulin that characterizes type 2 diabetes. 
Insulin resistance has been shown to be the best predictor for 
whether or not an individual with a family history of type 2 dia¬ 
betes will go on to develop diabetes. Recently, his team proposed 
a new mechanism to explain how an excess of fatty acids in the 
bloodstream increases the risk of diabetes by interfering with 
glucose metabolism. “Clearly too much fat is bad for you and 
somehow it interferes with insulin's ability to stimulate glucose 
uptake into skeletal muscle. We wanted to know how,” says 
Shulman. To find out, he and collaborators including Douglas 
L. Rothman, ph.d., Kitt F. Petersen, m.d., Robert G. Shulman, 
ph.d. (no relation to Gerald) and Gary W. Cline, ph.d., have 
used the tools of nuclear magnetic resonance (nmr) spec¬ 
troscopy to perform what Shulman calls “in vivo biochemistry 
in real time.” Their techniques allow researchers to measure 
metabolic changes noninvasively and with much greater sensi¬ 
tivity than was possible before. 
“In the old days, we would have had to perform muscle biop¬ 
sies to assess the concentration of a metabolite in a particular tis¬ 
sue. Even then we wouldn’t have had nearly as clear a picture of 
what was going on inside the cell because a cell doesn’t behave the 
same once you remove it from the body,” says Shulman, the 
associate director of the Yale Diabetes Endocrinology Research 
Center, professor of medicine and of cellular and molecular phys¬ 
iology, and a Howard Hughes Medical Institute investigator. 
An example of the power of the nmr technique was recendy 
demonstrated in a study in which his group used it to measure 
the amount of fat inside the muscle cells of normal volunteers. 
They found that higher levels of such intracellular fat are the best 
indicator of whether or not an individual is insulin resistant. 
In order to determine the way in which fatty acids trigger the 
chemical defects that interfere with insulin’s ability to stimulate 
glucose transport, the Yale researchers infused fatty acids into 
healthy volunteers and found that they could induce insulin 
resistance temporarily within five to six hours — demonstrating 
an inverse link between the presence of fatty acids and the body’s 
ability to metabolize glucose. In subsequent studies the Yale team 
found that excess fatty acids block insulin's ability to activate phos- 
phoinositol 3-kinase, a key enzyme responsible for mediating 
33 
For older adults, is moderate-intensity exercise sufficient to lower 
the risk or severity of diabetes? Must one exercise a little bit 
every day or is one intense training session a week just as good? 
Loretta di Pietro 
Robert Sherwin 
A tax on fat? 
The rise in obesity around the 
country has led a number of inves¬ 
tigators to seek solutions in the 
realm of public policy. Among 
those is Kelly D. Brownell, ph.d., 
director of the Yale Center for Eat¬ 
ing and Weight Disorders, who 
advocates a six-step solution that 
would, among other measures, 
impose a tax on foods of poor 
nutritional quality. 
While the idea of a "fat tax” 
has raised eyebrows (and the ire of 
many a conservative talk-show 
host concerned about limits on 
our right to eat whatever we 
want), it makes perfect sense to 
Brownell, a professor of psychol¬ 
ogy and of epidemiology and pub¬ 
lic health. He sees a health system 
far more focused on treatment 
than on prevention of obesity. He 
argues that “for every person we 
successfully treat and remove 
from the obese population, there 
are thousands more entering it.” 
In addition to taxing junk foods, 
his plan calls for publicly financing 
recreation centers and bike paths, 
regulating food advertising aimed 
at children, banning fast foods and 
soft drinks in schools, subsidizing 
healthy foods, and incorporating 
nutrition education in school 
lunch programs. “I think we have 
been obsessed with the biology 
and missed the obvious,” says 
Brownell. “It’s the horrible food 
and lack of physical activity that 
are causing the problem.” 
Loretta di Pietro 
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34 An epidemic in the making 
There have never been so many obese children. That is not 
to say that all these children will become diabetic—because 
it’s not too late. 
Sonia Caprio 
insulin’s capacity to stimulate glucose transport. This is the 
same step that the Yale scientists, in a study published last year 
in The New England Journal of Medicine, found to be defective 
in patients with type 2 diabetes. Further research into this path¬ 
way could lead to the development of new drugs that are more 
precisely targeted and carry fewer side effects. 
In another study, the Shulman group examined whether or 
not exercise training might be able to reverse the defect in insulin- 
stimulated glucose transport in the offspring of patients with 
type 2 diabetes. In 1995, Shulmaris team demonstrated that exer¬ 
cise alone can reduce or reverse this abnormality. In that study, 
also published in The New England Journal, the team examined 
10 sedentary adults whose parents had both developed type 2 
diabetes and who consequently faced a 40 percent lifetime risk 
of getting the disease themselves. All of the subjects were insulin 
resistant but none was obese. The exercise routine consisted of 
three 15-minute sessions on a stair-climbing machine, four times 
a week for six weeks. The researchers gave the volunteers glu¬ 
cose intravenously and took blood samples to monitor how well 
they processed sugar. After one workout, the muscle cells’ abil¬ 
ity to store glucose improved by 69 percent; after six weeks, by 
102 percent. At the end of the study, insulin sensitivity, the abil¬ 
ity of the body to use its own insulin, improved by 43 percent. “It’s 
clear that exercise training can reverse the major defect respon¬ 
sible for insulin resistance in these individuals,” says Shulman, 
“and that it is likely to be an effective means in preventing or 
even reversing type 2 diabetes.” 
AN AGGRESSIVE APPROACH TO TREATMENT 
While researchers including Shulman are doing the kind of basic 
research that leads to new drugs, clinicians are working directly 
with people vulnerable to the disease, especially children. 
“There have never been so many obese children,” says Sonia 
Caprio, m.d., associate professor of pediatrics in the section of 
endocrinology. She has shown that excess weight clearly carries 
with it the risk of type 2 diabetes. Last year at the ada meeting 
in San Antonio, Caprio reported that 19 percent of 180 children 
she tested during the course of treatment for weight disorders 
had impaired glucose tolerance. “That is not to say that all these 
children will become diabetic—because it’s not too late,” she says. 
"If they do improve their weight and increase exercise, they can 
prevent it.” 
Still, a decade ago it was rare for more than 5 percent of all 
pediatric diabetes cases to manifest themselves in the type 2 form 
of the disease; most children had type 1 diabetes. Today, in some 
clinics that number has soared as high as 40 percent, according 
to Caprio. Tire phenomenon is so new that epidemiologists 
haven’t yet compiled national statistics by age. To understand what 
is happening, Caprio began a five-year study last year to deter¬ 
mine the metabolic reasons behind the explosion of new cases of 
type 2 diabetes in children. “We want to learn more about the 
pathway and where the defect is,” she says. 
Meanwhile, the race is on to find better ways to treat this new 
subset of patients before complications set in. Because people 
with type 2 diabetes usually develop it in middle age, complica¬ 
tions often do not arise until their 60s or 70s. For the pediatric 
patients, the prospect of kidney failure or cardiovascular disease 
may come decades earlier, in their 30s or 40s. 
In August, Caprio was awarded a $3.5 million grant over seven 
years as the principal investigator at Yale for a multicenter trial 
to compare standard medical therapies such as insulin and glu- 
cophage to newer drugs that have not yet been used in children 
and adolescents. These include inhaled insulin, insulin sensitiz¬ 
ers and insulin secretagogues such as nateglinide. “We propose 
to be very aggressive in treating the disease in children, rather 
than taking the usual, laid-back approach,” Caprio says. “It used 
to be the case that you would try to improve diet a little and try 
a little exercise. But in 10 years, the pancreas is out of shape 
and the damage is done.” 
At the other end of the age spectrum are participants in 
studies conducted by Loretta A. di Pietro, m.p.h. ’85, ph.d. '88, 
an associate professor of epidemiology and public health and 
associate fellow at the John B. Pierce Laboratory in New Haven. 
Working with adults 60 and older, she is studying how fat is 
deposited and teasing out the differences between the physical 
changes caused by normal aging and those attributable to lack 
of exercise. Di Pietro is in the midst of a study including dozens 
of female volunteers at Heritage Village retirement community 
in Southbury, a 45-minute drive from her office at Yale. The 
aim is to study the impact of nine months of exercise training 
on hormonal regulation and sugar and fat metabolism. Partici¬ 
pants agree to provide blood samples and muscle biopsies 
that will yield information about precisely how exercise seems 
to reverse or prevent insulin resistance. 
The women are divided into three groups. One group does 
high-intensity aerobic training, jogging on mini-trampolines at 
about 85 percent of their maximum capacity as measured by heart 
rate. The second group jogs at moderate intensity. The third 
group, considered the placebo group, does stretching, tai chi or 
yoga. The mini-trampolines provide aerobic exercise without 
Clearly too much fat is bad for you and somehow it interferes 
with insulin’s ability to stimulate glucose uptake into skeletal 
muscle. We wanted to know how. 
Gerald Shulman 
Sonia Caprio 
Gerald Shulman 
Y
al
e 
M
e
d
ic
in
e
 
a
u
tu
m
n
 
2
0
0
1
 
36 An epidemic in the making 
the jarring impact of running on the ground. About five 
women can work out at a time, which di Pietro says makes the 
routine more fun and motivates the women to continue exer¬ 
cising when the study is completed. 
Fat in the abdominal area, which increases postmenopausally 
due to the drop in sex hormones, is linked to an increased risk 
of diabetes, says di Pietro, who is expanding the study to senior 
centers in New Haven and West Haven. These fat deposits, the 
deep kind that cover tissues within the abdominal cavity, are 
much more metabolically active than fat cells in the thighs and 
buttocks. In addition, there is a decline in both the quantity and 
quality of muscle mass with aging and disuse. 
Researchers theorize that when abdominal fat is broken 
down, it goes directly to the liver, where it interferes with insulin 
function and glucose metabolism. Di Pietro and research assis¬ 
tant )odi Crimmins, M.s., are studying hormonal responses to 
exercise and, in particular, the effect of exercise on growth hor¬ 
mone, insulin-like growth factor and cortisol and how these 
hormonal changes relate to improvements in whole-body glu¬ 
cose metabolism. The goal is to study how much exercise a 
subject must perform to garner the anti-diabetes effects. Are 
there gains after one bout of exercise or is long-term training 
necessary? Is moderate-intensity exercise sufficient? Must one 
exercise a little bit every day or is one intense training session 
a week just as good? 
FIGHTING EVOLUTION 
As any dieter knows, gaining weight is a breeze compared to 
losing it. The reason, as is becoming increasingly apparent, has 
more to do with the evolution of the human species than with 
gluttony. Humans evolved into a sturdy species because of an 
inherited ability to prevent starvation, says Sherwin. “We evolved 
on a planet where food was scarce and you had to work hard to 
get it. You needed a gene pool to hold onto calories.” In other 
words, those who survived long enough to produce offspring 
were able to pass along their calorie-hoarding genes. Those 
who dropped pounds easily died young. That was good for the 
survival of the species but is frustrating for those trying to lose 
weight today. 
Recent clues derived from studying the basic biology of the 
fat cell are lending credence to this theory. Several studies have 
shown that when individuals reduce their food intake, they also 
slow metabolism and increase their appetite, thereby negating 
the impact of fewer calories. Hunger and metabolism are con¬ 
trolled by an intricate system of hormonal signals to and from 
within the brain. A minor shift in this chemical balance can 
have a dramatic impact on weight loss or gain. 
For instance, a slight change in the hormonal milieu could 
prompt a craving for, say, an extra hundred calories a day and 
lead to a gain of 10 pounds in one year. Multiply that by five 
years, and the average-sized person becomes obese. Sherwin 
and others at Yale have been studying how leptin, a protein sig¬ 
nal released by fat cells, controls appetite. The name for leptin, 
identified in 1994 by scientists at Rockefeller University, comes 
from the Greek word leptos, which means thin, and its discov¬ 
ery prompted speculation that a better diet pill was on the way. 
Further research has revealed a much more complex picture, 
and many questions remain to be answered about leptin and its 
role in controlling appetite. 
Sherwin has shown that leptin acts by binding to receptors 
in specific regions at the base of the hypothalamus, triggering a 
cascade of hormonal changes. The leptin cascade, he says, “is a 
complex system that seems to have an enormous impact on 
how much we eat. 
“Theoretically, if a person has too much fat, the body would 
stop eating; if there is not enough, the body would increase 
feeding,” says Sherwin. The problem is that individuals who 
are obese appear to have an altered set point for leptin. “It takes 
more leptin to shut off feeding. Then you go on a diet and leptin 
drops, so you want to eat again.” Researchers hope these 
insights into the leptin receptor will lead to a new approach to 
weight loss, perhaps a drug that would latch onto the receptor 
and minimize appetite without slowing metabolism. 
As for the genetically blessed—those annoyingly lean peo¬ 
ple who eat whatever they want without gaining an ounce — 
scientists have a hunch that they may be endowed with more 
so-called brown fat than white fat. According to this theory, 
supported by animal studies, brown fat cells, so named because 
they have a redder hue due to an increased blood supply, burn 
calories faster than do white fat cells. The goal, then, for drug- 
makers would be to somehow increase the proportion of brown 
cells, promoting fat burning rather than storage. 
“We are trying to turn the tables on millions of years of evolu¬ 
tion,” says Sherwin. “We are not doing too well yet, but at least 
we are beginning to understand and recognize the problem.” ym 
RANDI HUTTER EPSTEIN, M.D. *90, 
has written about medicine for The 
Washington Post, the London bureau of 
the Associated Press and The New 
York Times. 
Faculty 37 
Ronald Duman 
Shirleen Roeder 
PeterSalovey 
SENIOR FACULTY 
HONORED WITH ENDOWED 
PROFESSORSHIPS 
Five faculty members with appoint¬ 
ments at the School of Medicine were 
recently named to endowed chairs. 
Ronald S. Duman, ph.d., was appointed 
the Elizabeth Mears and House Jameson 
Professor of Psychiatry. He has been 
on the Yale faculty since 1988, most 
recently as a professor of psychiatry and 
pharmacology, and has worked on char¬ 
acterizing the molecular and cellular 
mechanisms that mediate the long-term 
effects of psychotropic drugs and stress. 
His research suggests that antidepres¬ 
sant treatments increase the survival 
and health of neurons and alter their 
synaptic architecture. Duman’s labora¬ 
tory has also identified several neuropep¬ 
tide receptors that are expressed in 
drug reward and craving. 
Dean of the Graduate School of Arts 
and Sciences Susan Hockfield, ph.d., 
was named the William Edward Gilbert 
Professor of Neurobiology. She joined 
the faculty in the Section of Neurobiol¬ 
ogy at the medical school in 1985 and 
has served as dean of the graduate school 
since 1998, overseeing the academic and 
administrative policies of the school, its 
2,300 students and 750 faculty. Hockfield 
has sought to improve the quality of life 
for graduate students and increase oppor¬ 
tunities for informal interaction between 
faculty and students. Her research work 
has looked at the molecular substrates 
involved in brain development, and she 
discovered a protein in the space around 
cells that is involved in early development 
and may play a role in brain tumors. 
G. Shirleen Roeder, ph.d., was appoint¬ 
ed the Eugene Higgins Professor of Mol¬ 
ecular, Cellular and Developmental Biol¬ 
ogy. Also a professor of genetics, she 
was part of a Yale team that recently fully 
characterized the function of the yeast 
genome. She has studied the process of 
meiosis by isolating and characterizing 
yeast mutants defective in the process. 
She was named a Howard Hughes Med¬ 
ical Institute investigator in 1997. Roeder 
has been on the Yale faculty since 1981, 
and her work has appeared in the journals 
Cell and Science, among others. 
Peter Salovey, ph.d., a professor of 
epidemiology and public health and 
chair of the Department of Psychology, 
was named the Chris Argyris Professor of 
Psychology. He directs the Health, Emo¬ 
tion and Behavior Laboratory and with 
John D. Mayer coined the term “emotional 
intelligence” to describe how people 
understand, manage and use their feel¬ 
ings. He has focused on how feelings 
facilitate adaptive cognitive and behavioral 
functioning. Salovey has also investigated 
how public health messages can best 
encourage prevention and early detection 
behaviors for hiv/aids and cancer. He 
is deputy director of the Yale Center for 
Interdisciplinary Research on aids. 
Robert M. Weiss, m.d., was named the 
Donald Guthrie Professor of Surgery. He 
is a specialist in pediatric urology and 
urologic surgery and was listed in the 
latest edition of “Best Doctors in America: 
Northeast Region.” His research has cov¬ 
ered topics from the role of nitric oxide in 
urinary tract infections and the bio¬ 
chemical and functional changes in the 
bladders of diabetics to the use of pulse 
Doppler sonography in the diagnosis of 
urinary tract obstruction in children. He 
has been at Yale since 1967 and has 
served as chief of the Section of Urology 
since 1988. He also served as interim 
chair of the Department of Surgery. 
Weiss received a merit Award from the 
National Institutes of Health for his work 
on age-dependent factors in ureteral- 
vesical function and the Urodynamic 
Society’s Lifetime Achievement Award. 
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For their dedication to patients, stu¬ 
dents and the community, the 
husband-and-wife team of frank 
BIA, M.D., and MARGARET BIA, 
m.d., were nominated by Yale med¬ 
ical students for the 2001 aamc 
Humanism in Medical Education 
Award. The nomination was an¬ 
nounced April 5 at a reception in 
the third floor lounge of the Hope 
Building."The Bias treat patients 
and students fairly and ethically, 
regardless of gender, race or lifestyle 
options," wrote one student q uoted 
in the nomination.“Their mission,” 
wrote another,“is to serve people 
in need and in this way they serve 
the community every day.”The 
American Association of Medical 
Colleges, which will announce 
the final recipient at its annual 
meeting in November, created the 
award in 1999 with sponsorship 
from the Pfizer Corporation. 
IRWIN M. B RAVERM AN, M.D.'55, 
hs '56, professor of dermatology, 
was honored at a Yale symposium 
on April 28 to celebrate his career 
at Yale as an outstanding clinician 
and researcher. Braverman has 
provided insight into a wide range 
of cutaneous diseases, from lupus 
to hereditary hemorrhagic telang¬ 
iectasia toT-cell lymphoma. He 
is also a researcher and educator 
on the aging of the skin and cuta¬ 
neous microcirculation. With the 
help of Jacqueline Dolev, m.d. ’01, 
and Linda Friedlaender, curator of 
education at the Yale Center for 
British Art, he developed a tutorial, 
the "British Museum Project,” that 
uses highly detailed original works 
of art to train first-year Yale med¬ 
ical students to become more care¬ 
ful observers. 
DANIEL C. DIMAIO, M.D., PH.D., 
professor of genetics, was honored 
by the Yale Graduate School of Arts 
and Sciences for exemplary men¬ 
toring of graduate students. He 
was one of three winning faculty 
mentors who were chosen by the 
Graduate Student Assembly’s 
Awards and Evaluation Commit¬ 
tee, working with the Office of 
Teaching Fellow Preparation and 
Development,from nominations 
made by students. DiMaio’s 
research focuses on the molecular 
biology of tumor viruses and the 
mechanisms by which they affect 
cell proliferation and induce the 
development of cancer. One stu¬ 
dent commented in nominating 
DiMaio,"He has made me a more 
accountable scientist, a better crit¬ 
ical thinker and has inspired me 
toward a career in academic 
research and teaching.” 
HOWARD P. FORMAN, M.D., asso¬ 
ciate professor of diagnostic radi¬ 
ology and vice chair of finance and 
administration in the Department 
of Diagnostic Radiology, has been 
awarded a Robert Wood Johnson 
Health Policy Fellowship. He was 
one of six fellows chosen to parti¬ 
cipate in a one-year orientation 
and work experience program to 
help mid-career health profession¬ 
als assume leadership roles in 
health policy and management. 
Forman is coordinator of Yale’s 
newly implemented m.d./m.b.a. 
joint degree program. He also 
holds appointments in the Depart¬ 
ment of Economics and at the Yale 
School of Management and 
teaches graduate and undergradu¬ 
ate courses in health care finance 
and health economics. 
CARY E. FRIEDLAENDER,M.D., 
hs ’74, the Wayne 0. Southwick 
Professor and chair of ortho¬ 
paedics and rehabilitation, was 
named chair of the Council of 
Musculoskeletal Specialty Soci¬ 
eties (comss) of the American 
Academy of Orthopaedic Surgeons 
at its 68th annual meeting in 
March in San Francisco. As comss 
chair, he will serve on the acad¬ 
emy’s board of directors. Already 
active in the academy, Friedlaen¬ 
der is chair of the research com¬ 
mittee and Kappa Delta research 
award committee. He is also a 
member of the Council on Educa¬ 
tion, Council on Research, Bone 
and Joint Decade committee and 
Task Force on Patient-Physician 
Communication. 
On June 26, the School of Medi¬ 
cine announced the completion 
of a fund-raising effort that will 
establish the first endowed pro¬ 
fessorship in the Department 
of Anesthesiology and will honor 
NICHOLAS M. GREENE,M.D., 
Yale’s first professor of anesthesi¬ 
ology and founding chair of the 
department. A graduate of Yale 
College, Greene received his med¬ 
ical degree from Columbia Univer¬ 
sity in 1946. He had an enormous 
influence on medicine at Yale 
and around the world, and is cred 
ited with transforming the anes¬ 
thesia service at Yale from a tech¬ 
nical subspecialty of surgery into 
its own medical and academic 
discipline. In addition, an anony¬ 
mous donor has established the 
Betty Greene Research Fund in 
Anesthesiology for use at the dis¬ 
cretion of the incumbent of the 
Greene Chair. 
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BONNIE KAPLAN, PH.D., lecturer 
in anesthesiology (medical infor¬ 
matics), was recently inducted into 
the American College of Medical 
Informatics (acmi) and also 
received the President’s Award 
from the American Medical Infor¬ 
matics Association (amia). Fellow¬ 
ship in acmi recognizes leaders in 
the science and application of 
medical informatics. Kaplan was 
inducted during a dinner held at 
the amia 2000 Annual Symposium 
in Los Angeles last November.The 
President's Award, which Kaplan 
received at the same conference, 
recognized her work in spearhead¬ 
ing the formulation of amia’s 
Strategic Vision in Consumer Health 
Informatics and as chair of the Peo¬ 
ple and Organizational Issues Work¬ 
ing Group. Kaplan is also a member 
of Yale’s Interdisciplinary Bioethics 
Project, president of Kaplan Associ¬ 
ates and a senior scientist at 
Boston University’s Medical Infor¬ 
mation Systems Unit. 
ILONA S. KICKBUSCH, PH.d., pro¬ 
fessor of public health and of polit¬ 
ical science and head of the divi¬ 
sion of global health, received the 
Andrija Stampar Medal from the 
Association of Schools of Public 
Health in the European Region 
during the organization’s annual 
conference in Hungary on Septem¬ 
ber 22. Kickbush was honored for 
her lifelong distinguished service 
to public health. 
JAMES F. LECKMAN, M.D.,the Nei- 
son Harris Professor of Child Psy¬ 
chiatry, Psychiatry and Pediatrics, 
received a Distinguished Alumni 
Award at a meeting of the College 
of Wooster's Alumni Association 
on June 9 in Wooster, Ohio. Leck- 
man graduated from Wooster in 
1969. He first came to Yale as a 
postdoctoral fellow in 1976 and 
now serves as director of research 
at the Child Study Center. 
STEPHEN E. MALAWISTA, M.D., 
hs ’60, professor of medicine, has 
been named a Guggenheim Fellow 
by the John Simon Guggenheim 
Memorial Foundation. Fellows are 
appointed on the basis of unusu¬ 
ally impressive achievement and 
exceptional promise for future 
accomplishment. During the cur¬ 
rent sabbatical year he will study 
motile function of human white 
blood cells, in the context of the 
inflammatory response, at the 
Hopital de la Salpetriere, Paris. 
RAVI N D E R NATH, PH.D., professor 
of therapeutic radiology and head of 
the section of radiological physics, 
received the William D. Collidge 
Award in July from the American 
Association of Physicists in Medicine 
(aapm) at a special ceremony and 
reception during the aapm meet¬ 
ing in Salt Lake City.The Collidge 
Award, the association's highest 
honor, recognizes distinguished 
contributions to medical physics. 
PASKO RAKIC, M.D., PH.D.,chairof 
the Section of Neurobiology and 
the Dorys McConnell Duberg Pro¬ 
fessor of Neuroscience, gave the 
71st James Arthur Lecture on the 
“Evolution of Neocortex: Lessons 
from Embryoarcheology”atthe 
American Museum of Natural His¬ 
tory in the spring of 2001.The 
objective of Rakic’s research is to 
better understand the molecular 
mechanisms that govern cellular 
events during development of the 
mammalian brain, including neu¬ 
rogenesis, neuronal migration and 
synaptogenesis. He emphasized 
that advances in understanding 
corticogenesis in the embryo pro¬ 
vide insight into how spontaneous 
gene mutations that regulate the 
early stages of corticogenesis may 
have determined the species- 
specific size and basic organization 
of the cerebral cortex. 
ALAN c. SARTORELLI, PH.D.,the 
Alfred Gilman Professor of Phar¬ 
macology, received the 20th Amer¬ 
ican Association for Cancer 
Research-Bruce F. Cain Memorial 
Award in March, which honors 
outstanding preclinical research 
leading to the improved care of 
cancer patients. He was recognized 
for his pioneering work in cancer 
pharmacology. He is also the for¬ 
mer chair of the Department of 
Pharmacology and former director 
of the Yale Comprehensive Cancer 
Center. His contributions to the 
evaluation of the role of tumor cell 
hypoxia in anticancer drug action 
and in targeting this important 
cellular difference in human 
tumors for therapeutic interven¬ 
tion are of fundamental impor¬ 
tance in this field. 
M. BRUCE SH I ELDS, M.D., profes¬ 
sor and chair of ophthalmology 
and visual science, was elected to 
serve as chair of the American 
Board of Ophthalmology, a 
national organization that certifies 
more than 500 ophthalmologists 
each year. Shields will assume the 
position of vice chair of the organi¬ 
zation’s board of directors in 2002, 
and will become chair in 2003. His 
duties will include helping to 
supervise the hundreds of examin¬ 
ers who administer the written 
and oral certification exams and 
developing new strategies for cer¬ 
tifying ophthalmologists. 
SEND FACULTY NEWS TO 
Claire Bessinger, Yale Medicine, 
P.O. Box 7612, New Haven, CT 
06519-0612, or via e-mail 
to claire.bessinger@yale.edu. 
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40 students 
The epicenter of the earthquake struck near 
Bhuj, the capital of Kachchh, and left much of 
the city in ruins. 
HELPING, AND LEARNING, 
THROUGH DISASTER RELIEF 
IN INDIA 
After an earthquake and as many as 
60,000 deaths, Yale students and 
physicians help shore up health system. 
Midway through their 10-day trip to 
western India in March to help with 
earthquake-relief efforts, a team of Yale 
students and physicians visited the Chil¬ 
dren’s Hospital in Bhuj, a city near the 
earthquake’s epicenter. Shantiben Patel, 
m.d., the hospital director, had set up 
tents outside the damaged building and 
was seeing patients when the team 
arrived. "She had been working six 
weeks straight, day and night,” said Raj 
Krishnamurthy, m.d., who practices 
internal medicine at the VA hospital in 
West Haven and was a preceptor for the 
team. “She didn’t have a day off. She was 
the only pediatrician in the whole area.” 
Patel quickly put the Yale team to 
work seeing outpatient visitors while she 
tended to the neonatal intensive care 
unit in one of the many tents on the 
street. Over the next four hours the five 
students and their two preceptors tended 
to about 25 children, most suffering 
from diarrhea, dehydration, upper respi¬ 
ratory tract infections, malnutrition and 
urinary tract infections. 
The earthquake that struck the west¬ 
ern Indian region of Kachchh, on January 
26, measured 7.9 on the Richter scale. 
Estimates of the death toll vary, with the 
government estimating between 20,000 
and 30,000 deaths and relief workers say¬ 
ing as many as 60,000 people may have 
died. The Yale team, made up of five med¬ 
ical students, a public health student and 
two physicians, arrived six weeks later to 
scenes of rubble and ruin. They also 
found an already fragile health care sys¬ 
tem in shambles. 
In New Haven, students’ initial 
response was a fund-raising drive that 
netted about Si.ooo for earthquake relief. 
The students wanted to do more and 
approached Dean David A. Kessler, m.d., 
who agreed to send six students to India. 
It was up to the students to organize 
the trip. Seventeen students applied to go,. 
and six, all but one of Indian heritage, 
were chosen through an application 
process. After securing their preceptors — 
Krishnamurthy and David Litvak, m.d., a 
third-year resident in internal medicine— 
and finding a nongovernmental organiza¬ 
tion to work with, the students were on 
their way. Upon their return, the students 
filed a report with the dean’s office. 
Kachchh is 17,000 square miles of 
plains, desert and salt flats bounded on the 
north by Pakistan and on the south by the 
Arabian Sea. Most of its inhabitants farm 
grains, cotton and lentils. Some work in 
limestone, marble and gypsum mines. In 
recent years the region has suffered two 
droughts and a cyclone. “It’s a very 
difficult state to live in as it is,” said stu¬ 
dent Simran Singh. 
The team’s guide to the region and 
its medical needs was Anupam Banerjee, 
m.d., an intern in India fresh out of med¬ 
ical school who had begun a term of 
service in Kachchh just after the earth¬ 
quake hit. Banerjee, in turn, was working 
with the Shrujan Trust, an organization 
founded in 1969 to provide famine relief. 
The trust branched out into economic aid 
by marketing embroideries made by 2,500 
craftswomen in 85 villages. It also began 
medical outreach and provided the van that 
took Banerjee’s mobile medical unit into 
the countryside to provide primary care. 
The students arrived at the Shrujan 
compound about 20 miles west of the city 
of Bhuj ready to work, despite a 36-hour 
trip from New Haven and a 10-and-a-half- 
hour time difference. Their new home was 
a one-room, thatched-roof hut with a sin¬ 
gle bed. (Most of the team slept on the 
floor or outdoors in their sleeping bags.) 
The next day half the team joined Baner¬ 
jee on the medical van, while the other 
half went to the nearby village of Ghada 
to organize activities for schoolchildren. 
Although several members of the 
group spoke Hindi and one spoke 
Gujarati, language remained a problem 
in this country with more than 800 
dialects. The dialect spoken in Kachchh 
was at times incomprehensible to the 
one Gujarati speaker on the team, Rupal 
Badani, a third-year medical student. 
Nevertheless, because of their knowl¬ 
edge of Indian languages and with the 
help of interpreters, the students man¬ 
aged to communicate. 
Within a few days of their arrival, the 
team undertook a health assessment for 
Ghada, looking into nutritional patterns 
and access to health care, prenatal care 
and primary care. They also organized 
diabetes and hypertension screenings at 
a health camp at Shrujan. When it was 
time to leave, team members felt they 
had contributed something of value to 
the relief effort. The presence of the stu¬ 
dents and physicians on the medical van 
allowed more patients to be seen. Their 
survey left health workers a tool for pro¬ 
viding medical care to villages. Their dia¬ 
betes and hypertension screenings were 
the first for many patients and included 
follow-up via the mobile unit. And they 
established a program for children that 
others would continue after they left. 
They also returned to New Haven 
with valuable experience, having been 
able to participate in emergency and pri¬ 
mary care in a remote setting with lim¬ 
ited resources. “We felt like we were 
doing something for someone, but we 
were also really learning,” said third-year 
student Vivek Murthy. 
top Simran Singh took a patient’s blood pres¬ 
sure during a medical screening at the Shrujan 
camp. Free medical and orthopaedics care were 
provided. 
middle Simran Singh,David Litvak,Raj Krish¬ 
namurthy, Vivek Murthy, Shalini Kapur and 
Rupal Badani before their departure for Gujarat 
in March. Medical student Esther Choo joined 
them a day later. Another student, Rahul Rajku- 
mar, helped organize the trip but was pre¬ 
vented from leaving by a family emergency. 
bottom Children such as these girls, dressed in 
the brightly colored garb typical of the region, 
were a main focus of the team, which organized 
an interim day program to provide some struc¬ 
ture to their lives until schools could be rebuilt. 
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42 Alumni REUNION 2001 
FOR 500 ALUMNI AND 
THEIR GUESTS, A RETURN 
TO NEW HAVEN 
Congress Avenue Building, 
brain research, admissions process 
are the focus of 2001 reunion. 
At this year’s reunion, alumni donned 
hard hats for a tour of the Congress 
Avenue Building and put on their think¬ 
ing caps for a seminar on admissions 
that asked them to decide the fate of a 
hypothetical medical school applicant. 
More than 500 alumni and their 
guests attended reunion, which started 
Friday, June 1, with a discussion of the 
admissions process, a welcome from 
Dean David A. Kessler, m.d., and the tra¬ 
ditional evening clambake. Across town, 
at the New Haven Lawn Club, alumni in 
public health were honored for their ser¬ 
vice to their communities. 
The admissions discussion Friday 
afternoon in the Jane Ellen Hope Build¬ 
ing included an interactive exercise that 
offered the audience a chance to review 
the qualifications of various applicants 
and make their own selections. 
The next day discussion turned to 
“The Last Frontier: Understanding the 
Brain, Curing its Disorders,” with a 
panel that comprised Bennett A. Shay- 
witz, m.d., professor of pediatrics and 
neurology and in the Child Study Cen¬ 
ter; Patricia Goldman-Rakic, m.d., the 
Eugene Higgins Professor of Neurobiol¬ 
ogy and Psychiatry and Neurology; 
Jeffery D. Kocsis, ph.d., professor of 
neurology and neurobiology; Dennis D. 
Spencer, m.d., chair and the Harvey and 
Kate Cushing Professor of Neuro¬ 
surgery; and Stephen G. Waxman, m.d., 
ph.d., chair and professor of neurology. 
Topics ranged from dyslexia, including 
discussion of such famous dyslexics as 
Harvey Cushing, m.d., to memory loss 
and epilepsy. 
At the alumni meeting that followed 
the brain symposium, Jocelyn S. Malkin, 
m.d. ’51, right (top), received the Distin¬ 
guished Alumni Service Award for her 
contributions as a teacher of students 
and residents, her advancement of the 
field of psychoanalysis and her 
commitment to the Association of Yale 
Alumni in Medicine. 
Vincent T. Marchesi, m.d. ’63, ph.d., 
below (bottom), director of the Boyer 
Center for Molecular Medicine, also 
received the Distinguished Alumni Ser¬ 
vice Award, for his commitment to 
Yale and his research into the proteins 
of the red cell membrane, discoveries 
that are featured in student textbooks. 
Following the alumni meeting, Dean 
David A. Kessler, m.d., led alumni on a 
tour of the Congress Avenue Building, 
still under construction. Alumni climbed 
stairways to floors strewn with piping and 
wiring, while Kessler and John H. Bollier, 
executive director of facilities development 
and operations at the medical school, out¬ 
lined the building’s progress. 
On Friday, the School of Public Health 
observed the Yale Tercentennial by hon¬ 
oring 50 outstanding alumni who have 
had exemplary careers in government or 
community organizations. The 50 were 
named to the eph Alumni Public Service 
Honor Roll at a luncheon at the Lawn 
Club in New Haven. 
This year’s Distinguished Alumni 
Award went to James Hadler, m.d., m.p.h. 
’82, director of the Connecticut Depart¬ 
ment of Public Health’s Infectious Dis¬ 
ease division for almost 20 years. “I have 
one of the best jobs in the world," Hadler 
said in his address to alumni. Although 
he acknowledged the “dark side” of work¬ 
ing in government—the politics that 
sometimes interfere with programs — 
he said his work gives him “the ultimate 
reward, the feeling that what I do makes 
a difference to society.” 
REUNION REPORTS 43 
1941  
I want to thank the School of 
Medicine for a very pleasant 6oth 
reunion this June. It is always nice 
to follow the development of the 
facilities of the school and, more 
important, the achievements of its 
graduates, particularly those of 
classmates. It was great, this year, 
to talk with irv waltman who, 
if I remember correctly, I had not 
seen since the day we were dis¬ 
charged from the Army in 1946. 
I would like to thank the mem¬ 
bers of the Class of 1959 for their 
kind invitation to socialize with 
their group at the clambake, which 
I greatly appreciated. 
PETER A. DUNCAN 
1946 
The highlight of our 55th reunion 
was the traditional gathering at 
Evelyn and marty Gordon’s 
beautiful home on Linsley Lake in 
Branford. As always, the refresh- 
1 ments were lavish and the enter¬ 
tainment began with videotapes 
from previous reunions as far back 
as our 40th. It convinced us that 
we haven’t changed since then 
except, perhaps, in appearance. 
What Miki and Judy, child brides 
ofjIM KLEEMAN andTOM DOE, 
thought of this is not recorded. 
We also saw a tape of tim beck 
receiving the "Human Condition” 
award from the Heinz Foundation, 
which led to other accolades since 
our last reunion, including marty 
Gordon’s Distinguished Service 
Award and leadership of the 
associates of the Medical Library 
andviNNY longo’s rolein 
Pfizer’s development of Viagra — 
fascinating! 
Ourguest of honor was levin 
water’s widow, Priscilla Norton, 
who with Howard Spiro is writing a 
biography of Milton Winternitz, 
former dean of the medical school 
and promulgator of the Yale Sys¬ 
tem. Vivid memories were evoked of 
"Winter” and his pathology course, 
and for some—bill banfield, 
ELI wing,and bill and MOLLY 
albrink—Winter’s influence ex¬ 
tended beyond our graduation. 
the names of class members 
appear in bold. 
Our memories of the World War 
II years were further sparked by 
a recording of our astp marching 
song, MacNamara’s Band, which 
we received via do n s h e d d from 
the NEViLLES.The vocalist couldn’t 
compare with our maestro,tom 
wh elan, but perhaps no one 
could! don shedd polled the 
group to see how many of us wore 
hearing aids and, of those, how 
many were satisfied with them. 
The results would dismay the man¬ 
ufacturers of those gadgets! I was 
able to give our family pediatri¬ 
cian, bert filer,a favorable,45- 
year follow-up on our four kids, who 
were among his earliest patients. 
Those sending regrets due to 
illness or conflicting commitments 
were frank behrle, linus 
CAVE, GEORGE CUSICK.GREG 
flynn,Mary Judd,Muriel Murphy, 
JACK and LAURA NEVILLE, VINCE 
PEPEandBOB WAGNER. 
BILL WEDEMEYER 
1951 
We were a post-World War II class 
that lacked the homogeneity of 
pre-war cohorts at the School of 
Medicine and enjoyed a large 
diversity of age and life experiences. 
The majority were veterans of 
the armed forces who served over¬ 
seas and attained ranks from pri¬ 
vate all the way up to colonel. Of 63 
chosen to enter as first-year stu¬ 
dents, several dropped out early or 
altered course to pursue research 
and graduated with later classes. 
Fifty-two of us graduated in 1951, 
the last of Yale’s "small” classes, and 
then dispersed across the USA to 
resume our war-interrupted lives. 
Our 50th reunion began on a 
bittersweet note as we mourned 
and fondly remembered eight class¬ 
mates who had died since our 
45th reunion, which many of them 
attended.They were frank 
ALLEN,MURIEL BAGSHAW, 
ELEANOR CLAY B IG LE Y, S I D N E Y 
FURST,SUMNER GOLDENTHAL, 
CARROLD IVERSON,ALFRED 
OWRE JR. andjOHN SULLIVAN, 
who, as our secretary since grad¬ 
uation, best embodied the spirit of 
our class. Our condolences and 
best wishes go to their families. 
Any classmate returning to Yale 
for the first time since 1951 must 
have felt like Rip van Winkle awak¬ 
ening! The growth of the physical 
facilities and the size, diversity 
and excellence of the faculty are 
awesome. Yale is well positioned 
to move the frontiers of research 
and patient care forward in the 
new millennium. 
Our major activities during our 
reunion were renewing old friend¬ 
ships, reminiscing, sharing news of 
classmates unable to attend and 
listening to the excellent neurolog¬ 
ical sciences symposium and in¬ 
formative alumni association meet¬ 
ing. We applauded the award 
given to jocelyn malkin for her 
contributions as a medical school 
alumni representative to the parent 
aya and enjoyed meeting her 
mother and children, who were pre¬ 
sent. Classmates and spouses at 
the reunion were tom and Barbara 
AMATRU da, pau l and Polly 
BRUCH,JOHN FILLEY,LOWELL 
and lone Goodman, bob and 
Sonia hamburger, al and 
Cecelia katz, bill and Emily 
KIEKHOFER, JOCELYN MALKIN, 
wally Morgan, al and Donna 
mowlem.jim andJanRiLEY, 
and andy and Irene woNG.The 
medical school administration and 
alumni association treated us like 
vips. We were their guests at both 
the spectacular clambake and the 
elegant reunion dinner. 
john groel, bob and Dawn 
adams, john and Ruth berg, 
larry Harris,john and Mary 
Lou HAXO.and brad and Ruth 
straatsma could not attend and 
expressed their regrets, brad 
was invited to be the opening-day 
speaker at an international con¬ 
gress of ophthalmology in Istanbul 
on the same date. We agree with 
his choice and send congratulations 
for the honor he received. 
We left Yale Medical School with 
a renewed and increased respect 
for our school and the friendships 
we formed more than 50 years 
ago. Finally, on behalf of the class 
I would like to thank lowell 
Goodman for his efforts over 
many years as our class agent for 
the annual alumni fund drive 
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44 Alumni REUNION 2001 
and art pava for chairing the 
50th reunion gift fund. It is an 
always difficult and often thankless 
job to solicit money, no matter how 
important and wonderful the cause. 
THOMAS T. AMATRUDA JR. 
1956 
For the Class of 1956 it was a great 
reunion weekend. Of the remain¬ 
ing 66 classmates, 24 came back to 
New Haven. We all agreed we 
caught the golden age of medicine 
and that Yale was the best possi¬ 
ble entrance into that golden age. 
On Friday night the downings, 
for the fourth time, hosted an ele¬ 
gantly casual buffet at their 
home in Guilford. 
Saturday, the school’s activities 
were capped by a formal banquet 
at the Ouinnipiack Club. With most 
of the class in retirement, numer¬ 
ous addresses and invitations for 
visits were exchanged.The class 
wishes to thank Dean Kessler and 
the staff of the alumni office for 
their effort to make us feel welcome 
and have things run so smoothly. 
Attendees included levon and 
Gloria BOYAJIAN, ROSALIE 
burns, edwin and Barbara 
child, james and Tina collias, 
don and Leanne (MacDoughall) 
dalessio,steve and Helen 
downing, mitchell and Janet 
edson,gilbert and Rona 
eisner,tom and Carol FERRIS, 
JOHN and ArneGARDNER,SUM¬ 
NER and Shayna gochberg, 
ROBERT GROVES,CHARLES and 
Joan HOPPER, MARY LOUISE 
and Ken Johnson, Jerome and 
Linda klein,william and Gloria 
lewit, preston and Jane 
manning,dwight and Carol 
miller, donald and Anna Marie 
NALEBUFF,FREDERICK NORTH, 
david and Eleanor page,Robert 
scheig, james and Ruth 
scheuer,and Stanley and 
Anne (Falk) simbonis. Last- 
minute regrets were sent by bob 
and Joan hill,gary and Karen 
fry,joe and PattiecERNY.and 
bill and Jane o’brien. 
DWIGHT F. MILLER 
1961 
Our 40th reunion went very well. 
Attendees included victor and 
Laura altshul, kenneth and 
AnneARNDT.EARLand Kranie 
baker, robert and Joyce 
BRIGGS,DAVIDand Judith BROOK, 
chris and Susan Durham, john 
and Natalie fenn, david and 
Marcia Griffith, Bernard 
kosto, Ellen Levy,george and 
Christa lordi,vincent and 
Sally MARCHESI.ANOUSH 
MIRIDJANIAN, ROLAND and 
Grazina PAEGLE, ELAINE PITT, 
william and Melba rogoway, 
roy ronke,shaun and Millicent 
RUDDY, ROBERT TAUB, 
franklin and LoisTOP.and 
warren and Myra widmann. 
Ellen Levy presented to Yale the 
funds to endow a professorship, 
the Robert levy Chair in Preven¬ 
tive Cardiology.This substantial 
gift had been raised from family, 
friends and supportive companies. 
Eight other classmates spent 
much time writing suggestions for 
a class seminar entitled “If You Had 
to Go to Medical School again, What 
Changes in the Curriculum Would 
You Recommend?"Their efforts 
culminated in a 22-page handout. 
Our alumni suggestions may help 
expand the horizons of the Edu¬ 
cational Policy Curriculum Commit¬ 
tee (epcc) of the medical school. 
The committee consists nearly en¬ 
tirely of in-house academics.The 
four student representatives to the 
epcc cannot be expected to be 
familiar with practice problems 
either. Since most Yale graduates 
eventually enter private practice, 
alumni advice is quite relevant. 
VINCENT MARCHESI hosted 
the class meeting at the Boyer 
Center for Molecular Medicine on 
Saturday. It was noted that 
research and clinical practice have 
grown so much at Yale that support 
for teaching, although strong, has 
fallen behind. How to encourage 
good teachers became the topic 
around some class dinner tables at 
the Ouinnipiack Club, and at Sun¬ 
day breakfast, Lois and frank 
top suggested that our class con¬ 
tribute funds to reward excellence 
in teaching. Others pointed out 
that identifying a single best 
teacher of the year can be difficult 
and that a student survey may turn 
intoa popularity contest, vincent 
suggested that alumni arranging 
to take a medical school class to 
dinner with their best teachers 
would provide more widespread 
recognition for the dedicated fac- 
ulty. BILL ROGOWAY,our class 
reunion gift chairman, indicated to 
roland that alumni could desig¬ 
nate their donations also for the 
above-mentioned purposes. 
ROLAND PAEGLE 
1966 
Practicing half-time, detesting air¬ 
lines, having a pretty good car, early 
on Wednesday, May 30,1 headed 
east with CDs of late string quartets 
of Beethoven and a lengthy audio 
book. Reached New Haven mid¬ 
afternoon Thursday. Walked a lot. 
Saw long-ago familiar buildings re¬ 
cycled. Gas stations seem to endure. 
Yale has not so subtly expanded. 
Medical school tuition is now 
$3oK per year, $soK with expenses. 
Wow! In nominal dollars my class 
got the whole package for what 
would buy a few months today. 
... Did we live in the golden age, 
or what? 
Friday night, under holding sky, 
there was a clambake on the 
Harkness dorm lawn. Very pleasant. 
Lots of raw oysters and clams on 
the half shell. They must be med¬ 
ically safe. Overcooked steaks and 
perfect steamed lobster followed. 
As I was slurping half-shell 
critters, I felt a hand on my arm. I 
glanced right. It took 200 milli¬ 
seconds. Someone I had not seen 
in 35years. I proclaimed,“mary 
alice,you haven’t changed a bit!” 
Wryly smiling, mary alice 
bernet houghton replied,"Nei¬ 
ther have you!” 
Saturday morning there were 
impressive presentations on neuro¬ 
science. From the behavioral to 
cellular to genetic level. Gee-whiz 
computer graphics. I recall how 
legendary Professor of Pathology 
Liebow had chalk and a blackboard, 
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and a stick pointer as tall as himself 
to flail feckless interns who dropped 
the slides. Probably a good thing 
he didn’t have a laser. 
Saturday evening the class din¬ 
ner was held at an Italian restau¬ 
rant on the outskirts of New Haven’s 
Little Italy, in the shadow of Inter¬ 
state 91, unpretentiously named 
Adriana’s Restaurant. It turned 
out to be very nice. Mythic thirteen 
sat at table. 
During the early part of dinner, 
who should show up but Dean 
Kessler accompanied by two keep¬ 
ers, ladies from the alumni office. 
It reminded me of our beloved 
president, also with a Yale connec¬ 
tion, making the rounds of inau¬ 
gural balls. 
The members of the class of 
’66 (Latin, sextiest-sex), no shrink¬ 
ing violets, offered opinions 
and observations.The dean was 
reminded that he was going to 
have to feed that really big build¬ 
ing. And, was he doing the new 
graduates and the world any favor 
by sending the newbies out on 
graduation day $iooK negative? 
At dinner, and before, various 
class members briefly recited their 
current status. 
As I heard it: 
rey spector, after a distin¬ 
guished (rey is modest; this is my 
estimate) career including the Uni¬ 
versity of Iowa and Merck, is now 
semi-retired with several medical 
school appointments. He is build¬ 
ing a dream house in Colt’s Neck, 
N.J. He and wife Michiko are cur¬ 
rently having a memorable motel 
stay while getting a hard-knocks 
course in contractor delays and cost 
overruns. If anyone has a magic 
answer, rey is having cervical and 
lumbar disc problems and getting 
fed up with conservative therapy. 
JOHN and MARIAN MATHEKE 
melish, in from Honolulu, report 
that everything is not heavenly in 
paradise. Even though Hawaii has 
a unique health care funding sys¬ 
tem, gaps abound, and it sounds 
like they work pretty hard. When I 
mentioned to john some roof 
leaks I had this past winter, I was 
told Hawaii has industrial-strength 
termites that specialize in eating 
roofs. Marian also reports football 
linesman cockroaches play soccer 
with full size ball in kitchen late 
at night. 
MARY ALICE BERNET HOUGHTON 
and husband Bill (m.d. '64) are 
both still practicing psychiatry in 
Milwaukee. I understand psychic 
insight is little help in raising chil¬ 
dren, and traditional methods 
(scream and kickass) were used. 
ARNE YOUNGBERG,Senior 
radiologist in his group in Water- 
bury, is the group mammographer. 
He expects to hang it up in the 
near future. He was especially 
looking forward to a fishing trip 
in Patagonia. 
PETER GIBBONS, with Wife 
Christina, was here. He is a radiolo¬ 
gist in Brattleboro, Vt. He noted 
radiology, long somnolent after 
sunset, has become increasingly 
24-hour, a significant burden. 
jim brown, in medical oncol¬ 
ogy, from Middletown, also 
dropped in with wife Pat for the 
last night’s dinner. He looks five 
years older than he did in 1966. 
Still going strong. 
EUGENE P. CASSIDY 
1971 
The 30th reunion of the Class of 
1971 was attended by 29 of our 
class members: Drs.cates, cohn, 
COSSMAN.EISEN FELD, FOSTER, 
GARDNER, KINDER, KLEEMAN, 
KLEIN, KRINSKY, LIPPMAN, 
MENDEN-REESE, MILLER, MILLS, 
MIN I HAN, MOGGIO, MORGAN, 
PATTI, PERLMAN, RAND, 
RAPHAEL, R I NZLER, STEWART, 
TRAVERS,TSALBINS.VAUCHER, 
vignola, weihl and WOOD- 
HEAD. The class dinner was high¬ 
lighted by Dr. foster’s sartorial 
creativity and the dean’s visit. It is 
not true that Dr. Kessler was seen 
smoking on the 17th green. 
BARBARA KINDER graciously 
invited us to her lovely Branford 
home fora delicious brunch. Alice 
o’neill was lovingly remem¬ 
bered and an initiative for an 
annual lecture in her honor was 
discussed.joan menden-reese, 
a Brown/ Pembroke classmate, 
will share this idea with Alice’s 
family.DAViD li ppm an, unable 
to attend the Saturday dinner 
because of his daughter’s gradua¬ 
tion, gave yet more puzzles to pon- 
der.The solution to the puzzle— 
what do the words pact, vandal, 
floral, calamari, Coca-Cola, etc., 
have in common?—is that they 
are composed exclusively of the 
two-letter state abbreviations, e.g., 
pact = Pennsylvania (PA) + Con¬ 
necticut (CT). An unanswered query 
is what common medication can 
also be so composed. The answer 
will be given at the 35th reunion. 
See you there. 
DAVID LIPPMAN 
1976 
Outstanding 25th reunion, a trib¬ 
ute to the vitality and youthful¬ 
ness of our class! Delightful Friday 
night clambake, Saturday lunch 
and filled-to-capacity, delicious 
Saturday dinner at Zinc. Class¬ 
mates and family came from as far 
away as Buenos Aires (richard 
low) and California (dvora cyr- 
LAK, RANDY HAWKINS and 
SUSAN RYU). 
Attending were sarah auch- 
incloss (private practice psychia¬ 
try, NYC) and son Andrew; 
ALFREDO AXTMAYER (private 
practice orthopaedics, Wallingford, 
Conn.), wife Pat and daughter 
Caitlin;sharon bonney (associ¬ 
ate director clinical research, Pfizer, 
New London, Conn.) and husband 
Jim; Florence comite (Concen¬ 
tric Medicine, New Haven) and 
partner Jonathan Goldstein; 
dvora cyrlak (professor of radi¬ 
ology, University of California at 
Irvine) and husband Neil; vinnie 
dicola (private practice cardiol¬ 
ogy, New Haven); ken DOBULER 
(chair, Department of Medicine, 
Griffin Hospital, Derby, Conn.) and 
wifeSue;TODD estroff (psychia¬ 
try, Atlanta); Stephen GOLDFIN- 
ger (psychiatry, New York); rose 
Goldman (director of occupa¬ 
tional and environmental health, 
Cambridge Hospital, and associate 
professor at Harvard) and husband 
Alan; randy hawkins (private 
practice neurology, San Diego) 
and wife Penny; richard kayne 
(private practice endocrinology, 
Cheshire, Conn.) and wife Maria; 
norm kohn (private practice psy¬ 
chiatry, Chicago); b 1 ll levy (pri¬ 
vate practice cardiology, Abington, 
Penn.) and wife Karen (m.d. '77). 
Also, RICHARD LOW (CEO, 
lnfor*Med Corp., Buenos Aires and 
Woodland Hills, Calif.) and wife 
Isabel; sid mandelbaum 
(ophthalmology, NYC) and wife 
DianeOshin;CiNDY mann (pri¬ 
vate practice pediatrics, Hamden, 
Conn.); doug mann (private 
practice ent, Media, Pa.); rich 
pelker (professor of ortho¬ 
paedics, Yale); susan ryu (oph¬ 
thalmology, Palo Alto, Calif.); 
larry samelson (chief,Labora¬ 
tory of Cellular and Molecular Biol¬ 
ogy, NCl); RICHARD SCHOTTEN- 
feld (professor of psychiatry, Yale, 
and the new master of Davenport 
College); PETER SWANSON 
(family practice, Shelton, Conn.); 
charlie swenson (associate 
professor of clinical psychiatry, 
University of Massachusetts); bob 
taylor (oncology,Milwaukee); 
peter ting (anesthesia, Dover, 
Mass.); john wiles (private prac¬ 
tice dermatology, New London, 
Conn.) and wife Joan; and carol 
ziminski (associate professor 
of medicine, Johns Hopkins) and 
husband Terry. 
Classmates responding but 
unable to attend were bill 
bithoney (physician-in-chief and 
chair of pediatrics, St. Joseph's 
Children's Hospital, Paterson, N.J.); 
Roger boshes (assistant profes¬ 
sor of psychiatry, Harvard at Fall 
River, Mass.); Helen chang (pri¬ 
vate practice ob/gyn, Poway, Calif.); 
Joseph ciabattoni (retired this 
summer from internal medicine 
practice, Rhode Island); john 
Clemens (director, International 
Vaccine Institute, Seoul, and hus¬ 
band of classmate bonnie stan- 
ton);candace corson (lecturer 
on nutritional medicine, Granger, 
Ind., and married to George 
Knowles, m.d.’75); mark cullen 
v
a
le
 
M
ed
ic
in
e 
a
u
tu
m
n
 
20
01
 
46 Alumni REUNION 2001 
(professor of medicine and public 
health and director of occupa¬ 
tional medicine,Yale);J0HN elef- 
teriades (professor and chief 
of cardiothoracic surgery, Yale); 
carol epstein (co-founder, 
MediVector Inc., Cambridge, 
Mass.); RICHARD frank (private 
practice psychiatry, Milwaukee); 
ira cewolb (professor of pedi¬ 
atrics, University of Maryland); 
clenn harder (retiredfrom pri¬ 
vate practice of plastic surgery in 
1992,Weston,Mass.);pam Her¬ 
bert nagami (internal medicine 
and infectious disease. Southern 
California Permanente Medical 
Group, Woodland Hills, Calif., and 
married to Glenn Nagami, m.d. 
'78);clarion Johnson (medical 
director, Exxon Mobil, Fairfax Va.); 
david kawanishi (private prac¬ 
tice cardiology, Mission Viejo, 
Calif.); RICHARD kremer (ceo, 
Forward Associates, consulting in 
health care claims and negotiating 
facility fees, Williamsburg, Va.); 
carol lee (professor of radiology, 
Yale);DAN rahn (as of June the 
president of Medical College of 
Georgia, Augusta); norm rizk 
(professor of medicine, director 
of medical icus and senior associ¬ 
ate dean for research, Stanford); 
dan schuster (professorof 
medicine and radiology and asso¬ 
ciate dean for clinical research, 
Washington University); dirk 
sostman (professor and chair of 
radiology and senior associate 
dean for clinical affairs, Cornell); 
Bonnie stanton (chair of pedi¬ 
atrics, West Virginia University, 
Morgantown, and married to 
classmate john clemens);jack 
tauber (private practice 
orthopaedics, Beverly Hills); and 
jerry zeldis (chief medical 
officer, Celgene Corp., Warren, N.J.). 
Excellent to share the weekend 
with so many of you and to see 
that we are thriving in life and our 
careers. Our camaraderie remains 
great, and I hope that we can keep 
in contact and succeed in seeing 
each other more often. Start plan¬ 
ning for the 30th reunion now! 
Many thanks to my wife, Maria, 
who did almost all of the reunion 
work for us. 
RICHARD KAYNE 
1981 
The good news is that we had a 
wonderful time and everyone in 
our class looks the same as we did 
20 years ago.The weekend was a 
little wet, but that did not prevent 
us from catching up and sharing 
the events that have occurred in 
our medical and social lives. 
dave lebwoh l was there the 
first night for the clambake. He lives 
with his wife and two children in 
Connecticut, dave is working on 
drugs similar to Tamoxifen for can¬ 
cer treatments, erik fisher. 
always kind and understanding, 
runs a county psychiatric clinic in 
Oregon for the severely mentally 
ill. He believes that multidiscipli¬ 
nary practice is the best way to 
treat such patients and he works 
towards teaching them to live 
independently. He and his wife live 
in Eugene and he bicycles to work. 
DAVID GENDELMAN, his wife, 
Deborah Zuckerman, and I are hop¬ 
ing to coordinate our families to 
meet on a bicycling trail in Lexing¬ 
ton, Mass, dave is an ophthalmol¬ 
ogist working at Mass. Eye and Ear 
and his wife is a dermatologist.They 
have two boys and a girl (Isaac, Han¬ 
nah and Jacob) and a very quiet 
household no doubt, dovelet 
shashou is also an ophthalmolo¬ 
gist, specializing in pediatrics at 
Manhattan Eye and Ear. She drove 
up from New York with her hus¬ 
band, Jonathan Trambert, who is an 
interventional radiologist.They 
have two children—Steven, 11, 
and Emily,8. lisa babitz and 
STEWART GREISMAN WOrk in 
Manhattan.They took over stew- 
art’s father’s internal medicine 
practice after completing their res¬ 
idencies at Yale-New Haven. She 
specializes in geriatrics and he in 
rheumatology, lisa was the sec¬ 
ond resident at Yale to have chil¬ 
dren during the residency. Her old¬ 
est is Laura, 17, followed by Jill, 13, 
and Jack,9. Barbara roach and 
Rick Carroll are in practice at Yale- 
New Haven. Both are rheumatolo¬ 
gists. They have two children, 
Matthew, 13,and Emily, 10.They live 
in Hamden.cyndy and Raymond 
aten were both in attendance. 
cyndy has most recently practiced 
medicine at Yale and Wesleyan and 
is opening a private practice in 
New Haven.They are perhaps the 
first grandparents in our class. 
Hopefully we will all have that 
wonderful experience.david lu 
and his wife, Susan, are now living 
in david’s hometown (and mine), 
Washington, D.C. david is a cardi¬ 
ologist and has three children, 
Bobby, 15, Becky, 14, and Matthew, 7. 
He seemed happy and prosperous. 
bill hunt has not lost his sense 
of humor. He attended the reunion 
with his wife, Jan. He is in private 
practice in neurology at Bridgeport 
Hospital.They have three children, 
Diane, 14, Stephen, 12, and Gregory, 
10, all with great nicknames. 
Charles SHANAisa gastroen¬ 
terologist in Newport, R.I., and Fall 
River, Mass. He has a lovely wife, 
Miriam, and two children, David, 
io,and Philip,8.pat burke is 
married to Jolin Proffitt and is 
home with her 8-year-old twin 
boys. She is an internist and they 
reside in Downes Grove, III. 
I am still recovering from the 
fact that I graduated from medical 
school 20 years ago. I admit the stu¬ 
dents that I spoke to did look young, 
lama surgeon at the Brigham and 
Women’s Hospital, where I special¬ 
ize in the treatment of breast can¬ 
cer. I am married to Randall Ken¬ 
nedy, J.D.’82. We have three chil¬ 
dren, Henry, very 6, and Rachel and 
Thaddeus, both very two and a half. 
I see and hear about lots of our 
classmates from time to time. 
TROY BRENNAN,TOM KUPPER. 
DON INGBER and JOAN 
bengston all roam the halls at 
this institution. I have also heard 
great things about ada adimora, 
JUANITA MERCHANT and JANE 
asch. I am hoping this letter will 
entice them and others to attend 
our next reunion. Goodbye for now. 
yvedt matory 
1986 
The Class of 1986 reunion wel¬ 
comed DANIEL FIERER.JEREMY 
holtzman and his wife, Janet 
Mills, dae and Judy song, eric 
and Pamela suan.Catharine 
ARNOLD. ROBERT KINNEY. 
ROBERTO LEWIS-FERNANDEZ 
and his wife,Maria Almeida, john 
and Caroline wysolmerski,and 
betty klein back to New Haven. 
Food and drinks were again the 
starting point for reliving stories of 
anatomy lab, practical jokes and 
softball games, catching up on 
current news and sharing gossip 
of classmates unable to attend. 
daniel is in NYC focusing on 
aids research at Mount Sinai. 
jeremy continues his work in 
internal medicine and health care 
research at the University of Min¬ 
nesota. Ophthalmology was well 
represented this year, dae has 
started his own private practice in 
general ophthalmology in Selma. 
Ala. eric is in private practice in 
Baltimore, specializing in the 
retina, betty,our reunion chair, 
also specializes in the retina in Red¬ 
ding,Conn.Catharine is balanc¬ 
ing her career in rheumatology 
with shuttling her kids to various 
activities in Guilford, Conn, rob 
has the most sane position of all, 
serving as medical director for an 
insurance company in Hartford. 
john remains on the faculty at 
Yale in the endocrine section of 
the Department of Medicine. 
roberto has returned to the 
mainland from Puerto Rico, prac¬ 
ticing psychiatry at Columbia 
Presbyterian in New York. 
The most refreshing conclusions 
over the weekend were that none 
of us has changed a bit in outward 
appearance—although inside we 
are all a lot wiser.The group’s major 
regret was that we did not see more 
classmates in attendance. For 2006, 
if you are not here to deny rumors, 
rumors will turn into truths! Hope 
to see you all for the 20th in 2006! 
eric p. suan 
1991 
The Class of 1991, regarded by some 
as Yale’s greatest, reunited with 
characteristic largesse in numbers 
and spirit. While many were able 
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to be at the Friday evening dam- 
bake, all attended the dinner on 
Saturday night, which was held at 
Chateaux Leaubeau. In attendance 
werePETER Bernstein and wife 
Cathleen Barnhart; elizabeth 
bower and daughter Mara Leo; 
marcus butler and partner 
Christopher Yulo; cynthia car¬ 
ver smith with husband David 
Smith and family; douc Fleming 
with wife Robin Buckingham and 
family;DAViD frankfurter and 
family. wENDY grant with her 
husband, Steve Bowers, and son Ian; 
JEANNE HAIMOVICI ACKMAN 
with husband Robert Haimovici 
and family;CARL "The Good” 
HENNINGSON;LARRY HIRSCH 
and Gaetane Francis; Liz holt; 
doris iarovici with husband 
Larry Katz; John k i lty with wife 
Pat Janowski and young Joe Kilty; 
TOM LIN;PETER MARCUSand 
wife Lyree (family back home in 
Indiana); funda meric; jane 
MINTURN; MEG STEVENS 
o’neill and husband Michael; 
marc potenza and wife Susan 
Smith; liz roth; dan saal (fam¬ 
ily back home in California); jeff 
schechner and wife Christina 
Herrick; laurie shaker-irwin; 
james stanislaw and wife Ali¬ 
cia (family back home in North 
Carolin-);stacy beller stryer 
and husband. Dan Stryer (m.d. '90, 
poorfellow);DAVID utzschnei- 
der and wife Gordana, with young 
Nikiand Eva;and marco verga 
with wife Wendy. In addition, we 
were honored by a visit from Dr. 
Morris Dillard, whom many of us 
knew and loved as director of the 
Wednesday Evening Clinic. Mes¬ 
sages with regrets came from 
marc agronin (whose envelope 
art ensured that everyone opened 
their invitations), daryl Daniels, 
rick ihnat.ann denehy 
SMITH,BOB SPILLANE.SYM- 
phorosa williams,and,just 
now, Jim hicks. Last-minute 
regrets came from kent min and 
ELLEN MARKSTEIN GELLERand 
husband David.colleen foy 
could not make it but sent e-mail 
photos (which presided over the 
kitchen Saturday night) of herself 
with husband Craig Sterling and 
theiryoung son. And steve 
ugent revived the"Uge, Uge, 
Uge” chant during a hilarious tele¬ 
phone call Saturday afternoon. 
Finally, I must thank the Office 
of Alumni Affairs for makingthe 
dinner at my house possible and for 
arranging catering from the incom¬ 
parable Adriana’s Restaurant, one 
of New Haven's greatest culinary 
gems. I think it fair to say that every¬ 
one had a fabulous time at reunion. 
They seem to be getting better 
exponentially. So start thinking 
now about 15! 
FRANCIS M. LOBO 
1996 
This year’s fifth reunion class had a 
bumper crop of attendees. Many 
were still in New Haven doing resi¬ 
dencies and fellowships. However, 
our congratulations go to wolffe 
nadoolman, who came all the 
way from Berkeley, Calif., to join 
the gang. Both of the poggis 
came with their lovely 3-month- 
old daughter, Eliza. Those of us 
who have not yet attempted par¬ 
enthood,such as KATHLEEN 
FIGARO and LYNNE STRASFELD, 
fellows in NYC, had impromptu 
lessons on holding and soothing 
this open and elegant infant during 
the clambake.She and rebecca 
CRICHTON andsiMON COR- 
nelissen’s infant son were pic¬ 
tured together in what could be 
the youngest second-generation 
pairing of the class of 2026. ranya 
harvey, who made a brief visit to 
the clambake, is now a practicing 
pediatrician, peter ferren had 
come back to New Haven to do a 
fellowship at the Yale Child Study 
Center before possibly heading 
back to Atlanta, jon grauer and 
JOHN beiner, both orthopods 
at Yale,and jeff meyerhardt 
hung around, much like old times. 
JULIE (ROTHSTEIN) ROSENBAUM 
came with her husband, and 
susan truman and husband 
brought their two children, lisa 
Sanders did not bring her little 
ones to dinner, sarah clever, 
who is now an RWJ Clinical Scholar 
at U. of Chicago, breezed in late to 
reunion in order to finish recruit¬ 
ing some patients to her most 
recent study. She and I took in the 
tour of the Yale Center for British 
Art and had great fun. 
The dinner at the Graduate Club, 
where we were sponsored by the 
50th reunion class, was lively and 
intimate. We sat at two tables and 
discussed the difficulties of our res¬ 
idencies and our hopes for the 
future. In a surprise move, ng ho, 
who had been an ER resident, de¬ 
cided to become a Wall Street 
mogul and is now in the e-health 
section of drug giant Pfizer. Not so 
surprisingly,owen garrick,who 
was not there, is also on Wall 
Street at Goldman Sachs, also in 
the technology sector, ng s hus¬ 
band, actually Class of 1995, came 
to dinner with us. He is now a chief 
resident in plastics at Yale, marty 
m ays e, a fellow at Yale, also came. 
monica medynski sat glowing 
next to her new husband, Neil, pre¬ 
viously a Yale radiology resident, 
happy with her choice of radiology. 
Most of us seemed quite content 
with our choices in medicine, and 
many of us look forward to our 
next reunion when we can see 
each others’families growing. 
People we missed: Although 
these people were in New Haven, 
they did not make the reunion and 
were sorely missed, duane bryan 
is currently a physician at Yale Com¬ 
munity Health Clinic, and basem 
jassin isfinishing his surgical res¬ 
idency,as iSTONY PHAM.DAVID 
kim is a radiation oncologist. 
dana loo is a chief resident of 
medicine;jAviER davila is also 
in medicine at Yale. Most of the 
New York crowd did not make it: 
tim Johnson is currently finish¬ 
ing up ortho at Hospital for Special 
Surgery;Rachel Villanueva 
and clara lee are conquering 
ob/gyn and surgical residencies, 
respectively, at New York Presby¬ 
terian. LILLIAN OSHVAhaS 
finished ER at Bellevue, where she 
is now an attending doing clinical 
research, david lee and everett 
hsu are both married and living in 
California. Where are you, nelson? 
KATHLEEN FIGARO 
More on the Web 
info.med.yaie.edu/ymm 
For more photos from 
Alumni Reunion Weekend, 
please visit our website 
and select extras. 
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NOTES 
1960s 
JOSEPH F.J. CURI,M.D.’64, 
reports that he is "still in a solo pedi¬ 
atric practice after 31 years. My 
son, Michael, received his m.d. 
from UConn and is in a pediatric 
residency in Virginia. Anne has put 
her Harvard law degree aside 
and is a professional duo-athlete. 
Sarah, a part-time lawyer, is get¬ 
ting her m.p.h. at Harvard. Kath- 
eryn is studying for her m.a. in 
mental health counseling and is a 
professional mountain biker in 
Vermont. I thoroughly enjoyed rep¬ 
resenting the medical school at 
the Tercentennial weekend.” 
RALPH S. GRECO, M.D.'68, HS'73, 
was appointed the Johnson & 
Johnson Distinguished Professor 
and chief of the Division of General 
Surgery at Stanford University 
School of Medicine, where he is 
also director of the General Surgery 
Training Program. After complet¬ 
ing his surgical training at Yale, 
Greco spent two years in the U.S. 
Army Medical Corps in Seoul, Korea, 
and Fort Meade, Md., and then 
joined the faculty at the former Rut¬ 
gers Medical School. He became a 
full professor there in 1983, three 
years before the school changed its 
name to the Robert Wood Johnson 
Medical School. Greco was 
appointed chief of surgery at 
Robert Wood Johnson University 
Hospital in 1996. His clinical inter¬ 
ests include pancreatic surgery, 
surgical oncology and endocrine 
surgery. He has long pursued 
research directed at elucidating 
the response of host cells, namely 
neutrophils, to nonbiological 
surfaces utilized in biomedical 
implants and devices. Greco, his 
wife, Irene Wapnir, m.d., and 
their three children moved to Palo 
Alto, Calif., in August 2000. 
AUGUSTUS A. WHITE III.M.D., 
ph.d., HS '66, was recently 
appointed master of the Oliver 
Wendell Holmes Society, one of 
four academic societies at Harvard 
Medical School. As master, his goal 
is to help educate students to be 
excellent scientists and clinicians 
who will provide compassionate 
care to all of their patients, while 
preserving their own well-being in 
order to serve happily for many 
years. White, who focuses on the 
spine, is a professor of orthopaedic 
surgery at Beth Israel Deaconess 
Medical Center and a member of 
the Health Sciences and Technology 
faculty at Harvard Medical School. 
He also served as orthopaedic sur¬ 
geon-in-chief at Beth Israel Hospital 
for 13 years.The American Ortho¬ 
paedic Association honored White 
in June in Palm Beach, Fla., by nam¬ 
ing him the Arthur R.Shands, Jr., 
Lecturer, for outstanding contribu¬ 
tions to the orthopaedic profession. 
He delivered a lecture titled "Our 
Humanitarian Orthopaedic Oppor¬ 
tunity," in which he described the 
serious racial disparities in health 
care in the United States, which he 
attributed to racial bias. He spoke 
about the history of this phenom¬ 
enon and challenged his audience 
to try to eliminate health care dis¬ 
parities for society's well-being. 
197OS 
MICHAEL L.J. APUZZO, M.D., HS 
'73, received the William Beecher 
Scoville Prize from the World Feder¬ 
ation of Neurosurgical Societies at 
the opening ceremonies of the Sep¬ 
tember 2001 World Congress in Syd¬ 
ney, Australia.The prize is awarded 
to a neurosurgeon who has made 
a principal contribution to the art 
and science of neurosurgery on an 
international scale. William Sco¬ 
ville was a Yale neurosurgeon who 
made numerous contributions and 
innovations in the field while being 
active in globally organized medi¬ 
cine. Apuzzo was a pupil of Scoville’s 
and is now the Edwin M.Todd/ 
Trent H. Wells, Jr., Professor of Neu¬ 
rological Surgery and Radiation 
Oncology, Biology and Physics at 
the Keck School of Medicine of the 
University of Southern California 
in Los Angeles. He was honored for 
his work in introducing modern 
aspects of cellular and molecular 
biology to the operative armamen¬ 
tarium, as well as for his advocacy 
of the international exchange of 
ideas and unified global education. 
ATTILIO VINCENT GRANATA, M.D. 
’77, an associate clinical professor 
of medicine at Yale, was elected to 
the board of directors of the Citi¬ 
zens for Patients' Rights at the 
group’s July 19 meeting. Citizens 
for Patients' Rights is a grassroots 
organization dedicated to educat¬ 
ing and empowering the public to 
deal with problems in the health 
care system. In addition to his aca¬ 
demic practice, Granata is a con¬ 
sultant to a number of national 
and international clients on health 
care issues, such as strategic plan¬ 
ning, cost-effectiveness analysis 
and quality-of-care planning. He is 
president and ceo of Health Care 
Consulting Practice in Orange, 
Conn. Granata served his residency 
in internal medicine at Stanford 
University Medical Center and also 
completed an m.b.a. as a Palmer 
Scholar at the Wharton School of 
the University of Pennsylvania in 
1994. He serves on the Health and 
Public Policy Committee of the 
American College of Physicians. 
In a biographical sketch for the 
Centers for Disease Control and 
Prevention (cdc), daniel a. 
pollock, m.d. ’79, described a 
change in his career asfollows:"ln 
my work [as an emergency physi¬ 
cian], I saw the same injury types 
again and again and again. As a 
result, I thought it would be impor¬ 
tant to learn injury demographics 
and causes, and to find ways to 
prevent injuries, instead of contin¬ 
ually treating them and trying to 
limit their effects.”This conviction 
led him from a position as an in¬ 
structor of clinical medicine at New 
York University School of Medicine 
to a stint in the Epidemic Intelli¬ 
gence Service of the cdc in 1984. For 
two years, he worked on the Agent 
Orange Projects. He then continued 
within the cdc to become the team 
leader of the Acute Care Team with¬ 
in the National Center for Injury 
Prevention and Control (ncipc). 
Since 1999, he has served as the 
acting director of the ncipc’s Divi¬ 
sion of Acute Care, Rehabilitation 
Research, and Disability Preven¬ 
tion, which provides national lead¬ 
ership in preventing and minimiz¬ 
ing the impact of nonoccupational 
injuries. His goal is to engineer a 
shift in the way medicine is taught 
and researched toward a popula¬ 
tion orientation that includes pre¬ 
vention and complements the clin¬ 
ical approach of treating one 
patient at a time. 
198OS 
INA S. CUSHMAN, PA ’86, Was 
elected president of the American 
Academy of Physician Assistants. 
She has held a variety of other 
positions within the organization 
in the past. She is a senior physi¬ 
cian assistant with Harvard Van¬ 
guard Medical Associates, a pri¬ 
vate practice group providing hmo 
as well as fee-for-service care. 
Cushman works out of the 
Braintree, Mass., center, but con¬ 
sults and teaches throughout 
the organization and around the 
country. She pioneered a nation¬ 
ally recognized wound care pro¬ 
gram and contributed three chap¬ 
ters to the second edition of 
Telephone Medicine: Triage and 
Training for Primary Care. She was 
also honored by United Airlines 
for her treatment of a fellow pas¬ 
senger in cardiac crisis. 
MICHAEL SIMONS, M.D.’84, HS 
’87, has been appointed the Anna 
Gundlach Huber Professor of Med¬ 
icine and chief of the Section of 
Cardiology at Dartmouth Medical 
School. He moved to Dartmouth 
from Harvard Medical School, 
where he was an associate profes¬ 
sor of medicine and director of the 
Angiogenesis Research Center at 
Beth Israel Deaconess Medical 
Center. Simons transported his 
entire lab northward, including 
almost 20 researchers and $2 mil¬ 
lion a year in funding from the 
National Institutes of Health, the 
American Heart Association and 
industry sources. His research in 
angiogenesis focuses on the use of 
a growth factor called PR39 to 
stimulate blood vessel growth. 
SEND FACULTY NEWS TO 
Claire Bessinger, Yale Medicine, 
P.O. Box 7612, New Haven, CT 
06519-0612, or via e-mail 
to claire.bessinger@yale.edu. 
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50 in memoriam 
DONALD i. COHEN, M.D.'66, 
director of the Yale Child Study 
Center and Sterling Professor of 
Child Psychiatry, Pediatrics and 
Psychology, died October 2 after 
a year-long illness. He was 61. 
Cohen graduated from the 
School of Medicine in 1966, joined 
the Yale faculty in 1972, and in 1983 
became director of the Yale Child 
Study Center. Under his leadership 
the Child Study Center became 
internationally recognized for its 
multidisciplinary programs of clini¬ 
cal and basic research, professional 
education, clinical services and 
advocacy for children and families. 
Cohen’s clinical and research activ¬ 
ities focused on developmental 
psychopathology of the serious 
neuropsychiatric disorders of child¬ 
hood, including autism, pervasive 
developmental disorders and tic 
disorders such as Tourette’s syn¬ 
drome. His leadership in the study 
of the impact of violence on chil¬ 
dren and families created a world¬ 
wide network of collaborators. 
Cohen published more than 
400 articles, chapters and books. 
He served as president of the 
International Association of Child 
and Adolescent Psychiatry and 
Allied Professions, chair of the pub¬ 
lications committee and vice presi¬ 
dent of the Board of Governors of 
Yale University Press, co-chair of 
the Child Health and Development 
Institute, international president 
of the Telefon Azzuro Foundation 
in Italy and chair of the interna¬ 
tional advisory committee of 
the Schneider Children’s Hospital 
of Israel. 
He was a member of the Insti¬ 
tute of Medicine of the National 
Academy of Sciences and a train¬ 
ing and supervising psychoanalyst 
at the Western New England Insti¬ 
tute of Psychoanalysis. He received 
numerous awards, including an 
honorary degree in 1997 from Bar- 
llan University in Israel for his com¬ 
mitment to child psychiatry and 
the mentorship of young profes¬ 
sionals in Israel, a Special Presiden¬ 
tial Commendation from the 
American Psychiatric Association 
and a Lifetime of Research in 
Autism Award from the National 
Alliance for Research on Schizo¬ 
phrenia and Depression. 
Kenneth colby, M.D.'43, a psy¬ 
chiatrist and a pioneer in artificial 
intelligence and computerized ther¬ 
apy, died on April 20 at his home in 
Malibu, Calif. He was 81. 
In the early 1970s, Colby led a 
team that developed the software 
program Parry, which was designed 
to imitate the conversation of a 
paranoid schizophrenic. In test in¬ 
terviews, psychiatrists were unable 
to distinguish Parry’s responses 
from those of real paranoiacs. Parry 
was the only program to pass the 
“Turing test,’’ meaning that it could 
successfully impersonate a person 
in a typed conversation. 
In 1989, Colby and his son, Peter, 
founded Malibu Artifactual Intelli¬ 
gence Works to develop therapeu¬ 
tic software. One program they de¬ 
signed was called “Overcoming De¬ 
pression,” and it combined a text- 
based tutorial, cognitive therapy 
techniques and a free-association 
component.The program was used 
by the Department of Veterans 
Affairs, the Navy and Kaiser Perma- 
nente, among others, to reach peo¬ 
ple with mental illness who do not 
seek professional help. 
Colby was born in Waterbury, 
Conn., and graduated from both 
Yale College and the School of Med¬ 
icine. He practiced psychiatry for 
20 years, and then was a professor 
of computer science at Stanford 
University, where he created Parry 
at the university’s Artificial Intelli¬ 
gence Laboratory. He moved to 
ucla in 1974 to work in the psychi¬ 
atry and biobehavioral sciences 
departments. He retired from aca¬ 
demia in 1989, when he started 
Malibu Artifactual Intelligence 
Works. He published 10 books 
and over 100 articles in the fields 
of psychotherapy and artificial 
intelligence. He also wrote two 
books about chess and was a 
highly rated player. 
DONALD W. DEWALD, M.D., HS 
’41, died January 13 at MedCen- 
tral/Mansfield Hospital in Ohio. 
He was 86. 
Dewald trained as an intern and 
resident at Yale School of Medicine 
after graduating from Case West¬ 
ern Reserve University School of 
Medicine, where he received the 
Hoover Scholarship as valedictorian. 
He was a teaching fellow at Case, 
and then enlisted in the Army dur¬ 
ing World War II. He attained the 
rank of major and was chief of the 
medical service at Pasadena Re¬ 
gional Hospital in California. 
Starting in 1946, he practiced 
medicine in Mansfield, 21 of those 
years with his son. Dewald was on 
staff at MedCentral/Mansfield and 
Peoples Hospitals and was a past 
president of the Richland County 
Medical Society. 
LAWRENCE A. DOWNS, M.D.'64, a 
psychiatrist and one-time Yale bas¬ 
ketball star, died on May 20 at his 
home in New London, N.H., after a 
long illness. He was 65. 
Born in Indianapolis and raised 
in White Plains, N.Y., Downs later 
spent time as an English-speaking 
Union Fellow at Brighton College 
in Sussex, England. He came to Yale 
with the Class of 1959 and made the 
All-Ivy Basketball Team. 
He went on to the School of 
Medicine and then a residency in 
psychiatry at New York Hospital. 
He joined the faculty of Cornell 
Medical College and also served as 
the liaison psychiatrist at Memor¬ 
ial Sloan-Kettering Cancer Center. 
At the same time he maintained a 
private practice in both New York 
City and New London, N.H., until 
his retirement in 2000. 
PAULA YANEY C A M B I LL, M.P.H. 
'77, a recruiter and consultant to the 
health care industry, died in April 
2000 after a prolonged illness. 
After receiving her m.p.h. in 1977, 
she worked from 1981 to 1983 in 
the health and medical division of 
Booz, Allen & Hamilton, and then 
was a special assistant to the 
managing director of apm Inc. In 
1987, she started work at Empire 
Blue Cross and Blue Shield and 
advanced from a program evalua¬ 
tion and development specialist 
to a manager of professional ser¬ 
vices utilization review. In 1993, she 
rejoined apm Inc. as a manager of 
senior recruiting. 
ROBERT I. HINKLEY, M.D.'44, a 
general practitioner in Groveton, 
N.H., died on April 13 at the Morri¬ 
son Nursing Home after a brief ill¬ 
ness. He was 8i. 
Born in Lancaster, N.H., Hinkley 
graduated from Bowdoin College 
in Maine and then received his m.d. 
from Yale. He did an internship at 
Worcester City Hospital in Massa¬ 
chusetts from 1944 to 1945 and 
then served two years in the Army 
as a post surgeon at the Ogden Ord¬ 
nance Depot in Utah. He attained 
the rank of captain. 
On returning from the military, 
he settled in Groveton and re¬ 
mained there for the rest of his life. 
He started a general practice in 
1947 and was on the staff of Weeks 
Hospital until his retirement in 
1984. He developed the first car¬ 
diac care unit at Weeks. He was 
also president of the staff for two 
years and was on the hospital’s 
Board of Trustees. 
Hinkley was widely involved in 
local health care and government. 
He was a member of the New 
Hampshire Medical Society and 
served two years as president of 
the Coos County Medical Society. 
He was also elected a charter fel¬ 
low of the American Academy of 
Family Physicians in 1975. He was 
appointed to the New Hampshire 
Milk Sanitation Board by the gover¬ 
nor. For many years, he was the 
Groveton and Stark health officer, 
and he also served on the Groveton 
school board for nine years. He was 
a trustee of the York Educational 
Foundation and director and presi¬ 
dent of the Groveton Foundation. 
Additionally, he was a senior mas¬ 
ter in duplicate bridge and shot 
golf rounds in the 70s in each of 
seven decades. 
R. LEONARD K E M L E R, M.D.’43, a 
clinical professor of surgery at the 
University of Connecticut School of 
Medicine and a distinguished tho¬ 
racic surgeon, died on May 20 in 
Boston from leukemia. He was 82. 
Kemler was born in Hartford, 
Conn., where he would return to 
practice for the majority of his pro¬ 
fessional life. He received a b.a. 
and an m.d. from Yale, and then did 
his internship and residency at the 
Barnes Hospital in St. Louis, where 
he trained under Evarts Graham. 
He served in the Navy in World 
War II as a lieutenant in Shanghai, 
China. He was also a ship’s sur¬ 
geon aboard the uss Estes. 
He returned to Hartford to start 
a private practice in cardiovascular 
thoracic surgery in 1950, and was 
the founding president of Cardio¬ 
vascular and Thoracic Associates 
P.C. He joined the faculty of the 
University of Connecticut School of 
Medicine and also became a pro¬ 
fessor of biology and a member of 
the Pre-Med Advisory Committee 
at the University of Hartford. He 
was a staff member at Cedarcrest 
Hospital, past director of cardiovas¬ 
cular thoracic surgery at Mount 
Sinai Hospital, senior attending 
thoracic surgeon and director of 
cardiovascular and thoracic surgery 
at New Britain General Hospital, 
and a member of the Department 
of Surgery at Hartford Hospital. 
He received the Chairman's 
Award of the Yale Alumni Fund, 
as well as the Silver Bowl Award 
and the Distinguished Alumni 
Service Award of the Yale Univer¬ 
sity School of Medicine Alumni 
Fund Association. 
ANITA G. PEPPER, M.P.H.'60, PH.D. 
’72, a professor emerita at St. Louis 
University and an advocate for im¬ 
proving public health by bettering 
the services available to all people 
in society, died on April 7 of cancer 
at her home in Montague, Mass. 
She was 73. 
A native of New York, Pepper 
graduated from Smith College and 
the New York School of Social Work. 
She worked as a caseworker for the 
Jewish Family and Children’s Agency 
in Chicago and as a psychiatric 
social worker at the Bronx Munici¬ 
pal Hospital/Albert Einstein School 
of Medicine. She completed her 
M.P.H. at Yale in i960. She joined 
the eph faculty and became the 
special assistant to the dean of the 
School of Nursing. She helped pre¬ 
pare the school’s prospectus and 
gained her ph.d. in 1972. 
After leaving Yale, she headed a 
new social work and health service 
training program at Washington 
University. In 1976, she became a 
professor of epidemiology at St. 
Louis University’s school of nurs¬ 
ing. According to a former student, 
she was a strong advocate for 
improving health care services to 
the poor of St. Louis, as well as for 
maternal-child health. She and her 
husband, Max Pepper, m.p.h. ’59, 
helped to form the organization 
Health Care Is a Human Right. 
She retired from St. Louis Uni¬ 
versity in 1989 and moved to Mon¬ 
tague, Mass., but she continued to 
lecture at universities and hospi¬ 
tals. She held a clinical professor¬ 
ship at Tufts University School of 
Medicine and an adjunct position 
at the University of Massachusetts 
at Amherst. 
david h. riege, m.d.'46, a pedia¬ 
trician, died on October 11,2000, at 
Lawrence and Memorial Hospital in 
New London, Conn. He was 80. 
Riege was born in Springfield, 
Mass., and raised in Longmeadow, 
Mass. He graduated from Wesleyan 
University and Yale School of Medi¬ 
cine. He was on the staff of Hartford 
Hospital from 1952 until 1984. He 
practiced pediatrics in West Hart¬ 
ford, Conn., where he also lived and 
raised his family, retiring in 1984. 
JESSE G. RUBIN, m.d.’57, a clinical 
professor of psychiatry at George 
Washington University and a co¬ 
founder of a large chain of psychi¬ 
atric hospitals, died May 25 of 
prostate cancer at his home in 
Washington, D.C. He was 68. 
Rubin and a group of other psy¬ 
chiatrists founded Psychiatric Insti¬ 
tutes of America, a corporation 
that at one time oversaw 1,000 
hospital beds in 10 states. He acted 
as medical director for the com¬ 
pany from 1970 to 1973 and 1978 to 
1983. He also helped to establish a 
nonprofit institution, the Psychi¬ 
atric Institute Foundation, which 
supported privately run community 
services, including a halfway house 
and a drug treatment center. 
Rubin graduated Phi Beta Kappa 
from Marshall College and received 
his m.d. from Yale. He interned in 
Boston and then returned to Yale 
fora residency in psychiatry from 
1958 to 1961. He served two years as 
a captain and staff psychiatrist in 
the U.S. Air Force. 
He then moved to Washington, 
joining the faculty at George Wash¬ 
ington University as an assistant 
professor and working his way up 
to full clinical professor by 1977. He 
maintained a private practice and 
was a consultant to National Med¬ 
ical Enterprises after his involve¬ 
ment with Psychiatric Institutes of 
America. His research focused on 
forensic psychiatry and the rela¬ 
tionships between law enforce¬ 
ment organizations and communi¬ 
ties. He published The Police and 
the Community in 1972 and edited 
Readings in Law and Psychiatry. 
JOHN c. WONG, m.d.’81,an 
orthopaedic and hand surgeon, 
died on November 6,2000, in San 
Francisco. He was 44. 
Wong had practiced as an ortho¬ 
paedic and hand surgeon since 
1987. He was a native of Hong 
Kong and was on the board of 
trustees of the Chinese Commu¬ 
nity Health Care Association. 
JOSEPH F. ZIGARELU, M.D.’40, 
a well-known neuropsychiatrist and 
Bronze Star Medal winner, died April 
2 at Bethesda Memorial Hospital 
in Boynton Beach, Fla. He was 85. 
Zigarelli graduated from Cornell 
University, then received his m.d. 
from Yale in 1940. He maintained a 
private practice in neuropsychiatry 
for over 50 years in Paterson and 
Morristown, N.J. He was chief of 
children’s psychiatry at the state 
hospital of New Jersey at Grey- 
stone Park, and he was also on the 
staffs of Paterson General Hospi¬ 
tal, Morristown Memorial Hospital 
and Columbia Presbyterian Hospi¬ 
tal. His research and surgical tech¬ 
niques were directed toward 
finding alternatives to lobotomy, 
and were considered groundbreak¬ 
ing in theirtime. 
He served in World War II and 
received the Bronze Star Medal for 
his heroic medical treatment of 
the citizens of Naples, Italy. 
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52 Archives 
ALUMNI QUESTIONNAIRES 
TO BE MAILED SOON 
The School of Medicine will publish an updated alumni 
directory in the autumn of 2002, providing contact and profes¬ 
sional information for more than 11,000 graduates of the 
School of Medicine and its training programs. The directory 
will list alumni alphabetically and by program, class year, 
geographic location and area of medical specialty. The last med¬ 
ical school alumni directory was published in 1997. 
The Bernard C. Harris Publishing Co. will be mailing a 
questionnaire to each alumnus and alumna during the next 
several months. Please complete the form and return it as 
soon as possible. If we don’t have your current address, please 
contact the Office of Alumni Affairs at the address below 
so we can make sure you receive a directory questionnaire. 
Association of Yale Alumni in Medicine 
Spinelli Office of Alumni Affairs 
Suite 213 
100 Church St. South 
P.O. Box 7613 
New Haven, CT 06515 
Phone: (203) 785-4674 
Fax: (203) 737-5153 
Website: info.med.yale.edu/ayam 
YALE MEDICINE 
vuuu mum or nit <uan «* uwu wixn* u 
FROM “AN AFRICAN SUMMER” 
BY ROBERT McROBERTS, M.D. ’66, IN 
THE WINTER 1966 ISSUE OF YALE 
medicine:“Upon arriving in Ganta 
[Ganta Methodist Mission Hospi¬ 
tal in the hills of eastern Liberia], 
I soon discovered that tropical 
medicine would be considered a 
general practice by American 
standards. For example, on any 
given morning the first five people 
in the clinic line might include a 
child with amoebic dysentery, a 
man suffering for a long time with 
onchocerciasis, a boy whose blood 
smear for P. falciparum is 6 plus 
positive, a pregnant mother of 
eight who complains of back pain, 
and an old man whose scrotum 
extends almost to his knees. 
Later in the morning things 
might become somewhat more 
hectic. While you are examining a 
child with chickenpox, you send 
a man who has obviously broken 
his femur to the emergency room 
and hope that the woman who 
has just been taken into the exam¬ 
ining room doesn’t have an 
ectopic pregnancy as suspected. 
It’s hectic because you can’t send 
the man with the broken femur to 
X-ray. Instead you do the alterna¬ 
tive: that is, you roll out the old 
U.S. Army field unit and trust that 
there’ll be enough power to take a 
respectable film. You can’t send 
the pregnant woman to surgery 
for, unlikely as it might seem, you 
are surgery! In many ways one 
might consider such an experience 
a rotating internship. But instead 
of rotating every two months, you 
rotate with each new patient.” 
FROM WINTER/SPRING 1981: 
“Growth in medicine has meant 
growth in the Library.... A visit to 
the computer-search office gath¬ 
ers in a few minutes a volume of 
citations that would have taken 
days of hand searching. The com¬ 
puter terminal has available to it 
Medline, the online database 
equivalent to the last three years 
of Index Medicus. ...Technology 
now being developed holds even 
greater promise for libraries and 
library users. The National Library 
of Medicine, which developed 
Medline in the sixties, is working 
on a videodisk system that could 
fundamentally alter the concept 
of publishing. Electronic ‘publica¬ 
tion’ of journals, whether through 
videodisks or some other method, 
would eliminate paper copies. 
Readers could use computerized 
bibliographic searching to find ref¬ 
erences, then scan the articles on a 
computer terminal screen.... 
Eventually, perhaps as soon as 
the end of this century, books too 
would be published in electronic 
form. While older books and jour¬ 
nals would survive—and need 
to be stored—current publications 
would take up far less room. And 
their content would be available 
to computerized searching, freeing 
researchers from mechanical 
tasks to concentrate on the infor¬ 
mation itself.” 
O 
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Yale Medicine can help you stay connected with fellow alumni of the School of Medicine and its programs 
in Epidemiology and Public Health, the Graduate School of Arts and Sciences, and residency, fellowship 
and physician associate training. Share your personal and professional news for publication in the Alumni Notes 
department of Yale Medicine and on the Web, using this card or the online form at info.med.yale.edu/ayam. 
Please provide a recent photograph if possible. 
Please complete the card below and return 
it in an envelope to Yale Medicine Publications, 
Yale University School of Medicine 
P.O. Box 7612, New Haven, CT 06519-0612 
Alumni Notes 11/01 
Name New address □ 
Address 
City, State, Zip 
Daytime telephone with area code Fax 
I Yale degree Year(s) 
M.D. n 
M.P.H. □ 
PH.D. □ 
pa-c or M.M.SC. □ 
House Staff (hs) □ 
Fellow (fw) □ 
Other ( ) □ E-mail Date 
Please complete the card below and return 
it in an envelope to Yale Medicine Publications, 
Yale University School of Medicine 
P.O. Box 7612, New Haven, CT 06519-0612 
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Yale Medicine 
WINTER 20&£nts 
This season on the Web 2 
info.med.yale.edu/ymm 4 
Explore the following topics in 
greater depth by visiting our 
website and selecting extras: 
8 
10 
The Historical Library’s online 12 
exhibit about the School 13 
of Medicine’s last half-century 
A longer discussion of the 
Lessons from Anthrax roundtable 
14 
More photos from the White 
Jacket Ceremony, Hunger and 
Homelessness Auction and the 
annual symposium of the Com¬ 
mittee on International Health 
16 
On the website, readers can 
submit class notes or a change 
of address, arrange for a life¬ 
long Yale e-mail alias through 
the virtual Yale Station, check 
the alumni events calendar and 
search our electronic archive. 
24 
ON THE COVER 
A two-year assignment in Kenya’s 
capital gives a recent public health 
graduate a chance to make a 
difference in the effort to contain 
28 
aids. “In the two years I’ll spend 
here, 1 can’t really expect to see a 
noticeable change in the hiv 
incidence rate, and even if 1 did 
1 would be hard pressed to 
say 1 had contributed to it,” writes 
Karen Schmidt. But, she adds: 33 
"1 have to believe that every little 38 
bit helps.” Page 16 42 
Cover collage by Janis Melone; 46 
aids prevention poster (left) 
by Bella Kilonzo/Program for 
Appropriate Technology in 
Health, Nairobi 
48 
LETTERS 
CHRONICLE 
ROUNDS 
FINDINGS 
BOOKS 
ON CAMPUS 
CAPSULE 
MOVING BEYOND FEAR 
In Kenya’s lively and cosmopolitan capital, where hiv has 
made alarming inroads, there’s a desperate need for 
good prevention strategies. The right message, it seems, 
is one that encourages self-respect. 
By Karen Schmidt, m.p.h. 'oo 
LESSONS FROM ANTHRAX 
The deaths of five people exposed to anthrax this fall put 
bioterrorism squarely on the map. Where does the road lead 
from here? 
A Yale Medicine roundtable 
TARGETING CANCER BY SUBTYPE 
Drawing from an archive of 3 million tissue samples, Yale 
investigators are applying the latest in microarray technology 
to hunt down cures for tumors that resist treatment. 
By Marc Wortman 
FACULTY 
STUDENTS 
ALUMNI 
IN MEMORIAM 
ARCHIVES 
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Letters 
CHALLENGE FOR THE EYES, 
EVEN YOUNG ONES 
I received the new Yale Medicine 
[Autumn 2001] yesterday, and 
the new format is nice. I would 
like to say, however, that the type 
is a little small. It is bad enough 
for me, a member of the Class 
of 2000.1 can only imagine how 
blurry it must appear for your 
alumni who have lost the ability 
to accommodate. 
JOHN MAHONEY, M.D. '00 
FALLS CHURCH, VA. 
A CLASSMATE REMEMBERED, 
NEARLY FORTY YEARS LATER 
I remember Donald Cohen [In 
memoriam, Autumn 2001]. 
I recall our first meeting. Sep¬ 
tember 1962. By the democracy of 
the alphabet, Donald and I were 
teamed for the first year on that 
special experience, our own corpse. 
We got on well. Donald was seri¬ 
ous, but with dry humor. It came 
out that he was quietly religious, 
but took his Judaism with reser¬ 
vations and gentle banter. I had 
waved goodbye to the Pope a long 
time ago. Donald gave a shrug (he 
was good at shrugging) and never 
tried to sell me his package. 
From day one, Donald was 
interested in psychiatry, especially 
child psychiatry. I had a flirtation 
with shrinkery, and there was an 
informal student interest group, 
where we further met.The psychi¬ 
atry department was then heavily 
into psychoanalysis; I decided I 
did not need more religion. 
In our final year as students, 
we met again on a general surgery 
rotation. Our resident, Nicholas 
Passarelli, M.D. ’59, was really cool 
and sharp. Dr. Nick immediately 
realized Donald and I did not have 
the “right stuff" to be surgeons, 
but as long as we worked hard 
and did not sass, we got along fine. 
For some reason we all decided, in 
that era of overhead paging, that 
Dr. Nick needed two Irish assis¬ 
tants. And for six weeks Don Cohen 
was "Dr. Ouinn." 
Like some 19th-century cav¬ 
alryman in Austria-Hungary, I 
drifted to the fringes of empire, 
never to be heard from; remem¬ 
bered only by the alumni fund. 
Donald returned to the citadel in 
New Haven. Periodically, I saw 
mention of his work and growing 
academic rank. It gave a measure 
of reflected glory, for once we had 
been students in medicine and 
young, in rites of passage, together. 
We met briefly at class 
reunions.To my surprise, he was 
not at Reunion 35 earlier this year. 
His final illness explains the lapse. 
Tomorrow I go on a long auto 
trip.The audio book Swann’s Way 
from Remembrance of Things Past 
goes with me. I shall remember 
Donald and things past.... 
EUGENE CASSIDY, M.D.'66, HS’68, FW fo 
MARSHALLTOWN, IOWA 
A REMINDER OF WORDS 
FROM NOT SO LONG AGO 
Though tired after replacing a 
hip and intertrochanteric fracture 
that afternoon and evening, I 
was surprised to see an excerpt 
from my long-ago article —An 
African Summer—in the Winter 
1966 issue of Yale Medicine. My 
only concern was seeing the 
article being carried in the 
Archives section [Autumn 2001]. 
Instead of an excerpt from my 
article, I was expecting some¬ 
thing from the 1740s. 
But I’m flattered just the same. 
Your fellow archivist, 
ROBERT L. MCROBERTS, M.D. ’66 
ALBUQUERQUE, N.M. 
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FROM THE EDITOR 
New paths, new knowledge 
Ten years ago, when I was editing Karen Schmidt’s articles at the daily 
newspaper where we both worked, I wouldn’t have guessed that some¬ 
day I’d be fielding her dispatches from Africa. But life’s events brought 
me to Yale as an editor in 1994, and a few years later Karen enrolled 
as a master’s degree candidate here at the School of Public Health. Now 
she is living in Kenya and working for a nonprofit organization devoted 
to aids prevention. 
As her career has shifted full-speed into international health, 
Karen has retained her reporter’s eye; she has both a knack for quick- 
sighted observations and a gift for articulating them with style and 
a sense of humor. Her cover story—the second in the “Letter from ...” 
series that debuted last spring with Sharon Chekijian’s report from 
Armenia—offers a glimpse of life in a major African city and a look at 
the challenges facing health professionals trying to stem the global 
advance of hiv. 
Also probing unexplored territory this issue are the Yale scientists 
pushing the boundaries of microarray technology in search of new ther¬ 
apies [“Targeting Cancer by Subtype,” page 28], as well as the alumni 
and faculty experts who are wrestling with the threat of bioterrorism 
[“Lessons from Anthrax,” page 24]. As with Karen, their sense of intel¬ 
lectual adventure has led them down new paths. All three areas of 
inquiry promise to make a lasting contribution to medicine and public 
health around the world. 
Michael Fitzsousa 
michael.fitzsousa@yale.edu 
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4 chronicle news from cedar street 
By mid-January, the exterior of the Congress 
Avenue Building was largely finished and the 
project was slightly ahead of schedule. A cafe 
opened at the end of January, joining the new 
Yale Medical Bookstore (photo below right) in 
retail space across the street. 
MEDICAL SCHOOL SHOWS 
A CHANGING FACE 
As the Congress Avenue Building 
nears completion, a flurry of smaller 
projects alters the campus scene. 
Before suburbs lured people from cities 
and Route 34 drove a wedge through 
downtown New Haven, the neighbor¬ 
hood surrounding the medical school 
bustled with businesses, shops and 
restaurants. In recent years, however, 
campus buildings have offered a stern 
face to the outside world, uninviting to 
those not practicing or studying medi¬ 
cine or seeking medical attention. 
Now, as a number of construction 
projects near completion, the medical 
school campus is undergoing a major 
facelift. At the corner of Cedar Street 
and Congress Avenue, buildings which 
for years were open only to those bear¬ 
ing a Yale or hospital ID now include 
two stores catering to the public—the 
Yale Medical Bookstore and Cappuc¬ 
cino’s & More, a gourmet coffee shop. 
“With the opening of the Congress 
Avenue Building [cab], the school’s cen¬ 
ter of gravity will start to shift down 
Cedar Street,” said Irwin M. Birnbaum, 
j.d., the medical school’s chief operating 
officer. The corner of Cedar and Con¬ 
gress, he added, “is a place that is con¬ 
venient to all. By adding a bookstore 
and coffee shop we are recognizing the 
importance of having facilities near the 
cab that will be more convenient for 
our staff there.” 
Cappuccino’s & More, which opened 
in January, has seating for 32 with 
counter and takeout service. The Yale 
Medical Bookstore, affiliated with the 
Barnes & Noble bookstore on Broadway 
in New Haven, opened in October to 
replace the Yale Co-op’s medical branch 
on York Street, which closed last year. 
The bookstore caters largely to medical 
students and professionals, but man¬ 
ager Don Levy said many patients come 
straight from doctor’s visits to look for 
books describing their ailments. Also 
available are stethoscopes, tuning forks, 
scrubs and study guides. 
Among the major projects under way: 
- At the site of the 457,000-square-foot 
Congress Avenue Building, sched¬ 
uled to open in March 2003, workers 
have enclosed the building and begun 
to install plumbing, electrical wiring, 
hvac, partitions, shelves, benches and 
other laboratory casework. 
- At the end of the B wing in the Sterling 
Hall of Medicine (shm), construction 
began in March 2001 on the Center for 
Drug Discovery, a three-story addition 
that will provide 25,000 gross square 
feet of wet-bench laboratory, laboratory 
support and office space. Renovations 
to the B wing will provide an additional 
24,000 square feet of upgraded office, 
laboratory and support space for the 
Department of Pharmacology. 
- A full renovation of the second floor of 
the C wing, home to cell biology in 
shm, began in October and is scheduled 
for completion in August. About 15,000 
square feet will be reorganized into four 
laboratory modules, along with faculty 
offices and laboratory support spaces. 
- Construction is under way at the cor¬ 
ner of Amistad and Cedar streets 
on a no,ooo-square-foot building and 
garage, with six floors devoted to 
disease-based clinical services and 950 
parking spaces. 
WITH DIRECTOR’S PASSING, 
CHILD STUDY CENTER FINDS 
ITSELF AT A CROSSROADS 
In 1972, Albert J. Solnit, m.d., hs ’52, 
Seymour L. Lustman, ph.d., m.d., 
hs ’57, fw ’58, and Edward F. Zigler, 
ph.d., sat down with a recent graduate 
of the School of Medicine and made a 
pitch for him to return to Yale to join 
the faculty. Solnit was then director of 
the Yale Child Study Center, Lustman 
was a professor, and Zigler, a founder 
of the Head Start Program, was return¬ 
ing to Yale after two years as head of 
the federal Office of Child Development 
and U.S. Children’s Bureau. 
The new recruit was Donald J. Cohen, 
m.d. ’66, who accepted the offer and 
moved his young family to New Haven 
from Washington, where he had been 
Zigler’s special assistant. Cohen was 
the kind of scholar that Solnit, Zigler 
and Lustman thought would thrive in 
the rich intellectual setting of the Child 
Study Center. “Donald had a brilliant 
understanding of the biochemistry and 
genetics of child development, and at 
the same time he was becoming a psy¬ 
choanalyst and a talented child psychia¬ 
trist,” recalled Solnit. Cohen, who 
succeeded Solnit to become the center’s 
fourth director in 1983, went on to 
build it into an academic and clinical 
powerhouse with special strengths in 
the research and treatment of autism, 
obsessive-compulsive disorder and 
Tourette’s syndrome, the psychological 
problems of children exposed to vio¬ 
lence, and the developmental disorders 
of early childhood. 
Cohen died October 2 at the age of 
61, less than two years after being 
diagnosed with ocular melanoma. “His 
death was tragic and it was horribly 
premature. As a healer, as a scientist 
and as a leader, he is not a person 
who can be replaced,” said Dean David 
A. Kessler, m.d. Yet during the months 
and years before his death, Cohen did 
much to pave the way for his own suc¬ 
cessor through recruitment and fund¬ 
raising, according to James F. Leckman, 
m.d., the center’s director of research 
Donald Cohen left the Child Study Center 
in excellent condition, colleagues say. 
Above, the center’s Irving and Neison Harris 
Building addition, which opened in 1999. 
and Neison Harris Professor. “Donald 
left us in really superb condition.” 
Kessler said it is likely that a new 
director will be named early this year. 
The Child Study Center traces its 
roots to 1911, when Arnold Gesell, 
ph.d., m.d. ’15, established what would 
become the Yale Child Development 
Clinic. It was renamed the Child Study 
Center in 1948 with the arrival of the 
second director, Milton J.E. Senn, m.d. 
(See photograph, page 14), who recruited 
Solnit and others interested in child 
psychoanalysis and the role emotions 
play in healthy development. When Sol¬ 
nit became director in 1966, he began 
applying knowledge of child develop¬ 
ment to aspects of childhood that had 
been considered beyond the sphere 
of medicine. The center created a net¬ 
work of nursery schools and, through 
the work of Zigler and James P. Comer, 
m.d., hs ’66, began exploring ways to 
work with school systems to enrich the 
lives of children beyond academics. Sol¬ 
nit also established programs to help 
children in the juvenile justice system. 
During his years as director, Cohen 
not only created vigorous research 
and clinical programs but also became 
skilled at building the center’s resources. 
At the suggestion of Irving Harris, a 
Yale alumnus and benefactor, he 
formed the Associates of the Child 
Study Center, a national group of highly 
motivated volunteers that numbers 
160 today. Harris and his brother 
Neison endowed five professorships 
and the center’s recent 21,000-square- 
foot addition between Sterling Hall 
of Medicine and Harkness Dormitory. 
“Donald engaged the associates as 
our consultants and colleagues,” said 
Linda C. Mayes, m.d., the center’s 
Arnold Gesell Professor. “Some of our 
finest work has come from those 
collaborations." 
Maintaining the center’s preemi¬ 
nence will be one of the challenges 
facing the next director, said Mayes. 
Another will be preserving the collegial 
environment of the center as it contin¬ 
ues to grow. But perhaps most impor¬ 
tant for the next leader, said Solnit, 
will be making his or her own distinct 
imprint. “The blueprint that Donald 
set out will continue to maintain its 
momentum,” he said, “but the new 
director will have to resist the tempta¬ 
tion to try to be like Donald. The 
new director, as Donald himself was, 
will have to be his own person.” 
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chronicle 
INSTRUMENT SHOP ENDURES 
AS A PLACE FOR REPAIRS, 
A CATALYST FOR CREATIVITY 
Tucked into the basement of the Hope 
Building at the corner of Congress 
Avenue and Cedar Street is a warren 
of well-lit rooms filled with milling 
machines, table saws, welders and 
lathes — a place where a scientist in 
need can go for a centrifuge repair or 
a part for a pH meter. The Instrument 
Repair and Design Shop has catered 
to medical school researchers for more 
than three decades, building prototype 
devices for use in experiments and 
performing emergency repairs on 
equipment that fails. 
It’s a distinguished history that 
almost came to an end. According to 
faculty member Vinzenz M. Unger, 
ph.d., the staff provides researchers 
with essential technology not commer¬ 
cially available elsewhere. Yet years 
of running in the red threatened the 
shop’s existence, and in 2000 it appeared 
to be on its last legs. 
That was before a hue and cry arose 
from faculty members who had come to 
appreciate the instrument shop not only 
as a provider of engineering services but 
also as a catalyst for intellectual creativ¬ 
ity and innovation—something difficult 
to measure in terms of profitability. 
Faculty advisors Robert H. LaMotte, 
ph.d., and Kenneth R. Williams, ph.d., 
worked with administrators and the 
shop staff to find a solution. Shop engi¬ 
neers James F. Hogan and Eugene J. 
Modzelewski streamlined existing ser¬ 
vices, reconfigured the fee schedule and 
developed a marketing plan to increase 
the instrument shop’s customer base. 
Now, said Carol S. Marshall, the 
school’s director of training and quality 
improvement, the shop is in the black 
for the first time in seven years. The key 
to balancing the books, she said, was in¬ 
creasing the shop’s visibility and encour¬ 
aging an entrepreneurial approach to 
the shop’s business. 
Hogan and Modzelewski perform 
many services, from such mundane 
tasks as ordering specialized plastics 
and repairing Geiger counters to talking 
through experiments with researchers 
and planning the design and fabrication 
of delicate laboratory instruments. Hogan 
has been tinkering with designs for Yale 
researchers for 40 years, initially work¬ 
ing with the Department of Surgery in 
the design of pacemakers before joining 
the instrument shop staff in 1985. Trained 
as an electrical engineer, he said that his 
real education has come on the job while 
listening to the needs of researchers. 
One of their recent projects was a 
“heart phantom” developed for research¬ 
ers in the Department of Internal 
Medicine, with six progressively smaller 
chambers of Plexiglas sitting one within 
the other. The distance between cham¬ 
bers simulates the thickness of the myo¬ 
cardium during a contraction, allowing 
researchers to take measurements critical 
to their work. 
Hogan and Modzelewski took the 
project from a series of discussions and 
paper sketches to a model on the com¬ 
puter screen to the eight-inch Plexiglas 
prototype sitting on the table when a 
visitor toured the shop recently. Hogan 
lifted the heart phantom, demonstrated 
the way the top seals two outer cham¬ 
bers in a vacuum and pointed out 
how the four remaining inner chambers 
would fit inside each other. “It’s like 
being an artist,” Modzelewski agreed. 
“We see how the pieces of the problem 
connect the way an artist sees color, 
and it all comes together.” 
Engineers Eugene Modzelewski (left) and 
James Hogan see the pieces of a problem “the 
way an artist sees color." 
OVERCOMING JITTERS OF 9/11, 
YALE CELEBRATES 300 YEARS AND 
A GLOBAL FUTURE 
On September 11, when terror struck 
the nation and America’s mood sud¬ 
denly turned somber, less than a month 
remained in Yale’s Tercentennial year. 
The final weekend in the University’s 12- 
month observance of its 300th anniver¬ 
sary had been planned for October 5 and 
6, two days of festive celebration and 
academic ceremony. But in the days that 
followed the attacks on the World Trade 
Center and Pentagon, University leaders 
debated the wisdom of staging the Ter¬ 
centennial finale in the Yale Bowl. 
Was it safe? Was it appropriate? Would 
people come? 
“Carry on,” was the message President 
Richard C. Levin said he received from 
tire Yale community. Levin told 30,000 
people gathered in the Yale Bowl on 
October 5. The crowd had come for a 
multimedia spectacular featuring famous 
Yale alumni celebrating Yale’s contribu¬ 
tion to the nation and the world. With 
that, a 150-member orchestra played and 
a 200-member chorus, along with the 
audience, sang “America the Beautiful,” 
and the celebration continued. 
Security was dramatically tightened 
for events that included a pomp-filled 
Tercentennial Convocation on Cross 
Campus and a two-day symposium, 
“Democratic Vistas, Global Perspectives,” 
with talks by Yale faculty members, law 
school graduate and former President Bill 
Clinton and former President of Mexico 
Ernesto Zedillo, who holds a doctorate 
in economics from Yale and serves as a 
University trustee. 
With Yale emphasizing its role as a 
world university in its fourth century, 
the School of Medicine figured promi¬ 
nently throughout the Tercentennial 
year because of the growing awareness 
of the global nature of public health 
concerns and the enormous impact of 
medical research advances on individu¬ 
als and societies. In President Levin’s 
Tercentennial address at the convocation 
on October 5, he said, “Through the 
subjects and students we teach and the 
educational and research collaborations 
we undertake abroad, we can advance 
greater understanding among the world’s 
peoples. We can also contribute to the 
solution of problems that cannot be con¬ 
tained within national borders — such as 
the spread of disease.” 
In his talk before 8,000 people gath¬ 
ered on Cross Campus the following day, 
Clinton noted the phenomenal improve¬ 
ments in health care and life expectancy 
made possible by biomedical advances. 
He contrasted that progress in the devel¬ 
oped world with the abysmal health care 
and short life expectancy seen in under¬ 
developed nations, which result in the 
rapid spread of disease and political 
instability. That is why, he said, “Yale’s 
mission to build a truly global university 
is so very important" in this new cen¬ 
tury that will be marked by increasing 
interdependence among nations. 
In his speech, President Levin noted 
Yale’s commitment to invest nearly 
$1 billion in the coming decade in medi¬ 
cine, science and engineering facilities. 
“No investment,” he said, “... holds 
greater promise for the health and pros¬ 
perity of the nation and the planet.” And 
as a result of world events, Yale’s course 
for its next century has never been more 
clearly tied to a global future. 
In his Tercentennial address, President Levin 
stressed Yale’s role as an international university. 
et cetera 
FUNDING THE HUNT FOR PROTEINS 
Yale scientists have received a $15 million, 
five-year grant that will fund a search for key 
regulatory proteins in the human genome. 
The grant from the National Human Genome 
Research Institute will create the Center of 
Excellence in Genomic Science, to be headed 
by Michael Snyder, ph.d., professor and chair 
of molecular, cellular and developmental 
biology. “Much of the human genome is com¬ 
prised of dna whose function is not known,” 
Snyder said. “Our team’s methods will eluci¬ 
date the functions of many of these regions 
for the first time, and as a result of these 
studies, we will emerge with a much more 
detailed understanding of the human 
genome and its regulation.” Other investiga¬ 
tors at the center are Mark B. Gerstein, ph.d.; 
Richard P. Lifton, M.D., ph.d.; Perry L. Miller, 
M.D., ph.d.; and Sherman M. Weissman, m.d. 
ENDOWMENT DEFIES SLUMP 
While most other university endowments 
posted double-digit declines as the economy 
soured in 2000-2001, Yale’s endowment 
ended the fiscal year with a 9.2 percent return 
on its investments. Fund managers attributed 
the endowment’s performance to diversified 
asset allocation, strong active management 
and a value orientation. Last year’s increase 
boosted the total to $10.7 billion. For the 10 
years ending June 30,2001, the endowment 
returned an annualized 18.3 percent. As the 
endowment has grown over the past decade, 
from $2.6 billion, its contribution to the Uni¬ 
versity’s revenues has doubled, now account¬ 
ing for 28 percent of the total. Spending 
from the endowment in the current fiscal 
year is expected to reach $405 million, a 20 
percent increase over the prior fiscal year. 
DISCOVERY CHANNEL TAPS YSM 
When the breakthrough cancer drug Gleevec 
made headlines, Yale Cancer Center Direc¬ 
tor Vincent T. DeVita Jr., m.d., HS ’66, was on 
hand (and online) to share his perspective 
with Web surfers at discoveryhealth.com. 
When the threat of bioterrorism put the 
nation on edge, infectious disease expert 
Andre N. Sofair, M.D., m.p.h. ’97, HS ’90, 
weighed in with “10 Things You Need to 
Know About Anthrax.” Both pieces grew 
from a new partnership between Yale and 
the Discovery Health Channel, which will 
draw on expertise from throughout the med¬ 
ical school. Faculty will also contribute to 
four, hour-long television programs and to 
three online columns: "Family Matters,” 
"Cutting Edge Medicine” and “Views on 
Health News.” The first cable special, about 
adhd, will air later this year. 
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Rounds MEDICINE AND HEALTH AT YALE 
FOR SOME PATIENTS, 
THE ENEMY IS ANEMIA 
A link is found between 
low red blood count, high mortality 
among elderly cardiac patients. 
Nearly half of elderly patients admitted for 
a heart attack are anemic, according to a study 
in the October 25 issue of The New England 
Journal of Medicine. Harlan Krumholz (above) 
and colleagues also found that blood transfu¬ 
sions and higher hematocrit levels reduce 
the risk of short-term mortality. 
Although clinicians have long been 
uncertain about the benefits of blood 
transfusions in patients with heart 
attacks, a study by Yale investigators has 
found that they significantly improve 
chances for survival. 
“Our principal finding is that a low 
hematocrit on admission is associated 
with higher mortality rates in elderly 
heart attack patients," said principal inves¬ 
tigator Harlan M. Krumholz, M.D., asso¬ 
ciate professor of medicine (cardiology) 
and epidemiology. “However, blood trans¬ 
fusions, when given to these patients, 
can significantly decrease their mortality 
risk. This is the first study to highlight 
the important link between anemia, blood 
transfusion and mortality among elderly 
patients hospitalized for a heart attack.” 
Krumholz and researchers at Brown 
University Medical School, Yale’s Depart¬ 
ment of Epidemiology and Public Health 
and the Yale-New Haven Hospital Center 
for Outcomes Research and Evaluation 
conducted a retrospective study of 78,964 
Medicare beneficiaries 65 years and 
older who were hospitalized with acute 
myocardial infarction. After categorizing 
patients on the basis of their hematocrit 
levels, the researchers then explored 
links between transfusions and 30-day 
mortality. “Surprisingly, we found that 
43.4 percent of elderly patients hospital¬ 
ized with a heart attack are anemic, or 
have a blood count below 39 percent, at 
the time of admission,” said co-author 
Saif S. Rathore, m.p.h., a lecturer in the 
Department of Internal Medicine. 
The study also found that the most 
severely anemic patients were twice as 
likely to die within 30 days as those who 
were not anemic. Despite the higher 
mortality risk, fewer than a quarter of 
the patients with clinically significant 
anemia received a blood transfusion. 
“Our data indicate that blood transfu¬ 
sions provided to elderly anemic patients 
can significantly reduce their risk of 
short-term mortality,” said Krumholz. 
“Most promisingly, our data indicate that 
this benefit is observed in elderly patients 
with blood count levels as high as 33 
percent, a higher level than previously 
considered by clinicians. These data are 
particularly compelling given the lack 
of clinical guidelines concerning hemat¬ 
ocrit levels at which to transfuse elderly 
patients with heart disease.” 
The study was published in the Octo¬ 
ber 25 issue of The New England Journal 
of Medicine. In an editorial accompany¬ 
ing the study, Lawrence T. Goodnough, 
m.d., and Richard G. Bach, m.d., of the 
Washington University School of Medi¬ 
cine, underscored the importance of 
these findings. “For the first time, we 
have evidence that patients with a specific 
clinical presentation are affected adversely 
by the underuse of transfusion,” Good¬ 
nough and Bach wrote. Based on this 
research, they suggested “that hemato¬ 
crit levels should be maintained above 
33 percent in patients who present with 
acute myocardial infarction.” 
“We certainly feel that our findings 
should result in a change in clinical prac¬ 
tice,” said first author Wen-Chih Wu, 
m.d., a teaching fellow in internal medi¬ 
cine (cardiology) at Brown University. 
MEAT THE CULPRITS 
Eating one’s vegetables could help ward off a form of cancer 
that has been on the rise for the last quarter-century, according 
to a study by investigators at Yale and around the country. 
Since the mid-1970s the rate of adenocarcinomas of the esopha¬ 
gus and gastric cardia has increased by 300 percent. “We 
found that many nutrients in foods of animal origin are signifi¬ 
cantly associated with a risk of developing this class of can¬ 
cers,” said lead author Susan T. Mayne, ph.d. They also found 
that certain plant-based nutrients, including dietary fiber, 
dietary beta-carotene, folic acid and vitamins C and B6, were 
associated with a lower risk. Harvey A. Risch, m.d., ph.d., was 
the principal investigator on the study, published in the 
October issue of Cancer Epidemiology, Biomarkers & Prevention. 
et cetera . 
SEDATIVE LINKED TO DELIRIUM 
Older, hospitalized patients who take 
diphenhydramine, an often-prescribed anti¬ 
histamine and sedative, run a 70 percent 
greater risk of delirium, according to a study 
by Yale physicians. “The findings suggest 
that using diphenhydramine as a routine 
sleeping aid and for most other reasons 
should be actively discouraged in the older 
hospitalized population,” said Joseph V. 
Agostini, m.d., a postdoctoral fellow in the 
Robert Wood Johnson Clinical Scholars 
Program, whose findings were published 
in the September 24 issue of Archives of 
Internal Medicine. Diphenhydramine is a 
component of many over-the-counter cold 
remedies and allergy and insomnia med¬ 
ications such as Benadryl and Sominex. 
ANOTHER APPROACH TO ADHD 
The drug guanfacine can treat attention 
deficit hyperactivity disorder (adhd) with¬ 
out worsening tics, Yale investigators have 
found. Stimulants are first-round agents for 
adhd, but may worsen tics in some cases. 
“Guanfacine,” said first author Lawrence 
Scahill, m.s.n., m.p.h. ’89, ph.d. ’97, associate 
professor in the Child Study Center and at 
the School of Nursing, “appears to be a safe 
and effective treatment for children with 
tic disorders and adhd.” For the study, 
published in the July issue of The American 
Journal of Psychiatry, the researchers fol¬ 
lowed 34 children diagnosed with adhd and 
a tic disorder. Guanfacine was associated 
with improvement on the teacher-rated 
adhd Rating Scale, fewer tics and better 
performance on laboratory tests of atten¬ 
tion and impulse control. 
LIFE AND DEATH ON THE GRIDIRON 
This year across America, a handful of appar¬ 
ently healthy athletes will die on the playing 
field. Though efforts are made to detect 
abnormalities that might predict the sudden 
deaths resulting from hypertrophic cardiomy¬ 
opathy and undiagnosed asthma, there 
has been no cost-effective way of screening 
entire teams before the start of each season. 
But last August, Yale surgeon James “Butch” 
Rosser, m.d., launched his “Operation Beating 
Heart” telemedicine program during foot¬ 
ball practice at Savannah State University in 
Georgia. Rosser’s exam uses a five-pound 
ultrasound device and other portable gear 
to transmit data to Yale physicians. Rosser 
plans to expand the program to other 
schools this year. 
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Findings from the bench 
A PROMISING VACCINE 
FOR WEST NILE VIRUS? 
Engineered protein gives mice 
complete protection, could lead 
to a diagnostic test. 
A vaccine developed by Yale scientists has 
protected mice from the West Nile virus, 
a mosquito-borne infection that has been 
linked to about 10 deaths in the United 
States since the summer of 1999. 
The virus, first identified in Uganda 
in 1937, surfaced in the New York 
City area in 1999 and has subsequently 
appeared in the South and Midwest. It 
is considered an emerging disease, said 
Erol Fikrig, m.d., associate professor of 
medicine and of epidemiology and public 
health. “Its seriousness as a public health 
threat is not fully known yet,” said Fikrig, 
who directed the development of the 
vaccine. "That should become apparent 
over the next two to three years. If the 
vaccine proves necessary, its development 
will be valuable.” 
The virus, which infects birds as well 
as humans, spreads through mosquito 
bites primarily in warm-weather months. 
There is currently no cure, although 
infection does not generally cause seri¬ 
West Nile virus has led to about 10 deaths in 
the U.S. since it surfaced in New York in 1999. 
ous consequences. Elderly patients, 
however, can develop fatal encephalitis, 
a central nervous system infection. 
Fikrig and colleagues, including Tian 
Wang, ph.d., a postdoctoral fellow in his 
laboratory, and John F. Anderson, ph.d., 
research affiliate in epidemiology, and 
associates from the Connecticut Agricul¬ 
tural Experiment Station in New Haven, 
isolated a sample of the vims found in an 
infected bird. They genetically engineered 
a protein in the virus, which they then 
injected into uninfected mice. Immuniza¬ 
tion with the vaccine provided complete 
protection for the mice against West 
Nile vims. 
Because diagnosis of West Nile 
virus can be difficult using current 
methods, the protein used to make the 
vaccine could also be employed to 
develop a diagnostic test, Fikrig said. 
Results of the study were pub¬ 
lished online in the Journal of Immunol¬ 
ogy on October 23 and appeared in 
the November 1 print issue. 
MOLECULE THAT TARGETS 
TISSUE FACTOR IS FOUND 
TO THWART TUMORS IN MICE 
Yale researchers have developed a mole¬ 
cule that, when injected into tumors in 
mice, destroyed blood vessels in tumors 
and left normal tissue unharmed. Their 
findings, published in the October 9 
issue of Proceedings of the National Acad¬ 
emy of Sciences, hold the promise of a 
new therapy for metastatic cancer. 
The molecule, developed by Alan 
Garen, ph.d., and Zhiwei Hu, ph.d., in 
the Department of Molecular Biophysics 
and Biochemistry, is an immunoconju- 
gate, or icon, which joins elements of 
different molecules. The team’s strat¬ 
egy—targeting a tumor’s blood vessels 
without harming normal cells—led 
them to the molecule tissue factor (TF), 
which is expressed on the inner surface 
of the tumor blood vessels and initiates 
blood clotting. 
Garen and Hu’s icon is made up of 
two elements, one that draws it to TF 
and another that initiates an immune 
response. The first element is factor VII, 
a molecule that circulates in the blood 
and binds to TF. Once factor VII has 
drawn the icon to TF in the tumor, the 
icon triggers its second element, the Fc 
region of a human antibody, which acti¬ 
vates the immune system against cells 
that bind to the icon. A replication- 
incompetent adenoviral vector was used 
to deliver the gene encoding the icon to 
the tumor cells. The tumor, once 
infected, produces and secretes the icon 
into the blood, where it circulates through¬ 
out the body seeking tumor blood cells. 
“The result,” said Garen, “is that the 
tumor's blood vessels are destroyed by the 
immune system, and consequently, the 
tumor cells die because they lack a blood 
supply. Normal blood vessels survive 
because they do not express tissue factor 
and therefore do not bind to the icon.” 
Garen and Hu first generated human 
prostatic and melanoma tumors in mice, 
then injected the vector into one of the 
tumors. A control group of mice received 
a blank vector; those mice died within 63 
days after tumors appeared on the skin. 
In the mice that received the icon 
molecule, tumor cells were eliminated 
and the mice remained free of the dis¬ 
ease for at least 194 days. They received 
their last injection of the vector on the 
experiment’s 53rd day, suggesting that 
the molecule’s effects are long-lasting. In 
addition, the icon acted against tumors 
that had not been injected with the vec¬ 
tor, offering the possibility of a treatment 
for metastatic cancer patients. “This icon 
should work against all types of tumors 
that contain blood vessels,” Garen said. 
Zhiwei Hu and Alan Garen have created 
a chimeric molecule that makes tumors 
disappear in mice. 
KNOCK-OUT STUDY SHOWS 
HOW SOME WHITE BLOOD CELLS 
REGULATE SKIN CANCER 
A type of white blood cell that is found 
in the skin and assists in the body’s 
immune response also helps prevent 
skin cancer, Yale researchers have found. 
Gamma-delta T cells play a major 
role in local immunity and “are likely to 
be crucial to an early defense against 
skin cells that have recently transformed 
to a premalignant or malignant state,” 
said Michael Girardi, m.d., assistant 
professor of dermatology. Girardi, primary 
author of a paper on the findings pub¬ 
lished in Science in September, was part 
of a team that included colleagues at 
Guy’s King’s St. Thomas Medical College 
in London. The team genetically engi¬ 
neered mice that were incapable of pro¬ 
ducing gamma-delta T cells, then exposed 
the knock-out mice to three different 
models of skin cancer. 
In one model, tumor cells were in¬ 
jected into the skin. In another, a 
carcinogen was injected into the skin. 
For the third, carcinogens were repeat¬ 
edly painted onto the skin. This last 
model most closely resembles cancer 
et cetera . 
ROUTE OF INFECTION 
Investigators in microbial pathogenesis have 
described a secretion system that many bac¬ 
teria—including those that cause plague, 
dysentery and typhoid—use to infect other 
cells. The type III secretion system found in 
Salmonella is a hollow, needle-like structure 
that delivers bacterial proteins into a host 
cell. “Many pathogens use a similar mecha¬ 
nism,” said principal investigator Jorge E. 
Galan, ph.d., chair of the Section of Microbial 
Pathogenesis, of the findings published in 
the November 1 issue of Nature. “Insight into 
any of them gives you insight into all of them. 
From this fundamental information we can 
begin to develop completely new therapeu¬ 
tic strategies to halt or prevent infections by 
these pathogens.” 
CROSSING OVER 
Two Yale neuroscientists have discovered a 
pathway, apparently unique to humans, 
that guides neurons between different brain 
regions. "Disregarding boundaries between 
major brain divisions is unusual,” said prin¬ 
cipal investigator Pasko Rakic, m.d., ph.d., 
chair of the Department of Neurobiology 
and the Dorys McConnell Duberg Professor 
of Neuroscience, “and could explain how 
parts of the cerebral cortex associated with 
the highest cognitive functions may have 
coordinated their growth with subcortical 
structures during human brain evolution.” 
Rakic and graduate student Kresimir Letinic 
found that attractive and repulsive mole¬ 
cules directed neuronal stem cells from the 
ganglionic eminence to the diencephalon. 
They published their findings in the Septem¬ 
ber issue of Nature Neuroscience. 
development in humans because it 
mimics repeated exposures that 
progress from a benign thickening of 
tissue to premalignant papilloma to 
carcinoma formation. 
Girardi and his team found that, in 
all three models, the absence of gamma- 
delta T cells resulted in a higher level of 
skin cancer formation. In the third 
model, however, another type of T cell, 
alpha-beta, contributed to skin cancer 
development and progression. “There 
appears to be a yin-yang contribution by 
alpha-beta T cells to skin cancer, in that 
they can act in both the defense against 
and the promotion of carcinoma,” 
Girardi said. 
Gamma-delta T cells work by express¬ 
ing a protein, NKG2d, which binds to a 
molecule that is expressed by tumor cells. 
Once the molecule, Rae-i, is engaged by 
the NKG2d protein, gamma-delta T cells 
can kill the honor cell. Rae-i is expressed 
only in skin cells that have been exposed 
to chemical carcinogens that stimulate 
the transition to cancer. “This is an ini¬ 
tial and important distress signal to the 
local T cells, and to some other cells of 
the immune system, that things are 
wrong,” Girardi said. 
CLUES TO HOW A CELL MOVES 
Using X-ray crystallography, investigators at 
Yale and the Salk Institute have solved the 
structure of Arp2/3, a complex of seven pro¬ 
teins that helps cells move. “Knowledge of 
the three-dimensional structure not only 
provides key insights about the Arp2/3 com¬ 
plex, but it will also elevate the level of 
research on cellular movements for years to 
come,” said principal investigator Thomas D. 
Pollard, ph.d., the Eugene Higgins Professor 
of Molecular, Cellular and Developmental 
Biology. The Arp2/j complex initiates the 
assembly of the protein actin into filaments 
at the front end of a cell, which pushes the 
cell forward. The findings were published in 
the November 23 issue of Science. 
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Books 
from Oopm to Outing 
DEBRA W. 
HAFFNERmph 
Rfyond 
[he BIG TALK 
Every Parent s Guide to Raising 
Sexually Healthy Teens— 
Emm MiddJr School 10 lltsii School and Beyond 
Meselson. Stahl, 
and the Replication 
of DNA 
Nomads Five: A Family’s 
Journey Around the World 
by Honey Sharp Lippman, 
Alexandra and Nadia Lippman, 
with contributions from 
David H. Lippman, m.d. ’71 and 
Daniel Lippman 
Eighty Days Press 
(Great Barrington, Mass.) 2000 
In 1995, for a 50th birthday sab¬ 
batical, David Lippman took his 
adventurous and tolerant wife and 
three children on a trip around 
the world. The book is the fruit of 
a decision to record the adven¬ 
tures this family experienced as 
it traveled over a nine-month 
period. While Lippman is not sure 
he would recommend extensive 
travel to a young family after the 
events of September n, he hopes 
that our children can take their 
children on a once-in-a-lifetime 
trip which, for the Lippmans, 
brought them closer to each other 
and all their fellow travelers on 
our now-worried planet. 
Five Hundred Years of 
Medicine in Art: An Illustrated 
Catalogue of Prints and 
Drawings from the Clements 
C. Fry Collection 
edited by Susan Wheeler, 
curatorial consultant 
Ashgate Publishing Co. 
(Burlington, Vt.) 2001 
This meticulously researched vol¬ 
ume makes available an important 
collection of prints and drawings 
from the Cushing/ Whitney Med¬ 
ical Library at Yale and allows com¬ 
parative study of specific medical 
themes as they have been por¬ 
trayed over time by artists. The 
collection also reflects the profes¬ 
sional interests of Fry, a Yale psy¬ 
chiatrist, bringing together many 
works related to mental illness, 
including representations of 
patients, psychiatric institutions 
and therapeutic practice. 
Handbook of Alcoholism 
edited by Gerald Zernig, m.d., 
Alois Saria, ph.d., Martin Kurz, 
m.d., and Stephanie S. O'Malley, 
ph.d., professor of psychiatry 
crc Press 
(Boca Raton, Fla.) 2000 
While the war on drugs continues 
to attract worldwide attention, 
the fact that alcoholism remains a 
major worldwide health concern is 
often overlooked. No matter what 
one's expertise, the crc Handbook 
of Alcoholism can help practition¬ 
ers acquire the necessary skills to 
treat problem drinkers and alcohol- 
dependent patients. This compre¬ 
hensive handbook addresses the 
underlying psychological problems 
of alcoholism, and helps prac¬ 
titioners to better diagnose and 
treat the nonpsychiatric medical 
disorders caused by the disease. 
Psychiatry on Trial: Fact and 
Fantasy in the Courtroom 
by Ben Bursten, m.d. ’58, hs ’62 
McFarland Company Inc. 
(Jefferson, N.C.) 2001 
In some areas of the law, psychia¬ 
trists have become as much a part 
of the legal landscape as lawyers 
and litigants. Psychiatrists’specu¬ 
lations garner criticism from both 
the medical and legal communities. 
In this work, the author takes a 
close look at psychiatric testimony 
and examines the validity of what 
forensic psychiatrists do. Using 
depositions from actual cases and 
drawing from his own experiences, 
the author discusses the problem 
of misinformed professionals, 
appropriate and inappropriate tes¬ 
timony and the legal principles 
that help distinguish good testi¬ 
mony from bad testimony. Also cov¬ 
ered are a wide variety of psychi¬ 
atric and legal issues, including 
worker's compensation, murder, 
child abuse, repressed memory, mal¬ 
practice and sexual harassment. 
Beyond the Big Talk: Every 
Parent’s Guide to Raising Sex¬ 
ually Healthy Teens—from 
Middle School to High School 
and Beyond 
by Debra W. Haffner, m.p.h. ’79 
Newmarket Press 
(New York) 2001 
As children mature into potentially 
sexually active young adults, par¬ 
ents have an increasingly difficult 
time talking to them about the 
sensitive topics of sex and sexuality. 
The influences of the media, the 
Internet and peer pressure compli¬ 
cate relationships between parent 
and child and make it harderthan 
ever before for parents to pass 
their own values on to their teens. 
But parents who are able to stay 
involved in their children’s lives 
can make a big difference in the 
children's actions and behaviors. 
Writing in a realistic, practical 
and informative style, Haffner pro¬ 
vides a wealth of techniques and 
ideas for helping teens deal with 
sexuality issues. With checklists 
and sample conversations, she gives 
specific information particular to 
each age group: middle school, 
early high school, late high school 
and beyond. She addresses such 
crucial issues as peer pressure, dat¬ 
ing and parties, alcohol and drugs, 
sexual harassment and abstinence. 
Meselson, Stahl, and the 
Replication of dna: A History 
of "The Most Beautiful 
Experiment in Biology” 
by Frederic Lawrence Holmes, 
ph.d., Avalon Professor and 
chair of the Department of the 
History of Medicine 
Yale University Press 
(New Haven) 2001 
This book vividly reconstructs the 
complex route that led to the 
Meselson-Stahl experiment con¬ 
firming that dna replicates as 
predicted by Watson and Crick's 
double-helix structure. It also 
provides an inside view of day-to- 
day scientific research — its unpre¬ 
dictability, excitement, intellectual 
challenge and serendipitous wind¬ 
falls, as well as its frustrations, 
unexpected diversions and chronic 
uncertainty. Holmes uses research 
logs, experimental films, correspon¬ 
dence and interviews with the par¬ 
ticipants to record the history of 
Meselson and Stahl’s research,from 
their first thinking about the prob¬ 
lem through the publication of 
their dramatic results. Holmes also 
reviews the scientific community’s I 
reception of the experiment, the 
experiment’s influence on later 
investigations and the reasons for 
its reputation as an exceptionally 
beautiful experiment. 
The descriptions above are taken 
from the book jackets. 
SEND NOTICES OF NEW BOOKS TO 
Cheryl Violante, Yak Medicine, 
P.O. Box 7612, New Haven, CT 
06519-0612, or via e-mail 
to cheryl.violante@yale.edu. 
on campus 
Keeping values alive 
in the marketplace 
Most social institutions, according 
to Samuel O. Thier, m.d., former 
chair of the Department of Med¬ 
icine and now ceo of the Harvard- 
affiliated Partners Healthcare, 
have failed to keep pace with the 
transition from the Industrial Age 
to the Information Age. “Medicine,” 
he said, “is perhaps as complicated 
as any social system we have. Doing 
anything to change it is going to 
create major problems. 
“Nonetheless, if it continues to 
change in the fashion it is changing 
now, which is by chaos in the mar¬ 
ketplace, without values driving 
that change, I fear for what might 
come out at the other end,” Thier 
said, as he delivered the Depart¬ 
ment of Medicine’s fifth annual 
Samuel O. Thier Lecture, named in 
his honor, on September 20. 
Partners, founded in 1994 by 
Massachusetts General Hospital 
and Brigham and Women’s Hospi¬ 
tal, has used the strength of its 
affiliations to preserve its values 
in an increasingly competitive mar¬ 
ketplace. “Academic medicine,” 
Thier said, “provides not just the 
intellectual base, it provides social 
values, it provides education, it 
provides research, it advances care 
and it has been the safety net for 
the indigent and the people who 
are uncovered. The number of un¬ 
insured is still an embarrassment 
in this country. If those [academic] 
institutions are injured, then we 
have a major problem.” 
Getting it right for The Times, 
and in a hurry 
Journalists who cover medicine 
must do so under severe time con¬ 
straints and often under pressure 
from people hoping to exact com¬ 
mercial or political profit, said 
Gina Kolata, a medical reporter at 
The New York Times who gave 
the first Margaret Roth-Glynis 
McKiernan Annual Lecture during 
dermatology grand rounds in 
September. Typically, she said, 
publicists swamp her with letters, 
e-mails, faxes and phone calls, 
all touting a real or perceived 
advance in medical care. “One of 
the things you start to ask your¬ 
self is, ‘What am I supposed to 
believe and how am I supposed to 
believe it?’ ” she said. Her skepti¬ 
cism about a press release pro¬ 
moting an exercise regimen led 
her to a physician who had lost his 
license in New York for fraud and 
mistreatment of patients. “The 
onus in medical reporting is really 
on the reporter. You have to get it 
right. Sometimes you have to get 
it right in a very short time. It’s 
an imperfect system. I don’t know 
if there’s a better one.” 
“On the threshold of a 
gigantic new technology” 
“One can be sobered by the real¬ 
ization that virtually all the earlier 
technologies of our species — 
stonework, metallurgy, internal 
combustion, electronics — have 
been used for peaceful purposes, 
but all have also been exploited 
vigorously for hostile ones,” said 
Matthew Meselson, ph.d., a 
microbiologist and expert in bio¬ 
logical weapons. In a talk on Octo¬ 
ber 23 sponsored by the Institute 
for Social and Policy Studies, 
“Averting Hostile Exploitation of 
Biotechnology,” he noted that 
with the unlocking of the human 
genome the stakes are even 
greater. “We are on the threshold 
of a gigantic new technology,” 
said Meselson, Cabot Professor of 
the Natural Sciences at Harvard. 
“It is totally different from all the 
previous technologies because it 
has the potential to change what 
it means to be human.” Control¬ 
ling this new technology, he said, 
requires an international norm 
that would bar its hostile use. 
Production and use of biological 
weapons, Meselson believes, should 
rank with aircraft hijacking and 
state-sponsored torture as an 
international crime with universal 
jurisdiction. He used the example 
of former Chilean president 
Augusto Pinochet, who was 
arrested in England after a judge 
in Spain filed charges against him 
for the torture of dissidents in 
Chile. “The development, produc¬ 
tion and use of biological 
weapons is the result of decisions 
made by individuals,” Meselson 
said. "Why not hold individuals 
responsible?” 
With global health, 
“There is no them, only us” 
When anthrax scares put Americans 
on edge last fall, public health 
took center stage as a national 
security matter, said Nils Daulaire, 
m.d., m.p.h., the ceo of the Global 
Health Council, an organization 
that identifies and reports on world 
health problems. To be sure, noted 
Daulaire, health issues have always 
mattered in some security contexts, 
including the work of the cia, which 
uses infant mortality rates as a 
measure of a country’s stability. 
In a talk sponsored by the 
School of Medicine and the Depart¬ 
ment of Epidemiology and Public 
Health in October, “Fighting Terror 
with Hope: Global Health in the 
New Reality,” Daulaire placed post- 
September 11 health issues in a 
context of globalization, security 
and justice. “It is fundamentally 
unjust that a child born in Afghan¬ 
istan has a chance of dying in child¬ 
hood that is 30 times greater than 
that of a child born in Fairfield, 
Conn.,” he said of statistics that 
predate the bombing campaign 
that began October 7. "Focusing 
on global health is an appropriate 
rejoinder to what happened on 
September it. It is something we 
need to do for the good of our own 
security. We need it for a global 
sense of justice. Ultimately, we need 
it for our souls. When it comes to 
global health, there is no them, 
there is only us.” 
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14 capsule 
A half-century of growth 
The medical school was a quiet place in 1951, with a part-time dean 
and only 23 full professors. What a difference 50 years makes. 
by Pern McNerney 
In 1911, Arnold Gesell inaugurated services for emotionally disturbed children as well as research into 
the normal development of children. These services, later known as the Yale Child Development Clinic, 
became renowned worldwide. When Gesell retired in 1948, the name was changed to the Child Study 
Center, which took a more environmental and psychoanalytic approach to child development. Milton 
Senn (above), a nationally prominent pediatrician, succeeded Gesell as director, serving until 1966. 
In 1951, the School of Medicine oper¬ 
ated on a budget of just over $3 million. 
In 2001, annual revenue had grown 
239-fold, to $717 million. 
In 1951, $1 million was spent on 
research. Fifty years later, the total was 
382 times that figure. 
And at the century’s midpoint, the 
medical school faculty counted only 23 
full professors among its ranks. As of 
last October, that number had grown to 
379, still just a fraction of the total 
1,354 current full-time faculty. 
It’s fair to say that the school has 
grown dramatically over the past five 
decades. 
That growth is the focus of Medicine 
at Yale, 1951-2001, the third in a series of 
exhibits at the Cushing/Whitney Med¬ 
ical Library curated by Historical Librar¬ 
ian Toby A. Appel, ph.d., and Curatorial 
Consultant Lilli Sentz, m.l.s., as part 
of the 300th anniversary celebration of 
Yale’s founding in 1701. 
The role of federal money in the 
expansion of the school was significant, 
and remains a considerable factor in 
the school’s growth to this day. “After 
World War II, there were a number of 
agencies that got into funding science,” 
said Appel. “During and after the war, 
the country’s leadership decided that if 
you supported science, you would get 
breakthroughs, that there was a cause 
and effect.” The increase in funding led 
to growth on several fronts, including 
the administration. Instead of just a 
part-time dean who taught on the side, 
the school eventually would have a 
full-time dean, assistant deans, associate 
deans and deputy deans. 
The appointment of Vernon W. 
Lippard, m.d., as dean in 1952 was sig¬ 
nificant because his full-time status 
allowed him to do a thorough job of 
More on the Web info.med.yale.edu/ymm To view the online exhibit, Medicine at Yale, 1951-2001, please visit our website and select extras. 
15 
fund-raising, according to former Deputy 
Dean Arthur Ebbert, m.d., who served 
on the faculty from 1953 to 1988 and 
provided assistance for the exhibit. Lip- 
pard launched several major building 
programs, said Ebbert, noting that 
the construction of Harkness Dormitory 
and Harkness Auditorium and the 
expansion of the Sterling Hall of Medi¬ 
cine took place during his deanship. 
During Lippard’s tenure, the number 
of faculty more than doubled and the 
budget grew fivefold. 
Like the rest of the country, Yale 
experienced considerable unrest during 
the 1960s. Fredrick C. Redlich, m.d., 
dean from 1967 to 1972, led the school 
during the most turbulent years and 
oversaw the formation of five new depart¬ 
ments and a 25 percent increase in the 
size of the faculty. Redlich strengthened 
basic science departments and grounded 
the teaching of psychiatry in the bio¬ 
logical and behavioral sciences. He was 
succeeded by Lewis Thomas, m.d., 
former dean at New York University and 
a noted pathologist and essayist, who 
left after a year to become the director of 
Memorial Sloan-Kettering Hospital in 
New York. His successor, Robert 
Berliner, m.d., continued to build the 
school into a scientific powerhouse 
during his 11-year deanship, making it 
“one of the top two or three institutions 
in America in terms of hosting research 
supported by peer-reviewed grants,” 
then-Yale President A. Bartlett Giamatti 
said upon Berliner’s retirement. 
Leon E. Rosenberg, m.d., hs ’63, 
dean from 1984 to 1991, oversaw the 
completion of the Boyer Center for 
Molecular Medicine, the Yale Psychi¬ 
atric Institute, the Yale Physicians Build¬ 
ing and the expansion of the Medical 
Library. He also helped raise $155 mil¬ 
lion to increase the endowment. Robert 
M. Donaldson, m.d., led the school in 
1991-92 until the arrival of Dean Ger¬ 
ard N. Burrow, m.d. ’58, who returned 
to Yale after serving on the faculty of 
the University of Toronto and as dean 
and vice chancellor of the University of 
California San Diego. The exhibit cred¬ 
its Burrow with leading the School of 
Medicine through a difficult time of 
transition and promoting science and 
education despite threats of reduced 
external support. 
The school’s current dean, David A. 
Kessler, m.d., was appointed in 1997 
after serving for seven years as commis¬ 
sioner of the Food and Drug Administra¬ 
tion. Kessler has presided over the con¬ 
tinued growth of the school, shepherding 
construction of the Congress Avenue 
Building and a number of smaller build¬ 
ing projects (See Chronicle, page 4). 
Speaking to a gathering of medical, nurs¬ 
ing and public health alumni at the Yale 
Club of New York in January, Kessler said 
that the medical school will have added 
approximately 700,000 square feet of 
new or renovated space to its campus 
within several years and that the next 50 
years may surpass tire last half-century’s 
growth. “I think,” he said, “that we’re in 
the greatest period of expansion in the 
medical school’s history.” 
pem mcnerney is a writer and editor with 
Content Creation Co. in Madison, Conn., 
and director of communications for the Center for 
Nicotine and Tobacco Use Research at Yale. 
In 1952, Vernon Lippard (top right) 
became the first full-time chief 
administrator of the School of 
Medicine. Born in 1905, Lippard 
entered Yale College as a freshman 
in 1922. After three years of col¬ 
lege, he was interviewed by then- 
Dean Milton Winternitz for 
admission to the medical school. 
The interview process was less 
formal at that time, and at the end 
of the interview, the dean told 
him: “All right, you can come.” 
During Lippard’s tenure as dean 
from 1952 to 1967, medicine at 
Yale experienced dramatic growth. 
Under the chairmanship of Paul 
Beeson, the Department of 
Internal Medicine expanded from 
about 10 members in 1952 to 
nearly ioo in 1965. A noted special¬ 
ist in infectious diseases, Beeson 
encouraged doctors to start their 
studies of disease at the bedside 
at a time when medical science 
was becoming increasingly labora¬ 
tory oriented. In 1975, Beeson 
received an honorary doctor of sci¬ 
ence degree from Yale, and in 
1996 the medical service here was 
named in his honor. A biography 
entitled Physician: The Life of Paul 
Beeson by Richard Rapport, M.D., 
was published in 2001. 
Dorothy M. Horstmann made 
significant contributions to sci¬ 
ence, education and public 
health, especially to polio and 
rubella research. In 1942, she 
came to Yale to work with John 
Rodman Paul, and the following 
year she joined the Yale polio¬ 
myelitis unit. In 1961, she became 
the first female full professor 
at the medical school. Among 
her many achievements, she 
demonstrated that the polio virus 
reached the nervous system by 
way of the blood, a discovery that 
made polio vaccines possible. 
Later, Horstmann evaluated the 
oral vaccine program in Russia 
and studied the effectiveness of 
a rubella vaccine. She was 
elected to the National Academy 
of Sciences and also served 
as president of the Infectious 
Diseases Society of America. 
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Letter from Nairobi 
Collage 
by Janis Melone 
Photographs 
by Tara Murphy 
Moving beyond fear 
By Karen Schmidt, In Kenya’s lively and cosmopolitan capital, where Hiv has 
m.p.h. ’oo made alarming inroads, there’s a desperate need for 
good prevention strategies. The right message, it seems, 
is one that encourages self-respect. 
November 2001 
It’s a hot Wednesday in February, the evening rush in Nairobi is just 
starting, traffic is heavy and I have just swung my Subaru into a 
jammed-up roundabout in the Westlands section of the Kenyan capital. 
Most busy intersections in Nairobi feature a roundabout (we would 
call it a traffic circle or rotary in the United States), instead of traffic 
lights or stop signs. I’ve more or less gotten the hang of driving in 
Kenya — keep left, watch out for matatus (the speed demon minibuses 
that serve as the main form of public transport) and remember that 
the cars in the roundabout have the right of way. Since it’s rush hour, 
there’s even a cop directing trajftc at this particular roundabout. 
I slip happily into what looks to be an open lane, but turns out to be 
the wrong lane for where I want to go. The officer notices my oppor¬ 
tunism, looks at me in disbelief and waves me over. I put on my most 
respectful face and say, “I’m sorry, I’m new in town and still learn¬ 
ing about roundabouts.” I hold that this might have worked back home, 
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18 Moving beyond fear 
but the word “learning” only makes him more suspicious, so 
he rounds the car to speak to my colleague in the passenger 
seat; he must figure that, as a male, my co-worker is certainly 
in charge. 
"Is this driver under instruction?” the cop asks. 
"No, she’s just new in town,” says my colleague, C.Y. 
Gopinath, better known as Gopi. 
"Where are you from?” asks the cop. I lean over and say, 
“U.S.,” with a big American smile. The cop looks even more 
suspicious when Gopi says, “I’m from India.” 
The officer continues addressing Gopi. “Is she your wife?” 
"No, we work together.” 
“Where?” 
“PATH.” 
“What?” 
“p-a-t-h. Program for Appropriate Technology in Health. 
It’s an ngo [nongovernmental organization]. We work on 
aids prevention.” 
“You give medicine to people?” 
"No, we help keep people from getting infected.” 
I decide to pipe up. “We give them information they need 
to protect themselves,” I say. In fact, a basic tenet of behav¬ 
ior change communication (bcc) is that information is often 
not enough to change a person’s behavior, but I am trying 
to avoid a traffic citation, not teach a lesson on bcc theory. 
The officer mulls the idea of prevention for a few seconds 
before returning to known territory. “What are the symptoms?” 
“aids doesn’t have any symptoms on its own,” Gopi 
explains. “It’s when your body’s askari goes to sleep.” 
We launch into an analogy that has proved very useful 
here. An askari is a watchman or security guard (very com¬ 
mon in this high-crime city). When your askari is asleep, 
any thug can get into your house, hiv eventually puts your 
body’s askari to sleep, so any disease can get in unchal¬ 
lenged. One could quibble about the analogy’s accuracy from 
a scientific point of view, but it helps meet one of my pro¬ 
ject’s key communications objectives: increasing the perceived 
distance between hiv and aids. The idea is that if people 
believe being infected with hiv is the same as having aids 
and dying, they are less likely to be interested in being tested 
and more likely to stigmatize those with the virus. Under¬ 
standing the difference also makes the point that you can’t 
tell if a person has hiv by his or her appearance. 
CLOCKWISE FROM TOP LEFT 
Traffic flows heavily toward a 
roundabout in the Westlands sec¬ 
tion of Nairobi, where a traffic 
stop yielded a discussion of aids 
and an analogy: “It’s when your 
body’s askari goes to sleep.” A real 
askari, or watchman (top right), 
checks author Karen Schmidt’s 
identity at the entrance to her 
apartment complex in the 
city’s Lavington section. In the 
central business district, a 
man stands by one of Nairobi’s 
many matutus, waiting to 
drum up business while a child 
peers from a window of one 
of the brightly colored buses. 
SCARE TACTICS A FAILURE 
In 1999 Kenya’s president, Daniel arap Moi, declared aids a 
national disaster, and prevention and control efforts have been 
stepped up since then. Since August 2000, when I came to 
Kenya a few months after finishing my m.p.h. at Yale, I have 
been working on the communications component of impact 
(Implementing aids Prevention and Care), a global project 
funded by the United States Agency for International Develop¬ 
ment (usaid) and managed by Family Health International, 
a nonprofit based in North Carolina. My agency, path, is a 
Seattle-based nonprofit that employs about 365 people world¬ 
wide, with a mission to improve health, especially that of women 
and children, path’s Kenya site, with about 25 employees 
and still growing, specializes in using innovative communica¬ 
tions methods to change behavior, focusing especially on 
adolescent reproductive health, prevention of cervical cancer, 
eradication of female genital cutting and hiv prevention. 
In Kenya, path implements the communication and training 
components of impact. 
Though I function as a program officer for path, I’m not 
technically a path employee. I’m seconded to path Kenya 
through a somewhat complicated mechanism called the Uni¬ 
versity of Michigan Population Fellows program. Funded by 
usaid, the program places early-career public health profes¬ 
sionals in usaid missions and contracting agencies for two- 
year assignments; the goal is to provide technical assistance to 
the agency and professional experience for the fellow. My pay- 
check comes from the University of Michigan, and the fund¬ 
ing comes from usaid, but what’s most important for me is 
the opportunity to work in the field just out of graduate school. 
At Yale I had gained a strong academic background in eph’s 
International Health Division and learned a great deal about 
the research, community and policy context of the pandemic 
while working as community director at the Center for Inter¬ 
disciplinary Research on aids, based in the School of Public 
Health. But with no experience living and working in a devel¬ 
oping country, the fellowship was just the jump-start my 
career needed. One thing that is clear in Kenya—and in most 
of sub-Saharan Africa—is that nearly two decades of aware¬ 
ness raising and scare tactics have not done enough to curb 
the epidemic. People have heard of aids. They fear it. Many 
know aids is caused by a virus spread through sexual contact 
and have some idea of how to prevent transmission. But as my 
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20 Moving beyond fear 
CLOCKWISE FROM TOP LEFT 
Nairobi is a vibrant capital of 3 mil¬ 
lion people but its skyline, seen 
over the trees of Uhuru Park, sug¬ 
gests a smaller city. A large seg¬ 
ment of the population lives with¬ 
out sanitation or running water in 
slums such as Kibera (top right), 
which has a population estimated 
at 1 million. Thirty minutes from 
the downtown is Nairobi National 
Park, where impala roam in great 
numbers. Women sell maize and 
other produce in one of the city’s 
many markets. 
encounter with the traffic cop demonstrated, real understand¬ 
ing is generally poor. Myths and conspiracy theories abound — 
I recently heard that aids stands for “American Invention to 
Discourage Sex”—and when we ask people at outreach or 
training sessions to write down their questions about hiv and 
aids, someone always asks, “Where did aids come from?” 
People do have a strong sense that the aids epidemic is a 
powerful force in the country and on the continent. Kenya has 
been measuring hiv prevalence since 1985, mostly through 
sentinel surveillance at prenatal clinics, and the statistics show 
that an estimated 14 percent of Kenyans aged 15 to 49 are 
infected with hiv. Though that rate is lower than those in 
some southern African countries, where adult prevalence may 
top 30 percent, it still suggests that in Kenya more than 2 
million of the country’s 30 million people are living with hiv 
and aids. Hundreds of homeless children roam the streets 
of Nairobi, many of them aids orphans. Kenya’s daily newspa¬ 
pers carry pages of obituaries each day, most with photos. 
Usually readers are left to wonder whether the young person 
pictured died of aids, but in July, for the first time, one 
family had the courage to reveal their loved one’s cause of 
death: the color picture was flanked by two small red ribbons, 
the symbol of aids awareness. 
A LANDSCAPE OF BEAUTY AND DANCER 
Kenya is one African country most Americans have heard of, 
thanks to the film Out of Africa and the romantic idea of the 
big-game safari. Kenya does have spectacular natural beauty. 
Parts of the country fit the stereotype of the African desert, 
especially in the sparsely populated north, toward the Sudanese 
and Ethiopian borders, and the Taru Desert of the southeast. 
Shaba Game Reserve, in the semi-arid lowlands north of 
Mount Kenya, was the location for the third installment of 
Survivor, the popular cbs series. But Kenya also has lush green 
highlands in its Central Province, gently rolling hills and 
forests in the west toward Lake Victoria and Uganda, and the 
steamy Indian Ocean coast, with its distinct Islamic Swahili 
culture. The Great Rift Valley is home to the earliest human 
ancestors. Snowcapped Mount Kenya, at 17,000 feet, is the sec¬ 
ond-highest mountain in Africa, and Kilimanjaro, the highest 
peak on the continent, is just over the border in Tanzania. 
Numerous game parks preserve Kenya’s rich wildlife; on my 
first trip to Masai Mara Game Reserve a year ago last Octo¬ 
ber, I saw elephants, lions, rhino, buffalo, hippos, wildebeest, 
giraffes, zebra and more, as well as a startling variety of 
antelopes, primates and birds. Watching a cheetah patiently 
stalking an impala, or a mama lion playing with her cubs, is 
unbelievably magical. 
Nairobi is a busy, vibrant, cosmopolitan capital of about 3 mil¬ 
lion people, where virtually any goods and services are available 
to those who can afford them. Although it sits just south of the 
equator, Nairobi’s 5,500-foot altitude keeps the climate delightful 
most of the year, with the chilliest weather in July and August. 
Despite the country’s natural resources, Kenya’s economy is in 
trouble; the gnp actually shrank in 2000. The country recently 
tied with Cameroon, Bolivia and Azerbaijan as the fourth-worst 
in the world for corruption, according to a survey by Trans¬ 
parency International, a global coalition devoted to curbing cor¬ 
ruption. Unemployment is common, crime is rampant and 
government services are generally poor: roads are in bad shape, 
many police don’t have vehicles and garbage collection is spo¬ 
radic or nonexistent. A large proportion of Nairobi’s population 
lives in slums without running water or sanitation. For most 
of 2000, the power company was rationing electricity because a 
drought had reduced the country’s hydroelectric output; in some 
places, power was cut for 12 hours a day, and water was in short 
supply. The political climate is uncertain because President Moi, 
who came to power in 1978, is constitutionally barred from run¬ 
ning again in the 2002 elections; some wonder if he will try to 
run anyway, but in any case the next year is sure to be unsettled. 
For people in Nairobi, the terrorist attacks of September 11 
brought back the horrors of August 1998, when the U.S. Embassy 
here was bombed. A total of 213 people, most of them Kenyan, 
died in the attack, believed to be the work of Osama bin Laden’s 
A1 Qaeda organization. Thousands were injured. Many busi¬ 
nesses moved out of the congested city center after the bombing, 
but since security is already a priority here because of crime, the 
effect on daily life post-September 11 has been minimal. 
In this context, convincing individuals to worry about a virus 
that may kill them in a decade or so can be a challenge. At 
path, we’re trying to devise new ways to improve the effective¬ 
ness of peer education, the centerpiece of the impact project, 
with the ultimate goal of persuading people to protect themselves 
by using condoms, reduce the number of sexual partners 
and learn their hiv serostatus through voluntary counseling 
and testing. Given that the vast majority of infections in Kenya 
occur through heterosexual sex, our premise is that aids is 
not the problem, but the consequence: the problem is relation¬ 
ships. That includes relationships between a husband and 
wife, a young man and woman, a commercial sex worker and 
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Moving beyond fear 
Wildebeest and satellite TV: 
an expat’s African existence 
Maybe I’m just used to it, but 
some days, life in Nairobi seems 
indistinguishable from life in New 
Haven. I get up, make coffee, drive 
to work listening to silly contests 
and chatter on the radio (“Kiss 
100, Nairobi’s Fresh Hits”), spend 
the day pecking at a keyboard, 
attending meetings and juggling 
phone calls, and then head home. 
I might stop at the gym or the 
supermarket, or call a friend on 
my mobile phone on the way, and 
maybe arrange to meet for pizza 
or sushi or Indian food. I’ve found 
it relatively easy to meet other 
ex-pats to hang out with; we 
might go to the mall to eat at the 
food court and see a movie. Back 
home at my apartment complex, 
I might catch something on dstv 
(digital satellite television) or go 
for a short walk if I’ve managed to 
get home in time—the sun sets 
around 6:30, and walking after 
dark is dangerous. If it’s too late, 
I can walk around the apartment 
complex, a compound of seven 
four-story buildings. It’s safe 
behind the 10-foot wall, topped 
with an electric fence, with five 
askaris on duty around the clock. 
Weekends offer a chance to 
head out of the capital city’s bus¬ 
tle and smog. Just outside of 
town, beyond the suburb of Karen 
(named for Karen Blixen, who 
wrote Out of Africa under the pen 
name Isak Dinesen) are the Ngong 
Hills. Shaped like the knuckles of a 
fisted hand, legend holds that the 
hills were formed when a giant 
tripped over Mount Kilimanjaro 
and rested his fist to steady him¬ 
self. A walk along the spine of the 
hills offers a view of Nairobi on 
one side and a spectacular drop¬ 
off to the Great Rift Valley on 
the other. Venturing further away 
from Nairobi, there are game 
parks, campsites, eco-lodges, 
mountains to climb, lakes and the 
Indian Ocean. 
Beyond Kenya, the two other 
official East African countries, 
Uganda and Tanzania, offer their 
own charms. In Uganda last March, 
after a weeklong workshop in its 
pleasant, quiet capital, Kampala, 
I spent an insanely exhilarating 
day whitewater rafting on the 
Nile just below the source. While 
villagers on the banks watched 
in amazement, about 20 crazy 
tourists navigated class 4 and 3 
rapids, even going over a four- 
meter waterfall backwards (on 
purpose, according to our very 
relaxed guide). In April, I visited 
Zanzibar, the archipelago that 
forms, with the mainland of Tan¬ 
ganyika, the United Republic of 
Tanzania. Stonetown, on the main 
island of Unguja, is a maze of nar¬ 
row, winding streets, some so 
small you can reach out and touch 
buildings on either side. The cul¬ 
ture is very Swahili and very Mus¬ 
lim; the Kiswahili language has its 
roots in Zanzibar, and Zanzibaris 
believe they speak its purest form. 
(In Kenya, most people speak a 
more casual version of Kiswahili in 
addition to their native language 
and at least some English.) Most 
Zanzibari women wear a bui-bui 
(black robe and head scarf). 
Wooden dhows in the port are 
still very much in use. 
Wherever I go, and whatever 
exotic experiences I enjoy, I’m 
acutely aware that my privileged 
life here bears little relation to the 
lives of most Kenyans. Nairobi 
has a large expatriate community, 
working in government, business 
or the huge development sector. 
Most of us live far better here 
than we ever could at home, and 
our resources insulate us from 
many discomforts. When I arrived 
in August 2000, the city was 
gripped by severe power rationing 
and water shortages; I found an 
apartment complex with a backup 
generator and a well. I’ve become 
frighteningly accustomed to 
having someone else wash my 
clothes, clean my house and carry 
my groceries to my car. Most 
days do feel ordinary—except 
when I’m trying to make a phone 
call across town and it won’t go 
through, or I have to stop on the 
way home to let a cow or goat 
cross the road or I decide to spend 
a Sunday at the Nairobi Game 
Park on the edge of town, looking 
at giraffes or warthogs or lions. 
Then I remember—I live in Africa. 
For real. 
KAREN SCHMIDT 
CLOCKWISE FROM TOP LEFT 
Actors perform during a recording 
session for Kati Yetu (“Between 
Us”), a national weekly radio pro¬ 
gram that carries aids prevention 
messages. Peer educators for 
impact demonstrate how a con¬ 
dom is used in a section of 
Mombasa, Kenya’s second-largest 
city. Artist Bella Kilonzo with 
his poster for the second comic 
book in the Nuru series. A school¬ 
boy in Kakamega in Western 
Kenya works on a mural outside 
Kakamega Primary School. 
her client, a young girl and a “Sugar Daddy.” A key goal is 
reducing the despair and fatalism surrounding hiv and replac¬ 
ing it with messages of optimism, hope and greater self- 
respect, as a prerequisite for greater acceptance and involve¬ 
ment with lifesaving messages about hiv and aids. 
DRAMA ON THE AIRWAVES 
The theme of path’s communication strategy for impact 
is “Question Your Relationships.” In every activity, people are 
encouraged to ask questions, not necessarily to receive the 
answers from an all-knowing teacher, but to begin thinking in 
depth about the epidemic, their own risk of hiv, and how 
the nature and quality of their relationships affect that risk. 
Rather than imparting information from the top down, we’re 
training peer educators to facilitate intense dialogue and 
debate with a relatively small number of people. As the people 
in those groups raise issues and concerns, and even change 
their behavior, we’ll magnify the issues and changes on a 
national weekly radio program we launched in May. The pro¬ 
gram, called Kati Yetu (“Between Us” in the Kiswahili lan¬ 
guage), includes a soap opera and a magazine with interviews, 
panel discussions, music and news. Listening groups have 
been formed to help spark and deepen debate on issues raised 
in the program; feedback from those groups, and the peer 
education groups, will keep the program responsive to commu¬ 
nity concerns. We depend on impact’s large network of imple¬ 
menting partners to help carry out these activities; the partners, 
all funded by Family Health International, range from local 
clinics and ngos to the Kenya Girl Guides Association and the 
University of Nairobi and conduct activities such as upgrad¬ 
ing health centers and providing voluntary counseling and test¬ 
ing, in addition to peer education and listening groups in 
workplaces and in the community. 
path is also producing a comic book for youth, and did a 
series of murals in schools. For the latter, students developed the 
content through discussions and role play, then painted the 
murals with supervision from professional artists and wrote 
essays based on the topics depicted in the mural. These intense 
activities are more difficult than producing a poster that says 
“aids Kills." But we know that fear doesn’t reliably lead to pre¬ 
vention, and despite the probable wider introduction of anti¬ 
retroviral drugs in Kenya, prevention remains essential. 
The challenges to effective prevention are considerable. As 
in so many places, people are uncomfortable talking about 
sex and leery of talking to adolescents about sexuality. Years of 
continued on page 48 
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24 
The deaths of five people exposed to anthrax last 
fall put bioterrorism squarely on the map. 
Where does the road lead from here? 
A Yale Medicine roundtable. 
THE DISCUSSANTS FRANK J. BI A, M.D. 
professor of medicine (infectious 
disease) and laboratory medicine; 
co-director of the Yale Interna¬ 
tional Health Program 
JONATHAN B. BORAK, M.D. 
associate clinical professor of 
medicine and epidemiology, 
board-certified toxicologist, mem¬ 
ber of the National Research 
Council’s committee on chemical 
warfare agents 
RAVI V. DURVASULA, M.D. 
assistant clinical professor in the 
division of epidemiology of micro¬ 
bial diseases and medical director 
of Yale University Health Services; 
Durvasula has worked on projects 
aimed at developing pathogen 
countermeasures for use in bioter¬ 
rorist attacks 
At the 2001 annual meeting of the American Association for the Advance¬ 
ment of Science last February in San Francisco, an audience member 
asked a panel of experts on bioterrorism why the world had yet to see a 
major biological attack. After a moment’s pause, a response came from 
Stephen Morse, ph.d., director of the Center for Public Health Preparedness 
at Columbia University. “Nobody really knows the answer to that,” he 
said. “I suspect there have been a number of barriers, some cultural, some 
technical, to pulling this off. Clearly, there have been a number of groups 
as well as countries that have been interested. It is only a matter of time 
before the motivation and the knowledge of those people who wish to use 
bio will reach the point where you will see a real attack happen. I think, 
unfortunately, it is probably not that far in the future.” 
September n dispelled any doubts about barriers to perpetrating a 
major terror attack, and the ensuing rash of anthrax exposures made 
the notion of biological warfare real to Americans. The use of the mail to 
deliver anthrax, however, was a scenario no one on the panel of sol¬ 
diers, scientists and scholars had envisioned. We wondered what Yale’s 
experts in the field might be doing to try to anticipate the unantici¬ 
pated, and in early December, Associate Editor John Curtis asked faculty 
and alumni in medicine, public health and microbiology to comment 
on the anthrax scare and bioterrorism more generally. On the following 
pages are highlights of their responses. 
ROBERT HEIMER, PH.D. ’88 
principal investigator of the 
Yale Emerging Infections Program, 
associate professor of epidemi¬ 
ology and public health and 
of pharmacology 
STEPHEN C. JOSEPH, 
M.D. '63, M.P.H. 
former commissioner of health 
for New York City, former assistant 
secretary of defense for health 
affairs and a founding principal in 
the health consulting firm Black 
Dog Associates in Santa Fe, N.M. 
RICHARD M. SATAVA, M.D. 
professor of surgery, former 
program manager of the 
Advanced Biomedical Technolo¬ 
gies Program of Defense 
Advanced Research Projects 
Agency 
ANDRE N. SOFAIR, M.D., 
M.P.H. ’97, HS ‘90 
assistant professor of medicine; 
one of Sofair's research interests 
the development of surveillance 
systems to assist in the clinical 
recognition of unexplained infec 
tious diseases 
More on the Web info.med.yale.edu/ymm To read a longer discussion of the anthrax scare and bioterrorism, 
please visit our website and select extras. 
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26 Lessons from anthrax 
Five people have died and 13 others have become infected 
with anthrax in its inhalation or cutaneous form as of 
November 24. Given these cases, how serious is the threat of 
biological terrorism? 
DURVASULA 
The threat of bioterrorism should be considered very real. We 
now know that a bioterrorist attack can be launched success¬ 
fully in the U.S., that high-grade, highly infectious agents can 
be readily released in our country, that perpetrators of these 
acts may go undetected, that the health care system is entirely 
unprepared for such attacks, and that otherwise innocuous 
routes such as the mail may be used. 
BORAK 
The hoof-and-mouth infection that wiped out much of the beef 
herd in England in 2000 could have been an example of 
bioterrorism and could be readily reproduced in this country. 
There is an incredible ease about delivering enteric pathogens to 
the food sources in our very open society. Think of one per¬ 
son—a truck driver for a supermarket chain who sprays veg¬ 
etables prior to delivery. 
HEIMER 
Although bioterrorism is a threat because its sources and the 
potential for more terrorist dissemination are unknown, the 
health of the American public is far more threatened by infec¬ 
tious agents whose disease burden could be reduced by con¬ 
certed public health action. While we need to solve the criminal 
issue of anthrax terrorism, public health money could be more 
wisely spent combating the spread of preventable diseases. 
What other pathogens might pose a threat from bioterrorists? 
Smallpox? Tularemia? O fever? Ebola? Plague? 
DURVASULA 
Potential agents include bacteria such as the anthrax bacillus 
or plague bacillus, viruses such as smallpox or agents of 
hemorraghic fever, or even toxins such as staphylococcal toxin 
or botulinum. The greatest threat in terms of mass lethality is 
posed by those agents that can be aerosolized and for which 
treatments are limited and natural immunity is low. Therefore, 
in addition to anthrax, smallpox virus, plague bacillus and 
Francisella tularensis (the agent of tularemia) are considered 
potential agents. 
JOSEPH 
Perhaps an even greater problem is modified organisms, 
from strains of smallpox which might be resistant to current 
vaccines, to the chimera organisms we know the Soviets 
were working on. Chimera organisms could be developed to 
give a one-two punch where a second illness would break 
out after the first illness. 
What can we learn from the anthrax scare this fall? 
JOSEPH 
We were very fortunate in two ways. It was a noncontagious 
agent and the mechanism of dispersion used was relatively 
inefficient and very small-scale. 
In general, our disaster management programs in the states 
involve three sectors: law enforcement/military, disaster man¬ 
agement/environmental protection, and public health/clinical 
medicine. Traditionally, the public health and clinical part of 
that triad has been sort of a dragging dog. It is the law enforce¬ 
ment—and in some cases the military—that runs the operation. 
Except for industrial or chemical events, the health problems 
have been largely surgical triage and response. In the biological 
and chemical warfare world we are now in, that changes. The 
subtleties, complexities and degrees of uncertainty are so differ¬ 
ent that public health and clinical medicine need to take a much 
more expanded and important role. 
HEIMER 
We need to broaden existing ER and primary-care surveillance. 
Quick response means quick detection of suspect cases, rapid 
diagnosis, proper identification of and prophylaxis for those 
exposed. Immediate attempts to trace the source of infection 
and, in the case of agents that can be transmitted easily from 
person to person, the contacts of the index case must become 
routine parts of such surveillance schemes. 
What needs to be done to prepare our public health infrastruc¬ 
ture to deal with biological warfare? 
JOSEPH 
The infrastructure at the municipal and county levels is under¬ 
funded. It’s weak. It is not well coordinated with the clinical 
sector or the law enforcement sector. It often doesn’t do a good 
job with the media. In all sorts of ways we need to beef up 
everything, from computerized information systems that link 
horizontally as well as vertically, to increased laboratory 
resources, to tighter relationships between the clinical and 
public health sides. 
BORAK 
I have been trying to push the American College of Occupa¬ 
tional and Environmental Medicine to develop models so 
that corporations can use their existing facilities as adjuncts to 
the public health system. Most large corporations already 
deal with trying to get most of their employees to take flu shots. 
Let’s assume that it was necessary to vaccinate the entire 
population of a city. There is no way the city’s department of 
public health is going to do it. They don’t have the capacity. 
You could find the 50 or 100 largest employers and simply 
deputize them. You could ask corporate medical directors, 
“Can you develop a system so that any one of your facilities 
would be able to provide, within 48 hours, vaccinations for 
every employee and his or her immediate family?” It is a sys¬ 
tem that already exists. It just doesn’t know it exists. 
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What can this medical school do to better educate students and 
physicians to deal with biological terrorism? 
SOFAIR 
We need to think about which diseases we teach the students 
about. We need to teach students how to recognize something 
unusual, even if it is presenting in a common syndrome. 
Many of the agents that may be used in a bioterrorist attack 
may present as a pneumonia, or an encephalitis, and may be 
indistinguishable from more common etiologies without a 
high index of suspicion. And we need to teach our medical stu¬ 
dents how to take a good exposure history. 
BIA 
Our curriculum in medical microbiology is readily adaptable 
to dealing with the pathogenic features of potential bioterrorist 
agents. Much more difficult are the terrorism pieces. What con¬ 
ditions breed terrorism? How do lack of adequate health care, 
poverty and instability foster terrorism? This is not just a 
“wet bench” problem. It involves the social sciences — the very 
disciplines that physicians tend to avoid as "soft." 
Since the first case of anthrax was diagnosed this fall in Florida, 
information released to the public has been at times contra¬ 
dictory and at times inaccurate and incomplete. How can the 
federal government better coordinate its communications 
regarding biological threats? 
JOSEPH 
Public health people have to learn how to get out in front and 
make sure that political figures and the media are passing 
along good, consistent and useful information that helps the 
medical and public health process along. 
HEIMER 
Speaking with a single voice is not necessarily speaking the 
truth. A free society needs multiple sources of information and 
an appreciation that contradictory messages are a necessary 
part of a free society’s emerging response to the unknown. 
Only totalitarian states can choose a single path and adhere to 
it regardless of what new information becomes available. 
Are there ways of safeguarding potential conduits for bioterror¬ 
ism? In the case of anthrax, this might mean irradiating the 
mail. What other channels are vulnerable and how might they 
be protected? 
HEIMER 
It’s hard to comprehend all the possibilities. Life is not without 
risks, and if we considered all the possible risks and tried to 
prevent them, we would still be living in caves. The proper ques¬ 
tion is, “How should we respond when a new threat emerges?” 
SATAVA 
The solution to bioterrorism is not technology. I am not con¬ 
vinced that a huge investment in many of these preventive 
measures—which can drain our economy—is capable of pre¬ 
venting such acts from occurring. The solution is to eliminate 
the root cause, or perceived root cause, which may be impossi¬ 
ble. Temporizing solutions, such as tearing up the Al Qaeda 
network, are essential in the near term, but better long-term 
solutions on a multinational level are also required. 
Is the hoarding of antibiotics a public health threat in and of 
itself? How can people protect themselves without resorting to 
prophylactic use of antibiotics? 
DURVASULA 
The hoarding of Cipro is a public health nightmare, since it 
may lead to a shortage. There are numerous reports that peo¬ 
ple are taking the medications erratically, because of unpleas¬ 
ant side effects. This is a recipe for disaster in terms of emer¬ 
gence of antibiotic resistance. With the current anthrax scare 
and potential future bioterrorist threats, society may easily slide 
backward in the effort to use antibiotics wisely, creating a far 
greater epidemic of antibiotic resistance. 
HEIMER 
Compared to the overprescribing of antibiotics for all forms 
of viral disease, the current overuse of Cipro is a blip on the 
radar. For health threats, it makes sense that health officials at 
the municipal and state levels, with the backing of experts at 
the cdc, be given the forum they need to articulate who, if 
anyone, in their community needs medical prophylaxis. Indi¬ 
viduals in this society are free to accept or disregard this 
advice, but it’s important that the advice offered is sound med¬ 
ically and inclusive of all those at risk. 
SATAVA 
The bioterrorist threat cannot be solved with stockpiling of anti¬ 
biotics or vaccination against all possible agents. I don’t believe 
that anyone can protect themselves against bioterrorism, just 
as we cannot protect against nuclear holocaust. Bioterrorism 
has become a fact of life, and we as a nation must adjust, accept 
that we might possibly be subject to a horrific act and go on 
with our lives. In the meantime, we should develop only those 
technologies and response systems which have a high likeli¬ 
hood of mitigating specific areas of risk, ym 
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Targeting 
cancer 
by subtype 
Drawing from an archive 
of three million tissue 
samples, Yale investigators 
are applying the latest in 
microarray technology to 
hunt down cures for tumors 
that resist treatment. 
By Marc Wortman 
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opposite A portion of a glass slide 
dna microarray shows the differ¬ 
ences in gene expression between 
two human cancer cell lines. A 
single array can hold segments of 
more than 18,000 genes. Red 
spots are genes expressed only in 
one cell line and green spots are 
genes expressed only in the other. 
Yellow spots represent genes 
expressed equally in both lines. 
Similar comparisons can be 
made between tumor cells and 
normal tissue and in malig¬ 
nant cells at various stages of 
their development. 
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hen a pathologist looks 
at the biopsy of a suspi¬ 
cious lump, she checks 
for the telltale signs of 
cancer—the clumping of 
cells and distortion in 
their normal architec¬ 
ture—that reveal a malig¬ 
nancy. From there, she 
may test for biological 
markers that categorize 
the cancer, hoping to 
guide oncologists as precisely as possible in making treatment 
choices for the patient. That’s the hope, anyway. All too often, 
though, one cancer looks and tests very much like another. Yet 
chemotherapy will melt away one patient’s tumor, while having 
no effect on another, seemingly identical cancer. At that point, 
it may be too late to pursue other therapies, including experi¬ 
mental treatments that might have helped if used earlier on. 
Genetic oncologists are beginning to understand why can¬ 
cers that look the same react so differently to treatment. A 
range of new and related molecular technologies has begun to 
reveal a surprising fact about cancer: melanoma, lymphoma 
and virtually all other major cancer groupings have genetic 
subtypes, some of which resist treatment or may respond bet¬ 
ter to different therapies. Although the symptoms and the 
cells appear the same, they are effectively different diseases. 
The effort to define these subtypes begins with a map 
of the genome of the cancer cell. Once armed with that 
knowledge, pathologists will know whether one therapy or 
another will be more likely to work for the specific cancer 
subtype. It also provides tools for seeking out new and 
better treatments. 
That is why Vincent T. DeVita Jr., m.d., hs ’66, director 
of the Yale Cancer Center, and colleagues decided in February 
2000 to launch the Yale Tissue Microarray Facility. Together 
with the Keck Biotechnology dna Microarray Resource, which 
was expanded in 1999 with funds from the National Cancer 
Institute (nci), it provides scientists at Yale and other research 
centers around the world with a powerful set of tools for 
experiments to get at the genetic underpinnings of cancer. “I 
don’t know of a single cancer that doesn’t have an identifiable 
genetic abnormality,” says DeVita, a former nci director 
under Presidents Carter and Reagan and author of the leading 
oncology textbook. Once known, that abnormality becomes 
a potential marker for early detection and a precise target at 
which to shoot chemical compounds for a possible cure. 
The Tissue Microarray Facility and the dna Microarray 
Resource are part of a series of initiatives at the Cancer Center 
and elsewhere at Yale to apply the emerging technology of 
microarrays to the study of basic biology, cancer and other dis¬ 
eases. Most importantly, microarrays hold the potential for 
rapid advances in the design of new treatments. “You can 
address real and important questions with arrays,” says DeVita. 
“They’re going to be the tools for the future. I don’t have a 
crystal ball, but if I were a betting man, I’d bet that new treat¬ 
ments will happen faster than anyone expected previously 
because of them." In fact DeVita has made some big bets at 
Yale that those technologies are key to coming up with better 
ways to find and treat cancer. 
CHIPPING AWAY AT CANCER 
Microarrays, sometimes referred to as biochips, are created by 
positioning minute amounts of biological material, such as 
tiny slices of tissue or portions of genes or proteins, on a glass 
microscope slide or a computer chip. Robots drip nanoliter 
quantities through tiny tubes—in some instances spraying 
spots out like an inkjet printer and in others placing tiny drop¬ 
lets like a quill pen—at precisely known positions to create a 
matrix of spots on the chip’s or slide’s surface. 
There are several ways of capturing data from microarrays, 
which use either electrical current or biochemical reactions 
to measure gene and protein expression or the properties of 
tissue. The arrayed material—chemically tagged with a fluores¬ 
cent compound—can be treated with chemicals, complemen¬ 
tary dna, messenger rna or other proteins, with which it 
interacts. The fluorescent tags light up during the reactions, 
and laser scanners pick out the glowing spots. Computers read 
and display the results quantitatively or graphically. The green, 
red, and yellow colors of gene expression arrays, indicating 
genes that are active in a cell, have become something of a sig¬ 
nature image for microarray technology. 
Where previous methods allowed one gene, protein or tis¬ 
sue sample to be studied at a time, a single microarray can 
be used to look simultaneously at virtually every gene in a cell 
or at tissue samples from hundreds of patients. A single 
glass slide dna array can hold segments of more than 18,000 
genes, and a few slides provide sufficient capacity to study 
every known gene in the human genome or all the genes in 
model organisms such as yeast or certain bacteria. 
JANET HAGER/KECK BIOTECHNOLOGY DNA MICROARRAY RESOURCE 
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Tissue microarrays provide a 
means of analyzing hundreds of 
tumor samples simultaneously 
while conserving scarce sample 
material. Unlike gene chips, in 
which each spot represents a sam¬ 
ple of cloned cdna, tissue micro¬ 
arrays contain tiny plugs of tissue 
extracted from storage in paraffin 
blocks. The composite image (top) 
shows an array of 340 colon-tissue 
samples and closeups of individual 
spots stained using three different 
methods. The breast-tissue blocks 
for a single microarray (above) 
nearly fill a laboratory. 
Experiments result in the quick generation of massive 
amounts of information—a mountain of data whose interpreta¬ 
tion requires a combination of biology and computing skills 
that is currently in very short supply. Though there are many 
other bottlenecks in the ongoing development of technologies, 
microarrays already allow investigators to make advances far 
beyond what was possible with previous study tools. “An array 
gives you an all-inclusive opportunity to look at genes or 
tissue and to get a complete and much more accurate answer. 
There are hundreds of questions that could be addressed 
this way,” DeVita says. At least a dozen laboratories at Yale in 
departments including Genetics; Molecular, Cellular and 
Developmental Biology; and Pathology and the Section of 
Immunobiology are now using biochips to unlock the mecha¬ 
nisms of diseases, especially cancer. 
Yale is home to one of 24 dna microarray centers set up 
in 1999 at cancer centers around the country with nci funds. 
The Howard Hughes Medical Institute supplemented those 
funds at Yale’s Keck Foundation Biotechnology Resource Labo¬ 
ratory. Archibald S. Perkins, m.d., ph.d., associate professor 
of pathology and of molecular, cellular and developmental bi¬ 
ology, co-directs the dna Microarray Resource, which produces 
biochips for laboratories at Yale and around the world. Perkins 
uses microarrays in his own research to study how leukemia 
changes cells at the molecular level, in hopes of coming up with 
new targets for drug therapies. Microarrays permit him to study 
all the genes that are turned on in leukemia cells at various 
stages of their development. Before the advent of microarrays, 
that was impossible. “It’s really a fantastic achievement,” he says. 
According to Co-Director Janet Hager, ph.d., the capacity 
of the arrays has doubled in the last year, to a current 
maximum of 18,432 spots. “We now offer five different arrays 
for human and mouse,” said Hager, “some representing 
as many as 16,000 unique genes in the form of either cdna 
or oligonucleotides.” 
Much of the data produced remains undeciphered, and 
some laboratories specialize in studying raw data that gets 
posted on public websites. According to Perkins, “There’s 
almost a community effort to make sense of the results.” A 
major initiative is under way to create the Yale Microarray 
Database through the collaborative efforts of a group of 
investigators and the Yale Center for Medical Informatics. 
Though it is still an emerging technology, the data flood 
has begun to resolve a number of long-standing puzzles, such 
as why certain cancers that appear to be identical under the 
Powering protein chips 
pathologist’s microscope respond so differently to treatment. 
Small genetic differences are the key. When coupled with all 
i; the gene sequence data from the Human Genome Project, 
microarrays are giving scientists tools for understanding the 
genetic changes that take place when a normal cell becomes 
cancerous. Knowing the genetic defects specific to a cancer 
offers a potential diagnostic tool and gives pharmacologists a 
starting point for drug discovery. “We can now aim for a 
unique cancer target,” says DeVita, adding that such designer 
drugs hold great promise against previously untreatable 
cancers. One successful example is Gleevec, a pharmaceutical 
designed to cure certain forms of previously untreatable 
( leukemia and a rare stomach cancer. “Gleevec is the most 
effective targeted treatment ever for leukemia,” he says. “It 
I puts us in the era of specifically designed therapies. We’re 
i going to see lots of them from now on.” 
SCORING A DIAGNOSIS 
In 1999, nci scientists developed the tools to make tissue 
microarrays for two reasons: to stretch out limited supplies 
of tissue and to standardize conditions for studying and 
: comparing multiple samples. A single array can hold as 
many as 800 half-millimeter cross sections of tissue and can 
complement other types of large-scale studies in a variety 
of ways. Unlike tissue arrays, gene chips cannot be used with 
large patient populations because of their complexity and 
the huge amount of data that even a single dna array gener¬ 
ates. Laboratory results still require validation in larger, 
statistically verifiable studies, especially before expensive and 
complex clinical studies can begin. Studies of hundreds 
of patients can be done with a single tissue microarray—with 
minimal tissue expended—as a way of validating what was 
seen in other types of pilot experiments. 
Yale is exceptionally well placed to take advantage of the 
new technologies because of its huge collection of cancer 
tissue samples. Early last century, Yale pathologists began to 
store tumor sections from cancer patients at what was then 
New Haven Hospital. The standard practice at the time, as it 
still is in most hospitals, was to keep pathology samples 
around for a few years and then discard them. Yale kept 
many of the tissue samples on hand as a study and teaching 
collection, and they have contributed to what is now known as 
the Yale Tissue Archive. 
The pieces of tissue are, for the most part, plugs smaller 
than a thimble. They are embedded in paraffin blocks and 
Protein arrays are the least devel¬ 
oped of the emerging biochip 
technologies and very likely the 
most complex. Every gene codes 
for at least one and often many 
proteins, the macromolecules that 
carry out the activities necessary 
for life. While current estimates of 
the number of human genes range 
from 30,000 to 100,000 (with 
about 10,000 of them already 
mapped), the number of proteins 
encoded by those genes may 
number in the millions. Most cel¬ 
lular development and other life 
functions result from the myriad 
interactions of proteins, and most 
disease and other disorders result 
when those interactions go awry. 
That is why a paper in the 
September 14 issue of Science by 
Michael Snyder, PH.D., professor 
and chair of molecular, cellular 
and developmental biology, and 
colleagues attracted broad inter¬ 
est. They reported successful 
development of a chip that held 
virtually all 6,200 proteins of 
yeast on a single microarray. No 
array had ever held the complete 
proteome of an organism before. 
While the technology is still in 
development, many fundamental 
protein interactions, some shared 
with humans, can now be studied 
in a global manner, just as can 
the genes that code for proteins. 
A new company, Protometrix Inc., 
was founded in Guilford, Conn., 
based on Snyder’s work with pro¬ 
teome chips. 
Snyder’s team is now attempt¬ 
ing to create a human proteome 
chip. He also plans to use pro¬ 
teome chips in his own research at 
Yale’s new Center of Excellence in 
Genomic Science, which he directs. 
The National Human Genome 
Research Institute awarded Yale 
a $15 million, five-year grant this 
fall to search for gene and protein 
function (See Chronicle, page 7). 
Yale was one of only three recipi¬ 
ents of the awards. (Two separate 
centers at the University of Wash¬ 
ington at Seattle received the 
other grants.) 
Michael Snyder and colleagues at 
Yale and North Carolina State 
University spotted nearly all the 
6,200 proteins in yeast on a 
single, nickel-coated glass slide. 
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kept in labeled cabinets in the basements beneath the medical 
school and in the hospital. In 1935 the state of Connecticut 
established the Connecticut Tumor Registry, requiring all hos¬ 
pitals and clinics in the state to report every case of cancer, 
along with follow-up, treatment and survival data. It was the 
country’s first such database. With the establishment of the 
Tumor Registry, pathologists began to archive patient informa¬ 
tion along with tissue at Yale. 
In the early 1980s, Jon S. Morrow, ph.d. ’74, m.d. ’76, 
hs ’77, who is now chair and the Raymond Yesner Professor of 
Pathology, headed a team that developed a clinical database for 
tracking tissue pathology and patient information. (That sys¬ 
tem, known as CoPath, is now in wide use around the world.) 
With support from Yale-New Haven Hospital, available records 
for tissue in the Yale archive were entered into the CoPath 
database, which today covers more than 3 million separate tis¬ 
sue samples taken from about 1 million patients. At Yale, 
one can locate virtually any form of cancerous tissue or group 
of related tissues, compare treatments and their effects and 
follow the course of the disease. “If we go looking for a specific 
type of cancer, it’s there,” says David L. Rimm, m.d., ph.d., 
hs ’91, associate professor of pathology and director of the Tis¬ 
sue Microarray Facility. “The samples are usually thick, and 
we have instant 20 to 40 years of follow-up.” 
The combination of massive tissue archive and computer¬ 
ized database may also have a big impact on the future practice 
of medicine. Robert L. Camp, m.d., ph.d., an associate research 
scientist in Rimm’s laboratory, has developed software that 
can automatically “score” tissue arrays—that is, compare a 
cell’s features to those of other cancer or normal cells. The soft¬ 
ware, called Aqua, could eventually be used to measure tissue 
properties to determine the likelihood of response to therapy. 
Recognizing its commercial potential, the Office of Coopera¬ 
tive Research has been working with Rimm, Camp and outside 
investors to build a new company to develop it into a mar¬ 
ketable diagnostic tool. 
“Aqua,” says Rimm, “could replace some of the tasks cur¬ 
rently done by a pathologist. There may ultimately be a day 
when pathologists run machines as opposed to making a sub¬ 
jective determination of a diagnosis. It’s going to happen 
sooner rather than later.” 
ARRAYS FOR THE FUTURE 
The various microarray tools could eventually find their way 
into clinical use. Some predict that the first biochips for 
diagnostic purposes will be seen in hospitals within two years. 
Within the next decade, chips could indicate to pathologists 
that telltale genetic markers for early forms of cancer are pre¬ 
sent, opening the door to earlier treatment before the malig¬ 
nancy spreads. 
All the new technologies must be developed further, how¬ 
ever, if they are to prove more than tools for the laboratory. 
“You want something that is inexpensive, simple and fast,” 
says Associate Professor of Pathology Paul M. Lizardi, ph.d., 
who has invented several array-based technologies, including 
rolling circle amplification and whole genome amplification, 
which rapidly amplify genetic material for easier use of 
microarrays as diagnostic tools. Two New Haven companies, 
Molecular Staging Inc. and Agilix, have licensed technologies 
he developed at Yale for improved detection of dna using 
microarrays. Says Lizardi, “Microarray technology is too expen¬ 
sive today, and it has not yet been optimized for clinical use. 
There’s a real need for microarray-based tools that are cheaper 
and better.” 
Many Yale scientists are confident that as microarray tech¬ 
nology becomes refined it will lead to progress at an unprec¬ 
edented pace. In his laboratory DeVita hopes to find genes 
common to different cancers that resist standard chemother¬ 
apy. “If you find one gene that triggers a family of genes 
associated with drug resistance,” he says, “you could use the 
knowledge to solve a universal problem. That would be a 
tremendous advance.” 
According to DeVita, all the new tools will soon provide 
patients with ever-more-precise diagnoses and effective treat¬ 
ments for cancer. “In the not-too-distant future,” he says, 
“cancer will be a chronic disease treated on an ongoing basis 
like diabetes or hypertension. This is the real payoff. It is 
what we’ve spent $42 billion for in the war on cancer.” YM 
marc wortman isa contributing editor at Yak Medicine. 
INSTITUTE ELECTS 
TWO FROM FACULTY 
Expert in the neuroscience of dyslexia, 
scholar in health policy join ranks of 
national advisory body. 
Two faculty members at the School of 
Medicine have been elected to the Insti¬ 
tute of Medicine (iom) of the National 
Academy of Sciences in Washington, 
D.C. The iom recognizes major contribu¬ 
tions to health and medicine, and its mem¬ 
bers advise the nation on health policy. 
Bennett A. Shaywitz, m.d., chief of 
pediatric neurology, professor of pediatrics 
and neurology and a member of the 
Child Study Center, and his wife, Sally E. 
Shaywitz, m.d., have been recognized by 
the iom for their transforming studies of I dyslexia, which have placed the disorder 
on the cutting edge of neuroscience. 
(Sally Shaywitz was elected to the iom in 
1998.) The Shaywitzes are the founders 
and co-directors of the National Institute 
of Child Health and Human Develop¬ 
ment-Yale Center for the Study of 
Learning and Attention, which is widely 
regarded as the premier center of its 
kind nationally. Bennett Shaywitz joined 
the Yale faculty in 1972 and is the author 
of more than 300 scientific papers. In 
the late 1980s he brought the new tech¬ 
nology of functional magnetic resonance 
imaging to bear on the study of children 
with dyslexia and currently leads a 
research group that is using this tech¬ 
nology to investigate the neural basis 
of reading and dyslexia. 
Bradford H. Gray, ph.d. ’73, a lecturer 
in the Department of Epidemiology and 
Public Health at Yale and director of the 
Division of Health and Science Policy at 
the New York Academy of Medicine, is 
an authority on health care policy and the 
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FROM LEFT 
Bennett Shaywitz, 
Bradford Gray, 
Pietro De Camilli, 
Ira Mellman, 
Joseph Schlessinger 
ethics of human research. Gray joined 
the New York Academy in 1996 after 
eight years at Yale, where he was director 
of both the Institution for Social and 
Policy Studies and the Program on Non- 
Profit Organizations, an internationally 
recognized research center. He also has 
the unusual distinction of being an 
elected fellow of both The Hastings 
Center, the internationally recognized 
bioethics research institute, and the Acad¬ 
emy for Health Services Research and 
Health Policy. He is the editor of Milbank 
Quarterly, a leading health policy journal. 
THREE FACULTY MEMBERS 
ELECTED TO AMERICAN ACADEMY 
OF ARTS AND SCIENCES 
Among the 211 new members inducted 
into the American Academy of Arts 
and Sciences in October, six were from 
Yale and three from the School of 
Medicine. The academy’s newly elected 
members were formally inducted into 
the academy during a ceremony in Cam¬ 
bridge, Mass., on October 31. Honored 
for their “unique contributions to the 
nation and the world,” they are: 
Pietro De Camilli, m.d., professor of 
cell biology and a Howard Hughes Med¬ 
ical Institute investigator. De Camilli 
focuses his research on the biogenesis 
and exo-endocytosis of synaptic vesicles, 
the specialized secretory organelles that 
store and secrete neurotransmitters into 
the synaptic cleft. Current research 
includes the role of phosphoinositides 
and other lipids in coat recruitment, the 
function of actin in the endocytic reac¬ 
tion, and properties of a variety of acces¬ 
sory proteins that assist the clathrin coat 
in assembly, invagination and fission. 
De Camilli also studies stiff-man syn¬ 
drome, a human disease of the nervous 
system due to autoimmunity directed 
against synaptic proteins. 
Ira S. Mellman, ph.d. ’78, chair and 
professor of cell biology. Mellman 
explores fundamental questions of mem¬ 
brane traffic as they relate to two specific 
problems. The first is the question of 
cell polarity and asymmetry, and he aims 
to solve the molecular mechanisms 
responsible for the sorting, intracellular 
targeting and transport of membrane 
components to their appropriate mem¬ 
brane domains. The second is the ques¬ 
tion of antigen processing by cells of the 
immune system. This work involves 
understanding how the endocytic and 
biosynthetic pathways are modified and 
regulated to facilitate the generation of 
immunogenic peptides that can be 
loaded onto mhc class II molecules. 
Joseph Schlessinger, ph.d., chair and 
professor of pharmacology. Schlessinger 
has made pivotal contributions toward 
understanding hormone and growth fac¬ 
tor receptor function, the associated sig¬ 
nal transduction mechanisms and their 
relevance to human disease. He estab¬ 
lished the mechanism by which growth 
factor receptors are activated and discov¬ 
ered how signaling proteins containing 
SH2 and other protein modules relay 
information from the cell surface to the 
nucleus to control cell growth and 
differentiation. Schlessinger serves on 
the advisory boards of several journals, 
including Cell, EMBO Journal, Molecular 
Cell and The Journal of Cell Biology. 
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FOUR FACULTY MEMBERS 
IN PUBLIC HEALTH HONORED 
WITH ENDOWED CHAIRS 
Four faculty members with appoinments 
at the School of Public Health were 
recently named to endowed chairs. 
Dean Michael H. Merson, m.d., was 
named the Anna M.R. Lauder Professor 
of Public Health; Michael B. Bracken, 
m.p.h. ’70, ph.d. ’74, and Brian P. Lead- 
erer, m.p.h. ’71, ph.d. ’75, were each 
appointed Susan Dwight Bliss Professor 
of Public Health; and Hongyu Zhao, 
ph.d., was named the Ira V. Hiscock 
Associate Professor of Public Health 
and Genetics. 
Merson is a noted authority on aids 
and director of Yale’s Center for Interdis¬ 
ciplinary Research on aids, which 
was established in 1997 to support hiv 
prevention research in vulnerable and 
underserved populations in the United 
States and abroad. He focuses his own 
work on international aspects of hiv 
prevention and related policies. Prior to 
his involvement in aids research, Mer¬ 
son undertook studies of the epidemiol¬ 
ogy of diarrheal diseases, including 
cholera, in developing countries. 
Following his medical training Mer¬ 
son spent three years working for the 
Centers for Disease Control and Preven¬ 
tion, and then became the chief medical 
epidemiologist at the Cholera Research 
Laboratory in Bangladesh. From 1978 
until 1995 he worked for the World 
Health Organization (who) in Geneva, 
and from 1990 to 1995 he headed the 
worldwide effort to control the aids 
pandemic as the director, then executive 
director, of the who’s Global Pro¬ 
gramme on AIDS. 
At Yale Merson also directs the aids 
International Training and Research 
Program, based in St. Petersburg, Rus¬ 
sia, and the aids International Clinical, 
Operational, and Health Services 
Research Program based in Pretoria, 
South Africa. Both programs are sup¬ 
ported by the National Institutes of 
Health's Fogarty International Center. 
He has been a consultant to the World 
Bank and to its aids prevention projects 
in such countries as India, Russia, 
Bangladesh, Nigeria and Madagascar. 
He has chaired several national panels 
and committees focused on the preven¬ 
tion of hiv and other diseases. 
Bracken is head of the Chronic Dis¬ 
ease Epidemiology Division in the 
Department of Epidemiology and Public 
Health. He specializes in the epidemiol¬ 
ogy of diseases of pregnant women 
and newborns and has been instrumen¬ 
tal in developing therapies for acute 
spinal cord injuries. He combines these 
interests in his research and as director 
of the Yale Perinatal Epidemiology Unit 
and the National Acute Spinal Cord 
Injury Study. The former, which he has 
led since 1979, conducts research on 
obstetric, perinatal and neonatal disease. 
The latter, which Bracken has overseen 
since 1977, conducts randomized trials 
of therapies for preventing paralysis 
after spinal cord injury. 
Bracken and his colleagues identified 
the first successful therapy for acute 
spinal trauma in 1990. His articles in 
this area have examined the effective¬ 
ness and timing of the drugs methyl- 
prednisolone and naloxone in treating 
spinal trauma and the effectiveness of 
surgery in combination with drug thera¬ 
pies in treating spinal cord injuries. 
Leaderer is a noted authority on air 
quality whose research focuses on 
assessing exposures to air contaminants 
and the health impact of such exposures. 
His work includes developing a theoreti¬ 
cal framework for assessing exposure 
in epidemiological studies, determining 
the type and quality of health-related 
contaminants emitted from sources, 
assessing environmental concentrations 
of contaminants and developing moni¬ 
toring and modeling techniques. 
Leaderer is head of the Division of 
Environmental Health Sciences in 
the Department of Epidemiology and 
Public Health and is the principal inves¬ 
tigator of studies examining the role 
of indoor and outdoor air contaminant 
exposures in respiratory symptoms in 
infants and their nonsmoking mothers, 
risk factors for the development of 
asthma in infants and young children, 
and the relationship of indoor allergens 
and air contaminants to the severity 
of asthma in young children. 
Zhao studies the development of 
mathematical, statistical and computa¬ 
tional methods to address scientific 
questions raised in molecular biology 
and genetics. He is working with col¬ 
leagues on the development of tools for 
identifying genes underlying complex 
diseases, studying genetic variations in 
populations around the world and inves¬ 
tigating genetic mechanisms related 
to mental retardation. He is also devel¬ 
oping statistical methods to estimate 
gene expression levels from microarray 
data, to identify genes with correlated 
expression patterns and to understand 
a variety of biological pathways. 
Zhao is the principal investigator 
of three research studies currently 
under way in the Department of Epi¬ 
demiology and Public Health and 
is involved in several other studies. 
His work has been funded by the 
National Institutes of Health and the 
March of Dimes Foundation. 
19 FACULTY MEMBERS RECEIVE 
AWARDS FOR RESEARCH ON 
BRAIN DISORDERS 
Five Yale researchers have received 
Independent Investigator grants totaling 
almost $500,000 from the National 
Alliance for Research on Schizophrenia 
and Depression (narsad). 
The goal of narsad’s Independent 
Investigator Program is to provide sup¬ 
port for scientists at the critical juncture 
between initiating independent research 
and achieving sustained funding. The 
Yale researchers will each receive a two- 
year grant of about $100,000 to continue 
research on a variety of brain disorders. 
They are Meenakshi Alreja, ph.d., asso¬ 
ciate professor of psychiatry and neuro¬ 
biology; Nashatt Boutros, m.d., associate 
professor of psychiatry; Larry Davidson, 
ph.d., associate professor of psychiatry; 
Paul Lombroso, m.d., associate professor 
in the Child Study Center; and Bita 
Moghaddam, ph.d., associate professor 
of psychiatry and neurobiology. 
In addition, narsad has awarded 
14 Young Investigator grants totaling 
$840,000 to scientists at Yale, narsad 
is the largest nongovernmental organi¬ 
zation funding research in brain disor¬ 
ders worldwide. 
Each of the researchers will receive 
an award of $60,000. The researchers 
and their areas of interest are Amit 
Anand, m.b.b.s., assistant professor of 
psychiatry, bipolar disorder; Kevin L. 
Behar, ph.d., research scientist in psy¬ 
chiatry, depression; Robert Andrew 
Chambers, m.d., postdoctoral fellow in 
psychiatry, schizophrenia; Kristin K. Haga, 
ph.d., postdoctoral associate in psychia¬ 
try, post-stroke depression; Fiona M. Inglis, 
ph.d., associate research scientist in 
neurology, schizophrenia; Joan Kaufman, 
ph.d. ’90, assistant professor of psychi¬ 
atry and in the Child Study Center, child/ 
adolescent and adult-onset depression; 
Fusun Kilic, ph.d., associate research 
scientist in pharmacology, depression; 
JaakkoA.S. Lappalainen, m.d., ph.d., 
instructor in psychiatry, depression; 
Daniel H. Mathalon, m.d., ph.d., assis¬ 
tant professor of psychiatry, schizo¬ 
phrenia; Adrian Preda, m.d., assistant 
professor of psychiatry, schizophrenia; 
Gerard Sanacora, m.d., ph.d., assistant 
professor of psychiatry, depression; 
Gerald W. Valentine, m.d., resident in 
psychiatry, depression; Sheila Wang, 
ph.d., associate research scientist in 
psychiatry, post-traumatic stress disor¬ 
der; and Zoran Zimolo, m.d., ph.d., 
assistant clinical professor of psychiatry, 
bone loss in patients with schizophre¬ 
nia and depression. 
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NOTES 
HENRY J. BINDER, M.D., professor 
of medicine and of cellular and 
molecular physiology, will share in 
a five-year, $1 million research 
award from the Wellcome Trust 
and Burroughs Wellcome Fund to 
study diarrheal diseases in devel¬ 
oping countries. Binder, who is also 
director of the General Clinical 
Research Center at Yale, will work 
with collaborators in India and 
Scotland to develop an improved 
oral rehydration solution for diar¬ 
rheal diseases, one of the most 
common causes of death among 
the world's children. He previously 
collaborated to develop a starch 
that improves the effectiveness of 
rehydration solutions by improving 
fluid absorption.This new study 
will establish the treatment’s 
efficacy and determine how well 
patients follow treatment. 
SEND FACULTY NEWS TO 
Claire Bessinger, Yale Medicine, 
P.O. Box 7612, New Haven, CT 
06519-0612, or via e-mail 
to claire.bessinger@yale.edu. 
james p. comer, m.d., the Mau¬ 
rice Falk Professor in the Child 
Study Center and professor of psy¬ 
chiatry, was presented the Distin¬ 
guished Service Award in Novem¬ 
ber by Covenant to Care Inc., a 
nonprofit, interfaith organization 
that connects social workers and 
other child welfare professionals 
with faith communities through¬ 
out Connecticut in order to pro¬ 
vide programs, goods and services 
to abused, neglected and impover¬ 
ished children. Comer was recog¬ 
nized for demonstrating leader¬ 
ship, passion and vision through 
his work in enhancing the quality 
of life for Connecticut's most vul¬ 
nerable children. 
The Epidemiology and Public Health 
Emerging Infections Program was 
awarded a three-year, $1.2 million 
grant from the Association of 
American Medical Colleges and 
U.S. Centers for Disease Control 
and Prevention for the study of the 
causes of acute diarrheal illness 
among patients receiving primary 
outpatient care. Robert heimer, 
ph.d. ’88, associate professor of 
epidemiology, public health and 
pharmacology, will serve as princi¬ 
pal investigator for the Acute Diar¬ 
rheal Disease Surveillance study in 
collaboration with Stephen c. 
edberc, ph.d., professor of labo¬ 
ratory medicine and medicine; 
paul l. mccarthy, m.d., profes¬ 
sor of pediatrics; and PATRICK C. 
o’connor, m.d., professor of 
medicine.therese r. rabatsky- 
ehr, m.p.h. ’96, research associate, 
will be the study coordinator. 
ARTHUR L. HORWICH, M.D., HS 
’78, professor of genetics and pedi¬ 
atrics, received the 2001 Hans 
Neurath Award from the Protein 
Society.The award honors his 
contribution of unusual merit to 
basic research in the field of pro¬ 
tein science. Horwich has exam¬ 
ined the mitochondrial ''machinery" 
that recognizes and translocates 
precursor proteins and, in a genetic 
screen in yeast, uncovered Hsp6o 
(the yeast homologue of GroEL) as 
essential for folding newly imported 
proteins.This led to his studies in the 
last loyears on chaperonin-medi- 
ated protein folding. Horwich is a 
Howard Hughes Medical Institute 
investigator. He received a National 
Research Service Award and previ¬ 
ously was named an outstanding 
young investigator by the Society for 
Pediatric Research. He has been on 
the faculty at Yale since 1984. 
In August, the Ellison Medical 
Foundation announced the Senior 
Scholar Awardees in Global Infec¬ 
tious Diseases for 2001. Three 
members of the Yale faculty were 
among the recipients, keith a. 
joiner, m.d., section chief and 
WaldemarVon Zedtwitz Professor 
of Medicine (infectious diseases), 
epidemiology and cell biology, and 
ELIZABETTA U L LU , PH.D., prOfeS- 
sor of medicine (infectious dis¬ 
eases) and cell biology, were hon¬ 
ored for their research,"Develop¬ 
ment of New Genetic Tools To 
Identify Nutrient Uptake Pathways 
in Malaria Parasites.” HHMl inves- 
tigatorPETER CRESSWELL, PH.D., 
professor of immunobiology, 
biology and dermatology, was 
honored for his research entitled 
"Antiviral Effects of Interferon- 
Inducible Cytosolic Proteins.” 
becca levy,assistant professor 
of epidemiology (chronic disease), 
received the Adult Development 
and Aging Division 20 Springer 
Early Career Achievement Award. 
The annual award in recognition of 
outstanding early-career achieve¬ 
ments is designed to honor a psy¬ 
chologist whose work made a sig¬ 
nificant contribution to understand¬ 
ing critical issues in adult develop¬ 
ment and aging. Levy received the 
award at the August meeting of the 
American Psychological Association. 
RICHARD P. LIFTON, M.D., PH.D., 
left, chair of genetics, professor 
of genetics, medicine and molecu¬ 
lar biophysics and biochemistry 
and a Howard Hughes Medical 
Institute investigator, and pasko 
rakic, M.D., PH.D., chair of the 
Section of Neurobiology and the 
Dorys McConnell Duberg Professor 
of Neuroscience, received the 
medical research awards of The 
Robert J. and Claire Pasarow Foun¬ 
dation at its 14th annual medical 
and scientific awards dinner in 
Los Angeles. Lifton was recognized 
for his pioneering application of 
molecular genetic approaches to 
the study of hypertension. Rakic 
was recognized for his critical 
discoveries on the interaction of 
nerve and glial cells as they 
develop in the brain. Each received 
a $35,000 prize. 
PERRY L. MILLER, M.D., professor 
of anesthesiology and director of 
Medical Informatics, was awarded 
a $1.3 million grant as part of the 
new National Institutes of Health 
(nih) initiative to support plan¬ 
ning for Centers of Excellence in 
Biomedical Computing.This"pre- 
center” grant provides funds over 
three years to prepare Yale to host 
such a center, which could ulti¬ 
mately be funded at $5 million or 
more per year. Co-directors of this 
grant include Michael Snyder, pro¬ 
fessor and chair of molecular, cel¬ 
lular and developmental biology, 
and Martin Schultz, the Arthur K. 
Watson Professor of Computer Sci¬ 
ence.The nih has identified a criti¬ 
cal shortage of scientists trained in 
the interdisciplinary areas of bio¬ 
medical computing.The new cen¬ 
ters will help train new scientists 
in these areas. 
ALVIN novick, M.D., professor of 
ecology and evolutionary biology 
and of epidemiology and public 
health, received the community 
service award from aids Project 
New Haven (apnh) in September 
for his pioneering commitments 
to people living with hiv/aids, 
research and public policy. Novick 
was a founding member of apnh 
and was honored on the 20th 
anniversary of the aids epidemic. 
JOAN a. steitz, PH.D.,Sterling 
Professor of Molecular Biophysics 
and Biochemistry and a Howard 
Hughes Medical Institute investi¬ 
gator, was one of five recipients of 
the For Women in Science Program 
award from L’Oreal Beauty Com¬ 
pany and the United Nations Edu¬ 
cational, Scientific, and Cultural 
Organization (UNESCO) in 2001. 
Steitz was recognized for advances 
that could lead to improved diag¬ 
nosis and treatment of auto¬ 
immune diseases such as lupus. 
She discovered small particles, 
called snRNPs.that are necessary 
for converting raw genetic mater¬ 
ial into active proteins. 
STEPHEN M. STRITTMATTER, 
m.d., ph.D., the Vincent Coates Pro¬ 
fessor of Neurology and professor 
of neurobiology, received the Mem¬ 
ory and Brain Disorders Award of 
$300,000 from the McKnight 
Endowment Fund for Neuroscience, 
to support his research forthree 
years. Strittmatter’s research on 
“Nogo Regulation of Axonal Regen¬ 
eration and Plasticity"focuses 
on the extent to which axons, the 
wires in the brain, can rearrange 
themselves and recover after 
injuries to the nervous system.The 
research could lead to treatments 
for disabilities caused by spinal 
cord injuries, strokes and multiple 
sclerosis. 
morris traube, m.d., professor 
of medicine (digestive diseases) 
and director of the Gl Procedure 
Center, recently graduated with 
the highest grade point average in 
the history of Ouinnipiac University 
School of Law, and has been 
appointed an adjunct professor 
there. Traube completed his law 
degree in three years while contin¬ 
uing his clinical practice and 
administrative responsibilities at 
Yale. Over the years, Traube, who 
holds an m.s. in Talmudic studies 
and rabbinic ordination, has lec¬ 
tured on Jewish medical ethics. 
During a sabbatical 10 years ago 
he considered studying the rela¬ 
tionship between Jewish law and 
general law, in the context of clini¬ 
cal medicine. 
ROBERT I. WHITE JR., M.D., prO- 
fessor of diagnostic radiology and 
director of the Vascular Malforma¬ 
tion Clinical and Research Group, 
recently visited hospitals in Canada, 
Denmark, Singapore, Malaysia, 
Japan and Australia. In 1988, White 
founded the nation’s first clinic for 
patients with hereditary hemor¬ 
rhagic telangiectasia, a rare inher¬ 
ited disorder in which the blood 
vessels fail to form properly. The 
Yale center is following 600 patients 
with pulmonary arteriovenous 
malformations and an additional 
1,000 with various combinations 
of epistaxis, gastrointestinal bleed¬ 
ing and vascular malformations in 
the liver and brain. Since its found¬ 
ing, the center has trained 12 spe¬ 
cialists from around the world and 
helped establish similar clinics on 
four continents. 
tian xu, M.D.'90, associate pro¬ 
fessor of genetics and an investi¬ 
gator with the Howard Hughes 
Medical Institute, was the first 
recipient of a $100,000 Rothberg 
Award for Courage in Research 
presented by the Tuberous Sclero¬ 
sis Alliance. Xu was recognized in 
part for publishing findings that 
provide promise that further study 
of the insulin signaling pathway 
may lead to the development of 
treatments for tuberous sclerosis 
complex lesions.The award is made 
possible through a research fund 
established by Jonathan Rothberg, 
ph.d. ’91, founder and CEO of Cura- 
Gen in New Haven, and his wife, 
Bonnie Gould Rothberg, M.D. ’94. 
EDWARD F. ZIGLER, PH.D., Ster¬ 
ling Professor of Psychology 
and a faculty member in the Child 
Study Center, received the Con¬ 
necticut Higher Education Lifetime 
Achievement Community Service 
Award. Zigler has worked locally in 
Connecticut, helping to draft legis¬ 
lation to create a pilot paid family 
leave law and for preschool educa¬ 
tion, but he has had an interna¬ 
tional impact. He was one of the 
creators of the Head Start program 
and currently directs the Bush 
Center in Child Development and 
Social Policy.The award honored 
his outstanding leadership and 
contributions to the field. 
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38 students 
Following tradition, the members of the Class of 2005 posed in their newly donned white coats 
on the steps of the Sterling Hall of Medicine, below right New first-year students Samantha Wood, 
Sandra Smith, Bradley Raphael, Daniel Gibson, Jorge Galvez, Meg Pearson and Douglas Jacobson 
(from left) linked arms at the White Jacket Ceremony, below left Lianne Hirano wore two leis, one 
made by her friend, Cheryl Teso, and the other, made with orchids, sent by her mother from Hawaii. 
More on the Web info.med.yale.edu/ymm For more photos from the White Jacket Ceremony, the Hunger and Homelessness Auction and 
the annual symposium of the Committee on International Health, please visit our website and select extras. 
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COUNSEL FROM THE COUNCIL 
FROM FAR AND WIDE, 
IN CLASS OF THEIR OWN 
Along with top-notch academic 
credentials,first-year students bring 
a wealth of diverse experience. 
Collectively, the ioo members of the 
Class of 2005 have interned in the White 
House, built an orphanage in the Domini¬ 
can Republic, taught math to ex-convicts, 
worked in emergency rooms, helped 
run a women’s health clinic in Armenia, 
conducted research on diabetes, studied 
insects in the marshes of Costa Rica 
and narrowly escaped the Iraqi invasion 
of Kuwait in 1990. Their numbers 
include a vista volunteer, a biologist, a 
lifeguard, an emergency medical techni¬ 
cian and a student who speaks Mandarin, 
Cantonese and Spanish. 
This diverse and eclectic group of 46 
men and 54 women came together on 
August 28 for their induction into the 
world of medicine—the donning of the 
white jacket that identifies them as heal¬ 
ers. With that act came words of caution 
from the new chair of surgery. 
“Medicine without magic, without 
empathy, without insight into the desires 
and aspirations of the individual patient,” 
said Robert Udelsman, m.d., m.s.b., 
m.b.a., “can miss the mark.” 
In a talk at the White Jacket Ceremony 
titled “Medical Mysticism,” Udelsman 
invoked the symbolism of the occasion. 
“The white coat is but one of many tools, 
like the stethoscope,” he said. “It is in 
part a prop that has become associated 
with trust, faith and magic. We empower 
you to use these tools, to use them wisely, 
to use them selflessly.” Udelsmarfs call 
for a mix of skills, knowledge and com¬ 
passion echoed long-standing traditions 
of medical education at Yale. 
And, indeed, the Yale System of Med¬ 
ical Education was the main appeal of 
the medical school for the overwhelming 
majority of incoming students. A report 
from the admissions office revealed other 
facts about the new class. The students’ 
mean age is 23.5, and their cumulative 
gpa is 3.74. Nearly all in the group, 96, 
have engaged in research or independent 
study in science. In the group are five 
students with master’s degrees, one 
holder of a ph.d. degree, 49 members 
of minority groups, 89 science majors, 
and graduates of 50 colleges, with 
Yale, Harvard, Stanford, Dartmouth and 
Brown leading the list. 
On September 20, at a meeting of 
the Medical School Council, Richard A. 
Silverman, director of admissions, used 
the group’s own words from their appli¬ 
cation essays to paint a picture of the 
class. One student mentored learning- 
disabled children. Another was born in 
Sudan and lived in Syria, Oman and 
Thailand. Yet another grew up speaking 
English, French and an African dialect 
called Dida. 
“Statistics," said Thomas L. Lentz, 
m.d. ’64, associate dean for admissions 
and professor and vice chair of cell 
biology, “don’t reveal the remarkable 
accomplishments that you have made 
outside the classroom. These are in 
many different areas such as health care, 
research, campus government, athletics, 
letters, music and journalism. It is 
through these achievements that you 
demonstrate the qualities, such as 
leadership, creativity, motivation, inde¬ 
pendence and organization, that we 
are looking for in our students.” 
As first-year students arrived on campus, the 
Medical Student Council, led by President 
Kavita Mariwalla, Vice President Brian Nahed 
and Treasurer Mariah Ruth (from left below), 
guided them through orientation with a series 
of events. The council opened the student- 
run used bookstore for the academic year and 
held a sale of used scrubs and anatomy tools. 
To promote some camaraderie among stu¬ 
dents in the different health professions, the 
council organized Olympic games with stu¬ 
dents from medicine, public health, nursing 
and the Physician Associate Program. Earlier in 
the year the council organized a second-look 
weekend for medical school applicants and 
published a guide to the medical school and 
New Haven for first-year students. 
Y
a
le
 
M
ed
ic
in
e 
w
in
te
r 
20
02
 
40 students 
FUND-RAISING EVENT, 
NOW A FALL TRADITION, 
TAKES A DIFFERENT TACK 
In a break from tradition, anatomy pro¬ 
fessor William B. Stewart, ph.d., sold 
his trademark bow tie this year not at 
the Hunger and Homelessness Auction, 
but at a party a few days before the gavel 
banged down. It was one of many subtle 
departures from the traditional format of 
an event that is now in its ninth year of 
raising money for New Haven charities. 
The “Club Med” party in Edward S. 
Harkness Hall, featuring the band Plato’s 
Cavemen, kicked off a week of auction 
activities that have replaced the free¬ 
standing event of years past. It netted 
$630, including the $210 paid for Stew¬ 
art’s tie. 
New activities this year also included 
a tag football game pitting first-years 
against second-years, a relocation of the 
One of several new activities at this year’s 
fund-raiser was a tag football game between 
first- and second-year students that netted 
$700 for the Hunger and Homelessness Auc¬ 
tion. First-year public health student Derek 
Boucher lunges forward for a touchdown (top), 
while second-year medical student Jason Grif¬ 
fith tries to block hft advance. At a half-time 
ceremony (middle), Dean David Kessler cited 
the accomplishments of Dean Emeritus Gerard 
Burrow (left), to whom the game was dedicated. 
silent auction to the lobby in front of the 
Cushing/Whitney Medical Library and a 
new master of ceremonies, Frank J. Bia, 
m.d., professor of medicine (infectious 
disease) and laboratory medicine. Quick 
with a quip, Bia brought down the house 
more than once with his jokes about 
items for sale. Stewart’s offer of a beef ’n 
beer dinner for eight brought this from 
the emcee: “This just in. The cdc called 
this morning. They are classifying this as 
a level-four bioterrorist event.” When 
Herbert Chase, m.d., deputy dean for edu¬ 
cation, offered a behind-the-scenes tour 
of the Museum of Natural History in New 
York, Bia joked, “You don’t have to go to a 
faculty meeting to see dinosaurs.” 
Held November 15, the auction raised 
$30,000 for several New Haven organi¬ 
zations that help the poor and the home¬ 
less. Proceeds went to New Haven Cares, 
Loaves and Fishes, New Haven Home¬ 
less Resource Center, Douglas House, 
Downtown Evening Soup Kitchen, Moore 
House Soup Kitchen and New Haven 
Home Recovery. This year’s highest- 
selling item was a weekend at second- 
year student Dave Aversa’s Vermont ski 
condo, for $1,700. Dean David A. Kessler, 
m.d., paid $900 for two roles in the 
second-year show. Silent auction items 
included dinners, desserts, paddling and 
sailing outings, rides in airplanes, works 
of art, 20 hours of carpentry, massages, 
baby-sitting and dog walking. 
First-year students won the football 
game, 26-22, and the game raised $700 
for charity. Students dedicated the game 
to Dean Emeritus Gerard N. Burrow, m.d. 
’58, hs ’66, who has been appointed 
president and ceo of the Sea Research 
Foundation Inc., the not-for-profit orga¬ 
nization overseeing Mystic Aquarium & 
Institute for Exploration. (See Alumni 
Notes, page 45.) 
4' 
ADVICE FROM HIPPOCRATES 
Borrowing from the ancients, Charles A. Morgan 
III, m.d., offered advice and wisdom to the 35 
graduates of the Physician Associate Program 
on September 10. In his commencement address 
in Harkness Auditorium, he delved into the 
Hippocratic Corpus to urge the future practition¬ 
ers to care for themselves as well as for their 
patients, to offer their services for free at times, 
to avoid overwork, and to stick to the facts. “Stick 
to what you know and know what you don’t 
know," said Morgan, an associate professor of 
psychiatry and research affiliate in history of 
medicine. “Evidence-based medicine presents 
the best opportunity for offering good care to 
people who turn to us for assistance and help.” 
INTERNATIONAL SCHOLARS 
FIND THEIR WORK TAKES ON 
A NEW IMPORTANCE 
When the Committee on International 
Health held its annual symposium in 
early October, the events of September n 
and their implications for global stability 
were less than a month old. The commit¬ 
tee, however, reaffirmed its commitment 
to international health research. “Our pro¬ 
gram of international activities continues 
without interruption,” said Curtis L. Pat¬ 
ton, ph.d., director of the international 
fellowship program that sends students 
around the world. “Is the message clear?” 
Last summer 20 students who had 
received Downs International Health 
Travel Fellowships or other funding trav¬ 
eled to 16 countries to conduct research 
on topics including the integration of 
traditional and Western medicine in treat¬ 
ing pediatric cancer patients in Taiwan, 
birth practices in Ghana and hiv risk 
among abused women in South Africa. 
Three students were asked to make 
oral presentations of their work, said 
committee member Serap Aksoy, ph.d., 
associate professor in the division of 
epidemiology of microbial diseases, 
because their topics reflect the diversity 
of projects the committee considers for 
funding. Medical student Timothy ). 
Henrich explored causes of viral encepha¬ 
litis in Thailand and tried to find links 
between the epidemiology and the 
environment. Maya Nambisan, a public 
health student, studied the population 
genetics of the tsetse fly, in search of a 
subspecies that may be the main vector 
for sleeping sickness. And Susan E. Mar¬ 
tinson, a nursing student, studied mater¬ 
nal mortality in a rural section of Haiti. 
At the symposium Byron Waksman, 
m.d., a founding member of the Commit¬ 
tee on International Health, former profes¬ 
sor and chair of microbiology, was awarded 
an honorary Downs fellowship by the com¬ 
mittee for his contributions to the fellow¬ 
ship program and international health. 
“I think all of you who have gone in the 
direction of international health have cho¬ 
sen a very exciting and interesting future,” 
Waksman said, as he accepted the award. 
In the Jane Ellen Hope Building in early October, 
faculty and students perused the research of 
20 students in medicine, nursing and public 
health who spent part of last summer working 
on health projects abroad. 
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42 Alumni 
Francis Coughlin Jr. 
Donald Moore 
Francis Lobo 
FROM DOCTOR TO 
LAWYER—AND NOW THE 
PRESIDENCY 
New alumni leader hopes to build 
bridges across gender, the generations, 
and from academe to the community. 
When Francis R. Coughlin Jr., m.d. '52, 
decided to quit surgery at age 58, he 
reinvented himself as a medical mal¬ 
practice lawyer. He gets some grief about 
it from other physicians, but Coughlin 
has enjoyed learning how lawyers think. 
And medicine remains his first love. 
As the new president of the Associa¬ 
tion of Yale Alumni in Medicine (ayam), 
Coughlin hopes to investigate how med¬ 
icine can incorporate the needs and per¬ 
spectives of women, who constitute more 
than half of the current first-year class at 
the School of Medicine. Coughlin, who 
succeeds Past President Gilbert F. Hogan, 
m.d. ’57, also hopes to strengthen ties 
between Yale and community hospitals 
in Connecticut and to foster links between 
new graduates and older alumni. 
Coughlin trained as a cardiothoracic 
surgeon, taking part in the first open- 
heart surgeries at Massachusetts General 
Hospital in the late 1950s. He spent 25 
years in private practice in Stamford, 
Conn., raising eight children with his 
wife, Barbara Blunt Coughlin, m.d. ’52, 
a medical school classmate. When a 
cataract in one eye marred his depth per¬ 
ception in 1985, he left surgery. 
Since graduating from the University 
of Bridgeport School of Law at age 61, 
Coughlin has consulted with Connecti¬ 
cut attorneys for insurance companies 
that defend physicians and advised a 
New York law firm that prosecutes them. 
He evaluates cases for their merits and 
plans strategy but does not litigate. Since 
1990, he has been vice-chair of the 
Connecticut Commission on Medico¬ 
legal Investigations, which oversees the 
Office of the Chief Medical Examiner. 
When he became an attorney, Coughlin 
was intrigued by the different modes of 
thought used by doctors and lawyers. He 
says doctors make decisions based on a 
“convergence of probabilities,” discard¬ 
ing facts that seem irrelevant. Lawyers, 
on the other hand, “align all the facts in 
parallel lines of argument—the prose¬ 
cution argument and the defense argu¬ 
ment. ... A lawyer could move from the 
plaintiff’s side to the defense side and 
not miss a beat. 
“I think of myself as a physician first 
and always,” says Coughlin, 75. “Medicine 
is a very fine way to spend a lifetime. It 
makes a real difference in the lives of 
people. In the law, in the civil justice sys¬ 
tem, the remedy for legal wrongs is mon¬ 
etary.” Yet, he adds, “The medical mal¬ 
practice system is very important, and it 
is important that it be used properly.” 
As ayam president, Coughlin plans 
to study how women are affecting medi¬ 
cine. “We are going to have to design the 
curriculum and develop expectations of 
physicians based on those who serve as 
physicians, so let’s find out about the role 
of women in medicine, ” he says. Cough¬ 
lin believes that women have taught men 
new approaches to teamwork. From 
women, he says, “we have learned more 
and more how we depend on each other. 
We have learned that it’s important to 
share information, to arrive at consensus.” 
"MY VOCATION IS MY VACATION” 
ayam Vice President Donald E. Moore, 
m.d. ’81, m.p.h. ’81, practices family 
medicine in Brooklyn, N.Y., concentrat¬ 
ing on diabetes, aids, asthma and hyper¬ 
tension—“the diseases of our population." 
He even makes house calls. Moore 
describes reunions with senior faculty at 
alumni events as “a contemporary con¬ 
nection to the giants in medicine because 
they really have a lot of collective wisdom 
and individual wisdom.” Moore says the 
old-timers know that medicine has not 
always been—and will not always be — 
governed by the “contemporary wisdom” 
of efficiency above all. 
43 
Moore is interested in cultural differ¬ 
ences— “how the culture of the individ- 
E ual you’re treating impacts on their 
health and their care and the relationship 
t you are about to have. It’s very important. 
... Half of medicine is an art. That takes 
time, you know. You can’t push the artist.” 
Moore enjoys family activities with his 
wife, Christine Moore, and their two 
daughters, but otherwise, he says, “my 
I vocation is my vacation.” 
Francis M. Lobo, m.d. ’92, ayam secre- 
. tary, hasn’t really left New Haven since 
i medical school. He did his residency at 
Yale and is now an assistant professor of 
| medicine at Yale, doing basic research 
on gene activation in the immune sys¬ 
tem. He also works at the Dana Clinic, 
1 where he treats patients with allergies 
and immunological problems. 
Lobo considers his Yale classmates 
i'i “the nicest, smartest, kindest and gen¬ 
tlest people I’ve known.” He says the 
t medical school manages to admit high 
achievers “who can adapt to an environ- 
j ment in which you’re asked not to com- 
1 pete, but to work together and to help 
1 one another, within a mature, graduate 
|j school ethic.” 
NEW COMMITTEE MEMBERS 
1 New members of the executive commit- 
| tee are Cynthia B. Aten, m.d. ’81; Sharon 
L. Bonney, m.d. ’76; Joseph F.J. Curi, m.d. 
j ’64; David H. Lippman, m.d.’71; and 
Harold R. Mancusi-Ungaro Jr., m.d. ’73, 
I HS ’76. 
Aten is a pediatrician who served as 
! chief of undergraduate medicine at Yale 
for seven years. She is now studying how 
to augment the treatment of adolescent I eating disorders using Reiki, an ancient 
system of healing touch. As a medical 
student, Aten appreciated the school’s 
flexibility, which allowed her to extend 
her clerkships over two years to see more 
of her two young children. She lives with 
her husband, Raymond Aten, in Ham¬ 
den, Conn. 
After studying engineering at Duke, 
Bonney used the Yale System to get the 
liberal arts education she’d missed. “I 
like to say I minored in English in med¬ 
ical school.... I adore the Yale System 
and I adore Yale.” Currently at Pfizer in 
New London, she is running trials of a 
cardiac drug. Bonney lives in Old Lyme, 
Conn., with her husband, James Beattie, 
and has three stepsons. 
For 32 years, Curi has taken care of 
children and teenagers in the small city 
of Torrington, Conn., practicing solo. He 
likes preadolescents, “because you can 
still communicate with them.” He and 
his wife, Susannah Curi, have four chil¬ 
dren (two of them Yale College grads). 
Curi says that “because of the Yale Sys¬ 
tem, I was really able to become a 
human being,” with time for sports and 
volunteer work. He’s served the ayam off 
and on for 20 years. “Working for Yale is 
not a chore, believe me,” says Curi. 
Lippman has practiced psychiatry for 
two decades in Great Barrington, Mass. 
He worked as a doctor in Africa for two 
years in the mid-7os, and six years ago 
he and his wife, Honey Sharp Lippman, 
took their three children around the 
world (See Books, page 12). Lippman val¬ 
ued the noncompetitive atmosphere at 
Yale. “You were all in it together.” 
Mancusi-Ungaro had planned to join 
his father as a pediatrician in New Jersey 
until his first clinical rotation, when he 
observed a surgeon repair a child’s fusion 
defect of the head. “What I saw was 
instant gratification,” recalls Mancusi- 
Ungaro. He was sold on surgery from 
that moment. Now he does plastic and 
reconstructive surgery in Beaumont, 
Texas. A “Texan by choice” (with pickup 
truck), he does come East to visit his two 
children at Yale College. “Yale is never 
out of your bloodstream,” he says. 
New representatives to the Associa¬ 
tion of Yale Alumni are Arthur Ebbert Jr., 
m.d., and Betty R. Klein, m.d. ’86, hs 
’91. Ebbert studied medicine at the Uni¬ 
versity of Virginia and came to Yale in 
1953 as an instructor. He served as deputy 
dean of the medical school beginning in 
1973. The ayam made Ebbert an hon¬ 
orary alumnus when he retired in 1988. 
He sold his sailboat, Goose, last year, but 
still sails with friends. Klein is an oph¬ 
thalmologist in Danbury, Conn., special¬ 
izing in the retina. She and her hus¬ 
band, Eric Yale Brown, have two children. 
Cynthia Aten 
Joseph Curi 
Harold Mancusi- 
Ungaro Jr. 
Betty Klein 
Sharon Bonney 
David Lippman 
Arthur Ebbert Jr. 
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44 Alumni 
A YALE COUPLE, FACING POLIO, 
FOUND THEMSELVES “CALLED 
TO RISE” 
A BIG HELLO IN MUSIC CITY 
Victoria Holloway, m.d. ’94 (above, left), 
and Pamela Perry, m.d., a former Yale faculty 
member in emergency medicine, catch up 
on news during an alumni reception at the 
National Medical Association meeting in 
Nashville in August. Among those attending 
the reception were Perry’s brother, Victor 
Perry, m.d. ’93, and (top) Mary Kathleen 
Figaro, m.d. ’96, and Owen Garrick, m.d. ’98. 
The Association of Yale Alumni in Medicine 
hosted get-togethers for alumni in New York 
City, Vero Beach and Ft. Lauderdale in Janu¬ 
ary and Boston in February and will hold 
events in Chicago, Texas and California in 
March and April. For an updated schedule, see 
info.med.yale.edu/ayam/news.html. 
"The city streets were deserted at 11:30 
p.m. It was a balmy spring night in 1945 
when my husband, Larry, and I set out 
for a walk after work [at the New Haven 
Hospital]. Larry was a surgical intern 
and I was a student nurse and I had just 
come off duty on the evening shift.” 
So begins Called to Rise: A Journey 
Through Disability, Madeleine Crowley’s 
memoir about a life changed by polio. A 
little more than three years after this 
spring stroll, she lay gravely ill in the hos¬ 
pital where she had worked, fearing for 
her life and for the future of her husband, 
a 1944 graduate of the School of Medi¬ 
cine, and their two-year-old son. In the 
months and years that followed her hos¬ 
pitalization on Thanksgiving Day 1948, 
Crowley overcame most of the obstacles 
presented by the disease. She decided 
to write the book, published last May by 
Western Book/Journal Press in Reno, 
Nev., to inspire others with disabilities. 
Lawrence and Madeleine Crowley 
met as students on the medical ward on 
Fitkin 1 during the war years. In mid- 
November 1948, their only child, 
Lawrence Jr., became infected with the 
polio virus but recovered fully. Madeleine’s 
case was much more serious. After a 
week of intermittent consciousness, she 
awoke to discover that she had lost the 
use of her arms and legs. Despite several 
weeks of difficult breathing, she man¬ 
aged to avoid the iron lung, and early the 
next year began rehabilitation in Warm 
Springs, Ga., in a hospital designed by 
its most famous patient, President 
Franklin D. Roosevelt. 
The book’s title refers to a line in the 
first stanza of an Emily Dickinson poem: 
“We never know how high we are /Till 
we are called to rise;/And then, if we are 
true to plan, / Our statures touch the 
skies.” During that balmy spring walk 
in 1945, Madeleine Crowley told her 
husband that she wanted to live life to 
the fullest, and it was a promise that 
she kept. She regained partial use of her 
limbs and learned to walk on crutches 
before post-polio syndrome required her 
to use a wheelchair years later. She gave 
birth to two more children, Suzanne and 
Stephen, and ran the household as the 
family moved first to California, then 
Wisconsin. When the children grew up 
and left home, she went back to work, 
first as a hospital volunteer, then as a 
career counselor. 
From time to time, she said in a phone 
interview from her home in Cupertino, 
Calif., "I would feel a flood of sadness 
come over me and I’d wish life had been 
different. But there were so many things 
I wanted to do and the world was out 
there waiting. I’d say, ‘Oh the heck with 
it. I’m not going to let it stop me.’ ” 
The same was true for her husband, 
who thrived despite the initial interrup¬ 
tion in his career as an academic sur¬ 
geon. Lawrence Crowley, m.d. ’44, hs 
’51, scrambled to find a fellowship at 
Emory while Madeleine was in Warm 
Springs, then returned to Yale for two 
years to serve on the faculty. In 1953, the 
harsh New England winters drove the 
family to the easier climate and lifestyle 
of California, and Lawrence briefly left 
academic medicine for private practice 
in Los Angeles. Before long he joined 
the faculty at Stanford, rising to become 
dean of the medical school and vice 
president of the university. From 1974 to 
1978, he served as dean of the Univer¬ 
sity of Wisconsin Medical School. 
“It turned out to be a very wise move,” 
Lawrence Crowley said of the difficult 
decision to leave New Haven. “If things 
had been different, I might well have 
stayed at Yale and still be there today. But 
Madeleine was much more independent 
in California. And we had a great time.” 
Madeleine and Lawrence Crowley 
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ig40S 
JOHN L. CAN NON, M.D.’47, Of 
West Simsbury, Conn., who retired 
from active practice in 1998, writes 
to say that his 43-year-old daugh¬ 
ter, Cecily, a paramedic and fire¬ 
fighter, entered the University of 
New England College of Osteo¬ 
pathic Medicine in Biddeford, 
Maine, in August. He also has two 
sons: Jack, who works in the Hart¬ 
ford office of the New York invest¬ 
ment firm Roosevelt & Cross Inc., 
and Andy, who teaches marketing 
at the University of South Alabama. 
Cannon has nearly completed the 
restoration of a 50-year-old wooden 
sailboat and writes that he has two 
others yet to do, as well as other 
projects too numerous to mention. 
1950S 
Dean Emeritus gerard n. bur¬ 
row, m.d. '58, HS '66, has been 
named president and CEO of the 
Sea Research Foundation, the not- 
for-profit organization that over¬ 
sees Mystic Aquarium & Institute 
for Exploration. Burrow will work 
to extend the foundation’s mission 
of "education and research, with 
entertainment at the center” by 
supporting new technologies 
to bring the experience of the sea 
to people on land. Burrow was 
an intern and resident in internal 
medicine at Yale, and a fellow here 
in endocrinology. He served on the 
Yale faculty before becoming the Sir 
John and Lady Eaton Professor and 
chair of medicine at the University 
of Toronto, then vice chancellor and 
dean of the University of California 
San Diego School of Medicine. Bur¬ 
row was dean of the Yale School of 
Medicine from 1992 to 1997. 
197OS 
GEORGE J. DOHRMANN, M.D., 
ph.d., HS ’78, a neurosurgeon at 
the University of Chicago Medical 
Center and a member of the fac¬ 
ulty at the Brain Research Institute 
in Chicago, received the 2001 Bucy 
Award in recognition of his out¬ 
standing contributions to neuro¬ 
surgical education, both nationally 
and internationally.The award 
honors teacher and neurosurgeon 
Paul C. Bucy, m.d., who lived from 
1904 to 1992. Bucy collaborated on 
research in neurophysiology with 
John Fulton, M.D., at Yale before 
returning to Chicago, where he led 
the neurosurgery departments 
at the University of Chicago and 
Northwestern University. 
This fall DON ALD L. KENT, M.D. 
'72, HS ’76, of Great Neck, N.Y., 
encountered symptoms never seen 
before in his nearly three decades 
as an otolaryngologist. Beginning a 
week after the trauma of Septem¬ 
ber 11, a total of nine New York fire¬ 
fighters who had been part of the 
rescue operation in Lower Manhat¬ 
tan presented in his Long Island 
office with “a sandpaper-like 
inflammation" of the airways. The 
injuries did not seriously impair 
breathing, and they dissipated after 
several days of moisturizing ther¬ 
apy to reverse the effects of smoke 
and cement dust."Let us hope,” 
Kent writes in an e-mail to Yale 
Medicine,"that no physician sees 
these physical occurrences again!” 
LAWRENCE V. MEAGHER JR.. 
m.p.h. '76, of Garland,Texas, presi¬ 
dent and CEO of International 
Hospital Corporation, was selected 
as a 2001 Wheeling Jesuit Univer¬ 
sity (wju) Distinguished Alumnus 
for his work in bringing health 
care to Third World countries. He is 
co-founder of the Dallas-based 
company, which specializes in 
developing and managing acute- 
care hospitals and other health 
services in Mexico and Latin Amer¬ 
ica. Meagher said “lessons learned 
at wju were central to [his] 
approach today—a concern for 
people and energy, persistence and 
integrity, in an atmosphere of con¬ 
stant challenge to the status quo." 
I98OS 
The Tulane University Health 
Sciences Center has named tyler 
CURI EL, M.D., M.P.H., HS '86, as 
the new chief of the section of 
hematology-oncology at its school 
of medicine. Curiel, who holds the 
Henderson Chair in Medicine at 
Tulane, studied medicine at Duke 
and public health at Harvard and 
completed an internship and resi¬ 
dency in internal medicine at Yale. 
He has an interest in developing 
therapies for cancers and infectious 
diseases by boosting the body's 
immune system. He holds four 
patents and has more pending for 
novel therapies in these areas. 
SEND ALUMNI NEWS TO 
Claire Bessinger, Yale Medicine, 
P.O. Box 7612, New Haven, CT 
06519-0612, or via e-mail 
to claire.bessinger@yale.edu. 
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46 in Memoriam 
ROBERT W. BERLINER, M.D., 
professor emeritus of cellular and 
molecular physiology and a former 
dean of the School of Medicine, 
died on February 5. He was 86. 
Berliner came to Yale in 1973 
after a distinguished career at the 
National Institutes of Health (nih), 
and for the next 11 years guided 
the school as it became one of the 
country’s leading research insti¬ 
tutions. He was well known for his 
contributions to the study of 
renal physiology and was a leader 
in shaping American biomedical 
science. With colleagues, he was 
instrumental in elucidating the 
main features of potassium excre¬ 
tion by the kidney. 
A native of New York, Berliner 
graduated from Yale College 
in 1936 and studied medicine at 
Columbia University. He did his 
residency at Presbyterian Hospital 
and Goldwater Memorial Hospi¬ 
tal in New York, and began his 
research career at Goldwater. In 
1930 he left Columbia, where he 
was an assistant professor of med¬ 
icine, for a job at the nih.There, he 
built the Laboratory of Kidney and 
Electrolyte Metabolism and served 
as its chief for 12 years. He subse¬ 
quently became director of intra¬ 
mural research at the National 
Heart Institute and deputy direc¬ 
tor for science at the nih. 
He was a member of the 
National Academy of Sciences and 
of the Institute of Medicine. At 
Yale he was honored by the cre¬ 
ation of the Robert W. Berliner 
Chair and the Robert W. Berliner 
Lectureship in Renal Physiology. 
ALLEN CHETRICK, M.D.’53, HS’56, 
former associate clinical professor 
of medicine at Yale, died of cancer 
in Branford, Conn., on October 2. 
He was 74. 
Born in New Haven, Chetrick 
graduated from Yale College in 
1950 and from the School of Medi¬ 
cine three years later. He served an 
internship in medicine at Bellevue 
Hospital in New York City and 
two years of residency at the West 
Haven Veterans Administration 
Hospital and Grace-New Haven 
Community Hospital.The Ameri¬ 
can Heart Association awarded 
him a research fellowship in cardi¬ 
ology in 1956. 
Chetrick joined the Yale faculty 
in 1957 and practiced internal med¬ 
icine and cardiology in New Haven 
for 41 years. He was an attending 
physician at Yale-New Haven Hos¬ 
pital and The Hospital of St. Raphael. 
Chetrick also served in the Navy 
during World War II. He was a fel¬ 
low of the American College of 
Physicians and a member of the 
American Society of Internal Medi¬ 
cine. He was also past secretary of 
the internal medicine section of the 
Connecticut Medical Association. 
In 1969 Chetrick received the 
Israel Service Award from the 
Greater New Haven Israel Bond 
Committee. 
ALVAN R. FEINSTEIN, M.D., HS 
'54, Sterling Professor of Medicine 
and Epidemiology, died of a heart 
attack at an awards ceremony in 
Toronto on October 24. He was 75. 
A native of Philadelphia, Fein- 
stein received his bachelor’s degree, 
a master’s degree in mathematics 
and his doctor of medicine degree 
from the University of Chicago. He 
completed his clinical training in 
internal medicine at Yale and his 
research training at Rockefeller 
Institute. Feinstein joined the Yale 
faculty in 1962 and became the 
founding director of the Robert 
Wood Johnson Clinical Scholars 
Program at Yale in 1964. Under his 
direction, the program became 
recognized as one of the leading 
sites for training in the methods 
of clinical research. He was also the 
director of the clinical examination 
course (for second-year medical stu¬ 
dents) and created a course in quan¬ 
titative clinical epidemiology (for 
Johnson Clinical Scholars) that was 
imitated throughout the country. 
Because of his work on the sta¬ 
tistical analysis of clinical signs and 
symptoms of real patients—rather 
than on the historically nonclinical 
methods of pure statistics — Fein¬ 
stein was a key figure in the estab¬ 
lishment of the field of clinical 
epidemiology. His approaches and 
methods were reported in three 
books: Clinical Judgment, Clinical 
Epidemiology and Clinimetrics. His 
approaches to quantitative data 
were presented in three other 
books: Clinical Biostatistics, Multi- 
variable Analysis and Principles of 
Medical Statistics. Feinstein will 
be remembered for his influence 
on the careers of over 100 fellows 
who trained in the clinical scholars 
program and others who consid¬ 
ered him their intellectual muse. 
MONTE NELSON F R AZ I E R , M.P.H. 
’65, of Colebrook, Conn., a graduate 
in epidemiology and public health 
and a veterinarian, died June 29 at 
the age of 76. 
Frazier, as noted in an obituary 
in The Hartford Courant, had a 
worldwide reputation in an eso¬ 
teric specialty, the health of poul¬ 
try. He parlayed a boyhood chore 
on his father’s Michigan farm into 
an international career. Frazier 
taught in the agriculture depart¬ 
ment of the University of Con¬ 
necticut, then joined Arbor Acres 
Farm Inc. in Glastonbury, Conn., 
serving as director of poultry 
health for 25 years. 
He was an early advocate for 
using the highest standards of 
cleanliness and sanitation in order 
to eliminate diseases that could 
decimate whole flocks. He thought 
the best precaution was to isolate 
the birds from humans, other birds 
and animals. 
Frazier, known from Venezuela 
to India, worked for Aviagen Inc. 
(formerly Arbor Acres Farm Inc.), 
a company that does business 
worldwide. He logged up to 
100,000 miles a year, to 35 coun¬ 
tries in all, visiting farms and 
giving lectures on disease preven¬ 
tion. At the end of his career, 
Frazier lectured in Thailand to poul¬ 
try experts whom he had helped 
train over several decades. 
C. NORMAN CllLIS, PH.D., profes¬ 
sor emeritus of anesthesiology 
and of pharmacology at the School 
of Medicine, died in Boston on 
August 16. He was 68. 
Gillis, a native of Scotland, 
earned his ph.d. degree in 1957 
from Glasgow University. He came 
to Yale in 1961 as assistant profes¬ 
sor of pharmacology. In 1966 he 
was named associate professor of 
pharmacology, and in 1969, associ¬ 
ate professor of anesthesiology. 
In 1973 Gillis was named professor 
of anesthesiology and of pharma¬ 
cology, and served as director of 
anesthesiology research from 1979 
until 1993. 
Gillis, nationally recognized as 
a specialist in pulmonary vascular 
disease and pharmacology, pub¬ 
lished more than 250 scientific 
articles during his career. He had 
recently been appointed to serve 
on a committee of the Institute of 
Medicine and was an adjunct pro- 
fessor of medicine at Tufts Univer- 
' sity School of Medicine. He was 
an associate editor of the journal 
Biochemical Pharmacology and 
served on the editorial boards of 
several other journals in his field. 
RICHARD H. GRANGER, M.D., HS 
’51, of Guilford, Conn., a member of 
I the faculty in the Child Study Cen- Iter, an advocate for children and a 
former master of Morse College, 
suffered with multiple myeloma 
and died of pneumonia on April 9 
at Yale-New Haven Hospital. He I was 76. 
While at Yale, Granger sought 
to train pediatricians to under¬ 
stand the interface between physi¬ 
cal and psychological develop¬ 
ment. He established a program 
for the continuing education of 
:i pediatricians that brought them 
together with child psychiatrists to 
address the challenges faced by 
1; children and families. Granger had 
his own pediatric private practice 
i in New Haven before joining the 
Child Study Center in 1969, where 
he supervised three major facilities 
expansions and served under three 
of the Center’s four directors. He 
was master of Morse College from 
1975 to 1982. 
Granger served as president 
of both New Haven’s Dixwell Com¬ 
munity House and the New Haven 
Area Mental Health Association. 
He headed the research unit of 
Connecticut’s Mental Health Asso¬ 
ciation, and was also a delegate 
to the White House Conference 
on Children. 
LAURENCE VAN DOREN HARRIS 
jr., m.d.’51,formerly ofThomas* 
ton, Conn., died of spinal cancer on 
September 7 in Longwood, Fla. He 
was 78. 
Harris was born in Wallace, 
Idaho. He attended high school in 
Kent, Conn., and completed one 
year at Williams College in Wiiliams- 
town, Mass., before enlisting in 
the Army during World War II. He 
returned to Williams after the war 
to complete his bachelor’s degree 
and then received his medical 
degree from Yale. Harris served his 
internship and residency at Water- 
bury Hospital, and after four years 
in private practice in Thomaston, 
he returned as a surgeon to the 
Army Medical Corps with the 
rank of major. Harris served in the 
United States, Germany and Thai¬ 
land and completed his 20 years of 
service as a colonel before retiring 
to Florida. 
JEROME K. MYERS, PH.D.’50, a 
retired Yale sociology professor 
and pioneer in the fields of social 
psychiatry and medical sociology, 
died May 7 at the age of 79. 
Born in Lancaster, Pa., Myers 
graduated from Franklin and Mar¬ 
shall College in 1942 and served 
in World War II before earning his 
master’s and doctoral degrees in 
sociology at Yale. 
Myers remained at Yale 
throughout his 43-year career of 
teaching and research. During that 
time he co-founded and directed a 
National Institutes of Mental 
Health training grant program in 
medical sociology. 
Myers was principal investiga¬ 
tor of a number of large-scale 
community surveys on mental 
health and mental health services, 
which culminated in the first 
major study of the prevalence of 
mental disorders in the United 
States. He authored and co¬ 
authored many books, including 
Research Techniques in Schizophre¬ 
nia-, Family and Class Dynamics in 
Mental Illness-, A Decade Later: A 
Follow-up of Social Class and Men¬ 
tal Illness and Community Surveys 
of Psychiatric Disorders. Among 
Myers' honors were the Rema 
Lapouse Award from the American 
Public Health Association and the 
Distinguished Career Award from 
the Psychiatric Sociology Section 
of the Society for the Study of 
Social Problems. 
RAYMOND E. PA R KS, M.D.’45, 
died August 9 at his home on St. 
Simons Island, Ga., at the age of 78. 
Born in St. Paul, Minn., Parks 
received his medical degree from 
Yale and was awarded the Camp¬ 
bell Prize, which is given to the 
student obtaining the highest 
standing in medical studies. He 
served his internship at Ramsey 
County Hospital in St. Paul,fol¬ 
lowed by a tour in the U.S. Army 
Medical Corps, where he attained 
the rank of captain. He completed 
his residency at Johns Hopkins 
Hospital. 
Certified in radiology and 
nuclear medicine, Parks was a con¬ 
sultant for the Florida State Board 
of Health. He was appointed to the 
Florida Air Pollution Control Com¬ 
mission in i960, serving until 1967. 
He was also a radiologist on the 
heart transplant team at Cape¬ 
town University in South Africa 
during 1968. Parks was a member 
of the National Advisory Council 
on Radiation in Washington. He 
served as associate dean for con¬ 
tinuing education at the Univer¬ 
sity of Miami (UM) and professor 
and chair of the Department of 
Radiology at the UM School of 
Medicine. 
During his career Parks also 
served as director of radiology at 
Jackson Memorial Hospital in 
Miami, Kendall Hospital, Cedars of 
Lebanon Hospital, National Chil¬ 
dren’s Cardiac Hospital, Broward 
General Medical Center, North 
Broward Hospital and Imperial 
Point Hospital. He retired as clini¬ 
cal professor of radiology at the 
University of California at Davis. 
ROBERT R. WAGNER, M.D. '46, of 
Charlottesville, Va., professor 
emeritus of microbiology at the 
University of Virginia Medical 
School, died of lung cancer on Sep¬ 
tember 15 at the University of Vir¬ 
ginia Hospital. He was 78. 
A native of New York and a 1943 
graduate of Columbia University, 
Wagner taught microbiology at 
Yale and Johns Hopkins before 
moving to Charlottesville. He was 
on the faculty at Yale as an instruc¬ 
tor in medicine from 1951 to 1953 
and as an assistant professor of 
medicine from 1953 to 1955. 
Wagner joined the University 
of Virginia faculty in 1967 as chair 
of the microbiology department 
and remained chair until 1996. He 
was founding director in 1983 of 
the school’s cancer center and 
served in that position until 1995. 
He co-edited the multivolume 
texts Comprehensive Virology and 
The Viruses and published more 
than 200 articles in scientific jour¬ 
nals. Wagner was a president of 
the American Society for Virology 
and a diplomate of the American 
Board of Internal Medicine. 
SEND OBITUARY NOTICES TO 
Claire Bessinger, Yak Medicine, 
P.O. Box 7612, New Haven, CT 
06519-0612, or via e-mail 
to claire.bessinger@yale.edu. 
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Archives 
Moving beyond fear continued from page 22 
talking about high-risk groups, instead of high-risk behavior, 
have led to the idea that hiv is for someone else: for sex workers, 
truck drivers or “immoral” people. Too many people have 
decided they simply aren’t at risk. We’re trying out a method of 
measuring an individual’s perceived distance from the epi¬ 
demic based on the kinds of questions he or she asks — a 
“Continuum of Enquiry.” Designed as a matrix, on the far left 
is someone who feels far from the epidemic and at virtually 
no personal risk. On the far right is someone living with aids. 
In between are people practicing multipartner sex, people 
who have contracted a sexually transmitted infection, people 
who are contemplating a test and people who are living with 
hiv. Moving from left to right, the questions become more 
detailed, heartfelt, and personal, and the person’s risk percep¬ 
tion increases. As a person feels closer to the epidemic, the 
possibility of behavior change should increase as well. 
For example, a person who asks, “Can mosquitoes transmit 
hiv?" or “What is the shape of the virus?” probably does not 
feel at great personal risk. But someone who asks, “If you’ve 
had gonorrhea, does that put you at risk for hiv?” may be feel¬ 
ing a little closer to the reality of the epidemic. And when a 
child asks, “Why are people with aids so harsh?” we can feel 
sure he or she has had personal experience. The key is to 
help the child use that experience to think about risk, protec¬ 
tion and a future free from hiv. 
At the Westlands roundabout, the traffic has degenerated 
into merry chaos behind us and the traffic cop is still asking 
questions—relatively superficial ones according to our matrix, 
but questions just the same. After a few minutes, he gives 
us a last probing look, then stops traffic and waves me through. 
In the two years I’ll spend here, I can’t really expect to see 
a noticeable change in the hiv incidence rate, and even if I did 
I would be hard pressed to say I had contributed to it. But I 
know that one police officer learned a few things he didn’t know 
before, and asked some questions that may have made him 
think. He might talk to others and raise a few questions in their 
minds, and as they search for the answers they may change 
their risk perception. I have to believe that every little bit helps. 
And I did manage to dodge the traffic ticket, ym 
karen schmidt, m . p. h oo, worked as a journalist for io years 
before coming to Yale in 1997 as a student in the School of Public Health. 
She can be reached by e-mail at karens@aya.yale.edu. 
YALE MEDICINE 
FROM “ANATOMY DEMONSTRATIONS 
telecast” in the winter 1966 
issue: “Among the many things in 
life and art that will never be 
the same as they were before tele¬ 
vision is the prosection of the 
infratemporal fossa. 
Formerly, when first-year 
medical students at Yale watched 
anatomy prosections in groups 
of 12 or 14, it was possible for only 
one student in each group (or 
two at the most, forehead to fore¬ 
head) to peer directly into the 
three-inch-deep infratemporal cav¬ 
ity while the instructor identified 
and explained its parts. The others 
in the group, unable to see what 
was being demonstrated, could 
only try to visualize and commit 
to memory the divisions of the 
trigeminal nerve and the branches 
of the maxillary artery. 
The close view that was once 
available to only a few students 
is now shared, via closed circuit 
television, by 80 students simul¬ 
taneously, each of whom benefits 
to a far greater degree than before. 
Because the demonstration is 
recorded on videotape, it can be 
repeated as many times as one or 
more students wish to study it while 
performing their own dissections.” 
Yale_Medicine 
FROM “THE MIND OF THE TERRORIST1 
BY JERROLD M. POST, M.D. ’60, 
summer 1989: “While the public 
regularly assumes such blood¬ 
shed can only be the product of 
deranged minds, the acts of crazed 
fanatics, most terrorists do not 
suffer from serious (Axis I) mental 
disorders-, indeed, psychotic 
disorders would be incompatible 
with the level of planning and 
group cooperation required to 
carry out sophisticated terrorist 
action. Moreover, behavioral 
scientists ... have not succeeded 
in identifying a unique'terrorist 
mindset,’a particular psycho¬ 
logical type, a particular person¬ 
ality constellation. 
But while there is a diversity 
of personalities attracted to the 
path of terrorism, individuals with 
particular personality traits and 
tendencies are drawn to terror! 
careers. One pattern frequently 
described resembles the socio-| 
pathic personality—action- 
oriented, aggressive individua 
with a diminished capacity for 
empathy, who are stimulus-hun| 
and seek excitement. Another 
type is the angry paranoid, read] 
to lash out at his enemies—reaj 
and imagined.... 
As the product of generatioj 
forces, political terrorism will b 
here for generations to come, i 
is no short-range solution to th 
problem. In the long run, the n 
effective ways of countering t 
rorism are to reduce external 
port, to facilitate pathways 01 
terrorism, and, most importai 
to reduce the attractiveness c 
terrorist path for alienated y< 
./ 
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ON THE COVER 
Robert Udelsman’s arrival at 
Yale last June as chair has focused 
major attention on the Depart¬ 
ment of Surgery. Recruited from 
Johns Hopkins, where he helped 
develop new techniques for 
thyroid and parathyroid surgery 
and made laparoscopic adrena¬ 
lectomy standard, Udelsman has 
set his sights on making the 
department one of the world’s 
leaders. Page 16 
Cover photograph by 
Sean Kernan 
Yale Medicine 
PRI 
This season on the Web 
info.med.yale.edu/ymm 
Explore the following topics in 
greater depth by visiting our 
website and selecting extras: 
-Surf the Janeway and 
Medzhitov lab websites and 
learn more about innate 
immunity. Pay a virtual visit 
to the Howard Hughes 
Medical Institute. 
-Visit the ayam and learn 
about Reunion 2002 (and view 
photos from 2001 reunions). 
See which of your classmates 
are coming to Alumni Reunion 
Weekend on June 6 to 8. 
-View additional photos from 
the second-year show, 
O Doctor, Where Art Thou? 
and recent alumni events. 
On the website, readers can 
submit class notes or a 
change of address, check the 
alumni events calendar, 
arrange for a lifelong Yale 
e-mail alias through the 
virtual Yale Station and search 
our electronic archive. 
20 
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16 REINVENTING SURGERY 
Robert Udelsman left one of the busiest medical centers on the 
planet to lead Yale’s Department of Surgery out of its doldrums and 
into national prominence. He’s a man on a mission. 
By Cathy Shufro 
24 PUTTING EVOLUTION TO USE 
From the landscape of an ancient “rna world” springs an idea 
that could lead to the creation of ultrasensitive biosensors based on 
molecular switches. 
Interview by Marc Wortman 
28 THE TOLL ROAD 
In science, an idea can lie dormant for a century and then enjoy a 
fantastic rebirth. That’s what happened when Charlie Janeway 
proposed a theory about human immunity in 1989 that captured the 
imagination of Ruslan Medzhitov. 
By Trisha Cura 
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Letters 
ANOTHER LESSON 
FROM ANTHRAX 
Yale Medicine’s roundtable on 
bioterrorism was an encouraging 
take on a very discouraging 
subject (“Lessons from Anthrax,” 
Winter 2002), It was particu¬ 
larly heartening because so much 
care has gone into thinking about 
how to deal with the possibility 
of great tragedy. 
The big issue that those inter¬ 
viewed skirted, however, was 
the politics of coercion in public 
health policy. This is an old issue 
within public health, certainly. 
But it becomes much more salient 
as discussions proceed about 
mass vaccination for diseases such 
as smallpox and anthrax, either 
before or during an epidemic. 
Under what circumstances 
would it be permissible for 
the federal or state governments 
to require vaccination for such 
diseases? Right now, most public 
health authorities are advocating 
only “ring vaccination” in case of 
an outbreak of smallpox. And 
even Anthony Fauci has eloquently 
written in a recent issue of The 
New England Journal of Medicine 
that the formulation of smallpox 
vaccination policy must proceed 
through democratic dialogue. 
But how will we balance the 
often-competing values of democ¬ 
racy and authority, coercion and 
informed consent, in the midst of 
a bioterror crisis? 
One thing is certain: we 
need to begin to reflect on these 
matters now, not during such 
an episode. The time to begin is 
now, and our discussions must 
include ordinary citizens as well 
as public health elites. 
ROBERT JOHNSTON 
ASSOCIATE PROFESSOR OF HISTORY 
A SLIGHT FOR 
SORE EYES? 
Apropos of the letter from John 
Mahoney, m.d. '00, in the Winter 
2002 issue, I’m gratified that he, 
as a young person, pointed out the 
difficulty of reading the small 
print in the magazine. The maga¬ 
zine itself is very attractive, but we 
needed a magnifying glass to read 
much of it. Also, in our age group 
many of us have painful arthritis 
in the hands, and the stiff cover as 
well as stiff binding and stiffer 
(than in old format) pages make it 
hard to turn the pages. Miserere 
nobis.... 
Thanks. 
LAURA NEVILLE, M.D. '46 
JOHN NEVILLE, M.D. '46 
COTUIT, MASS. 
Amen, amen and amen to John 
Mahoney’s comments regarding 
the size of the print in Yale 
Medicine. On the other side, thank 
you for using adequate contrast 
between the print and the colored 
background. 
EDNA MAY KLUTAS, M.P.H. ’57 
NEWVILLE, PENN. 
GOOD NEWS, 
BAD NEWS 
We found ourselves on the receiv¬ 
ing end of a brief flood of opinions 
this spring from readers who found 
our new typeface too small. "Your 
format is great—it will win awards, 
but not from your senior readers. 
One needs a magnifying glass 
to read it,"wrote George R. Barnes, 
m.d. '47, hs ’so, of Tucson, Ariz., 
one of a half-dozen readers who 
weighed in on the topic. 
Dr. Barnes was right on both 
counts. In April, Yale Medicine 
won the silver medal for best maga¬ 
zine and bronze medal for Visual 
Design in Print from the 23,500- 
member Council on Advancement 
in Support of Education. The cate¬ 
gory in which we were judged was 
special-interest magazines, which 
includes entries from graduate and 
professional schools nationally. 
These honors follow the Award of 
Excellence granted last November 
by the Association of American 
Medical Colleges, the group's high¬ 
est level of recognition. But regard¬ 
less of these glories, it is also true 
that Yale Medicine is hard to 
read for many in our audience. To 
address this, we are tuning up 
the type for better legibility in time 
for the Summer issue. 
HOW TO REACH US 
Yale Medicine welcomes news 
and commentary. Please send letters 
to the editor and news items to 
Yale Medicine, P.O. Box 7612, New 
Haven, CT 06519-0612, or via 
electronic mail to ymm@yale.edu, 
and include a daytime telephone 
number. Submissions may be 
edited for length, style and content. 
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FROM THE EDITOR 
Feedback mechanism 
Two years ago, the spring issue of Yale Medicine included a feature story 
on an initiative by Dean David A. Kessler, m.d., to review the curriculum 
and examine the larger questions surrounding medical education at the 
start of the 21st century. The magazine also featured an interview with 
the school’s new education dean, Herbert S. Chase Jr., m.d., and a collec¬ 
tion of alumni essays titled “Eight Decades of the Yale System.” Several 
issues earlier we had invited alumni to reminisce about what the Yale 
System meant to them and to their generation. The response we received 
was overwhelming, as was the obvious affection nearly every alumnus 
and alumna appears to have for the Yale System. 
This past February, a new generation of Yale scholars brought the 
topic into focus once again with a statement and petition, mailed to 
alumni, seeking to prevent proposed changes to the second-year testing 
format. The nine medical students who circulated the petition felt that 
requiring certain qualifying exams was incongruous with the Yale System, 
conceived in the 1920s by then-Dean Milton C. Winternitz, m.d. His 
vision was to give students freedom to pursue knowledge in a graduate- 
school-like environment by eschewing grades, class rankings and required 
exams in favor of close mentoring relationships between students and 
faculty and the completion of a thesis based on original research. 
The proposed second-year qualifiers have since been dropped, but 
not before the issue elicited a huge response from alumni. From their 
mailing to more than 4,000 addresses, the students received well over 
400 replies, many echoing Stanford oncologist William M. Rogoway, m.d. 
’61, who wrote: “The freedom to chart one’s own course with support 
and encouragement along the way (and few inhibiting rules) is a model 
for a professional career.” 
As a course director at Columbia P&S in the mid-1990s, Chase 
lobbied for the abolishment of grades for the first- and second-year 
courses, and he came to New Haven excited about Yale’s emphasis on 
intellectual independence. He thinks there are other, more serious 
threats to the Yale System: the incursion of managed care into teaching 
time, class sizes that are too large, an overstuffed schedule and inca¬ 
pacitating student debt. In response, the faculty has increased the num¬ 
ber of small-group discussions and reduced class hours and the total 
number of qualifying exams. Chase is working on ways to boost financial 
aid and the rewards for teaching. 
Following our initial coverage in 2.000, we planned to revisit this 
topic as it evolved and will do so in depth in an upcoming issue. The 
intense interest of both current students and alumni reinforces the view 
that the Yale System is not only central to the experience of Yale medical 
students but also that it is here to stay. 
Michael Fitzsousa 
michael.fitzsousa@yale.edu 
Y
a
le
 
M
e
d
ic
in
e
 
s
pr
in
g 
20
02
 
4 chronicle news from cedar 
Pete Kenyon survived longer than any 
other American—three years—on a device 
that replaced the diseased left side of 
his heart. After a successful heart transplant 
in January, Kenyon, shown with his wife, 
Kathy, returned to the medical center for a 
checkup in February. 
STREET 
WAITING FOR A HEART, 
BROKER BEATS THE ODDS 
A Connecticut man sets record 
for survival on heart pump and 
receives a gift of life. 
In his 63 years Robert “Pete” Kenyon 
has been a Navy officer, an amateur 
race car driver and, most recently, 
a reinsurance broker. As someone who 
makes his living assessing risk, he 
surely knew the odds as he reached 
a difficult milestone last year. In August, 
he became the longest-surviving recip¬ 
ient in the United States of a mechan¬ 
ical pump that replaced the diseased left 
side of his heart. 
At that point he had lived three years 
on the pump, the outer limits of the 
manufacturer’s warranty. Novacor’s left 
ventricular assist system (lvas) 
remained in place because none of 
more than a dozen hearts offered to 
Kenyon from the organ sharing network 
had been immunologically compatible. 
“We were getting increasingly 
concerned communications from the 
engineers at Novacor,” said John 
A. Elefteriades, m.d. ’76, hs '83, who 
implanted the device. By October 
Kenyon's physicians decided the pump 
should be replaced. “The machine 
was making a lot of abnormal noises, 
and it was misfiring,” Kenyon said. 
He prevailed upon the doctors to 
wait until the Christmas holidays, 
when his chances of getting a new heart 
would increase. On New Year’s Eve, 
Kenyon went into the operating room, 
where an expected problem turned out 
to be even worse than imagined. “The 
ivas had been in such a long time that 
the body’s fibrous tissue had virtually 
encased it,” Elefteriades said. The device 
was replaced with an identical, semi¬ 
permanent pump. 
In a fateful turn of events, another 
donor heart became available 36 
hours later—and this time it matched. 
Despite having just undergone the 
ordeal of surgery to implant the new 
lvas, Kenyon seized the opportunity. 
"Dr. Elefteriades felt I was strong 
enough to undergo surgery, so off we 
went,” Kenyon said. 
From the moment of the donor’s 
death, a deadline loomed. For the trans¬ 
plant to succeed, the donated heart 
had to be pumping in the recipient’s 
chest within four hours. Fortunately, the 
surgeons had freed the three-year-old 
lvas from his tissue the day before. 
“I do not think we could have gotten 
everything out fast enough for the heart 
to be viable,” Elefteriades said. 
Three more surgeries followed the 
heart transplant. A lung infection 
had to be treated, a pacemaker was 
installed and Kenyon’s gall bladder had 
to be removed. 
After recuperating from five 
surgeries in the space of a few weeks, 
Kenyon is back at work part time, 
telecommuting from his home office in 
Darien. “I usually get tossed out of 
bed at nine o’clock in the morning,” he 
said with a grin at his wife, Kathy, dur¬ 
ing an interview in February. “I go down 
the hall to my office and do my office 
work. My wife doesn’t like me sitting 
there for hours at the computer. She 
wants me up and around. I’m trying to 
walk as much as possible. I’ll take a nap 
and read. My appetite is coming back 
but I can’t eat the quantities of food that 
I used to.” 
He plans to return to a childhood 
sport learned on frozen ponds—ice 
hockey. The man whose heart now beats 
inside Kenyon’s chest was a 30-year-old 
hockey coach from the Boston area who 
died of a brain aneurysm. “I want to 
thank the donor’s family for giving me 
the gift of life,” Kenyon said. 
EVEN AFTER HIS DEATH, 
A SKEPTIC INSPIRES 
A LEGION OF SCHOLARS 
Alvan R. Feinstein, m.d., hs ’54, joked 
in his 400th scholarly article that he 
hoped to continue writing until he faced 
“the ultimate rejection, by adverse 
pathophysiology.” When Feinstein did 
die in October—at age 75, while partici¬ 
pating in the Gairdner Foundation con¬ 
ference in Toronto—his former student, 
Peter A. Singer, m.d., m.p.h., found 
himself taking Feinsteirfs place on the 
podium. Instead of listening to Fein¬ 
stein speak, Singer delivered a eulogy. 
The first part of Singer’s tribute was 
what one might expect: He described 
Feinsteirfs leadership in establishing the 
field of clinical epidemiology, in which 
researchers use scientific principles to 
study decisions about patient care— 
what one colleague called “conducting 
research at the bedside.” And he spoke 
of Feinsteirfs “pattern of challenging 
orthodoxy.” But then Singer did some¬ 
thing unusual: he quoted a comment 
Feinstein had written on a manuscript 
that Singer sent him. 
“I don’t think your writing is actually 
bad,” Feinstein wrote to Singer, the Sun 
Life chair in bioethics at the University 
of Toronto. “After you fixed the tone 
and removed most of the sociobabble in 
this manuscript, the paper could be 
understood despite its prolixity, ver¬ 
bosity, and subadequate inter- and intra¬ 
sentence structure.” 
That Singer would affectionately 
recall the man who offered such criti¬ 
cism reflects Feinsteirfs mystique: he 
had almost impossibly high standards 
and never minced words, yet his stu¬ 
dents deeply valued his guidance. Many 
of those students were young physicians 
Feinstein supervised as founding direc¬ 
tor of the Robert Wood Johnson Clinical 
Scholars Program at Yale, which since 
1974 has provided two years of post¬ 
residency training in research. 
Although Singer now studies bio¬ 
ethics rather than the clinical epidemiol¬ 
ogy in which he immersed himself 
as a clinical scholar from 1988 to 1990, 
he says he uses what Feinstein taught 
him every day. “He didn’t teach us only 
clinical epidemiology. He taught us 
how to think,” said Singer in an inter¬ 
view. He said Feinstein also imparted to 
students “a fundamental irreverence 
for scientific authority and established 
beliefs. ... He was one of the giants 
of 20th-century American science. It 
was really an honor to be able to learn 
from him.” 
The core values that Feinstein estab¬ 
lished for the clinical scholars program 
will endure, said Ralph I. Horwitz, m.d., 
a program scholar from 1975 to 1977 
and now chair of internal medicine at 
the School of Medicine. The scholars— 
four to five are admitted each year—will 
continue to study quantitative methods 
in depth, to think critically not only 
about methodology but also about the 
merit of research questions themselves, 
and to work closely with faculty men¬ 
tors, said Horwitz, co-director of the pro¬ 
gram with Harlan M. Krumholz, m.d. 
Second-year scholar Thomas M. 
Morgan, m.d., said that he and fellow 
scholars learn to recognize hidden 
assumptions underlying research and to 
find limitations to methodology. “They 
want us to be able to think critically 
about the techniques used rather than 
just to be able to plug numbers into a 
computer and get results,” said Morgan. 
“We deconstruct research and try to 
build it up from the rubble.” He said the 
scholars are taught to evaluate whether 
a question is even worth studying. “The 
difference between good research and 
great research, as defined by the men¬ 
tors of this program, is determined by 
the quality of the question.” 
The clinical scholars program is at 
a crossroads now: Yale faces unprece¬ 
dented competition in seeking renewed 
funding for the 28-year-old program, 
because The Robert Wood Johnson 
Foundation will reduce training sites 
from seven to four beginning in 2005. 
To win a grant, Yale must successfully 
argue that its program not only ranks 
among the best four programs but also 
outflanks new competitors from top- 
ranked schools. Lewis Sandy, m.d., the 
foundation’s executive vice president, 
said it decided to fund fewer sites for 
two reasons. First, although the clinical 
scholars program was unique in 1974, 
other fellowships now provide similar 
training. Second, the foundation hopes 
that through consolidation it can pro¬ 
vide more in-depth training in clinical 
epidemiology and health services 
research, with an option to extend the 
fellowship for as long as six years. 
Whatever the future of Yale’s pro¬ 
gram, Singer believes that Feinsteirfs 
model for rigorous research and his 
“unswerving devotion” to training his 
students will have a lasting effect. More 
than 100 clinical scholars studied with 
Feinstein. Those men and women, 
said Singer, compose Alvan Feinsteirfs 
“living legacy.” 
Alvan Feinstein (right) plays guitar during a 
performance of the Beatles song "Let It Be” 
at Commencement in 1991, accompanied by 
Robert Gifford, then dean of students. They 
had previously performed their rendition at 
the Class of i99i’s second-year show. 
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chronicle 
YALE CROUP LAUNCHES NEW 
EFFORT TO UNDERSTAND 
WHY ORGAN TRANSPLANTS FAIL 
By 11 a.m., Yinong Wang, M.D., is 
performing his fifth transplant proce¬ 
dure of the day. Each one is the same, 
and not what you would expect: Prepare 
a snippet of blood vessel from a donor 
patient and slip it into the aorta of 
the anesthetized recipient. Suture and 
close. Repeat. 
Though Wang is indeed a surgeon, 
it would be misleading to call these 
recipients patients. They are mice. The 
delicate suturing is part of a long¬ 
term study to determine why coronary 
arteries narrow over time and become 
blocked. By using so-called severe com¬ 
bined immunodeficiency (scid) mice 
that have been bred without the genes 
necessary to create T and B cells, the 
study’s designers are able to introduce 
immune cells from one human and 
see how they interact with the blood 
vessels of another. A week after the 
microsurgery, the study team will intro¬ 
duce T cells and macrophages from 
the second human into the mouse’s 
circulation, then watch for signs of 
inflammation in the transplanted artery. 
It’s a model that mimics the real-life 
battle that occurs after the transplanta¬ 
tion of a heart, kidney or liver and 
which can speed the rejection of the 
organ. Wang, along with George 
Tellides, m.d., hs ’93, Marc I. Lorber, 
m.d., and Jordan S. Pober, m.d. ’77, 
ph.d. ’76, hs ’78, is interested in see¬ 
ing how the cytokine interferon 
gamma may affect that interaction. 
The sciD-mouse model for inflamma¬ 
tion is one way Yale scientists are explor¬ 
ing common ground between the basic 
science of the vessel walls and the clinical 
problems of organ transplantation. Their 
efforts were formalized at the medical 
school in 2000 with the establishment of 
the Interdepartmental Program in Vascu¬ 
lar Biology and Transplantation (vbt), a 
working group of 24 scientists and physi¬ 
cians in 10 departments. 
“Our goal is not to become the 
world’s largest transplant program but 
to change the ways that transplanta¬ 
tion is being done,’’ said Pober, the pro¬ 
gram’s director. 
vbt has succeeded in attracting new 
support from the nih in the form of 
a $6.4 million program project grant, 
and is embarking on a collaboration 
with Cambridge University funded by 
Britain’s Medical Research Council. The 
Interdisciplinary Program in Clinical 
Transplantation (ipct), the vbt’s com¬ 
panion program, also received $2.5 mil¬ 
lion last year in the first round of fund¬ 
ing from the Yale-New Haven Medical 
Center’s new Clinical Program Develop¬ 
ment Fund. More than a dozen visiting 
scientists have presented their work in 
the program's seminar series. 
The science in this area is promis¬ 
ing, and that’s a good thing. With 
long waiting lists for organ transplants 
(4,323 people died last year waiting 
for a heart, lung, kidney, liver, intestine 
or pancreas) and a shortage of donors, 
transplant physicians are eager to 
find new ways of protecting those scarce 
organs that are available. 
The new generation of immunosup¬ 
pressive drugs that emerged during 
the past decade has greatly reduced the 
threat of acute rejection immediately 
following a transplant. Solving the prob¬ 
lems of chronic rejection, which leads 
to the failure of transplanted organs 
within the first year, is the next step in 
the effort to reduce demand and 
stretch supply. Creating a new source 
of organs through the creation of 
engineered pig organs, or xenografts, 
is another. Yale scientists are working 
in both areas, as well as searching 
for ways to create artificial tissues or 
synthetic skin to improve graft viability. 
Applying the rapidly unfolding sci¬ 
ence of immunology to clinical prob¬ 
lems will make a huge difference, said 
Lorber, director of the ipct. “Most 
organs that fail do so not because of the 
failure of immunosuppression in the 
early post-transplant period. Rather they 
fail over a period of months to years 
from the process of chronic rejection," 
said Lorber. “We believe that under¬ 
standing this process may dramatically 
improve the long-term outlook.” 
Toward that end, the group’s research 
is focused on the possibility that 
chronic rejection may result from an 
attack by the immune system on 
the blood vessels, Lorber added. The 
same process that causes coronary 
artery disease and heart attacks may 
be similar to the events leading to 
chronic organ rejection. 
Hence, the group’s interest in scid 
mice and the “vascular remodeling” 
they’ve observed in the studies of trans¬ 
planted vessels. After doing more than 
100 of the procedures, they reported 
last May in Nature that interferon 
gamma actually contributed to a thick¬ 
ening of the vessel wall and sped the 
division of smooth muscle cells, con¬ 
trary to the conventional wisdom. 
Both factors contribute to the narrow¬ 
ing of the arteries that supply blood 
to transplanted organs. 
For Tellides, chief of cardiac surgery 
at the Veterans Administration hospital 
in West Haven, the finding is an impor¬ 
tant step. “By knowing which molecules 
exacerbate vascular disease, we can 
improve diagnosis and eventually treat¬ 
ment,” he said. “Right now we can only 
bypass the blockages.” 
Surgeon Marc Lorber (left) accepts a kidney 
from colleague Amy Friedman during 
a transplant procedure at Yale-New Haven 
Hospital. The medical school and hospital 
have launched new programs to speed 
the translation of scientific knowledge to 
benefit transplant recipients. 
7 
ALCOHOL AND THE BRASN 
Since the 1950s, when Yale scientist E.M. Jellinek pioneered the 
notion that alcoholism is a disease, investigators have discov¬ 
ered links between certain genes and problem drinking. Now, 
with a $9 million grant from the National Institute on Alcohol 
Abuse and Alcoholism, investigators at Yale, the University of 
Texas and Columbia University will explore the biochemistry of 
a brain circuit that appears to make some people more likely 
to become alcoholics; they will also look for ways to apply that 
knowledge to the treatment of the disease. “With new imag¬ 
ing tools to look at brain chemicals, and molecular genetics 
studies, we now have an opportunity to observe broad clinical 
implications from molecular neuroscience,” said John H. Krystal, 
m.d. ’84, hs ’88, the Albert E. Kent Professor of Psychiatry. 
Krystal, the principal investigator on the five-year grant, said it 
will fund the new Center for Translational Neuroscience of 
Alcoholism at Yale. 
et cetera 
CLEAR GUIDANCE ON CONFLICTS 
Since the Bayh-Dole Act of 1980, technology 
transfer has brought thousands of academic 
inventions to the private sector. For almost 
as long, universities have struggled with the 
conflicts of interest that could arise if inves¬ 
tigators held a financial stake in the out¬ 
come of their research. When an Association 
of American Medical Colleges task force 
issued guidelines on conflicts of interest in 
December, it all but ruled out participation 
by scientists who might profit from the 
research. The panel, which included Yale Vice 
President and General Counsel Dorothy K. 
Robinson, urged institutions to presume that 
individuals with a financial interest in a clini¬ 
cal study may not conduct it and to enforce 
that view through close scrutiny of research 
proposals. “Transparency,” the task force 
members agreed,“must be the watchword.” 
COMMUNITY MINDED 
Libraries at the School of Medicine have 
teamed up with the New Haven Free Public 
Library to offer health information to the 
public. Located at the main public library on 
Elm Street and three branches throughout 
New Haven, the Consumer Health Informa¬ 
tion Center (chic) will provide workstations 
with computers, consumer health books 
and access to health resources on the Web. 
The partners in the chic are the public 
library, the School of Medicine, the Harvey 
Cushing/John Hay Whitney Medical Library 
and the Epidemiology and Public Health 
Library. A $43,885 grant from the National 
Network of Libraries of Medicine will fund 
the program for 18 months. 
SIGN OF COMPASSION 
Emotions have a legitimate place in the 
practice of medicine, according to Associate 
Dean for Student Affairs Nancy R. Angoff, 
m.p.h. ’81, m.d. ’90, hs ’93. Writing in jama: 
The Journal of the American Medical Associa¬ 
tion last fall, Angoff reported that of 182 
Yale students surveyed, 133 said they had 
cried at least once during their first year of 
clinical rotations. Thirty had been on the 
verge of crying and only 19 said they didn’t 
cry even once. In her jama essay, “Crying 
in the Curriculum,” Angoff wrote that 
“medical educators who fail to look for or 
listen to stories of crying may be missing 
an opportunity to have an impact on stu¬ 
dents’emotional [development as doctors], 
... We should let [students] know that not 
only is it normal and okay, but it may be a 
sign of a valuable capacity for compassion.” 
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Rounds MEDICINE AND HEALTH AT YALE 
WAR AND ITS IMPACT 
ON AMERICAN HEALTH 
For veterans who witnessed combat, 
there's more to look for than ptsd, 
new analysis of health outcomes finds. 
For American society, the war in Viet¬ 
nam was unlike any other. It spawned 
widespread protests, a questioning 
of the nation’s role in the world and, in 
the medical field, a new diagnosis. 
Society, as well as medicine, recognized 
that soldiers could not go from fire- 
fight to firefight without psychological 
consequences. What had once gone 
by the names “shell shock” and “com¬ 
bat fatigue” got a new name. Post- 
traumatic stress disorder (ptsd) was 
what happened to people who had 
fought for their lives and seen their 
comrades die. But it was just one 
of the many consequences of surviv¬ 
ing battle. 
Years after soldiers came home, the 
ghosts of combat haunted them in the 
form of not only ptsd but also divorce, 
depression, drug and alcohol abuse and 
domestic violence. These lingering 
effects of combat have affected society 
as well as individual soldiers, according 
to epidemiologist Holly G. Prigerson, 
ph.d., fw ’91. How, she asked, do the 
experiences of combat veterans burden 
society as a whole? “No one had looked 
at societal outcomes,” said Prigerson, 
an associate professor of psychiatry and 
of epidemiology and public health. 
Using as her database interviews with 
about 2,500 men between the ages of 18 
and 54 from the 1992 National Comor¬ 
bidity Survey, which examined psychiatric 
FIRST THE STUD, THEN THE SEQUELA 
At last, the news that horrified parents everywhere have been 
waiting for: piercing certain parts of one’s anatomy might not 
be so healthy. Last year, Yale physicians Richard A. Martinello, 
m.d., and Elizabeth L. Cooney, M.D., linked a young woman’s 
brain infection to the tongue-piercing she received a month 
earlier. “The bacteria that caused the abscess in this patient 
were those typically found in people’s mouths,” said Martinello. 
A few days after the piercing, the patient’s tongue was swollen 
and tender and produced a foul-tasting discharge. The symp¬ 
toms cleared up after she removed the jewelry, but a month 
later she presented with headaches, fever, nausea and vomiting, 
and a CT scan showed an abnormality in her brain. Six weeks 
of treatment with intravenous antibiotics led to a full recovery. 
The physicians presented the case at the annual meeting of 
the Infectious Disease Society of America in October. 
disorders in the United States, Prigerson 
focused on the roughly 7 percent who 
had seen combat, mostly in Vietnam. 
“How are these vets doing now?” Priger¬ 
son asked. “The answer is, not very well. 
And these are not just the vulnerable 
few.” Prigerson noted that the survey did 
not single out men who reported prob¬ 
lems stemming from combat. “They just 
asked: ‘Did you witness combat?’” 
The numbers of respondents with 
psychiatric problems and other adverse 
outcomes, Prigerson found, were “really 
huge. We were struck by the magnitude 
of the effects this long after combat.” 
And men who avoided developing ptsd 
were not off the hook: decades later, even 
without suffering from ptsd, combat vet¬ 
erans were significantly more likely than 
noncombatants to lose jobs, to divorce 
and to abuse drugs or alcohol. “Our find¬ 
ings,” said Prigerson, “have important 
implications for the thousands of Ameri¬ 
cans now involved in military strikes 
against Afghanistan. Depending on what 
the soldiers there see and do, their 
lives may be disrupted for longer than 
they may anticipate.” 
Prigersorfs analysis showed that a 
significant portion of societal problems 
could be linked to combat exposure. 
In the year preceding the survey, combat 
veterans accounted for 7.4 percent of 
major depression nationally, 8 percent 
of substance abuse and 27.8 percent 
of ptsd. They accounted for 21 percent 
of current spouse abuse, 8.9 percent 
of unemployment and 7.8 percent of 
current divorce or separation. 
Compared to other men in the 
study, a combat veteran was six times as 
likely to be suffering from ptsd, more 
than twice as likely to be suffering from 
recent major depression or substance 
abuse and more than twice as likely to 
be separated, divorced or unemployed. 
The likelihood that he had lost a job 
in the past year was almost triple the 
norm and that he’d abused his spouse, 
more than quadruple. 
Combat veterans, Prigerson said, 
“have assumed huge risks. Recognizing 
what the outcomes of war are likely to 
be can help policy makers determine 
how to help them reintegrate into soci¬ 
ety as civilians.” When a veteran does 
not show signs of ptsd, she said, “The 
assumption shouldn’t be that every¬ 
thing’s well and good.” 
Results of Prigerson s study appeared 
in the )anuary issue of the American 
Journal of Public Health. Co-investigators 
were Paul K. Maciejewski, ph.d., asso¬ 
ciate research scientist in psychiatry, 
and Robert A. Rosenheck, m.d., hs ’77, 
professor of psychiatry and of epidemi¬ 
ology and public health. 
Exposure to combat scenes such as this, near 
Hue, South Vietnam, in 1968, increases the 
chances of psychological problems and other 
adverse outcomes later in life. "Our findings,” 
said principal investigator Holly Prigerson, 
“have important implications for the thou¬ 
sands of Americans now involved in military 
strikes against Afghanistan.” 
et cetera. 
NO LAUGHING MATTER 
A new study suggests there might be some¬ 
thing to the notion, first proposed by physi¬ 
cians in ancient Greece, that seasonal mood 
swings are caused by “humors.” According 
to Yale investigators, patients with seasonal 
affective disorder (sad) have lower noctur¬ 
nal levels of the bile pigment bilirubin. The 
study is the first scientific investigation 
of circadian levels of bilirubin in the blood 
of people with depression. Psychiatrist Dan 
A. Oren, M.D. ’84, HS ’88, and colleagues 
found that nighttime bilirubin levels were 
lower in nine patients with sad, compared 
to a group of seven healthy volunteers. The 
patient group’s levels of bilirubin increased 
after exposure to a light source, a standard 
therapy for the disorder. The article was 
published in the March 1 issue of the journal 
Biological Psychiatry. 
COCAINE VACCINE ADVANCES 
Scientists at Yale are exploring a new 
method to help cocaine users stay clean and 
sober. A vaccine that produces antibodies 
that dull the cocaine high has been found 
safe in a phase I clinical trial, according to a 
report in the January 15 issue of the journal 
Vaccine. The vaccine, ta-cd, is recommended 
for people who are already trying to kick the 
habit. “We found that the vaccine is safe 
and that there is no significant toxicity,” 
said principal investigator Thomas R. Kosten, 
m.d., hs ’81, professor of psychiatry, who is 
testing the vaccine for Xenova Group pic. of 
Cambridge, England, which owns and is 
developing the compound. Subjects who 
received the highest dosages also produced 
the most euphoria-depressing antibodies. 
A BOOST FROM NICOTINE 
Why do so many patients with schizophre¬ 
nia smoke? It may be because nicotine 
improves one aspect of cognitive function 
and helps compensate for other brain 
impairment associated with schizophrenia. 
“This is one of only a few studies to sug¬ 
gest that nicotine has a beneficial effect on 
spatial working memory, which is known 
to be impaired in schizophrenic patients,” 
said principal investigator Tony P. George, 
M.D., who published findings in the journal 
Neuropsychopharmacology in January. 
Smokers without schizophrenia did not 
show an improvement in spatial working 
memory, and in fact, nonschizophrenic 
smokers had an impairment of this cogni¬ 
tive function, which improved when they 
quit smoking. 
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Findings from the bench 
A LIVELY DEBATE ABOUT 
THE BRAIN’S CAPACITY 
FOR RENEWAL 
Two competing views of neurogenesis 
are played out in the pages of Science. 
Neurogenesis, an arcane and complex 
issue, has leaped out of scientific jour¬ 
nals and conferences in the last few 
years to land in the pages of newspapers 
and magazines, including Newsweek 
and The New Yorker. 
The source of this growing interest is 
an ongoing debate over the brain’s abil¬ 
ity to generate new neurons in the cor¬ 
tex. Pasko Rakic, m.d., ph.d., the Dorys 
McConnell Duberg Professor of Neuro¬ 
science and chair of the Department of 
Neurobiology, believes that the neocor¬ 
tex of primates, including humans, gets 
« J 
its lifetime share of neurons during 
development and shortly after birth. 
Elizabeth Gould, ph.d., a professor 
of psychology at Princeton, has pub¬ 
lished studies asserting that primates 
generate neurons in the neocortex well 
into adulthood. 
The two camps have reached such 
different conclusions using largely the 
same experimental design, but with 
variations in their techniques and crite¬ 
ria for identifying new cells. Each publi¬ 
cation on the topic rekindles the debate. 
Rakic fired the latest salvo in the 
December 7 issue of Science when, 
with colleague David R. Kornack, ph.d., 
his former postdoc who is now at the 
University of Rochester, he reported 
that Gould had indeed found new cells 
in the neocortex. They simply weren’t 
neurons. Instead, reports Rakic, Gould 
mistook glial and endothelial cells 
for neurons. 
“Our study shows that neurons of 
the cerebral cortex are created in a 
precise sequence during restricted peri¬ 
ods of development before birth and 
during the neonatal period,” Rakic said. 
“Therefore we have to live our entire 
lives with the cortical neurons we are 
born with.” 
With a preponderance of evidence in 
its favor, this view has dominated study 
of the brain since the 1980s, when Rakic 
published his findings after conducting 
lengthy studies of macaque monkeys. 
Subsequent studies with new labeling 
techniques found evidence of neurogen¬ 
esis in other parts of the mammalian 
brain—the hippocampus and the olfac¬ 
tory bulb. But neurogenesis in the neo¬ 
cortex remains a controversial topic. 
A LINK FROM SLEEP TO PAIN 
A neuropeptide whose absence may be a factor in sudden 
sleep attacks also appears to modulate pain. A team that 
included Anthony N. van den Pol, ph.d., professor of neurosurgery 
at Yale, and colleagues at the University of North Carolina, 
found that hypocretin neurons provide a biochemical link from 
the hypothalamus—which regulates eating, drinking, sleep¬ 
ing, waking, body temperature, chemical balances, heart rate, 
hormones, sex and emotions—to the spinal cord. “We found 
that most cells in a region of the spinal cord responsible for 
detecting pain (pictured at left) show a significant physiological 
response to the peptide hypocretin-2,” said van den Pol, a co¬ 
author of the study published in the January issue of the 
Journal of Physiology. New drugs related to hypocretin, which 
plays a role in narcolepsy, could help in the treatment of pain. 
Gould insists she has found new 
neurons in the cortex. Like Rakic, she 
used the thymidine analog BrdU, 
along with other markers that would 
stain new cells. And she said she has 
factored in the possibility of false posi¬ 
tives. When viewed through a confocal 
microscope and rotated, she said, it’s 
clear that the cells she found are neu¬ 
rons. Rakic counters that BrdU labeling, 
although essential to identify new 
cells, is not by itself sufficient evidence. 
“Incorporation of BrdU may also occur 
during dna repair, cell degeneration 
and during cell death,” he said. And 
large and multiple injections of BrdU 
may also induce dna synthesis, he said. 
“There are lots of reasons there 
could be a discrepancy in the findings,” 
Gould said. “We don’t go about it in 
the same way. Our histological tech¬ 
niques differ. Our animals could have 
different experiences.” Stress, for 
example, limits production of neurons, 
while a stimulating environment 
encourages it, she said. 
It is also unclear what function, if 
any, the new neurons may have in the 
neocortex. Gould notes that the cortex, 
which is associated with higher func¬ 
et cetera. 
BLEACH, WATER AND HIV 
Although proven effective in preventing the 
spread of hiv, needle exchange programs 
remain unfunded by the federal govern¬ 
ment, largely for political reasons. Yale sci¬ 
entists, whose earlier work was fundamen¬ 
tal in proving the efficacy of needle 
exchange, reported recently that in a worst- 
case scenario in which sterile syringes are 
not available, rinsing syringes with a bleach 
solution or even plain water can provide 
effective protection against infection. “We 
found that for the type of syringe usually 
used by drug injectors, a solution of bleach 
and nine parts water disinfects the syringe if 
the solution is drawn in and squirted back 
out twice,” said Robert Heimer, ph.d., asso¬ 
ciate professor of epidemiology and phar¬ 
macology and principal investigator of the 
tions, is very large. The number of 
new neurons she has found is so small 
relative to the total number that their 
impact may be minimal. Indeed, she 
said, the generation of new neurons 
might be a vestige of a developmental 
process that was never turned off. 
But what Gould sees as a very small 
number is, to Rakic, “staggering.” To 
accommodate these new neurons, Rakic 
said, the brain would have to grow or 
kill off existing neurons. Rakic said he 
has found evidence of neither. 
He also believes that neurogenesis 
in the neocortex makes no functional 
or evolutionary sense. Early in their 
evolution humans traded the ability to 
grow new neurons, as seen in fish, 
amphibians and reptiles, for the ability 
to retain memory in existing neurons, 
he said. “We use neurons to store our 
life experiences and if we change neu¬ 
rons every season like male canaries 
do, then we would lose a lot of our life 
experiences,” Rakic said. “Neurogenesis 
in the neocortex could eliminate cru¬ 
cial, learned cognitive functions and 
long-term memories. We have to learn 
how to preserve our neurons during 
disease and natural aging.” 
study, published in the December issue of 
the Journal of Acquired Immune Deficiency 
Syndromes: JAms.“\Ne found that rinsing 
three times with clean water reduced the 
likelihood of recovering live virus by 99 per¬ 
cent.” While not absolutely protective 
against hiv, Heimer said, “these measures 
reinforce the adage that prevention is never 
perfect and never ending.” 
Experiments by Pasko Rakic more than 
a quarter-century ago laid the foundation 
for current thinking about the brain’s 
ability to grow new neurons. 
COCAINE AND THE FETUS 
When pregnant women use cocaine, their 
offspring may suffer permanent harm 
to an area of the brain that governs short¬ 
term memory, leading to learning impair¬ 
ments and symptoms resembling attention 
deficit disorder. According to two recent 
animal studies by Yale scientists Bret A. 
Morrow, ph.d., John D. Elsworth, ph.d., and 
Robert H. Roth, ph.d., the effects are mani¬ 
fest in the prefrontal cortex. “Children 
exposed to cocaine in the womb may have 
a problem inhibiting excitable neurons in 
the part of the brain that helps control 
attention and memory,” said Morrow, asso¬ 
ciate research scientist, associate clinical 
professor and lead author of both studies, 
published in February and March in the 
journals Behavioral Brain Research and 
Neuropsychopharmacology, respectively. 
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Books 
CONNECTICUT On the Other Side 
. {Africa*. Slwriaoti 
* cell ojTHadha. 
HOWTO 
KEEP YOUR 
HUSBAND 
Accessible Connecticut: 
A Guide to Recreation for 
Children with Disabilities 
and Their Families 
by Nora Ellen Groce, ph.d., 
associate professor of public 
health and anthropology, 
Lawrence C. Kaplan, m.d., 
and Josiah David Kaplan 
Yale University Press 
(New Haven) 2001 
This guide helps parents of chil¬ 
dren with disabilities plan family 
outings in Connecticut that are 
stimulating and fun. Intended for 
parents of youngsters who use 
wheelchairs or who have visual, 
hearing or mental impairments, 
the book presents places through¬ 
out the state that are easily acces¬ 
sible and reasonably priced and 
that require little or no prior plan¬ 
ning. For each place or activity the 
authors list location, directions, 
phone numbers, Web information, 
hours, admission fees, a brief 
description and an assessment of 
accessibility by type of disability. 
Joining the Club: 
A History of Jews and Yale, 
revised edition 
by Dan A. Oren, m.d. ’84, 
hs ’88, associate professor of 
psychiatry 
Yale University Press 
(New Haven) 2001 
Using archival records and inter¬ 
views, Oren, a Yale graduate now 
at the medical school, has pro¬ 
duced a thoroughly researched 
account of the Jewish experience 
at Yale from the first Jewish grad¬ 
uate in 1809 to the present. Not 
only does he chronicle the history 
of Jews at Yale, but he compares 
it with the experiences of other 
minorities at Yale as well as the 
saga of Jews at other elite schools. 
The discriminatory quota system 
and other problems that Jews in 
American higher education faced 
during much of the 20th century 
are well documented. 
An Elementary Textbook of 
Ayurveda: Medicine with a Six 
Thousand Year Old Tradition 
by Frank John Ninivaggi, m.d., 
assistant clinical professor in 
the Child Study Center 
International Universities 
Press Inc. 
(Madison, Conn.) 2001 
The author presents the first 
scholarly description of the origins, 
development and theories of 
Ayurveda (Sanskrit for life wis¬ 
dom), a traditional Hindu system 
of medicine. One of the oldest 
extant organized bodies of med¬ 
ical knowledge, Ayurveda is 
emerging as a leader in the field 
of complementary medicine. The 
concept of the person as a bio¬ 
psychospiritual, integrated field, 
who is in responsive, dynamic 
interaction with other persons as 
well as with nature, is introduced, 
and its implications for health 
and disease are explored. 
On the Other Side: African 
Americans Tell of Healing 
by Alita Anderson, m.d. ’01 
Westminster John Knox Press 
(Louisville, Ky.) 2001 
On the Other Side is a collection of 
oral narratives and original art¬ 
work by the author that presents 
the story of a diverse group of 
speakers who have one thing in 
common—a profound experience 
with the power of healing. The 
narratives are woven together 
with the verses of African- 
American spirituals that punctu¬ 
ate each story. 
How to Keep Your Husband 
Alive: An Empowerment 
Guide for Women Who Care 
about Their Man’s Health 
by Siegfried J. Kra, m.d., 
associate clinical professor 
of medicine 
Lebhar-Friedman Books 
(New York) 2002 
In a new approach to men’s health, 
Kra explores the manner in which 
women can help to prolong the 
life span of their mate. Kra encour¬ 
ages women to develop simple 
communication techniques for 
nudging their man to seek med¬ 
ical attention when warning signs 
such as fatigue, weight gain or 
loss and changes in breathing pat¬ 
terns and alcohol use are evident. 
In clear and direct language, Kra 
offers a guide for women to the 
appropriate questions to ask and 
the relevant tests to request 
once their mate has scheduled 
that first appointment. 
Primer on International 
Health 
by Robert W. Buckingham, M.D., 
DR.P.H. '78 
Benjamin Cummings 
(San Francisco) 2000 
This book addresses the process 
of sharing knowledge of inter¬ 
national health among colleagues 
and students, a process that 
Ground Beetles 
of . 
Connecticut 
becomes more important as 
commerce and international travel 
accelerate both the globalization 
of human life and the pace of 
human and disease interactions. 
Buckingham and his co-contributors 
cover issues including global envi¬ 
ronmental health, primary care, 
malnutrition, maternal and child 
health, comparative national health 
care systems, epidemiology and 
the future of international health. 
Ground Beetles of 
Connecticut (Coleoptera: 
Carabidae, excluding 
Cicindelini): An Annotated 
Checklist 
by William L. Krinsky, m.d. ’71, 
and Michael K. Oliver, ph.d. '84 
Connecticut Department 
of Environmental Protection 
(Hartford, Conn.) 2001 
With the information presented in 
this book on their occurrence and 
distribution, carabids become the 
best-known beetle family in Con¬ 
necticut in terms of species-level 
distribution and historical records. 
The diversity of habitats in which 
carabids occur and the large num¬ 
ber of species that exist provide 
the basis for the use of this group 
of beetles as a significant indica¬ 
tor of changes in the environment. 
The descriptions above are based on 
information from the publishers. 
SEND NOTICES OF NEW BOOKS TO 
Cheryl Violante, Yale Medicine, 
P.O. Box 7612, New Haven, CT 
06519-0612, or via e-mail 
to cheryl.violante@yale.edu. 
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Immersing himself 
in Cushing’s “harem” 
Out of earshot, the women who 
worked for Harvey W. Cushing, 
m.d., referred to themselves as “the 
harem.” The “chief,” said Cushing 
biographer Michael Bliss, ph.d., 
would not have been amused. 
In a talk in the Historical 
Library of the Cushing/Whitney 
Medical Library in February, Bliss, 
a historian at the University of 
Toronto and biographer of William 
Osier, said Cushing enjoyed a 
decidedly professional relation¬ 
ship with his female staff and 
was less than tender as a boss. He 
paid the women who worked as 
secretaries, histologist and pho¬ 
tographer low wages and worked 
them long and irregular hours. 
He dictated up to 10,000 words a 
day, expected a high level of 
performance and seldom thanked 
anyone. Yet he also offered perks 
such as coveted football tickets, 
invitations to his home and even 
trips to Europe. 
The most devoted of his assis¬ 
tants was Madeline Stanton, 
who followed him from Harvard 
to Yale, where she became direc¬ 
tor of the Historical Library. In one 
of her journal entries, Stanton 
wrote, “I shall be miserable, I am 
sure, if i ever have to work with 
anyone else.” Bliss’s biography of 
Cushing is due out in 2006. 
In genomics, the end 
of the beginning? 
At the very least, the Human 
Genome Project was a technical 
and scientific challenge; it’s 
no simple matter to sequence 
3 billion pairs of dna, as the 
project’s public consortium set 
out to do in 1990. But the solu¬ 
tion to the puzzle was in many 
ways not a technical one, Robert 
L. Nussbaum, m.d., said in a visit 
to the medical school in January. 
"It became very clear early on 
that this project was never going 
to work unless everyone did 
just a few things over and over 
again, really, really well,” said 
Nussbaum, chief of the genetic 
disease research branch at 
the National Human Genome 
Research Institute. “It was the 
introduction of management and 
organizational techniques from 
outside of science that probably 
made the biggest difference.” 
Nussbaum said a debate is now 
brewing within the institute on 
whether to declare the project 
over next April, an even 50 years 
after Watson and Crick’s descrip¬ 
tion of the double-helix struc¬ 
ture of dna, by which time it is 
believed the final sequence will 
be assembled."Should we declare 
it complete in 2003 and pack 
up and go home? Some say yes,” 
he said. “The others take the more 
Churchillian view that this is 
neither the end, nor the begin¬ 
ning of the end, but rather the 
end of the beginning—that we 
have now launched a whole 
new field called genomic science, 
and let’s get started.” 
Nurse warns against 
repeating Tuskegee abuses 
The last living health care pro¬ 
vider involved in the infamous 
Tuskegee experiment, which fol¬ 
lowed African-American men 
with syphilis for 40 years while 
withholding treatment from a 
fraction of the cohort, warns that 
the American public needs to 
remain alert to comparable 
abuses that still exist.“I’m con¬ 
cerned that this is still going on,” 
said Mary Starke Harper, r.n., 
ph.d., a student nurse during the 
research at the Tuskegee Institute 
in Alabama. She spoke of her 
experiences on February 18 as 
part of the Black History Month 
commemoration at the School 
of Nursing. Harper, 82, known 
nationally and internationally 
as a patient-care advocate and 
research consultant in geriatric 
psychiatry, said that neither 
she nor the two registered nurses 
with whom she worked at the 
time knew which patients were 
in the experimental control group. 
The study became a symbol of 
racism in medicine, ethical mis¬ 
conduct in human research and 
government abuse of the vulnera¬ 
ble, and led to the National 
Research Act of 1974. 
The world’s biggest country, 
and biggest market 
If you wanted to find one place 
with some of the thorniest 
issues confronting biotechnology, 
you’d need look no further than 
China. With more than a fifth 
of the world’s people living inside 
its borders, China has an enor¬ 
mous market for food and drugs, 
as well as an emerging biotech 
industry and venture capitalists. 
And it faces serious problems 
as it applies biotechnology to 
agriculture and pharmaceuticals. 
The country’s pharmaceutical 
industry lacks original discov¬ 
eries in its portfolio and, said 
Zhangliang Chen, ph.d., director 
of China’s National Laboratory 
of Protein Engineering and Plant 
Genetic Engineering, "You have 
20 companies producing the same 
drug.” In a talk in December spon¬ 
sored by the Peking-Yale Joint 
Center for Plant Molecular Genet¬ 
ics and Agro-biotechnology, 
Chen said China is also producing 
genetically modified foods— 
which he believes to be the most 
efficient way to produce food 
in poor countries, despite contro¬ 
versy over their safety. “If we 
use organic agriculture in China,” 
he said, “many people are going 
to die because of starvation.” 
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Anatomy of an insurrection 
Grave robbing wasn’t something a Yale man did By Rachel Engers 
in the early 19th century—unless he was in medical school. Illustration by Ken Perkins 
Early on the morning of January 12,1824, 
Jonathan Knight, Yale’s first professor 
of anatomy and physiology, received a 
startling piece of news. During the night, 
a body had been snatched from a fresh 
grave in the West Haven burying 
ground and the incensed townspeople 
were pointing fingers at the college. 
Some suspicion of the medical stu¬ 
dents was justified. Grave robbing by 
anatomists was still common in America 
at the beginning of the 19th century— 
for contrary to the practice in Europe, 
there was no legal way to obtain cadavers 
for medical study. One reason was the 
deeply ingrained prejudice against the 
work of anatomists. The inhabitants of 
New Haven “were the direct inheritors 
of a flourishing Puritan tradition that 
naturally fostered strong religious feel¬ 
ings,” wrote Yale historian Hannibal 
Hamlin in his account of the incident. 
"Their respect for the sanctity of the 
sepulcher bordered on superstition. 
The Doctor of Physic was held in high 
esteem; but the dissection of a cadaver 
by the surgeon or anatomist was, 
in general, considered a nefarious and 
unmentionable business.” 
A search began for the missing 
body of Bathsheba Smith, “a respectable 
young female of nineteen” and the 
daughter of a local farmer. The West 
Haven burough constable, Erastus 
Osborn, was dispatched immediately 
to the college. His account of discover¬ 
ing the corpse in the medical school 
building at Grove and College streets 
appears in a letter to his father, quoted 
below with its irregular spelling intact: 
“We came to a place in the pave¬ 
ment (the Cellar being paved with large 
flat stones) which lookd generally like 
the bottom of the Cellar throughout, but 
appeard to have a trifle of fresh dirt 
lying scatterd about... 1 scratchd with 
the end of my walking stick and the 
more I examind the more suspicion 
was created. We soon found the earth 
appeard fresher between the stones 
& finally took up a large flat stone where 
we discovered a white bundle, appar¬ 
ently a bundle of cloathes. We examind 
it & found a human body doubled up 
in a heap entirely coverd up with grave 
cloathes. We took it out and it was 
immediately known to be the body of the 
young woman we were searching for.” 
Not since the British invaded New 
Haven in 1779 had the townspeople 
been so incensed, Elizabeth H. Thom¬ 
son wrote in her unfinished history 
of the School of Medicine. The scandal 
stirred up such a ferocious anger that 
a mob of some 600 men armed with 
pistols, clubs and daggers stormed the 
On the night of January 12,1824, the Governor’s 
foot guard, armed with bayonets, swords 
and rifles, assembled on the New Haven Green, 
ready to quell a furious mob assaulting the 
medical school, which was then located on 
Grove Street. Earlier that day, a body missing 
college at nightfall. The authorities 
read the state’s Riot Act several times, 
but the crowd kept pelting the building 
with stones and shouting “tear down 
the college” and “death to the students.” 
Those inside feared the mob would 
batter down the walls. Justus D. Wilcox, 
a medical student who witnessed the 
attacks, gave this account of the escalat¬ 
ing attacks in a letter: “[At nearly mid¬ 
night] the Governor’s foot guards were 
called out. They assembled on the 
green, each man provided with sword 
and bayoneted gun, with ball and 
cartridge; they marched at quick step 
to the Medical college inspired [by] 
fife and drum which beat the revelle, 
and sounded the notes of war." 
During the investigation, sensational 
newspaper headlines (“Another Grave 
Plundered!”) fanned the fury and gos¬ 
sips spun some outlandish tales about 
from the West Haven burying ground had been 
found in a medical school building at Grove 
and College streets. With no legal means of 
acquiring cadavers for the study of anatomy, 
medical students of the era sometimes resorted 
to grave robbing. A Yale medical assistant was 
the medical school. In later years, one 
rumor held that the institution had 
been purposely sited near the Grove 
Street cemetery so that bodies could be 
easily stolen, and some even speculated 
that an underground tunnel linked 
the basement of the building and the 
graveyard. But in 1824, that cemetery 
was as yet unbuilt. 
While the New Haven dissection 
riots of 1824 are certainly a strange 
chapter in the history of the medical 
school, Yale was by no means alone. 
Despite epidemics of cholera, smallpox 
and other diseases, the general public 
had little appreciation for the work 
of anatomists. In fact there were violent 
attacks at medical institutions around 
the country, including the deaths of 
seven people in the New York “Doctor’s 
Mob” of 1788 and riots at Wiesenthal’s 
School in Baltimore. 
scapegoated, paid a fine of $300 and served 
nine months in jail. A subsequent act of the 
state legislature made the bodies of those 
who died in prison or were executed available 
“to be used for the purpose of advancing 
medical science.” 
A Yale medical assistant named 
Ephraim Colborn was scapegoated for 
the plundering of Bathsheba Smith’s 
grave. Although there were no witnesses 
against him, he was found guilty of the 
crime, fined $300 and sentenced to nine 
months in jail. Soon thereafter, Con¬ 
necticut passed an act that established 
more severe penalties for grave rob¬ 
bing and made it legal for the bodies of 
those dying in prison and those cap¬ 
itally punished “to be used for the pur¬ 
pose of advancing medical science.” 
This landmark legislation, well ahead of 
that in other states and preceding the 
Warburton Anatomy Act of 1832 in Eng¬ 
land by eight years, helped bring about 
progress in medical teaching both at 
Yale and in Connecticut. 
Rachel ENGERSisa writer in Bedford, N.Y. 
ken perkins is an artist in Broomfield, Colo. 
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Reinventing surgery 
Surgery Chair Robert Udelsman 
looks up from the operating 
table during a procedure at 
Yale-New Haven Hospital in late 
February. At Johns Hopkins, 
where he was chief of endocrine 
surgery, Udelsman pioneered 
minimally invasive techniques 
for removing the thyroid and 
parathyroid. 
Robert Udelsman left one of the busiest medical centers on the planet to lead Yale’s Department 
of Surgery out of its doldrums and into national prominence. He’s a man on a mission. 
By Cathy 5 h afro 
Photographs by Gale Zucker 
Third-year medical student Jennifer Schutzman was acing 
the middle-of-surgery quiz administered by Robert Udelsman, 
m.d., m.b.a. She had already correctly described the three 
causes of primary hyperthyroidism, listed the three veins and 
two arteries that supply blood to the thyroid gland, and 
named the two main vocal cord nerves near it—all while hold¬ 
ing a retractor steady on either side of a small opening in 
the patient’s neck. As Udelsman and third-year resident Steven 
Williams, m.d., probed and cut their way toward the patient’s 
diseased thyroid, Udelsman threw his medical student a curve: 
What famous 20th-century opera singer had undergone 
thyroid surgery with disastrous results? 
Schutzman was silent. 
“Amelita Galli-Curci,” Udelsman told her. “In 1935, the story 
goes, Dr. Arnold Kegel removed a goiter, and in a single day, 
two careers were forever changed.” 
Schutzman knew her anatomy well enough to understand 
what Udelsman implied: the surgeon had cut an important 
nerve controlling the vocal cords. By cutting the nerve, the sur¬ 
geon had damaged both Galli-Curci’s voice and his own 
reputation. That was the nerve that Udelsman and Williams 
were painstakingly protecting during this thyroidectomy. 
In telling the story, which he’d heard from his mentor 20 
years before, Udelsman was continuing the tradition of passing 
on knowledge to a new generation of surgeons. Yale’s new 
chief of surgery is always teaching. In the operating room, he 
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peppers residents with questions, coaching them as they 
cut and telling them stories that teach anatomy. When 
another surgeon steps into the OR to say hello, Udelsman 
explains his minimally invasive approach to parathyroid 
surgery, in which the parathyroid gland is removed while the 
patient is awake. (It’s an innovation that allows the patient 
to go home the same day, leaves a scar on the neck that’s 
only an inch long and cuts hospital fees in half.) Outside the 
operating room, Udelsman remains a teacher—presenting 
cases at the standing-room-only grand rounds in Hope 
216 (attendance is mandatory), painstakingly describing to 
patients what will happen during surgery and explaining 
to house staff why white coats are required in the lunch line 
(scrubs are unprofessional). In all of this, Udelsman is 
perhaps even more intense and focused than your average 
intense and focused surgeon. 
It’s nothing new for a department chair to guide young 
surgeons and to help senior staff keep current. But Udelsman 
is on a mission. In his soft-spoken, persistent way, he is 
determined to help transform surgery at Yale. He aims to help 
make Yale, long known as a research powerhouse, into one of 
the world’s top clinical centers as well. Udelsman came to New 
Haven last June to head a department that, despite a distin¬ 
guished past and many strengths, does not have a national rep¬ 
utation and hasn’t turned a profit for several years. Recruited 
from Johns Hopkins, where he helped develop the new tech- 
top Udelsman listens to a 
colleague while waiting for a fax 
in the small office that serves 
as the hub of the operating suite 
at Yale-New Haven. The day’s 
schedule is posted on the board 
to his left. He’s determined 
to make the OR run as smoothly 
as possible; time wasted due 
to inefficiencies is a drag on the 
system and an obstacle to good 
patient care, above After remov¬ 
ing a diseased thyroid, Udelsman 
sketches the anatomy and makes 
notes about the case, opposite 
He reports on the outcome of the 
surgery to the patient’s husband 
in the waiting room. 
'9 
niques for parathyroid surgery and made laparoscopic adrena¬ 
lectomy standard, Udelsman says he wants Yale to become the 
kind of innovative and profitable surgical center that he left 
behind in Baltimore. 
“The Mayo Clinic, Johns Hopkins, the Cleveland Clinic. 
That’s the level we want to play at,” says Udelsman. “I do not 
view our referral base as southern Connecticut. Our referral 
base is the world.” 
“IF MRS. JONES CAN’T PARK ... ” 
Udelsman believes Yale will draw patients from far away if 
they hear that it is simply the best in certain specialties. 
Udelsman [pronounced You-delsman] is still getting to know 
a department with 300 employees in 13 sections running the 
gamut from trauma to transplantation, otolaryngology to 
urology. He already has a few ideas for what Yale’s areas of sur¬ 
gical excellence should be: kidney transplantation and perhaps 
surgical oncology and heart surgery. “You don’t have to be great 
at everything. You have to be spectacular at some things. It 
doesn’t even matter what they are,” he says. He will strengthen 
research that complements key surgical subspecialties, though 
research is already strong; Yale surgery ranks seventh in the 
nation in funding from the National Institutes of Health. 
The breast center Udelsman imagines exemplifies the kind 
of comprehensive care he wants Yale to provide. It would offer 
diagnostic and therapeutic radiology, surgery, chemotherapy 
and counseling, all in one place—and fast. “In a typical sce¬ 
nario, a woman has an abnormal mammogram, and she 
thinks she has breast cancer and that she's going to be dead in 
three years. What women want is service, and they want that 
service in 24 hours or less. It can’t be you’re called [about an 
abnormality] and two weeks later, you get an appointment." 
Udelsman is determined to make sensitivity to the patient’s 
experience central to the jobs of medical center staff—the 
first priority for nurses, facilities planners, doctors and custodi¬ 
ans alike. He tells the galling story of a woman who drove 
hours to reach New Haven for a scheduled appointment and 
was told to return the next week because the doctor wasn’t 
there. Inconvenient parking and shabby buildings convey a 
similar message, says Udelsman. “You can be as empathetic as 
you want, but if Mrs. Jones can’t park, then she can’t come to 
the clinic and the whole system breaks down. If there’s dirt in 
the hallways at the medical center and no one cleans it, the 
message is, we don’t care. If the phone is answered by voice 
mail, we don’t care.” 
Ralph I. Horwitz, m.d., hs ’77, says Udelsman’s focus on 
patients is right on target. “We have not made quality 
of clinical care a strong-enough focus of the institution,” says 
Horwitz, chair of the Department of Internal Medicine and 
head of the search committee that nominated Udelsman. 
“I think Rob is going to focus the attention of the entire med¬ 
ical center on clinical care.” 
Reinventing surgery 
Udelsman also contends that clinical medicine at Yale won’t 
thrive until the medical school and Yale-New Haven Hospital 
cement a partnership that is truly based on a common vision. 
“They are not,” he said, “competing institutions.” 
His chief of cardiothoracic surgery, John A. Elefteriades, 
m.d. ’76, hs ’83, said in December that he had already 
seen dramatic changes in Udelsmaris first months as chair. 
“The department is already revitalized by his arrival. It’s 
palpable in many different ways. He clearly has great determi¬ 
nation, energy and insight, and 1 think everyone feels that. 
The weekly grand rounds is revitalized, there's active recruit¬ 
ment to fill needs the department has had for a long time 
and there’s a general sense of energy and direction and forward 
momentum. 1 think that’s all new,” said Elefteriades, an expert 
on aneurysms and cardiac arrhythmias who has spent his 
career at Yale. “I can feel that Rob is committed with every 
fiber of his body to making this the best academic department 
that he possibly can. He’s very savvy in terms of the finances 
of running a department. In this era, that’s critically important, 
because all the fat has been trimmed from reimbursements.” 
Elefteriades reads Udelsman correctly where finance is con¬ 
cerned. Udelsman thinks constantly about efficiency, school¬ 
ing those around him to understand an operating room as 
a profit center. “We’re a nonprofit organization, but that doesn't 
mean we don’t have to be profitable,” he says. “At the end of 
the day, if we can’t balance our books—if we’re spending more 
than we’re taking in—we're going to have to close the doors.” 
Udelsman even campaigns for fiscal efficiency on the fly. 
He had just completed a thyroidectomy one morning when he 
was told that his patient could not be moved to the recovery 
room; it was filled with overflow patients from intensive care. 
above and opposite Preparing 
for surgery and making the first 
incision, Udelsman is in his ele¬ 
ment: "Surgery is fun. You get to 
fix things. It’s a technical tour de 
force. If you ask surgeons what 
the best part of their day is, it’s 
when they’re in the OR.” 
Udelsman quietly fumed. With the operating room now 
serving temporarily as a recovery room, the next case could not 
begin. Doctors, nurses and technicians were being paid to 
mark time. Patients anxiously awaiting surgery would wait 
longer. As he headed up the hall to visit three patients—two in 
line for surgery and one recovering—Udelsman buttonholed 
the nursing director for perioperative services. Had she 
informed anyone of the bottleneck? Yes, the associate medical 
director. Had she also written to the hospital’s chief of staff? 
No, she hadn’t. Udelsman asked her to write to him about the 
wasted time. 
As he walked briskly away down the hall, Udelsman turned 
back and called to her; “I want so many letters on his desk, he 
goes nuts!” 
Until a few years ago, high finance for Udelsman had been 
limited to buying a house and car. Then he went back to 
school at night, earning a master’s degree in business adminis¬ 
tration and another in business in medicine at Hopkins. “I 
don’t want some administrator running circles around me, 
someone who has no concept of what it is to be a surgeon run¬ 
ning the show.” Udelsman now knows enough about profit- 
loss statements, spreadsheets and business plans to guide a 
department with an annual budget of $40 million. 
Efficient billing is so important—“the blood of our sys¬ 
tem”—that Udelsman wants same-day billing. “I want a billing 
and collections person right in the OR,” he joked. In one 
sense, he means that literally: he invited clerks from billing to 
gown up and witness surgery "so they can experience the 
magic of what we do.” 
Pat Napoletano watched Udelsman and a resident operate. 
“We deal with pieces of paper. We don’t deal with the patients,” 
she said, adding that what struck her most about her experi¬ 
ence in the OR was “seeing the enjoyment they get out of help¬ 
ing someone." 
That is precisely how Udelsman views surgery. “Surgery 
is fun. You get to fix things. It’s a technical tour de force. 
If you ask surgeons what the best part of their day is, it’s when 
they’re in the OR, by far. ... There are few things in medicine 
where we can so dramatically change a person’s life. Diabetes 
gets a little better or a little worse, hypertension gets a little bet¬ 
ter or a little worse. In surgery, in a half-hour or an hour inter¬ 
val, a patient comes out a different person than they went in.” 
“IF YOU CAN’T CUT, YOU’RE NOT PART OF THE CROUP” 
The evolution from surgical acolyte to priest is gradual, says 
Udelsman. When young surgeons face a decision, they 
ask themselves, “What would so-and-so have done in this situa¬ 
tion?” For every surgeon, there eventually comes a day when 
“there’s no one to ask. There’s no one better at this than 
you. That is a maturational moment when you really are on 
your own.” Now that he is a mentor himself, Udelsman trains 
surgeons in part by quizzing his assistants, by telling stories, 
“by teaching them the tricks.” Udelsman hopes that the sur¬ 
geons he and his colleagues train “will always hear our voices.” 
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Reinventing surgery 
He schedules two days a week in the operating room and 
wants to increase it to three, both because he enjoys surgery 
and because his reputation depends on it. “As a chairman, 
it’s very important for me to operate. I’m in the trenches like 
everyone else. My colleagues, the nurses, the medical stu¬ 
dents—everybody is testing my skills every day. If you can’t 
cut, you’re not part of the group.” 
Elefteriades made a similar observation: “If a chairman 
is simply an administrator, he doesn't gain the respect that he 
does if he is up there at the plate along with the faculty he’s 
leading. Rob is not only up there, but he is an extremely 
accomplished, respected and experienced clinical surgeon.” 
Udelsman is fascinated by what he calls “the operating 
culture. It’s very much a ‘captain-of-the-ship,’ military model.” 
Surgeons may feel frustrated when they find they can’t recreate 
this system outside of the hospital. “When a surgeon goes 
home to their family, they want structure,” says Udelsman. He 
says his wife, Nikki (oan Holbrook, ph.d., a distinguished cell 
biologist at the medical school, will jokingly call his bluff when 
he tries to apply the surgical model at home in Woodbridge. 
“My wife certainly has said, Tm not your scrub tech! Forget it!”’ 
He brings his life as a surgeon home. “I never let go of 
the hospital. I carry the hospital with me.” His children— 
eight-year-old daughter Kelly and sons Andrew, 13, and Brooks, 
14—have a general idea of what’s going on at the hospital. 
One of the boys will answer the phone and tell his father, “Oh 
no, so-and-so’s got another calcium problem.” Last Halloween, 
Udelsman had to cut short trick-or-treating to return to the hos¬ 
pital for an emergency, to the disappointment of a small witch. 
In surgery things do go wrong. Surgeons have a long 
tradition of gathering to examine their failures, a weekly mor¬ 
bidity and mortality meeting that “has almost religious 
Udelsman compares Yale’s clin¬ 
ical mission to those of the Mayo 
Clinic, Johns Hopkins and the 
Cleveland Clinic and aspires to 
raise the medical center’s profile 
to the same level. “I do not view 
our referral base as Southern 
Connecticut,” he says. “Our refer¬ 
ral base is the world.” 
connotations. ... We publicly discuss our worst problems. 
It takes on an almost confessional aspect. We take our failures 
very seriously. People do die. You have to ask: Was that a 
preventable death or not?” 
Udelsman moderated when about 40 physicians met for 
the general surgery morbidity and mortality meeting in Fitkin 
Amphitheater recently. Residents reported on problems with 
patients: one who developed a postoperative clot in his heart, 
another whose hand was mysteriously burned during surgery. 
For each case discussed, the doctors proposed various ways 
the complications might have been handled. Udelsman orches¬ 
trated the exchanges, occasionally complimenting a resident, 
repeatedly asking leading questions: Why is it that using a gas- 
trograffin enema may be therapeutic as well as diagnostic? 
What treatment is available for an obstructed gall bladder in a 
patient too weak for surgery? 
Udelsman talked about a close call with his own patient, 
who had developed a rare bleed following removal of cancer¬ 
ous lymph nodes. A few hours after surgery, the man’s 
neck had swelled, a sign of internal bleeding that could block 
his airway. Udelsman rushed the patient back to the OR 
and found the source of the bleed. The patient recovered. 
"WHY YOU, I DON’T KNOW” 
The most intense and exhausting work of Udelsmarfs week is 
clinic. Patients referred to Udelsman usually have compli¬ 
cated cases. He reviews their histories, explains illnesses, 
describes surgeries, confers with family members and reas¬ 
sures patients. He leans forward, one foot tapping, while the 
clock ticks. He pretty much keeps to his schedule, doing 
a biopsy, calling a colleague in another hospital, scrutinizing 
mri films, seeing one patient after another ushered in—and 
out—by Patricia I. Donovan, R.N., who came with Udelsman 
from Hopkins to be the department’s manager of patient 
care and quality assurance. 
Among the patients at a recent clinic, the last faced the most 
serious illness. The man, a musician in his 30s, hadn’t expected 
to be back; Udelsman had removed one lobe of his thyroid 
three weeks before in what is usually a curative procedure. But 
the pathologist had diagnosed medullary cancer, a rare thyroid 
cancer that spreads quickly. Udelsman felt sure that it had 
invaded the man’s lymph nodes. When last tested, the man’s 
tumor marker was at 97; a normal reading is below 3. 
“It’s such a rare disease that many endocrinologists haven’t 
seen a case,” Udelsman told the fit, dark-haired man who 
had come to the clinic with his wife and 4-year-old son. “Why 
you, I don’t know.” 
He would need a central and lateral neck dissection to 
remove the rest of his thyroid and 20 to 50 lymph nodes that 
Udelsman believed contain tumors the size of specks of 
pepper. Surgery would take all day. “This operation is io-fold 
what you had before,” Udelsman told him. 
Two factors complicated the case. Udelsman explained that 
it was possible that this cancer was genetic. If testing showed 
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During a meeting with architects 
in February, Udeisman insists 
that space for newly recruited fac¬ 
ulty members be ready by the 
start of the next academic year on 
July i. The $40 million depart¬ 
ment has to run like a business, 
he says: “We’re a nonprofit 
organization, but that doesn’t 
mean we don’t have to be 
profitable. At the end of the day, 
if we can’t balance our books— 
if we’re spending more than 
we're taking in—we’re going to 
have to close the doors.” 
that it was, then each of the man’s four children would have 
a 50-50 chance of developing the cancer and would need 
preventive thyroidectomies. And the man is a professional 
singer. As did Galli-Curci, he faces surgery, again, that 
will put his voice at risk. Udeisman told him the chance of 
damage to his voice was 2 percent. “I expect you to do great. 
But let me give you the picture. This is serious business. 
You can have big problems” if the cancer spreads, he told the 
man. His wife listened silently. 
The man was upbeat, well informed from research on the 
Internet. “I’m still in a good place about it,” he said. “I am not 
in any kind of denial, but I’m not going to accept that this is 
going to take me down.” 
“I’m not saying it’s going to take you, but you’ve got some 
hurdles to jump,” Udeisman replied. “Our goal is to keep you 
alive for a long, long time.” 
“IF IT COMES BACK MALIGNANT, 
THEN WE’VE DONE A REALLY GOOD THING” 
It’s a Tuesday, the first of Udelsmaris two days in the OR. His 
first case is a parathyroidectomy, removal of one of the (usu¬ 
ally) four raisin-sized endocrine glands on or near the thyroid. 
The parathyroid glands are intimately involved with the hor¬ 
mone that regulates calcium metabolism. Udeisman is talking 
to his patient—who is awake. 
“Barbers and surgeons were in the same field back in 
England,” Udeisman tells the patient, a retired business execu¬ 
tive in his 60s, as he shaves his upper chest. The man has 
a parathyroid adenoma, probably not cancerous, but causing 
him problems with calcium levels that leave him weak and 
up at night urinating. Udeisman will use the minimally inva¬ 
sive technique. 
As Udeisman and Chief Resident Rabab F. Hashim, m.d., 
begin working through an opening in the man’s neck the size 
of a half dollar, Udeisman explains to Hashim: “This is very 
unusual. Most people would put this patient to sleep.” 
He teaches Hashim about the benefits of this minimally 
invasive technique for parathryroid surgery. By keeping 
the patient awake, sedated a bit and injected in the neck with 
local anesthesia, Udeisman tells her, they gain two things: 
they can ask the patient to speak from time to time, a method 
of checking whether the surgery is affecting the recurrent 
nerve crucial for speech; and they minimize the effects of 
anesthesia for the patient, reducing risk and speeding recov¬ 
ery so that the patient can go home the same day. (In this 
case, the patient will go to a hotel. He and his wife drove up 
from Maryland for the surgery because they heard that 
Udeisman is “the best.”) 
The man's parathyroid is hard to find, and the surgery is 
taking longer than the anticipated hour. “We're getting there,” 
Udeisman tells both Hashim and the patient. “It’s a very 
posterior parathyroid. You see that little mother now?” he asks 
Hashim. “That’s what we're after. It’s a very tricky one.” 
Udeisman shows Hashim that the parathyroid is enlarged. 
“It’s a little bit more stuck [to the thyroid lobe] than I like to 
see,” he tells her. He can’t tell for sure where the parathyroid 
ends and the thyroid begins, which might indicate that the 
parathyroid is cancerous. Statistically, the chance of malig¬ 
nancy is only 1 percent, but Udeisman tells Hashim that they 
will remove the thyroid lobe as well, to be sure the parathyroid 
is completely out. (With the rest of his thyroid intact, the 
patient will feel no effects of losing a lobe.) 
“In my heart of hearts, I think it will prove to be benign,” 
Udeisman tells Hashim, “but the time to make the call is in 
continued on page 52 
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From the landscape of an ancient “rna world" springs an idea that could 
lead to the creation of ultrasensitive biosensors based on molecular 
the potential of so-called rna switches. 
Biosensors exploit the natural 
tendency of proteins to recognize 
and react to other molecules. 
Ron Breaker theorized that the 
rna in proteins could be isolated 
and serve as a "switch” that 
targets specific molecules. The 
central image at left repre¬ 
sents a binary rna switch as it 
goes through the chemical 
machinations necessary to recog¬ 
nize a molecule—it must bind 
to two different molecules before 
the ribozyme can cleave. Biosen¬ 
sors could be used to diagnose 
patients, monitor for bioterror 
weapons and detect metabolites 
in clinical samples, contaminants 
in food or pollutants in water. 
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26 Putting evolution to use 
Ronald Breaker 
When Ronald R. Breaker, ph.d., associate professor of molecular, 
cellular and developmental biology, wanted to develop a high- 
tech tool for detecting everything from infectious agents like 
hiv in the blood to contaminants such as arsenic in water, he 
figured that the place to start was about 3.5 billion years ago, 
when life began. 
Some have theorized that rna, the active component in 
genes, and not dna, the genetic library, composed the first life 
forms. Based on that theory, Breaker supposed that RNA would 
have needed to act like a simple switch when it came into 
contact with another molecule, sending out signals in order to 
control metabolism. He and his team put that evolutionary 
theory to work in a test tube to “back-engineer” RNA-based 
molecular switches. As he reported in a paper published in 
Nature Biotechnology in April 2001, the switches worked. In fact, 
they worked so well that some believe they could be key to 
one day developing small, easy-to-use biosensors for detecting 
everything from tumor cells to toxic chemicals. 
rna molecular switches could be used to construct a kind of 
dashboard panel to detect when sought-after molecules are 
present. Such biosensors might be developed to detect contami¬ 
nants in food, pollutants in water, metabolites in clinical sam¬ 
ples or biological-warfare agents on the battlefield. 
Yale licensed the rna molecular-switch technology to a 
Cambridge, Mass., biotechnology company that Breaker helped 
found, Archemix Inc., which is developing possible commercial 
applications of the biosensor technology. In his own labora¬ 
tory, he is continuing to explore the science behind molecular 
switches. Contributing Editor Marc Wortman asked Breaker 
to explain how biosensors work and to discuss the challenges 
of developing the technology. 
What is a biosensor? 
A biosensor is a device that uses biological molecules (usually 
proteins) to detect chemicals or other biological molecules. Each 
of our cells holds a complex mixture of chemical compounds, 
and all of these compounds are created and used in a highly 
orchestrated fashion. To do this, our cells mostly use intricately 
folded proteins to selectively recognize many of these com¬ 
pounds and to make use of them in very specific ways. Scientists 
found that they could remove one or more of these proteins 
from their natural setting and use them as biological compo¬ 
nents of sensor devices. 
Perhaps the best-known target for a biosensor is glucose. For 
many diabetics, frequent monitoring of the concentration of 
glucose in their blood is necessary. However, glucose is only one 
This article is adapted from an interview published in the March 15 
issue of the Yale Bulletin & Calendar. 
type of molecule within the very complex mixture of chemical 
and biological compounds present in blood. One way to “see” 
glucose in this vast sea of other compounds is to use an enzyme 
called glucose oxidase. This enzyme can identify glucose among 
all the other compounds and cause it to react with oxygen to 
produce hydrogen peroxide. Then a second enzyme called cata¬ 
lase destroys hydrogen peroxide in a process that can be moni¬ 
tored electronically. Higher levels of glucose in a drop of blood 
will give higher electronic signals, and thus one can determine 
precisely how much glucose is present. 
How difficult is it to detect the presence of a potentially 
harmful biological agent, such as anthrax or Salmonella, in the 
water or air or on the surface of things? 
Detecting infectious agents such as anthrax, Salmonella, or hiv 
is very difficult, particularly if the contamination is low and 
if you want the results fast. The challenge largely centers on the 
number of targets you want to see. Glucose concentrations 
are typically measured in "millimolar” units, which means that 
there are more than a billion trillion glucose molecules in a pint 
of blood.There are so many glucose molecules that it is quite 
easy to detect and accurately measure them. However, hiv con¬ 
centrations could be present in “zeptomolar” units, where only 
a few hundred virus particles might be present but still able to 
cause disease. Biological agents such as bacteria and viruses can 
make billions of copies from a single infectious particle. There 
might be only a few hiv particles in a pint of blood, but they 
need to be detected in order to ensure that donated blood is 
safe for transfusion. 
What are the usual methods? 
Detection of biological infections has routinely been achieved 
by growing cultures from samples taken from patients, or by 
looking for the production of antibodies. 
More recently, scientists have exploited two technologies— 
enzyme-linked immunosorbent assays (elisa) and polymerase 
chain reaction (pcr)—to expand the power of biosensors and 
bioanalytical methods. 
Sometimes natural proteins are not available for a particular 
target; interestingly, the immune systems of animals can be 
used to produce new antibodies that selectively bind to new tar¬ 
gets of interest. These antibodies are typically used in elisa tests. 
More recently, pcr tests have become commonplace. These 
tests rely on the power of DNA-making enzymes (dna poly¬ 
merase) to selectively amplify genetic fragments of infectious 
agents such as anthrax and hiv. dna fragments of just a few 
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Biosensor technology of this advanced type could be used to 
diagnose patients in a doctor’s office, help discover new 
treatments for disease, detect industrial contaminations and 
even aid in monitoring for chemical or biological attacks. 
infectious particles in a sample are used in pcr to make billions 
of copies, which can then be observed by any one of several 
different methods. 
What are the problems or limitations of those current methods? 
Speed, shelf life, and cost are of significant concern with all 
existing methods, elisa and pcr assays take time to run and 
are usually labor intensive. Automation of some aspects of 
these tests can reduce the time needed to set up and interpret 
multiple tests, but the biochemical processes themselves also 
take time. Antibodies and many other proteins are notoriously 
unstable, and most biosensor kits have a shelf life that is mea¬ 
sured in months—far too short to be of use to most consumers. 
Finally, proteins can be expensive to produce and store, which 
drives up the cost of making most biosensors. 
Given concerns about bioterrorism, what efforts are under way 
in your laboratory and elsewhere to develop better biosensors? 
Several science funding agencies had embarked on efforts to 
accelerate biosensor development even before recent events 
brought attention to bioterrorism. I think that this was a recog¬ 
nition that improvements were needed in detection technol¬ 
ogy, and also that recent advances in biological research indeed 
make possible great advances in biosensor sophistication. 
Our laboratory took a rather unusual path to enter the 
area of biosensor research. We were testing a theory of how life 
began some 3.5 billion years ago. It is believed that an “rna 
world” once existed, where all enzymes and other molecular 
components of primitive cells were made of ribonucleic acid, or 
rna. Although this entire way of life has long since become 
extinct, we can perhaps use evolution in a test tube to recreate 
many of these long-lost rna molecules. Through these efforts, 
we invented RNA switches that can be used as biosensor 
elements. For example, we have made many types of rnas that 
self-destruct only when they come in contact with a specific 
target molecule. We recently assembled these on a prototype 
RNA biochip that can be used to detect toxic metals such as 
cobalt, drug compounds such as theophylline and natural com¬ 
pounds such as cyclic amp and cyclic gmp. 
What types of applications could they have? 
We expect that this new type of biological switch will be used 
to make next-generation biosensor devices that detect a variety 
of chemical and biological agents in a single assay. Scientists 
have recently developed “gene chips” that can be used to see 
thousands of genes on one miniature platform. We imagine 
similar platforms that see genes, metabolites, drugs, toxins, bio¬ 
hazards and any other targets of interest all in a single assay. 
Biosensor technology of this advanced type could be used to 
diagnose patients in a doctor’s office, help discover new treat¬ 
ments for disease, detect industrial contaminations and even aid 
in monitoring for chemical or biological attacks. 
Are rna molecules stable enough to serve as biosensor elements? 
Nature has chosen dna to store genetic information because 
each link in the chain is extraordinarily stable. In contrast, each 
link in rna’s chain is about 100,000 times more likely to break. 
If this occurs in one of our switches (which are about 100 links in 
size), then its function is likely to be destroyed. Fortunately, rna 
is sufficiently stable to provide a shelf life of several years. After 
immobilization, the rna array can be stored for long periods of 
time simply by letting the surface air dry and storing it at room 
temperature. Of course this is assuming that the rna is not 
being digested by contaminating enzymes. Even the oils cover¬ 
ing our skin carry enzymes that can degrade rna very rapidly. 
Again, we are fortunate because chemists have created many 
modified rna links that resist destruction by nucleases. In other 
words, the science to create modified rna switches that resist 
attack by chemicals and enzymes is already well developed. 
Will we eventually have low-cost, easy-to-use biosensors in our 
homes and workplaces? 
Without question. Glucose tests and pregnancy tests have 
already become routinely self-administered. If the technology 
continues to advance, I imagine that home diagnostic tests 
for diseases such as cancer and viral infections might become 
the first line of defense for health care. 
What might they look like and how would they be used? 
Perhaps not surprisingly, we need to look at our science fiction 
stories to give us some sense of the possibilities. Although 
biosensors of the near future might look more like home preg¬ 
nancy tests than a tricorder from Star Trek, I think that handheld 
biosensor devices that can detect thousands of important tar¬ 
gets are being envisioned by many in the field. They will contain 
some sophisticated electronics and some savvy computer algo¬ 
rithms for interpreting various signals and perhaps for giving 
courses of action to the user. But at their core, they are likely to 
contain an advanced form of biochip that is engineered to 
recognize and report the presence of thousands of targets, ym 
marc wortman isa contributing editor of Yale Medicine. 
James yang is an illustrator in New York City. 

The toll road 
In science, an idea can lie dormant for a 
century and then enjoy a fantastic rebirth. 
That’s what happened when Charlie Janeway 
proposed a theory about human immunity 
in 1989 that captured the imagination of 
Ruslan Medzhitov. 
By Trisha Gura 
Photographs by Frank Poole 
Yale professor and Howard Hughes 
Medical Institute investigator 
Charles A. Janeway Jr. in his office 
in Lauder Hall. Janeway had 
planned to become a physician but 
switched his focus to the basic 
sciences underlying immunology. 
In so much of science and medicine, breakthroughs begin sim¬ 
ply as questions. A provocative one came by chance in January 
1989 to Charles A. Janeway Jr., m.d., an immunologist and 
Yale professor. Although the question—about the initial trigger 
for the body’s immune response—inspired an unorthodox 
idea, the story might well have ended there had Janeway’s spec¬ 
ulative answer not been noticed half a world away. 
Janeway did write a paper about his idea—a theory about 
how a little-studied arm of the immune system alerts the 
body’s T and B cells to the presence of an invader—but the 
1989 paper drew little immediate interest. Three years later an 
impoverished graduate student in Moscow stumbled upon it 
and was galvanized. Launching the kind of quixotic adventure 
that could have been scripted by Hollywood, the young bio¬ 
chemist followed a circuitous route to Janeway’s lab. There, the 
novice with no lab experience and the veteran scientist col¬ 
laborated on research that has broken open an important and 
useful field within immunology. Together, Janeway and 
Ruslan M. Medzhitov, ph.d., have elevated Janeway’s theory 
from obscurity to cutting-edge prominence. 
Charlie Janeway wasn’t supposed to have been an immunol¬ 
ogist in the first place; as a young man, he seemed destined to 
fulfill a family tradition of practicing medicine. But during his 
second year at Harvard Medical School in 1964, Janeway began 
to realize that, in his words, “the evidence for treating patients 
the way we were was flimsy.” Rather than admit that they had 
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30 The toll road 
no effective treatment for a malady, physicians would prescribe 
something anyway. It bothered Janeway to hear patients thank¬ 
ing their doctors for unproven therapies. 
His skepticism prompted a break from his medical studies 
and a two-year excursion into basic research from 1965 to 
1967, first in the lab of immunologist Hugh O. McDevitt, m.d., 
at Harvard for a summer and then with John H. Humphrey, 
m.d.. at the National Institute for Medical Research at Mill Hill 
in London for two years. When a more focused and critical 
Janeway returned from England for his last two years of med¬ 
ical school and a year of internship at the Peter Bent Brigham 
Hospital in Boston in 1969-1970, he couldn’t accustom himself 
to prescribing treatments with so little information to go on. 
“Clinical medicine” he said, “was rotting my soul.” 
Janeway countered this disillusionment by working for the 
next five years at the National Institute of Allergy and Infec¬ 
tious Diseases under the tutelage of immunologist William E. 
Paul, m.d., chief of the Laboratory of Immunology. In 1977, 
he came to Yale as an assistant professor in the Department 
of Pathology’s immunology division. During the 15 years 
of research that followed, Janeway gained insights into how 
T cells originate, develop and then become activated to pick off 
specific fragments of specific invaders. 
Indeed, the key to T-cell action is specificity. Janeway has 
been at the forefront of efforts to understand how each of 
the millions of T cells formed in our bone marrow and later 
launched into our circulation has the capacity to respond 
to one, and only one, unique invader or insult. That pairing of 
T cell and target takes several days to happen, from the ill 
person’s first feelings of malaise to the moment when the body 
has amassed its cellular troops and molecular weaponry. But 
the delay is necessary, pregnant with potential. Meanwhile, 
a second immune player, the B cell, produces antibodies, and 
these two protagonists coordinate an entire arm of human 
immunity known as the adaptive immune system. 
During the 1980s, when the world of immunology revolved 
around problems of adaptive immunity, there was a basic 
question that no one gave much thought to: during the initial 
delay period, how are T and B cells first alerted that an 
intruder has invaded the body? 
That was the question first posed to Janeway by his wife 
and colleague, immunologist H. Kim Bottomly, ph.d., professor 
of immunobiology, dermatology and molecular, cellular and 
developmental biology. The couple attended a Keystone Symposia 
meeting in Steamboat Springs, Colo., in January 1989, and 
were bantering as usual. “He and I would argue in the car all 
the time and then we’d forget what we said,” Bottomly recalls. 
"But,” she adds, “this time we brought a notebook.” 
THE PATTERN RECOGNITION HYPOTHESIS 
Janeway offered this answer to her question: the alert signal 
given to T and B cells must come from another arm of the 
immune system, the one long referred to as innate immunity. 
Given only a page or two in medical texts, innate immunity 
is provided by skin, mucous and other epithelial barriers. It had 
been proposed that some unknown biochemical component 
combines with those simple barriers to act as a first line of 
defense against everyday assaults. Just cut a finger, and the ten¬ 
der redness that develops will demonstrate the workings of the 
body’s inflammatory process, a function of innate immunity. 
As he jotted down Bottomly’s question and its provocations, 
Janeway began to muse on that long-ignored system. The field 
of innate immunity had languished in the years since Ilya I. 
Mechnikov had proposed his revolutionary cell-based theory of 
immunity in 1883. With subsequent discoveries in the 1940s 
about the powerful roles of T and B cells in allergic reactions, 
graft rejection and microbial attack, researchers had relegated 
innate immunity to a footnote. In fact, Janeway wrote his 
own terse section about it in his book, Immunobiology, now in 
its fifth edition. 
Janeway began considering the links between the innate 
immune system and the adaptive system he’d studied over the 
years. Perhaps innate immunity worked as the intelligence 
network to tip off the adaptive system, he thought. Perhaps 
cells within or near the skin, mucous membranes and intesti¬ 
nal lining bore molecules on their surfaces that could recog¬ 
nize some general aspect of microbes and signal the adaptive 
immune system that a foreigner had breached security. 
Janeway came up with an idea, which he dubbed the “Pat¬ 
tern Recognition Hypothesis.” It goes like this: classes of germs 
carry molecular patterns, either anchored on their surfaces 
or secreted from their insides. All multicellular organisms have 
pattern recognition receptors that can signal, only in verte¬ 
brates, the adaptive immune system. Of course, the microbial 
molecules that carry the patterns would have to be critical to 
the pathogen in some way; otherwise it would have evolved a 
way to do without those molecular patterns centuries ago. 
“I couldn’t let go of the idea,” recalls Janeway. In June 
1989, he attended a meeting on quantitative biology in Cold 
Spring Harbor, N.Y., an event at which invited researchers 
have a chance to discuss ideas in an intimate setting. After the 
meeting, the immunologist laid out some of the ideas he’d 
begun developing at Keystone in a paper entitled “Approaching 
the Asymptote? Revolution and Evolution in Immunology,” 
published as a chapter in the Cold Spring Harbor Symposia 
later the same year. 
According to Janeway, that paper was “pretty much ignored” 
by the scientific community. But it intrigued an eager young 
student at Moscow University who stumbled across it. That stu¬ 
dent was Ruslan Medzhitov. 
NARY A REAGENT IN SIGHT 
Born in 1966 in Tashkent, Uzbekistan, Medzhitov made his 
way to graduate school in biochemistry at Moscow University 
in 1990, a time when the Soviet Union was breaking up and 
science in Russia was in deep trouble. As funding dried up, 
biochemistry labs lay bare of a single reagent. Entire depart¬ 
ments operated on monthly budgets of $20. In fact, only the 
Ruslan Medzhitov 
In the fall of 1992, [Medzhitov] laid his hands on Janeway’s 
paper and found his calling. [He] wanted to study immunology, 
and he wanted to do so with Charles Janeway.... 
Janeway had no idea of what to make of this unknown student 
who was writing to him. Recalls Bottomly, “Charlie told me, 
‘I’ve got this fabulously bright guy from Russia who wants to 
work in my lab/ ” Not surprisingly, Bottomly was skeptical. 
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32 The toll road 
opposite The wall of photographs 
in Janeway’s office tells the story of 
his personal and professional rela¬ 
tionships, many of which are inter¬ 
twined. The portrait of his father, 
Charles A. Janeway (top row, cen¬ 
ter), was painted on his retirement 
after many years as chief of pedi¬ 
atrics at Boston Children’s Hospi¬ 
tal. Below that is a photograph of 
Janeway’s colleague Richard K. 
Cershon, and to his right, the late 
John Humphrey, Janeway’s mentor 
in London. The third photo down 
from the top left shows Janeway 
and his wife, immunobiology 
professor Kim Bottomly, on their 
wedding day in March 1977. Their 
daughters Katherine Anne and 
Hannah Heath are pictured above 
and below, respectively. 
Academy of Natural Sciences carried the journals Science 
and Nature, and its lone copy of each made its rounds through 
every lab before landing, worn and barely legible, on the 
shelves of the academy’s decaying library. Due to politics 
between the university and the academy, university students 
were unilaterally denied access to the library. But Medzhitov, 
by wit, resourcefulness and charm, managed to get in. “I 
sweet-talked the librarians,” he says. 
Indeed, in the fall of 1992, the graduate student laid his 
hands on Janeway’s paper and found his calling. Medzhitov 
wanted to study immunology, and he wanted to do so with 
Charles Janeway. 
Medzhitov had been working on his doctorate by studying 
how molecules evolve to recognize each other; how, for exam¬ 
ple, a receptor and the signaling molecule that binds to it inter¬ 
act. As he read Janeway’s theory about microbial patterns 
being picked up by human receptors, he was drawn to its logic. 
“Although I didn’t know much about the subject,” Medzhitov 
says, “I realized that the way he thinks, I think.” 
The problem was that Medzhitov’s department in Moscow 
had no supplies and, thus, its students gained no lab experience. 
As a “theoretical” protein biochemist who knew no one with the 
prestige or resources to back him, Medzhitov almost gave up. 
But he didn't. He photocopied the Janeway paper. This was 
no simple feat, as it cost half his monthly student stipend 
of $2. Then Medzhitov began e-mailing Janeway, using the 
solitary account shared by 400 faculty, staff and students, each 
of whom was allotted only 300 words a day in order to control 
the costs of operating the account. 
Janeway, meanwhile, had no idea of what to make of this 
unknown student who was writing to him. Recalls Bottomly, 
“Charlie told me, ‘I’ve got this fabulously bright guy from 
Russia who wants to work in my lab.’” Not surprisingly, 
Bottomly was skeptical. 
Medzhitov set to work. He won a fellowship given to scien¬ 
tists in developing countries by the United Nations Educa¬ 
tional, Scientific and Cultural Organization. That would get 
him to the United States for three months in 1993 to work in 
the lab of Russell F. Doolittle, ph.d., at the University of 
California, San Diego. Medzhitov scraped together the plane 
fare by borrowing from a cousin. 
Money in hand, Medzhitov faced another hurdle before he 
could leave for California: getting a passport. As the Soviet 
Union was unraveling politically, Medzhitov was considered a 
citizen of nowhere, having been born in Uzbekistan, but not 
residing there, and living in Russia, but not having been born 
there. In the end, the student wended his way through the 
bureaucracy. He reached California and began working in the 
burgeoning area of bioinformatics, in which scientists were 
beginning to write software to comb through and order data¬ 
bases of decoded dna sequences. 
Medzhitov continued to correspond with Janeway. In fact, 
the Moscow student spoke nonstop about Janeway’s ideas to 
Doolittle, who in turn arranged a seminar at which Medzhitov 
could present his work. Attending that presentation, given in 
halting English, was Richard W. Dutton, ph.d., then the presi¬ 
dent of the American Society of Immunology. When Dutton 
caught wind of Medzhitov’s ambition of working with Janeway, 
Dutton immediately called his colleague in New Haven. He 
told him, “You have to hire Medzhitov.” 
And Janeway did. “Dick’s phone call tipped the balance,” 
he says. 
Medzhitov arrived at Yale in January 1994 as Janeway’s 
postdoc. He set out to show that the innate immune system 
could recognize molecules that did not belong in the human 
body—via alien patterns carried by the invaders. And once 
the system did its duty, Medzhitov had to show that it could 
transmit this information to the adaptive immune system. 
The first task was this: find at least one example of a pattern 
recognition receptor on some cell in the body that could be 
linked to innate immunity. 
The beginning stages looked grim. Medzhitov says Janeway 
tried to instill confidence by telling him, “Lab work is a lot 
like cooking.” Medzhitov answered sheepishly, "I’ve never 
cooked, either.” 
After several unsuccessful attempts to pinpoint the candi¬ 
date receptor using conventional methods, Medzhitov turned 
to the experience he had gained in bioinformatics. He began 
with a template—a dna sequence for a human gene that 
encodes the interleukin-i (IL-i) receptor, a mammalian protein 
known to trigger inflammation. The receptor itself, however, 
is triggered by a cytokine, rather than a microbial pattern. 
Perhaps humans bear another receptor like IL-i that could 
spur the adaptive arm of immunity, the researchers reasoned. 
With the IL-i gene sequence and others like it, Medzhitov 
began searching through warehouses of dna for sequences for 
novel genes expressed by all kinds of organisms, from fruit 
flies to humans. In early 1996, he finally hit pay dirt. 
Medzhitov found and decoded a new human gene. It 
resembled the gene for IL-i and one other—a fruit fly gene 
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opposite Also displayed on 
Janeway’s office wall are photo¬ 
graphs of four generations of 
Janeway doctors. Top left, below 
the photo of the boat, is Janeway’s 
great-grandfather, Edward 
Gamaliel Janeway—“beside a 
body that could be living or dead 
as he was a professor of medicine 
and pathology at Bellevue,” 
Janeway points out. “Below him 
is my grandfather, Theodore Cald¬ 
well Janeway, whom I never knew 
as he died in 1917 of pneumococcal 
pneumonia. He described the 
famous ‘Janeway lesions.’ ” Next is 
Janeway’s father, who discovered 
gamma globulin deficiency, fol¬ 
lowed by Janeway and Bottomly 
three years ago at the wedding of 
their daughter Katie. 
dubbed toll for the German word that means “amazing.” Geneti¬ 
cist Kathryn Anderson, ph.d., at Memorial Sloan-Kettering 
Cancer Center, had shown in 1988 that insect toll orchestrates 
the assembly of flies’ front and back sides during development. 
At the time of her discovery, however, no one could make a 
clear connection between fly development and human immunity. 
Then in the spring of 1996 in the Cape Ann village of 
Annisquam, Mass., Medzhitov and Janeway hosted a meeting 
of scientists who wanted to delve into the connections between 
microbial defense in insects and human immunity. Fly guru 
Jules A. Hoffmann, ph.d., director of the Institute for Molecu¬ 
lar and Cellular Biology at the Centre National de la Recherche 
Scientifique in Strasbourg, France, had written a Human 
Frontiers in Science grant and asked Janeway and others to 
join in. Janeway, in turn, saw the collaboration as an opportu¬ 
nity to advance the use of fly genetics to probe the molecules 
important in human immunity. 
Says Hoffmann, in admiration, “Not many m.d.s would 
have been interested in flies.” Especially when scientists had no 
hard evidence of any insect-mammal connections in this area 
of immunology. 
At that meeting on Cape Ann, Hoffmann announced his 
surprising discovery: that flies with defects in their toll genes 
became hypersusceptible to fungal infection. He waved about a 
photograph of an infected fly covered with a fuzzy fur of 
fungus. The photo appeared on the cover of the journal Cell 
later that year. 
Janeway and Medzhitov could barely contain their delight. 
Could their human toll perform the same antifungal tour 
de force? Immediately, Medzhitov set to work. In essence, he 
wanted to know if human toll functioned as a sensor—a 
molecular scout for microbes—as well as a signaler to the 
adaptive immune system. After a year of experimentation, the 
answer to both questions was a resounding yes. 
“The discovery that toll was part of the recognition pathway 
gave the field a handle on the most front-line sensor within 
the circuit,” says immunologist Michael A. Zasloff, m.d., ph.d., 
dean of research and translational science at Georgetown 
University School of Medicine. 
The findings appeared in the July 24,1997, issue of Nature. 
THE FRENCH FLY CONNECTION 
Two and a half years later, the idea of innate immunity in 
humans and its connections to defense in invertebrates had 
already taken hold. At least 150 scientists gathered at a 
National Academy of Sciences colloquium in Irvine, Calif., 
entitled “Virulence and Defense in Host-Pathogen Interac¬ 
tions: Common Features between Plants and Animals.” At the 
meeting, 12 researchers specifically discussed their work on 
toll in flies and “toll-like receptors”—as the mammalian ver¬ 
sions are now known—and other aspects of innate immunity. 
Two dozen other scientists focused on patterns common to the 
insect and mammalian pathogens. 
By March 2001, scientists had found 10 other human 
toll-like receptors, including toll-like receptor 2, which Shizuo 
Akira, m.d., and colleagues at Osaka University showed 
responds to a particular sequence found in bacterial dna but 
not in mammalian dna. To get an idea of how fast the field 
has grown since 1997, a literature search for the term “toll-like 
receptor” in February brought up 450 abstracts. 
Other biochemicals that operate in the toll pathway have 
also come to light. Dozens of labs have focused solely on the 
tail end of the toll pathway—the production of the antimicro¬ 
bial peptides that constitute the body’s ancient first line of 
defense. For example, Hoffmann launched a pharmaceutical 
company in Strasbourg called EntoMed to exploit the anti¬ 
microbial peptides produced by flies, moths and other insects 
after toll pathway stimulation. Micrologix Biotech Inc. in Van¬ 
couver, B.C., for example, has reached the late phases of 
clinical trials for drugs to prevent catheter-related infections 
and is testing other compounds to treat acne and to prevent 
infections caused by a particularly recalcitrant bacterium 
known as methylene-resistant Staphylococcus aureus. 
Georgetown’s Zasloff has focused on boosting the body’s 
ability to quickly spot and deal with a microbe. “We could 
create a class of immunostimulants,” suggests Zasloff, whose 
laboratory is exploring compounds meant to do exactly that. 
The evolutionary connections have also awed researchers, 
as they eventually found toll-like molecules in worms, mice, 
even plants. Plant geneticist Santosh Misra, ph.d., and col¬ 
leagues at the University of Victoria in British Columbia have 
genetically engineered antimicrobial peptides into potatoes 
to get the crops to withstand fungal infection. Protective com¬ 
pounds produced by plants could conceivably work as new 
classes of antibiotics in people as well. 
And there are even more fundamental questions being 
asked about toll and innate immunity. Quite simply, how are 
plants, flies and people connected in their defense against 
the microbes that infect them? And, as Janeway first proposed 
at the Keystone meeting, might the innate arm of immunity— 
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the more ancient system—actually be the means by which 
the body distinguishes itself from foreign invaders? If 
so, understanding its mechanisms might have crucial impli¬ 
cations for the study ot both infectious diseases and autoim¬ 
mune disorders. 
“This is the hottest area in immunology right now,” says 
Richard A. Flavell, ph.d., chair of the Section of Immuno¬ 
biology. 
Indeed, in the aftermath of their breakthrough, Janeway 
lobbied for Medzhitov’s recruitment for a faculty position 
at Yale. Medzhitov had seven other offers, including positions 
at Harvard and mit, which he turned down. “I knew that at 
Yale I 'd be given a lot of intellectual freedom to pursue riskier 
ideas,” he says. 
Then, Janeway did something unusual: he handed over to 
Medzhitov the reigns of their collaboration. Mentors often 
give away parts of projects to exiting postdocs. But to do so for 
“the biggest discovery in immunology in a decade is rare and 
typical of Charlie’s generosity,” Flavell says. 
The decision had to do with Janeway’s personal circum¬ 
stances as well as with Yale’s policy of discouraging direct com¬ 
petition between two faculty members working on the same 
project in the same department. In order to get Medzhitov in, 
Janeway would have to step aside. “It was an admirable move,” 
says Alfred L.M. Bothwell, ph.d., professor of immunobiology 
and an investigator in the interdepartmental Program in 
Vascular Biology and Transplantation. 
The close-knit immunobiology faculty unanimously 
chose Medzhitov to join them as an assistant professor. They 
apparently bet on the right horse. Last year, Medzhitov was 
appointed a Howard Hughes Medical Institute (hhmi) assist¬ 
ant investigator, allowing him additional freedom to pur¬ 
sue less-conventional ideas. (Janeway, Flavell and four other 
members of the immunobiology faculty also have hhmi 
appointments.) Medzhitov has since identified at least seven 
more molecular players in the toll pathway and definitively 
characterized two of them, including an adapter protein he 
reported on in Nature Immunology last September. 
When Medzhitov was first introduced to biochemistry, 
he was a college student in Tashkent as well as a field laborer 
required to pick cotton for two to three months each year 
(“one of the idiotic ramifications of the Soviet political system,” 
he says.). At 36, he is mapping new territory in an emerging 
discipline that has major implications for the treatment of 
disease. How did he get there? 
“There is a hypothesis that if you have to struggle a bit early 
on, you’ll put more into it later,” says Bottomly. 
Meanwhile, Janeway has added to his accomplishments. 
Two years ago, he was elected both to the National Academy 
of Sciences and to the American Academy of Microbiology. 
“Charlie has had a succession of accomplishments,” says 
Carolyn W. Slayman, ph.d., the medical school's deputy dean 
for scientific affairs. “But this [discovery of the essential 
role played by innate immunity] is the most colorful of them.” 
A TEXTBOOK CASE 
Despite his scientific success, Janeway has struggled in 
recent years. A researcher who spent his career studying the 
body’s defense system, he fell prey to its limitations. A year 
after Medzhitov arrived at Yale, Janeway began to complain of 
fatigue. A series of medical exams and tests over the next 
several months showed that Janeway had developed B-cell 
lymphoma, and that it had progressed from the bloodstream 
to his brain. He’s now in remission but a relapse in 1999 
and several years of treatment have drained him. 
He has reduced his lab personnel and steered back toward 
his initial interests. He is currently working on projects to 
develop vaccines against diabetes and autoimmune diseases 
such as multiple sclerosis. In December, he flew to London 
to work on the next edition of his immunology textbook. And 
this February, he traveled to another Keystone meeting to 
brainstorm with Hoffmann and other colleagues about ancient 
defense systems. 
While cancer may have limited Janeway in some ways, 
people about the lab characterize him now as much more mild 
and reflective. Indeed, in talks and conversation, he refers 
often to his personal history, which is encapsulated on a wall of 
his cramped office. 
There, in a display of photographs, hangs a column of per¬ 
sonas, a legacy of medical minds. Near the top is a 19th-century 
photo of Janeway’s great-grandfather, New York City Health 
Commissioner Edward Gamaliel Janeway, m.d., posed in formal 
attire next to a person on a gurney. He is lecturing a crop of 
medical students. (Janeway notes that his great-grandfather was 
a pathologist, making it hard to say if the subject of the lecture 
was a patient or a cadaver.) Next is his son, professor of medi¬ 
cine Theodore Caldwell Janeway, m.d., who died in 1917 after 
contracting pneumonia from the soldiers he treated in an Army 
camp. Next there is pediatrician Charles A. Janeway, m.d., 
Janeway’s father and longtime chief of pediatrics at Boston Chil¬ 
dren’s Hospital, who in 1953 discovered, reported and success¬ 
fully treated the first cases of gamma globulin deficiency. And 
there is Janeway himself, wearing a summer suit and bouton¬ 
niere, standing next to Bottomly at the wedding of their daugh 
ter Katherine Anne Janeway in the summer of 1999. 
In his presidential address to the American Association of 
Immunologists five years ago, janeway referred to Robert 
Frost’s “The Road Not Taken,” comparing life’s choices to fork, 
in the road. These decisions, sometimes taken on a whim, 
“have a profound impact on our lives,” he said. By handing th< teVi 
toll project to Medzhitov, he knew he was relinquishing a 
chance for greater fame, but his satisfaction in seeing his 
younger colleague thrive made awards seem unimportant. 
Choosing to mentor Medzhitov, says Janeway, has made all th 
difference: “He basically changed my whole outlook on 
immunology, on life.” YM 
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PSYCHOLOGIST TO LEAD 
CHILD STUDY CENTER 
Alan Kazdin, an expert on the 
behavioral problems of children, 
is named center’s fifth director. 
Early in his career as a clinical psycholo¬ 
gist, Alan E. Kazdin, ph.d., asked two 
fundamental questions about the work 
he was doing with emotionally troubled 
children: Does treatment work? And 
if so, why? 
These questions might seem obvi¬ 
ous, but Kazdin, the John M. Musser 
Professor of Psychology and professor 
in the Child Study Center, was surprised 
by how infrequently they were asked. 
“There are hundreds of interventions in 
practice but very few of them are exam¬ 
ined in research. The key is making 
sure there is firm empirical evidence to 
guide patient care.” 
That desire to know what works, and 
why, has made him an expert on empiri¬ 
cally based treatment and one of the 
most frequently cited authorities on 
aggressive and violent behavior in chil¬ 
dren. His reputation as a down-to-earth 
problem solver and a personable leader 
with a sense of humor helped him 
guide the Department of Psychology 
through a major period of transition 
from 1997 to 2000. 
All of these qualities contributed to 
his appointment at the end of February 
as the fifth director of the Yale Child 
Study Center, one of the medical 
school’s 22 academic departments and 
an international leader in child psychi¬ 
atric treatment, research and profes¬ 
sional training. The center was founded 
in 1911 by child development pioneer 
Arnold Gesell, m.d., ph.d. 
“Of the 75 or so chair appointments 
I’ve made, this is one of the three or 
four best. Alan Kazdin is a distinguished 
scholar and [was] an extraordinarily 
successful chair of the Department of 
Psychology,” Yale President Richard C. 
Levin said when he announced Kazdirfs 
selection February 28 in the center’s 
Harris Auditorium. In a letter to med¬ 
ical school faculty later that day. Dean 
David A. Kessler, m.d., cited Kazdin’s 
accomplishments, including 10 years of 
merit funding from the National Insti¬ 
tutes of Health, 500 journal publica¬ 
tions and 35 books, then added: “What 
cannot come across in reading about Dr. 
Kazdirfs background—but what I have 
come to learn and appreciate during 
countless hours of discussions with him 
over the last several weeks—-is his deep 
commitment to child psychiatry and the 
Child Study Center. He has enormous 
respect for the center’s faculty and its 
staff and is very eager to build on the 
pre-eminence of its programs.” 
A Cincinnati native raised in Los 
Angeles, Kazdin received his doctorate 
in clinical psychology from Northwest¬ 
ern University in 1970 before teaching 
at Penn State and, later, the University 
of Pittsburgh School of Medicine, where 
he directed both inpatient and outpa¬ 
tient services for children with psychi¬ 
atric disorders. In 1989, Kazdin joined 
the Yale psychology department with a 
joint appointment in the Child Study 
Center. As the center’s director, he suc¬ 
ceeds Donald J. Cohen, m.d. ’66, who 
died in October. 
Kazdin, who assumed his duties on 
April 1, leads a faculty of about 90 
members who are involved in an 
extremely wide range of activities and 
have special expertise in autism, 
Asperger and Tourette syndromes, 
obsessive-compulsive disorder, develop¬ 
mental disorders and the problems 
of children exposed to violence. “The 
center today is a world-ranked institu¬ 
tion,” said Edward F. Zigler, ph.d., a 
founder of the federal Head Start Pro¬ 
gram and a professor in both the Child 
Study Center and psychology depart¬ 
ment for the past 40 years. As for 
Kazdin, Zigler added: "He is without a 
doubt the finest child clinical psycholo¬ 
gist in the United States today.” 
In an interview in March, Kazdin 
said he is awed by the center’s greatness 
and, in close collaboration with the fac¬ 
ulty, hopes to extend it. 
“Yale has this tradition of taking a 
place that’s really great and asking, 
‘How can we do this even better?”’ he 
said. “The Child Study Center is Yale at 
its best. It has a stellar faculty and a 
tremendous reputation, and we are in 
the wonderful position of being able 
Alan Kazdin, former chair of the Depart¬ 
ment of Psychology, became director of the 
Yale Child Study Center on April 1. 
CAROLYN MAZURE, A LEADER 
IN WOMEN’S HEALTH RESEARCH, 
APPOINTED ASSOCIATE DEAN 
to build on that, thanks to commitments 
made by the president and dean." These 
include provisions for additional slots 
to hire new faculty, a review of the 
salaries of all existing faculty "to make 
sure the greatness we have here is 
secure” and additional resources to sup¬ 
port the center’s future growth. “Captain 
Kirk said space is the final frontier,” 
Kazdin quipped. “That applies very 
much to a university, too.” 
As chair of the psychology depart- 
| ment, Kazdin took charge at a moment 
! when several senior faculty members 
were nearing retirement and others had 
moved to other universities. He guided 
the faculty in recruiting fifteen new 
members, including five in the senior 
ranks—more than half the current 
department, said Peter Salovey, ph.d., 
professor of psychology and of public 
health, who succeeded Kazdin as psy¬ 
chology chair. “Alan is an energetic 
recruiter and an inspired organizer of 
l research,” Salovey said. “I think he’ll be 
' terrific in this new role.” 
Kazdin will continue to direct the 
Yale Child Conduct Clinic, an outpatient 
j treatment service for children and their 
; families that he brought to Yale from 
! Pittsburgh, but his focus will be on the 
Child Study Center. 
“I’m eager to meet with the faculty 
| and discuss what they perceive as 
strengths and weaknesses and to move 
on those issues with their help,” Kazdin 
said before assuming his new duties. 
“We have to solve the problems of child 
psychiatry. That requires discipline 
and careful planning. It’s something 
we’ll do together, and my job will be 
to mobilize that plan." 
Carolyn M. Mazure, ph.d., professor 
of psychiatry and director of Women’s 
Health Research at Yale, has been 
named associate dean for faculty affairs 
at the School of Medicine. Her respon¬ 
sibilities include overseeing the appoint¬ 
ment and promotion process, providing 
counsel to the dean and deputy dean 
for academic and scientific affairs 
regarding faculty issues and collaborat¬ 
ing with other key members of the med¬ 
ical school administration to facilitate 
the academic life of the faculty. Mazure 
assumed her new role in February. 
Mazure will also continue to direct 
Women’s Health Research at Yale, the 
largest interdisciplinary women’s health 
research program in the country. The 
program funds innovative studies in 
women’s health and focuses on under¬ 
standing sex-specific determinants of 
health and disease. Mazure has played a 
national role in support of research 
funding, testifying before the U.S. Con¬ 
gress in two consecutive years. 
A member of the faculty since 1982, 
Mazure has focused her research on 
depressive disorders, and she remains 
an active clinician. She has served on 
special ad hoc and standing grant 
review committees for the National 
Institute of Mental Health. She is inter¬ 
ested in predictors of illness onset 
and outcome in depression and, more 
recently, in addictive disorders. She is 
the principal investigator for the nih- 
funded Yale Interdisciplinary Women’s 
Health Research Scholar Program 
on Women and Drug Abuse, and is the 
principal investigator for the Sex- 
Specific Factors core of the NiH-funded 
Transdisciplinary Tobacco Use Research 
Center, studying sex-specific factors 
in nicotine dependence and treatment. 
Mazure was director of the Adult 
Inpatient Psychiatry Program for nine 
years, and more recently was chief of 
psychology for the Yale-New Haven Psy¬ 
chiatric Hospital. She is a fellow of 
the American Psychological Association 
and serves on two editorial boards. 
Carolyn Mazure will oversee the 
appointment and promotion process 
and advise the administration on 
faculty matters. 
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40 Faculty 
Joseph Piepmeier has been named the 
Nixdorff-German Professor of Neurosurgery. 
RENOWNED NEUROSURGEON, 
SPECIALIST IN BRAIN TUMORS, 
NAMED ENDOWED PROFESSOR 
Joseph M. Piepmeier, m.d., who spe¬ 
cializes in brain tumors and spinal 
cord traumas, has been appointed the 
Nixdorff-German Professor of Neuro¬ 
surgery. A member of the Yale fac¬ 
ulty since 1982, Piepmeier serves as 
director of the Neuro-oncology Unit 
at the Comprehensive Cancer Center 
and is director of the School of Medi¬ 
cine’s Neuro-oncology Laboratory. 
In both the clinic and the laboratory 
he focuses on neuro-oncology and 
is among the first neurosurgeons in 
Connecticut to use the gamma 
knife, an instrument that allows sur¬ 
geons to operate on the brain with¬ 
out using a scalpel. 
Piepmeier has served as a co¬ 
investigator on two research projects 
on spinal cord trauma, the National 
Acute Spinal Cord Injury Study 11 and 
the National Acute Spinal Cord 
Injury Study in. He was also the pri¬ 
mary investigator on several grant- 
funded research projects on brain 
abnormalities. Piepmeier’s honors 
include an Allied National Research 
Award and the Wakeman Award 
for Research in the Neurosciences. 
Piepmeier has been a visiting profes¬ 
sor and lecturer at universities across 
the globe, including the Nipon Med¬ 
ical School in Tokyo, the A1 Shorouk 
Hospital in Cairo, the Hospital Sainte- 
Anne in Paris, the University of 
Lund in Sweden and the University 
of Torino in Italy. The chair of the 
American Association of Neurological 
Surgeons from 1999 to 2001, he is 
currently secretary of the Neurosurgi¬ 
cal Society of America and of the 
Connecticut Neurosurgical Society. 
He is editor-in-chief of the Journal of 
Neuro-oncology, and has served on 
the editorial boards of several other 
professional journals. 
NOTES 
A New York magazine cover article 
titled "Surgery Without Scars ...” 
has included nine surgeons in the 
Yale Medical Group on a list of the 
top 100 minimally invasive sur¬ 
geons in the tri-state area.The 
surgeons are kevin r. Ander¬ 
son, m.d., joh n A. ELEFTERI- 
ADES, M.D. '76, HS ’83, AMY L. 
FRIEDMAN, M.D., RICHARD GUS- 
BERG, M.D..JAMES C. ROSSER 
JR., M.D., RONALD R. SALEM, 
M.D., CLARENCE T. SASAKI, M.D. 
’66, HS ’73, NEAL SEYMOUR, M.D., 
and ROBERT UDELSMAN, M.D. 
SONJA V. BATTEN, PH.D., has 
been hired as the associate direc¬ 
tor of Women’s Health Research at 
Yale. Batten has demonstrated tal¬ 
ents in research, clinical work, 
supervisory responsibilities and 
educational outreach efforts. Her 
primary interest is the effect of 
traumatic events on women’s psy¬ 
chological and physical health. 
Batten earned her ph.d. in clinical 
psychology from the University of 
Nevada, Reno, and interned at the 
Medical University of South Car¬ 
olina. She is completing a two- 
year postdoctoral fellowship with 
the Women’s Health Sciences 
Division of the National Center for 
Post-Traumatic Stress Disorder 
in Boston. 
PAUL G. BARASH, M.D., professor 
of anesthesiology, delivered the 
Winter College Lecture to the Col¬ 
lege of Anesthetists at the Royal 
College of Surgeons in Ireland in 
December. His lecture was entitled 
Myocardial Ischemia Monitoring: 
A Sequential Systems Approach. 
This lectureship is one of two 
awarded annually by the Royal 
College and is delivered by a promi¬ 
nent individual who is not a fellow 
of the college. Barash also served 
as one of the judges for the Annual 
Registrar Research Award. 
A symposium and reception to 
honor the contributions of Sidney 
j. b l att, PH.D., professor of psy¬ 
chiatry and psychology, were held 
on April 13 at the annual meeting 
of the American Psychological 
Association's Division 39 (Division 
on Psychoanalysis). Paul Wachtel, 
distinguished professor of psychol¬ 
ogy, and Diana Diamond, associate 
professor of psychology, both at 
the City University of New York, 
and former students of Blatt, made 
presentations at the symposium. 
The events were sponsored by 
i institutions and organizations with 
which Blatt has been affiliated 
during his career, including the Yale 
Departments of Psychiatry and 
Psychology; the Austen Riggs Cen¬ 
ter in Stockbridge, Mass.; The 
Sigmund Freud Center for Psycho¬ 
analytic Research at the Hebrew 
University of Jerusalem; The West¬ 
ern New England Institute for 
Psychoanalysis; The Institute for 
Psychoanalytic Training and 
Research; The Society for Personal¬ 
ity Assessment; The Connecticut 
Society for Psychoanalytic Psychol 
ogy and the Sections on Clinical 
Research and Clinical Practice of 
the apa’s Division 39. 
VALERIE MAHOLMES, PH.D., 
above, the Harris Assistant Profes¬ 
sor of Child Psychiatry, and 
JAMES P. COMER, M.D., HS ’67, 
the Maurice Falk Professor of Child 
Psychiatry and founder of the 
33-year-old School Development 
Program, spoke at the opening 
of The Discovery Room at Public 
School 28 in Paterson, N.J., in Janu¬ 
ary. The Discovery Room is a Yale 
program that was first developed 
during Comer's "School Power” 
days. Maholmes revived the pro¬ 
gram and tailored it to meet the 
needs of children with behavioral 
problems. Students are provided 
with instruction and support and 
are taught how to interact appro¬ 
priately in the classroom, with the 
ultimate goal of improving their 
academic achievement. 
MARTIN E. GORDON, M.D. ’46, 
clinical professor of medicine and 
chair of the Cushing/Whitney 
Medical Library Associates’ board 
of trustees, was a finalist in the 
basic and clinical category of the 
Time Inc. International Health and 
Medical Media Competition in 
November, for his film Microscopy, 
Tools of the Biomedical Sciences. 
Created in honor of the Yale Uni¬ 
versity Tercentennial Celebration, 
the film was supported by an 
unrestricted grant from the Carl 
Zeiss Foundation. 
Yale School of Medicine Dean 
DAVID A. KESSLER, M.D., was 
elected in January to chair the 
board of directors of The Elizabeth 
Glaser Pediatric aids Foundation. 
He will lead the foundation’s 
efforts to improve the lives of chil¬ 
dren worldwide through pediatric 
research, training and advocacy. 
Kessler served as commissioner of 
the U.S. Food and Drug Adminis¬ 
tration from 1990 to 1997, where 
he spearheaded efforts to acceler¬ 
ate drug review, improve food 
labels and curb teenage tobacco 
use. In 2000 the Elizabeth Glaser 
Pediatric AIDS Foundation created 
the Glaser Pediatric Research Net¬ 
work, which consists of five aca¬ 
demic medical centers that collab¬ 
orate on finding better treatments 
for seriously ill children, training 
pediatric clinical investigators and 
serving as a united voice to advo¬ 
cate for policies that improve 
children’s health worldwide. 
WILLIAM V. TAMBORLANE JR., 
M.D., professor and section chief 
of pediatric endocrinology, is 
heading a national group that will 
be testing the most advanced 
blood sugar sensing technology 
for children with type i diabetes, 
research that may lead to the first 
artificial pancreas.The project, 
involving five centers around the 
country, is sponsored by the 
National Institute of Child Health 
and Human Development. In addi¬ 
tion to Yale, the group includes 
diabetes centers at the University 
of Colorado, Stanford University, 
the University of Iowa, and in Jack¬ 
sonville, Fla. The first study the 
centers will undertake is validat¬ 
ing the accuracy of the two avail¬ 
able glucose sensors and how 
they work under various condi¬ 
tions, such as during exercise or 
after eating different meals. 
ANTHONY N. VAN DEN POL, 
ph.d., professor of neurosurgery, 
was awarded a $1.4 million grant 
from the National Institutes of 
Health to study a neurotransmit¬ 
ter whose loss in the brain is 
believed to be responsible for nar¬ 
colepsy, an often-misunderstood 
disease marked by an uncontrol¬ 
lable desire to sleep. The grant 
will enable van den Pol and col¬ 
leagues in his lab, including Xiao- 
Bing Gao, ph.d., and Ying Li, ph.d., 
cellular electrophysiologists, and 
Prabhat K. Ghosh, ph.d., associate 
research scientist, to focus on 
the electrical behavior of the 
nerve cells in the hypothalamus 
that make hypocretin. 
SEND FACULTY NEWS TO 
Claire Bessinger, Yale Medicine, 
P.O. Box 7612, New Haven, CT 
06519-0612, or via e-mail 
to claire.bessinger@yale.edu. 
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42 students 
top As usual, pranks by other classes abounded 
at the Saturday night performance. This year 
a balloon mocked the show’s title. 
above Nancy Angoff, one of the show’s many 
targets, wears a bemused smile as the 
Class of 2004 teases her, with affection. 
ANOTHER SECOND-YEAR SHOW: 
UTTERLY FORGETTABLE, 
AND WELL WORTH REMEMBERING 
Behind every great fortune, the saying 
goes, lies a great crime. The same could 
be said of the second-year show. Always 
committed with the best of intentions, 
the foul deed exists largely to drive the 
plot forward and send second-year stu¬ 
dents singing and dancing to a finale of 
forgiveness. In recent years the crimes 
have included the theft of the Cushing 
brain collection and the cloning of 
Robert H. Gifford, m.d., hs ’67, the for¬ 
mer deputy dean for education. The 
crime in O Doctor, Where Art Thou?, the 
revue presented by the Class of 2004 in 
February, was the kidnapping of Dean 
David A. Kessler, m.d. It fell to the 
second-years to find and rescue the dean 
since, as the script would have it, fourth- 
years were on the wards, first-years were 
busy with their studies and third-years 
just wouldn’t show up. 
The second-years raced through the 
medical school in search of Kessler, 
displaying a preoccupation with strange 
diseases, first-year students, sex, 
digital rectal exams, third-year students, 
anatomy professors, fourth-year stu¬ 
dents and bodily functions. 
One of the show’s leading targets 
this year was Nancy R. Angoff, m.p.h. 
’81, m.d. ’90, hs ’93, associate dean for 
student affairs. In a devastating imper¬ 
sonation, Michael Shapiro donned a 
salt-and-pepper wig plus Angoff’s trade¬ 
mark calf-length skirt, boot and sweater 
combination, as he portrayed her 
announcing the dean’s kidnapping to 
shocked students. 
Angoff herself then appeared from 
the wings angrily demanding, “Who the 
hell are you?” By the end of the scene, 
Angoff and Shapiro were singing a duet 
of “Bosom Buddies.” 
“You know I ’ll always be there 
for you if you ever have a problem,” 
sang Angoff. 
“Yeah, if I plan my problem three 
months in advance. Louise said you’re 
booked until May,” answered Shapiro. 
No show would be complete without 
a dig at the dean and his past as a 
thorn in the side of the tobacco industry. 
With the dean missing, an impostor 
takes his place, but gives himself away 
by remembering people’s names and, 
yes, smoking cigarettes. By show’s end 
the kidnapper is revealed to be Peggy 
Bia, m.d., professor of medicine. Her 
motive? Kessler rejected her proposal 
for a symposium on—what else—sex. 
At the end, the real Kessler confronts 
Bia, portrayed by Margo Simon, only to 
forgive her. After a tap dancing sequence 
featuring Jillian Catalanotti, Reena 
Rupani. Richard Chung, Michael Shapiro 
and Carlos Wesley, the entire Class of 
2004 took the stage to sing the praises 
of Yale Med to the tune of “Footloose.” 
"It’s Yale Med, Yale Med 
Just as great as they said 
Tests—pass/fail 
Submit them over e-mail... 
Everything’s great at Yale Med.” 
43 
top Kavita Mariwalla played the host and 
Spencer Epps bared his chest as the cabana boy 
in "Who Nabbed the Dean?,” a game show 
spoof, middle Allyson Bloom in “Club Med,”a 
dance sequence in the second act. bottom 
Dean David Kessler appeared as himself in “The 
Payoff” as he returned from his "kidnapping.” 
top Cordelia Carter and Elena Gimenez in “Sex¬ 
ual History," which made fun of doctor-patient 
encounters, bottom For the traditional finale, 
the entire class gathered on stage to sing 
“Everything is Great at Yale Med!!!!” 
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44 Alumni 
At "the game” 
The latest installment of “The Game” brought 
almost 400 alumni, faculty, students and 
their guests to the Yale Bowl on November 17. 
A lunch of New England clam chowder, hot 
dogs, chicken breasts, steak burgers, veggie 
burgers and five-year kettle beans, served 
by Dean David Kessler, preceded the game. 
Despite high spirits and splendid weather, the 
game ended in a loss, as Harvard’s football 
team trounced Yale, 35-23. top left Anya 
Szeglin Enriquez, scheduled to graduate next 
year, with her daughter, Acadia, and husband, 
Louie, a fourth-year medical student, bot¬ 
tom left Jorge Galvez, a first-year medical 
student, escorted Clara Saldarriaga, a medical 
student from Medellin, Colombia, who was 
at Yale for a cardiology rotation, top right 
John Muller, from the Class of 1991, brought 
his wife, Suzanne, and their three children, 
Carolyn, John and James, to the game, bot¬ 
tom right John Forrest, director of student 
research, and Ombudswoman and Associate 
Dean Merle Waxman cheered the team. 
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45 
A decontamination crew wearing hazmat suits 
stands outside Ottilie Lundgren’s Oxford, Conn., 
home after the house was declared a crime 
scene in late November. 
SPOTLIGHT FALLS 
ON ANTHRAX CASE 
After the fifth fatal exposure last fall, 
alumni in Connecticut pieced together 
the clues behind death of woman, 94. 
A case of inhalation anthrax discovered 
in a small Connecticut hospital in 
November gave Ramin Ahmadi, m.d., 
m.p.h. ’97, the scare of his life—and 
he was 7,000 miles away. 
Ahmadi, program director for inter¬ 
nal medicine at the 160-bed Griffin 
Hospital in Derby, Conn., was spending 
a lonely evening in the small city of 
Maizuro, Japan, where he’d just arrived 
to teach a course on health and human 
rights at the local hospital. Ahmadi had 
settled down on the sofa with a book 
and an Asahi beer. He was half watch¬ 
ing the news in Japanese when Patrick 
Charmel, m.p.h. ’83, his boss from 
back home, appeared on the screen. 
“I wondered,” said Ahmadi, “if I was 
having visual hallucinations.” 
Charmel, the president and ceo of 
Griffin Hospital, was on every channel. 
Searching for a program in English, 
Ahmadi switched to cnn and soon had 
an explanation: a 94-year-old woman 
from the rural town of Oxford, Conn., 
had been diagnosed with anthrax. She 
was a patient at the community hospital 
where Ahmadi worked. 
Back in Derby, Charmel and Kenneth 
J. Dobuler, m.d. ’76, hs ’79, chair of 
medicine at Griffin, were caught in what 
Dobuler described as a media maelstrom. 
The calls from journalists began minutes 
after word got out on Tuesday, November 
20, that a patient at Griffin had inhalation 
anthrax, and attention intensified when 
she died the next day. Television satellite 
trucks encircled the hospital. 
When Ottilie Lundgren had arrived 
at the hospital the Friday before, she 
seemed to have a mild illness and 
was admitted largely because she lived 
alone. Her case looked more compli¬ 
cated by the next morning, a Saturday, 
when four blood cultures were found 
to contain sporulating gram-positive 
bacteria. When Lydia Barakat, m.d., fw 
’00, heard about the lab results that 
morning, she drove to the hospital to 
have a look. Barakat, who had trained 
at Yale in infectious diseases the year 
before, recalls telling the laboratory 
technician: “This looks exactly like 
anthrax, but what are the odds?” She 
didn’t think it was a likely diagnosis 
for an elderly woman living in a rural 
town in Connecticut. 
She did take the possibility seriously 
enough to ask Lundgren if she’d opened 
any powdery mail; Lundgren remem¬ 
bered none. Barakat prescribed three 
antibiotics, including Cipro. By Monday, 
with more test results in, Barakat felt 
pretty sure she was seeing anthrax. 
Lundgren was getting sicker. Still, the 
treatment had begun early. “I had 
hope,” Barakat said. 
When State Epidemiologist James L. 
Hadler, m.d., m.p.h. ’82, heard about 
the case that Monday morning, he was 
incorrectly told that only one blood 
culture had come back positive for the 
bacillus. “I was a little bit skeptical,” 
said Hadler, an assistant clinical profes¬ 
sor of epidemiology and public health at 
Yale. He suspected the positive culture 
might have resulted from contamina¬ 
tion on Lundgren’s skin when the blood 
was drawn. 
Since early October, when letters 
containing anthrax were sent to promi¬ 
nent politicians and journalists, the 
state health department lab had been 
working seven days a week on “powder 
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46 Alumni 
incidents.” “We were already in full 
anthrax mode without having had a sin¬ 
gle case of anthrax,” said Hadler. “Since 
early October, my job had been 100 
percent anthrax.” Suspicious substances 
had included nondairy creamer and 
powdered sugar. 
Despite his skepticism, Hadler 
arranged for immediate transportation 
of the organism to the state laboratory, 
which was able to do confirmatory tests 
not done in hospitals (a phage test and 
a direct fluorescence antibody test). By 
Tuesday morning it seemed clear that 
Lundgren had anthrax. Hadler called 
the state health commissioner, the fbi 
and the Centers for Disease Control 
and Prevention (cdc). In the next 24 
hours the cdc sent a dozen advisors to 
Hartford, since no one knew if Lund¬ 
gren would prove to be a lone victim or 
the first of many. 
The cdc wanted to get final confir¬ 
mation, based on a polymerase chain 
reaction test. When Hadler tried to 
send Lundgrerfs blood on the next 
flight from Connecticut to Atlanta, the 
airline balked. Hadler says there’s no 
way to get anthrax from bacillus in 
blood, even if it spills, but the cdc had 
to send its own plane. Meanwhile, 
staff from the fbi, the state police and 
the state Department of Environmental 
Protection drove to Oxford and cor¬ 
doned off Lundgren’s house. 
Back at Griffin Hospital, Charmel 
knew he needed to talk to Griffin 
employees before the story became pub¬ 
lic. More than 300 of the 1,100 hospital 
staff members attended a meeting that 
afternoon. Charmel told them about the 
case, urged them not to tell anyone 
the patient’s name if they knew it and 
reassured them that anthrax could not 
be spread from one person to another. 
At about the same time, word of the 
case reached the media: Gov. John G. 
Rowland had announced a 5 p.m. press 
conference on a Connecticut anthrax 
case, and “about two minutes after that 
went out on the [news] wire,” Charmel 
said, “the phone began to ring off the 
hook.” He had a plan for responding. 
“The conventional wisdom is to pick a 
single hospital spokesman,” said 
Charmel. “My gut told me that wasn’t 
right in this situation." The press, he 
said, “wanted to talk to clinicians. The 
public needed to see and hear from 
credible experts, to be reassured that 
everything possible was being done for 
the patient and that they were getting 
accurate information.” The panel that 
answered reporters’ questions included 
Charmel, Dobuler, Barakat and Stephanie 
Wain, m.d., fw ’89, chair of pathology 
and laboratory medicine at Griffin. 
(Ironically, Dobuler is a rarity among 
American physicians in having seen 
anthrax outside a textbook. As a Yale 
medical student, he spent three months 
studying infectious disease in Iran, 
where cutaneous anthrax is common 
among shepherds. Seeing anthrax then 
was interesting, he said, “but clearly 
irrelevant to my future.”) 
Charmel’s media panel held news 
conferences and answered reporters’ 
questions nonstop until 1 a.m. A 
Washington Post reporter even managed 
to get Dobuler’s pager number. On the 
whole, Dobuler said, “the press did a 
remarkably credible job given the frenzy.” 
Although the hospital refused to name 
the patient, it didn’t take long for 
reporters driving around Oxford to locate 
a house surrounded by yellow tape and 
monitored by people in white suits. 
Lundgren died Wednesday morn¬ 
ing—“a very sweet lady who was 
beloved by her family ... murdered,” 
said Dobuler. She was the fifth Ameri¬ 
can since early October to be killed by 
anthrax. Although investigators never 
found anthrax spores in her house, 
Hadler said investigators are now “pretty 
sure” that Lundgren was exposed to con¬ 
taminated mail. Spores were later found 
on four mail-sorting machines in the 
Wallingford, Conn., distribution center, 
including the bin that contained mail 
for Lundgren’s route. 
Hadler says the case seems to dis¬ 
prove animal studies suggesting that 
thousands of spores are needed to cause 
an infection. “In theory,” he said, “one 
spore, in the right place at the right 
time, can do it. She seems to have had a 
low-dose exposure.” 
The day that Lundgren died, Ahmadi 
returned to teaching his course at the 
Japanese hospital to find himself an 
object of interest. Physicians, residents, 
interns—even the cleaning woman— 
had seen his supervisor on television 
and were asking about Griffin Hospital 
by name. 
Traveling halfway around the world, 
said Ahmadi, “you think you are get¬ 
ting away from New Haven and Griffin 
and Yale and your usual surroundings. 
You think you are somewhere very 
far away. Then you are reminded that 
you’re part of a little global village. It’s 
kind of unsettling.” 
47 
A Boston reunion 
Over cocktails and hors d’oeuvres, about 
50 Boston-area alumni and guests gathered 
at a reception at the Cafe Louis on Berkeley 
Street on February 21. The alumni spanned 
nearly a half-century, from 1955 to 2001, 
and included house staff and public health 
alumni. Among those attending were 
from top Katherine Auerswald, Class of 
1998, with her husband, Phil, and their 
daughters; Floyd Atkins (left), who completed 
his residency at Yale in 1967, and Daniel 
Arons, Class of 1967; Michele Baker, Class of 
1997, James Morgan IV and Elissa Arons, Class 
of 1970; Padraic Burns, Class of 1955, with 
Iko Burns and Associate Dean Jane Reynolds 
(center);and far right Elliott Marcus, who 
completed his residency at Yale-New Flaven 
Hospital in 1959, came with his wife, Nuran 
Turksoy-Marcus, also a physician. 
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48 Alumni 
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Past President 
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Cynthia B. Aten, m.d. '81 
Susan J. Baserga, m.d. '88, ph.d. '88 
Sharon L. Bonney, m.d. ’76 
Arthur C. Crovatto, m.d. '54, hs '61 
Joseph F.J. Curi, m.d. '64 
Evangeline Franklin, m.d. '82, m.p.h, '82 
Carol Goldenthal, m.d. ’44 
David H. lippman, m.d. '71 
Harold R. Mancusi-Ungaro Jr„ 
m.d. 73, hs '76 
Romeo A. Vidone, m.d. ’57, hs '58 
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Ex officio 
David A. Kessler, m.d. 
Dean 
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Associate Dean 
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Chair, Medical School Alumni Fund 
Samuel D. Kushlan, m.d. '35 
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Association of Yale Alumni 
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Arthur Ebbert Jr., m.d. 
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NOTES 
1940s 
AARON T. BECK, M.D.'46, profes¬ 
sor emeritus of psychiatry at the 
University of Pennsylvania, was 
named a Fellow of the American 
Psychological Association (apa) for 
2002. apa fellows are selected for 
their contributions to the research, 
teaching or practice of psychology. 
The apa, headquartered in Wash¬ 
ington, is the largest scientific 
and professional organization rep¬ 
resenting psychology in the 
United States. 
RICHARD W. FINNER, M.D., 
hs ’49, a psychiatrist from San 
Bernardino, Calif., writes to say 
that he has retired. 
Since retiring from the practice of 
internal medicine eight and a half 
years ago, david e. morton, 
m.d. ’48, hs ’55, has been busy 
writing books, playing tennis, 
bowling, motorboating, and trav¬ 
eling around America and Japan. 
Morton writes that he misses 
his former patients, colleagues 
and nurses, but not the stresses 
of HMOs, malpractice, Medicare 
and Medicaid. 
196OS 
HAROLD J. ALFERT, M.D., HS ’65, 
retired in December from the 
faculty of the department of 
urology at The Johns Hopkins Uni¬ 
versity School of Medicine. Alfert 
writes that he plans to do "gentle¬ 
man farming" on a newly pur¬ 
chased farm in central Virginia. 
JOHN D. BAXTER, M.D. ’66, HS 
’68, professor of medicine and 
director of the Metabolic Research 
Unit at the University of Califor¬ 
nia, San Francisco, has endowed 
the John D. Baxter Lectureship in 
Endocrinology at the Yale Medical 
School. The Baxter Lectureship is 
given biannually to an individual 
who has made seminal contribu¬ 
tions to the field of endocrinology. 
LAURENCE A. BOXER,M.D., 
hs ’68, professor and director of 
pediatric hematology/oncology at 
the University of Michigan, was 
named the Norman Kretchmer 
Professor in September at his alma 
mater, Stanford Medical School. 
Boxer was the Grover Powers Lec¬ 
turer in Pediatrics at Yale in March 
2000. His wife, GRACE JORDISON 
boxer, m.d. ’68, is in the private 
practice of medical hematology/ 
oncology. Their son, David, is on 
the staff at Columbia Teachers Col¬ 
lege and is engaged to be married 
this year. 
ALICE COBB IPSEN, M.P.H. '67, 
who is retired and has lived in 
Denmark for the last 29 years, 
writes to say that "I draw, 
paint and make lithographs on 
stones—a far cry from public 
health.” During her career in 
public health, Ipsen was at the 
University of Pennsylvania 
and the University City Science 
Center in Philadelphia. 
NEAL KOSS, M.D.'66, HS '74, of 
Palos Verdes, Calif., is still practic¬ 
ing plastic surgery part time, while 
pursuing his hobbies, which 
include computers, photography, 
tennis and travel. Koss also writes 
that he now has three grandchil¬ 
dren to add to his enjoyment. 
ELI H. NEWBERGER, M.D.'66, 
hs '67, assistant professor of pedi¬ 
atrics at Harvard Medical School, 
child advocate and jazz musician, 
has been appointed to the 
Berklee College of Music board 
of trustees. Newberger plays 
piano but is best known as a jazz 
tuba player and has made over 
40 recordings with the New Black 
Eagle Jazz Band and others. 
CHARLES T. POST JR.,M.D.'68, 
an ophthalmologist, writes to say 
that he and his wife, Bonnie, spent 
three months sailing around Cen¬ 
tral America last winter."Too many 
pals getting heart attacks and can¬ 
cer, so I took the winter off from 
ophthalmology, bought a Little 
Harbor 58 named Flight—and away 
we went. I kept a journal of my 
impressions, one of which describes 
our visit with former classmate 
RODRIGO MARTINEZ, M.D.’68, 
in Honduras. We are both pilots, 
hence the name of my boat." 
197OS 
ROBERT W. BUCKINGHAM, 
ph.d. ’78, professor of public 
health at New Mexico State 
University, returned recently from 
a sabbatical in Thailand, where 
he was a distinguished visiting 
professor of public health at 
Mahidol University in Bangkok. 
49 
JAMES R. MERIKANCAS, M.D., 
hs ’73, of Chevy Chase, Md., is 
director of the neuropsychiatry 
program at the Georgetown 
University School of Medicine in 
Washington. Merikangas, also 
a lecturer in psychiatry at Yale, 
has begun a collaboration with 
the Center for Public Integrity in 
Washington, D.C., regarding 
the criminal justice system and 
prosecutorial misconduct. 
ROBERT M. PEARL, M.D.'72, a 
plastic and reconstructive surgeon, 
is executive director and ceo of 
The Permanente Medical Group Inc. 
(p/v\c),the largest medical group in 
the nation. Pearl, a member of the 
Federation Executive Committee of 
the PMC, is responsible for strategy 
development and implementa¬ 
tion of the national Internet and 
e-health care efforts for Kaiser 
Permanente, and on a national 
level he oversees the health care 
provided to eight million citizens 
across the nation. Classmate 
DAVID MOYER, M.D.’72, chief of 
the allergy department at Kaiser 
Permanente, sent this news to us. 
198OS 
DAVID A. COTTRELL, D.M.D., 
hs ’88, was named chair of the 
Department of Oral and Maxil¬ 
lofacial Surgery (oms) at Boston 
University School of Dental Medi¬ 
cine (busdm) in January. He is 
also the director of the oms Resi¬ 
dency Program and of OMS 
Resident Research at busdm. 
ROBERT V. LEVINE, M.P.H.'80, 
president and CEO of Peninsula 
Hospital Center in Far Rockaway, 
N.Y., received the Award of Dis¬ 
tinction from the Metropolitan 
Health Administrators’ Association 
(mhaa) in collaboration with the 
American College of Healthcare 
Executives at the mhaa annual 
dinner held in June in Queens, N.Y. 
DAVID R. MARKS, M.D. '89, a 
health reporter for wvit Channel 
30 in Connecticut for the past four 
years, is now a health reporter on 
The Today Show on NBC. In 2001, 
while at Channel 30, Marks won a 
statewide journalism award from 
the Connecticut Chapter of the 
Society of Professional Journalists. 
The award, the Best In-Depth Tele¬ 
vision Report of the Year, was for 
his story about the influence of 
pharmaceutical representatives on 
doctors’ prescription writing. 
199OS 
BRIAN C. COLE, M.D., M.P.H.'95, 
is an internist with the Maui 
Medical Group in Hawaii, where 
he runs the Lahaina Clinic on 
the island of Maui. Cole says that 
he loves his job, which includes 
working closely with the board- 
certified neurosurgeon on the 
island. He plans to open his own 
practice this winter in the town 
of Kihei. Cole lives in Maui, has 
a second home in Paris and likes 
to travel. 
ALBERTO PEREZ MORELL.M.D., 
fw ’98, writes to say "that thanks 
to [his] visiting research fellowship 
in plastic surgery at Yale with John 
A. Persing, M.D., and colleagues, 
[he is] able to share the knowl¬ 
edge with [his] fellows and stu¬ 
dents working in reconstructive 
microsurgery at Padre Rachads 
Oncology Hospital in Caracas.” 
While at Yale, Morell completed a 
research project, Further Investiga¬ 
tions on the Effect of Prolonged 
Clamping and Vascular Stasis on 
the Patency of Arterial and Venous 
Microanastomoses, which was 
presented at the New England 
Society of Plastic and Reconstruc¬ 
tive Surgery. 
PAULA I. WATNICK, M.D. '91, 
ph.d., assistant professor at Tufts 
University School of Medicine and 
New England Medical Center in 
Boston, received the Interscience 
Conference on Antimicrobial 
Agents and Chemotherapy Young 
Investigator Award from the 
American Society for Microbiology 
in December in Chicago. Watnick 
was given the award, which is 
sponsored by Merck U.S. Human 
Health, for her research on the 
environmental survival of Vibrio 
cholerae, the infectious agent 
responsible for cholera. Her genetic 
analysis of V. cholerae has 
advanced the understanding of 
bacterial evolution and the emer¬ 
gence of new pathogens and has 
defined environmental signals 
and regulatory genes that control 
the way V. cholerae attaches 
to surfaces, a process known as 
biofilm formation. 
SEND ALUMNI NEWS TO 
Claire Bessinger, Yale Medicine, 
P.O. Box 7612, New Haven, CT 
06519-0612, or via e-mail 
to claire.bessinger@yale.edu. 
from top David Morton walks his 
daughter Aiko down the aisle last 
July at her wedding in Colorado 
Springs; Laurence and Grace Jordison 
Boxer; Rodrigo Martinez (left) and 
classmate Charles Post next to 
Martinez’s Cessna 122 in Honduras; 
Brian Cole during a vacation to 
Santorini, Greece. 
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5° in Memoriam 
DAVID W. BARRY, M.D.'69, HS ’72, 
a prominent aids researcher, died 
on January 28 of a heart attack 
while on a business trip. He was 58. 
Barry graduated magna cum 
laude in French literature from 
Yale College in 1965 and received 
his medical degree from the 
School of Medicine. He served 
his internship and residency train¬ 
ing at Yale from 1969 to 1972. 
In need of an expert on yellow 
fever, the Food and Drug Adminis¬ 
tration (fda) recruited Barry, who 
had studied the disease for his 
thesis. A year later he became the 
deputy director of the agency’s 
virology division. 
In 1977 he joined Burroughs 
Wellcome and became head of 
clinical investigation, later serving 
as director of worldwide research. 
While at Burroughs Wellcome, one 
of his first tasks was to develop 
the herpes drug acyclovir. Barry 
also was a co-developer of azt, the 
first drug developed to treat the 
aids virus. Working with the FDA, 
the Burroughs Wellcome team 
pushed the drug through clinical 
and review stages in 22 months, 
establishing a model for fast-track 
approval of treatments for life- 
threatening diseases. He was an 
advocate for the aids ‘‘cocktail” 
treatment, which uses more than 
one drug to fight the infection. 
After 18 years, Barry left Bur¬ 
roughs Wellcome, when it merged 
with Glaxo Holdings pic., to help 
start Triangle Pharmaceuticals in 
Durham, N.C., where he served as 
CEO and chairman of the board. 
Barry saw Triangle as an opportu¬ 
nity to do the impossible in the 
field of drug development. Rather 
than focus on therapies for 
common ailments, he wanted to 
cure the incurable diseases. 
fred w. buse, M.D.’33, of Roslyn, 
N.Y., died on June 27,2001, of 
congestive heart failure at the age 
of 93. 
Buse, born in the Whitestone 
section of Queens in New York 
City, served during World War II in 
the Army’s medical field service 
school and received the European 
Theater of Operation Ribbon, the 
American Theater Ribbon and a 
Victory Medal. 
A general surgeon who later 
specialized in plastic and recon¬ 
structive surgery, Buse was known 
for his innovative treatment for 
patients with catastrophic burns. 
Buse had a private practice in 
Flushing, Queens, and in the Man- 
hasset Medical Center (now part 
of the Long Island Jewish Medical 
Center) until he retired in 1979. 
He served on the staff at the New 
York Hospital Medical Center of 
Queens and the New York Flushing 
Hospital Medical Center. 
An avid jogger, swimmer and 
sailor, Buse walked daily to his 
practice in Flushing. He was buried 
at sea in a military ceremony by 
the U.S. Coast Guard off Point 
Judith, R.l. 
EDWARD L. EYERMAN JR., 
M.D. ’57, a retired neurologist from 
St. Louis, Mo., died on December 15 
of complications from cancer. 
He was 69. 
Eyerman was among a group 
of neurologists and neurosur¬ 
geons who helped introduce the 
imaging techniques of computed 
tomography and magnetic reso¬ 
nance to the St. Louis area. After 
completing an internship and 
residency training at the Univer¬ 
sity of Virginia, the nih and 
Columbia, he returned to his 
hometown in 1964 as an assistant 
professor of neurology at the St. 
Louis University School of Medi¬ 
cine. He also established a private 
practice in St. Louis and later 
had offices in Belleville and south 
St. Louis County. 
In the mid-1970s Eyerman 
co-founded the former Neuroscan¬ 
ning Associates in St. Louis. He 
also did extensive research on 
multiple sclerosis and published 
widely on neurological advances. 
During his career Eyerman served 
on the medical staff at Memorial 
and St. Elizabeth hospitals in 
Belleville and St. Mary’s Health 
Center in Richmond Heights. 
JAMES R. FITZGERALD,M.D.’57, 
an orthopaedic surgeon from 
Ozona, Fla., died on December 9. 
He was 70. 
Born in Hartford, Fitzgerald 
graduated cum laude from the 
University of Connecticut in 1953 
before studying medicine at Yale. 
He practiced orthopaedic surgery 
in the Hartford area for more 
than 25 years, and was a member 
of the American Academy of 
Orthopaedic Surgeons. Fitzgerald 
retired to Naples, Fla., in 1984 and 
moved to Ozona in 1995. 
EDGAR L. GEI B El, M.P.H.'49, Of 
Stamford, Conn., died at the High¬ 
land Center in Brackenridge, Pa., 
on December 8 of complications 
from acute inflammatory bowel 
disease. He was 90. 
Geibel, born in Butler, Pa., 
served as the health officer for the 
city of Butler from 1936 to 1943. 
He attended the Carnegie Insti¬ 
tute of Technology and graduated 
from the University of Pittsburgh 
in 1941. He served as a captain in 
the Army Medical Corps from 1943 
to 1947 on the hospital ship 
Chateau Thierry. He was awarded 
the World War II Victory Medal, 
the European-African-Middle 
Eastern Campaign Medal, the Army 
Commendation Ribbon, the Ameri¬ 
can Campaign Medal and the 
Asiatic Pacific Campaign Medal. 
After receiving his master’s in 
public health, Geibel served for 
five years as the assistant director 
of Genesee Hospital in Rochester, 
N.Y. In 1954 he returned to Con¬ 
necticut and began a 23-year 
tenure at Stamford Hospital as 
chief administrator. Under his 
leadership the hospital experi¬ 
enced significant change and 
growth. Geibel was a lecturer in 
epidemiology and public health 
at Yale from 1961 to 1978. His affili¬ 
ation with the Connecticut Hospi¬ 
tal Association (cha) spanned 
more than four decades; he served 
on various committees from 1955 
to 1979 and as president of the 
cha from 1964 to 1965. After his 
retirement he was a special advi¬ 
sor to the cha from 1977 to 1983. 
JACOB D. GOLDSTEIN, M.D.,a 
retired anesthesiologist, died on 
February 3 at the age of 89. 
Goldstein was a clinical instruc¬ 
tor in anesthesiology at Yale 
from 1969 to 1970, when he was 
named assistant clinical professor. 
Goldstein became associate 
clinical professor of anesthesiology 
in 1982. 
JAMES O. HARALAMBIE, M.D.’35, 
a retired pediatrician, died of 
cancer on January 6 at The Con¬ 
necticut Hospice in Branford. 
He was 92. 
Born in Philadelphia, 
Haralambie earned his a.b. degree 
in 1931 from Oberlin College and 
his M.D. from Yale. He interned at 
the Massachusetts General 
Hospital, where he was on the 
house staff in pediatrics from 
1935 to 1936, and did his residency 
in pediatrics at Children’s Memo¬ 
rial Hospital in Chicago from 
1937 to 1939. Haralambie was 
an instructor in pediatrics and 
director of the Pediatric Outpa¬ 
tient Service at the New York 
Hospital, Cornell University Med¬ 
ical College, from 1939 to 1941. 
Haralambie started a private 
practice in Larchmont, N.Y., in 
1941, but in 1942 he joined the 
Army as a captain. In 1946 he left 
the service with the rank of 
major after commanding the 183rd 
Station Hospital in Alaska. He 
resumed his practice until his 
retirement in 1978. 
Haralambie also taught 
pediatrics at New York Hospital, 
retiring as clinical professor of 
pediatrics emeritus and honorary 
attending physician. He served 
as president of the Westchester 
County Medical Society from 
1965 to 1966. 
DAME SHEILA S H E R LOC K, M.D., 
FW '48, an authority on liver 
disease and a pioneer in the sci¬ 
ence of hepatology, died on 
December 30 at her London home. 
She was 83. 
Born in England, Sherlock 
earned her medical degree from 
the University of Edinburgh, 
Scotland, in 1941, after medical 
schools in England refused to 
accept her because of her gender. 
She became chair of the Royal 
Free Hospital’s Department of 
Medicine in 1959, where she 
helped set up and direct a clinical, 
research and training center for 
liver disease. 
Sherlock was at Yale from 1947 
to 1948 as a Rockefeller Founda¬ 
tion postdoctoral fellow working 
with physiologist C.N.H. Long, 
M.D., who was then dean of the 
medical school. In 1966, she 
helped create what is now a stan¬ 
dard test for diagnosing primary 
biliary cirrhosis, and in 1971 she 
showed that treating autoim¬ 
mune hepatitis with steroids was 
effective. Her reference book, 
Diseases of the Liver and Biliary 
System, now in its nth edition, 
"put liver disease on the interna¬ 
tional map,” according to James L. 
Boyer, M.D., director of the Yale 
Liver Center. Peter Scheuer, M.D., a 
colleague of Sherlock’s who wrote 
an appreciation of her career in 
Britain's Guardian newspaper in 
January, said that when she was 
starting out “the specialty of 
hepatology did not exist; Sherlock 
was its main creator, and, in a 
glittering 60-year career, became 
one of the world’s most famous 
names in clinical science.” 
RICHARD C. THOMPSON, M.D., 
hs ’46, of San Mateo, Calif., died 
on October 8,2000, at his home. 
He was 80. 
Thompson, a California native, 
received his medical degree 
from Stanford. He served in the 
Navy during World War II as a 
physician in Guam, Saipan and 
Japan.Thompson completed his 
residency in anesthesiology at 
Yale. In i960 he practiced on the 
hospital ship hope, and in 1968 
he embarked on a missionary 
practice in Ghana, where he origi¬ 
nated a new treatment for ven¬ 
omous snakebites. 
Thompson designed a 
mechanical retractor that bears 
his name and is used around the 
world to alleviate problems of 
manual retraction at the operat¬ 
ing table. He was on the staff of 
Mills-Peninsula Health Services in 
California for more than 30 years. 
RUTH WHITTEMORE, M.D., HS 44, 
a retired pediatric cardiologist who 
provided pre- and postoperative 
care for the baby who received the 
first “blue-baby" operation, died on 
December 27. She was 84. 
Whittemore, a graduate of The 
Johns Hopkins University School 
of Medicine, joined the Yale faculty 
in 1947 as an instructor of pedi¬ 
atrics. At the request of the Fed¬ 
eral Children’s Bureau in 1947, she 
established and served as director 
of the first rheumatic fever and 
cardiac clinic in New England, 
which was located in the pedi¬ 
atrics department at Yale. 
With the introduction of 
penicillin, the incidence of 
rheumatic fever began to decline 
and Whittemore devoted more 
of her time to children with con¬ 
genital cardiac abnormalities. Her 
major research contribution to 
this field was a detailed, long¬ 
term follow-up study of her 
former patients to ascertain the 
congenital anomalies in the 
next generation. 
During her 45 years at Yale, 
Whittemore also served as instruc¬ 
tor of pediatrics, clinical professor 
of pediatrics and director of pedi¬ 
atric cardiology. She created and 
directed a lipid clinic to evaluate 
the children of parents who had 
died from heart attacks or strokes. 
SEND OBITUARY NOTICES TO 
Claire Bessinger, Yak Medicine, 
P.O. Box 7612, New Haven, CT 
06519-0612, or via e-mail 
to claire.bessinger@yale.edu. 
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Archives 
Reinventing surgery continued from page 23 
the operating room, not later. If it comes back malignant, then 
we’ve done a really good thing.” 
"Say ‘E’ for me,” he tells the patient. 
“Eeeee,” says the man, from behind the drape over his face. 
“That’s so good,” says Udelsman. “It makes me so happy 
to hear that!” 
Udelsman pulls off his latex gloves and writes notes about 
the case. Leaving the operating room, he lowers his mask 
to reveal a trim graying beard, grabs his briefcase, and walks 
quickly down the hall, through the surgeons’ lounge and 
into the cramped transcription room. He picks up the dictation 
phone and spits out the details of the case without checking 
his notes or seeming to pause for a breath. The dictation com¬ 
plete, he takes a yogurt out of his briefcase and phones his 
office. For a promotions committee meeting later that day, he 
wants to know, "Am I leading this committee this afternoon, 
or am I going for the ride?” He asks about plans for a depart¬ 
ment party at his home and reminds his administrative 
assistant about a problem with his computer. He finishes his 
yogurt, tosses the container in the trash and pricks his finger 
to check his glucose levels. He has type 1 diabetes, diagnosed 
less than two years before at age 43, and he wears a glucose 
pump. He chomps half a glucose tablet, snaps closed his brief¬ 
case and heads out to greet the next patient. After two more 
operations, he will attend committee meetings for admissions, 
promotions and fund-raising and meet with the dean of the 
School of Medicine. If he can find time before heading home 
at 8, he will work on his article for the Annals of Surgery, “656 
Consecutive Explorations for Primary Hyperparathyroidism.” 
“My biggest problem is time management,” he says. 
But for now, he is heading back to where he wants to be: 
in the OR, teaching a resident and a medical student how 
to do what he does. 
“It’s not how many thyroids can I do in my lifetime. Isn’t 
it far better if I teach another generation to do it well?” ym 
YALE MEDICINE 
FROM “FIFTEEN YEARS OF 
GROWTH: YALE MEDICINE 1952- 
1967” IN THE SPRING 1967 
issue: “Speaking at the Yale 
Alumni Meeting in St. Louis in Jan¬ 
uary this year, Dean [Vernon] 
Lippard noted:‘When Whitney 
Griswold invited me to take on 
the deanship (in 1952), he pointed 
out a number of problems that 
had to be faced, and I soon discov¬ 
ered others. The physical plant 
had many deficiencies; the rela¬ 
tionship with the Grace-New 
Haven Hospital, as it was then 
called, was cordial but needed 
definition; the clinical depart¬ 
ments did not, in general, measure 
up to the predinical; the Depart¬ 
ment of Public Health was seri¬ 
ously undernourished; and there 
was, as there still is, need for 
more financial support for opera¬ 
tion. On the other hand, there 
were assets that money could not 
buy—association with a great 
university; a glorious tradition; a 
faculty that, although thin in 
spots, was loyal and devoted; and 
a brilliant group of students.’ ” 
cathy shufro is a contributing editor of Yale Medicine. 
gale zucker is a photographer based in Branford, Conn. 
YALE MEDICINE 
FROM "RESEARCH IN MOLECU¬ 
LAR BIOLOGY,” WINTER 1970: 
"A new department of Molecular 
Biophysics and Biochemistry was 
established at Yale last year to 
promote the interaction between 
advanced research in the biologi¬ 
cal sciences and the development 
of clinical techniques in medicine. 
It brought together two disci¬ 
plines that were previously in sep¬ 
arate departments. 
"The former Department of 
Biochemistry at the medical 
school was one of the oldest in 
the country, having been founded 
in 1875 as the Department of 
Physiological Chemistry. The for¬ 
mer Department of Molecular 
Biophysics was part of the Yale 
Faculty of Arts and Sciences 
and grew out of the Department 
of Physics shortly after World 
War II.... 
“In the past decade, with the 
enormous proliferation of knowl¬ 
edge in the biological sciences, 
department lines have become 
more and more arbitrary. It has 
been especially difficult to draw 
any intellectually meaningful 
boundaries for molecular biology, 
which now pervades the entire 
field. Thus, the joining of Molecu¬ 
lar Biophysics and Biochemistry in 
one department brings together 
investigators whose studies range 
from questions of theoretical 
physics and chemistry to prob¬ 
lems of clinical medicine." 
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THESE PACES 
Before starting her residency at 
Yale, Monique Tello traveled to 
Guatemala City for training in a 
pediatric burn unit. While she 
was there, she jearned something 
about her own family and her 
attitudes about poverty, wealth 
and suffering. 
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ON THE COVER 
Twenty-five faces from the Class of 
2002 reflect the elation and aspira¬ 
tions of a new generation of doc¬ 
tors and public health practitioners. 
The University awarded 112 med¬ 
ical degrees, 114 master’s degrees 
in public health and nine doctoral 
degrees in public health. Students 
in the Physician Associate Program 
will graduate at summer’s end. 
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Eyes wide open 
The suffering of the boy who had fallen into boiling water 
was like the misery of the city’s streets: possible for 
some to ignore but searing to a medical student working 
in the hospital’s burn unit. A letter from Guatemala. 
By Monique Aurora Tello, m.d. 
Commencement 2002 
A large class, an inspired speaker and a tall order— 
to do some good in the world. 
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Letters 
HOW TO REACH US 
Yale Medicine welcomes news 
and commentary. Please 
send letters to the editor and 
news items to Yale Medicine, 
P.O. Box 7612, New Haven. 
CT 06519-0612, or via elec¬ 
tronic mail to ymm@yale.edu, 
and include a daytime tele¬ 
phone number. Submissions 
may be edited for length, 
style and content. 
State-of-the-art surgery 
Dr. Robert Udelsman's concerns 
about departmental fiscal 
efficiencies reminded me of a 
study that indicated hospital 
business offices had the most 
timely and comprehensive 
details about a patient’s hospital 
stay. Every chargeable service 
and material used (or at times 
anticipated) was immediately 
transmitted to the hospital 
business office. Business office 
records, with professional input, 
are excellent resources for 
up-to-the-minute patient infor¬ 
mation. Dr. Udelsman may be 
assured that the hospital 
business office is right there 
in the OR with him. 
A.Z. Hamburg, m.p.h. 54 
Philadelphia 
I’ve been reading Yale Medicine 
for a good many years, but 
never once do I recall this publi¬ 
cation ever telling us that 
Yale’s Department of Surgery 
was "in the doldrums.’’ 
Quite the contrary. The arti¬ 
cles always gave us the impres¬ 
sion of a state-of-the-art 
department filled with talented, 
dedicated people. Who was 
chair of the surgical department 
when Yale was “in the dol¬ 
drums?" I’m sure he’d have a few 
words on that. 
John Barchilon, m.d. ’65 
Sherman Oaks, Calif. 
A thing of beauty 
I am on the list of those who 
receive Yale Medicine. I can’t tell 
you how much I enjoy this publi¬ 
cation. Each page is an artistic 
delight and tells the story with 
simplicity and dignity. 
Ian Minin berg, mus ’34 
New Haven 
As we went to press 
At press time we received the 
sad news that Albert J. Solnit, 
m.d., hs ’52, died following 
an automobile accident in Beth¬ 
lehem, Conn. Solnit and his 
wife, Martha, were en route to 
their weekend home in Lakeville 
when the accident occurred 
on June 21. Martha Solnit was 
recuperating in Waterbury 
Hospital following the crash. 
Solnit, 82, came to Yale in 
1948 as a resident in general 
psychiatry and was the first 
child psychiatry resident from 
1950 to 1952. He served as 
the third director of the Child 
Study Center from 1966 to 
1983, when he was succeeded 
by Donald J. Cohen, m.d. ’66. 
Cohen died last October 2 
of melanoma. A collaborator of 
Anna Freud, Solnit was a Ster¬ 
ling Professor at Yale and, from 
1991 to 2000, Connecticut’s 
commissioner of mental health 
and addiction services. 
“He was a professional 
father throughout my career,” 
said John Schowalter, m.d., 
the Albert J. Solnit Professor of 
Child Psychiatry. “As a mentor, 
he was always accessible and 
combined both a wise brain and 
a moral backbone.” 
Alan E. Kazdin, ph.d., who 
became the center’s fifth direc¬ 
tor in April, called Solnit’s death 
“a huge loss for the Child Study 
Center, for the faculty and staff, 
and for children everywhere. 
“Al Solnit was a monumental 
figure in child psychiatry, a 
pioneer,” said Kazdin. “He had 
enormous impact on individ¬ 
uals because of his acumen as 
a clinician, and at the same 
time he had a major influence 
on the profession throughout 
the world.” 
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From the Editor 
Hand-eye coordination 
It’s been a humbling spring here at Yale Medicine headquar¬ 
ters. Just when we thought we had come up with the perfect 
design for the magazine, a number of letters and comments 
pointed out a small flaw in our master plan. A tiny flaw. 
A miniscule yet serious flaw, if one takes one’s mail to heart, 
as we do. “Yale Medicine is attractive in layout. I am very 
interested in reading it but am unable to do so,” Thomas L. 
Buckey, m.d. ’43 Dec., wrote. “The design and type selec¬ 
tion must have been made by a very young person and 
amounts to elder abuse.” He was only half joking. 
1 phoned Dr. Buckey as this issue was in layout stage 
to assure him that none of us on the magazine’s staff is a 
day under 40, that many of us have failing eyesight and that 
we have come to agree that the type shrank a little too much 
during Yale Medicine’s redesign last autumn. Readers will 
notice a significant increase in the type size in this issue, 
and our page format is returning to a full 8.5-by-n inches 
to accommodate the change. The Summer issue is also a bit 
lighter than our other three, down to 32 pages from our 
Vooa' A. VAH L£0AA/&MHo&K.'n 
normal 48 or more, as is befitting the season. The Autumn 
2002 issue, with a beefed-up alumni section and complete 
reunion coverage, will return to full strength. 
This edition’s main feature story continues our “Letter 
from ...” series with a narrative by second-year medicine resi¬ 
dent Monique Tello, m.d., from her experience working in 
a pediatric burn unit in Guatemala City. Medicine is increas¬ 
ingly crossing borders geographic, political and cultural, 
and given Yale’s international focus at the start of its fourth 
century, the “Letter from ...” articles have been enormously 
popular. If you have such a story, please share it with us. 
Meanwhile we’ll keep our eyes on the big picture as 
well as the fine print, responding to your interests and 
concerns as alumni. “No, you don’t have to send a large-print 
edition—just a normal-size print one,” Dr. Buckey wrote. 
Done. 
Michael Fitzsousa 
michael.fitzsousa@yale.edu 
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chronicle news from cedar street 
Neurosurgeon Dennis Spencer believes 
new imaging technology could permit targeted 
surgery or drug delivery. 
Yale sets its sights on 
biomedical engineering 
Program gets a boost from nih’s 
newest institute with $7.1 million for 
imaging work in epilepsy. 
In 1996, when President Richard C. 
Levin laid out his vision for the Univer¬ 
sity’s future in an essay titled “Prepar¬ 
ing for Yale’s Fourth Century," he said 
that the principle of “selective excel¬ 
lence” would guide Yale as it branched 
out into certain new fields. “Rather than 
seek broad coverage of an entire disci¬ 
pline,” he wrote, “it may be wise to build 
a few distinguished groups of faculty 
who can compete with the best in the 
world in their areas of specialization.” 
One of the areas Levin pointed to 
was biomedical engineering, a field that 
got its start when engineering strat¬ 
egies contributed to medical inventions 
such as X-rays and prosthetics. After 
World War II the field gained more for¬ 
mal acceptance as universities and 
hospitals discovered that radar and com¬ 
puters had medical applications. In 
1998 Yale established an undergraduate 
biomedical engineering program, which 
has since become the most popular 
engineering major. Access to medical 
research facilities encouraged doctoral 
candidates in the applied physics and 
mechanical, chemical and electrical 
engineering departments to explore bio¬ 
logical problems. A ph.d. concentration 
focusing on medical imaging, molecu¬ 
lar engineering and biomechanics was 
formally approved late last year, and five 
students will be admitted this year. 
Biomedical engineering at Yale 
got another boost in April, when the 
National Institute of Biomedical 
Imaging and Bioengineering (nibib) 
awarded its first research grant to Yale 
and two other institutions. As a mem¬ 
ber of a team that includes the Univer¬ 
sity of Minnesota and Albert Einstein 
College of Medicine, Yale will receive 
Si.4 million this year and up to $7.1 
million over the next five years for the 
development of advanced imaging 
techniques for the treatment of neocor- 
tical epilepsy. Another sign that bio¬ 
medical engineering’s day has come 
was the establishment of the nibib 
itself in 2000 as the newest member 
of the National Institutes of Health. 
“Bioengineering, through imaging, 
offers a way for surgeons to examine 
the incredible and complex functions of 
the brain,” said neurosurgeon Dennis 
D. Spencer, m.d., hs ’76, co-principal 
investigator of the epilepsy project. 
Advances in imaging technology could 
eventually reduce surgery time, elimi¬ 
nating the need for electrodes and 
open-brain surgery, and instead permit 
targeted surgery or delivery of drugs 
through small openings in the skull, 
said Spencer, the Harvey and Kate 
Cushing Professor of Neurosurgery 
and the department’s chair. 
According to principal investigator 
James S. Duncan, ph.d., professor 
of diagnostic radiology and electrical 
engineering, mathematical models 
will be used to analyze an individual 
human brain before and during sur¬ 
gery to provide the surgeon with 
precise information in order to guide 
an intricate procedure that will elimi¬ 
nate the seizures. The technique 
combines data from both high-field 
magnetic resonance spectroscopy 
and functional magnetic resonance 
imaging to create a three-dimensional 
view of the brain, Duncan said in 
an interview in his office on Cedar 
Street, pointing to a rotating, computer¬ 
ized image of a human brain, with 
grids and boundaries in brilliant color. 
The close collaboration of physicians 
and scientists from both sides of cam¬ 
pus is not yet typical of American medi¬ 
cine, according to Paul A. Fleury, ph.d., 
5 
who came to Yale in 2000 as dean of 
engineering, succeeding Allan Bromley, 
ph.d. Engineering strategies can be 
applied to countless biological systems 
and medical problems, Fleury said, yet 
“too often medical researchers regard 
engineers as ‘providers of gadgets,’ with 
little real collaboration. Overall, medi¬ 
cal and engineering researchers have 
more to offer each other than what has 
been exploited so far.” 
The challenge of the new educa¬ 
tional programs is balancing breadth 
and depth in a number of subject areas, 
including mathematics and biochem¬ 
istry, according to Duncan, an electrical 
engineer who began his career working 
on night vision systems at the Hughes 
Aircraft Company. He is the overall 
director of the program and also directs 
the undergraduate program, now in its 
fourth year. “We need math tools to 
even approach these problems, but we 
also need to talk with biologists and 
clinicians to understand the problems.” 
Such collaborations cannot be 
dictated, but only emerge from genuine 
mutual curiosity, Fleury said. Engineer¬ 
ing’s newest recruit is Cornell Univer¬ 
sity’s W. Mark Saltzman, ph.d., whose 
research focuses on drug delivery and 
tissue engineering, with an emphasis 
on the use of polymeric materials for 
these purposes rather than more costly 
animal proteins. His lab has designed 
polymer implants that permit controlled 
release, which could be applied to treat¬ 
ing serious brain disease, including 
Alzheimer’s and brain tumors. 
“The potential for collaboration 
between engineering and medicine is 
exactly what attracted me to Yale,” says 
Saltzman, who will be a professor of 
chemical and biomedical engineering. 
“Yale has a rich tradition of excellence 
in both of these areas and it has already 
established an interdisciplinary envi¬ 
ronment that supports the exchange of 
ideas across the interface. I believe 
that biomedical engineering is about to 
enter a period of tremendous growth, 
and Yale is well positioned to be at the 
leading edge of these developments.” 
Citing accomplishments, 
Levin reappoints Kessler to a 
second term as dean 
Five years ago, when David A. Kessler, 
m.d., was appointed the School of 
Medicine’s 15th dean, the focus was on 
the future. In making the announce¬ 
ment in a packed Harlcness Auditorium 
on February 13, 1997, Yale President 
Richard C. Levin spoke of the things 
Kessler was likely to accomplish as 
dean and the support he had from the 
central administration. “I think this 
is the right man at the right time for 
taking the school forward.” 
On May 7, Kessler was reappointed 
to a second five-year term, and the 
focus was on the dean’s track record 
since 1997. 
In a message to the medical school 
community, Levin praised Kessler for 
making “a succession of outstanding 
appointments to positions of depart¬ 
mental leadership” and for planning 
and initiating the construction of the 
new Congress Avenue Building. He also 
cited Kessler for establishing the new 
Clinical Program Development Fund in 
partnership with Yale-New Haven 
Hospital and for overseeing significant 
improvements in medical education. 
Kessler, a graduate of Amherst 
College, Harvard Medical School and 
the University of Chicago School of 
Law, was commissioner of the Food 
and Drug Administration from 1990 
to 1997 under former Presidents Bush 
and Clinton. He served as medical 
director of the Hospital of the Albert 
Einstein College of Medicine from 
1984 to 1990 after training in pedi¬ 
atrics at The Johns Hopkins Hospital 
and working on Capitol Hill. 
Kessler said he “couldn’t be more 
thrilled to remain at Yale and continue 
to work hard on advancing the school’s 
three missions” of patient care, research 
and education. 
“What I knew before coming here 
was that Yale is a world leader in medi¬ 
cine and science,” he said. “What I’ve 
come to appreciate even more since 
At the Yale-Harvard game last fall, David Kessler 
chatted with one of the medical school’s guests 
at the Yale Bowl. 
then is just how special the medical 
school is, and how packed it is with aca¬ 
demic talent and clinical expertise. We 
have a very bright future ahead of us.” 
Under Kessler’s deanship, new 
chairs have been appointed in the 
departments of Cell Biology, Cellular 
and Molecular Physiology, the Child 
Study Center, Genetics, Obstetrics and 
Gynecology, Pharmacology and Sur¬ 
gery. He also recruited Herbert Chase, 
m.d., as the school’s deputy dean for 
education and negotiated an affilia¬ 
tion agreement with Yale New Haven 
Health System that established a fund 
to develop cutting-edge clinical pro¬ 
grams with Yale-New Haven Hospital. 
Construction of the Congress 
Avenue Building, a 457,000-square- 
foot teaching and research facility, 
began in early 2000 and is nearing 
completion; more than 700 faculty and 
staff will begin moving in this com¬ 
ing winter to conduct disease-oriented 
research in eight key areas; to teach 
anatomy, histology and other medical 
school courses; and to support teach¬ 
ing and research activities. 
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chronicle 
Genomics innovator, bold 
as ever, makes a few waves 
during visit to Yale 
When the name J. Craig Venter, ph.d., 
appears in print the words “genome” 
and “maverick” are seldom far behind. 
Venter, one of the prime movers 
behind the sequencing of the human 
genome, has made a career out of 
doing things his way. “1 have learned,” 
he told an audience in the Fitkin 
Amphitheater “to ignore people’s 
advice on many occasions.” 
Indeed, Venter has not only rejected 
conventional wisdom, but often run 
counter to the scientific establishment. 
His independence has worked for 
him: even before he set out to sequence 
the human genome he discovered 
hundreds of new genes, decoded the 
first full genome of a living organism 
(the bacterium H. influenzae) and 
deciphered the genome of the fruit fly. 
It was his impatience with what he 
considered the plodding methods of 
the National Human Genome Research 
Institute (under the leadership of 
Francis S. Collins, m.d., ph.d. ’74, 
fw ’84) that led him into a race to 
sequence the genome. Venter had 
developed methods that he believed 
would be faster and cheaper. Yet the 
National Institutes of Health (nih) 
denied his early requests for funding 
because it was thought they wouldn’t 
work. “The nih is not very good at 
funding new ideas,” Venter said, “but 
when an idea is established, they are 
extremely good at funding it.” 
Venter came to Yale in April to 
deliver the 54th annual keynote lecture 
to the Associates of the Cushing/ 
Whitney Medical Library. He also spoke 
at grand rounds for the Department 
of Internal Medicine and attended a 
lunch with about 20 medical students. 
What, he was asked, were his 
future plans? 
The scientific community has been 
waiting for this shoe to drop. In Janu¬ 
ary Venter left Celera Genomics, the 
company he founded in 1998, because 
of a disagreement over business strat¬ 
egy. The company chose to pursue 
drug development, considering that a 
more profitable pursuit than subscrip¬ 
tions for its genome data. 
While at Yale, Venter had little to 
say about his future plans. Not one 
to steal his own thunder, he saved his 
announcement for an interview he 
gave The New York Times during his 
stay in New Haven. But he offered 
a hint to medical students. “One of the 
many things I’ll be spending a little 
time on is trying to deal with the social 
and ethical issues of sequencing the 
human genome,” he said. 
During the next few days Venter 
would twice grace the pages of the 
Times, first with the revelation that 
Celera’s decoding of the genome was 
based on a sample of his own dna. 
A few days later came the news that 
Venter plans to write his autobiogra¬ 
phy and start two not-for-profit insti¬ 
tutes to explore issues such as genetic 
discrimination and the genetics of 
race and to develop clean energy alter¬ 
natives possibly by developing or 
discovering new microbes that can 
convert carbon dioxide into hydrogen. 
In his keynote address at the 
Historical Library, Venter traced the 
history of genomic sequencing and 
his role in it. Applying the power of 
new computers and algorithms, Venter 
and colleagues at The Institute for 
Genomic Research sequenced the H. 
influenzae genome in 1995. The project 
was a challenge to the nih, which 
was also working to sequence the 
genes of the bacterium. “We thought 
we could sequence the genome in a 
year at about a tenth of the cost of cur¬ 
rent projects,” Venter said, adding that 
At a lunch with students, Craig Venter 
discussed the human genome, cloning and 
his future plans. 
his group did apply for federal funding 
only to be turned down. “What we were 
doing,” he recalled nih officials telling 
him, “was absolutely impossible and 
could never work.” 
After sequencing a few more small 
organisms, such as other bacteria 
and the fruit fly, Venter tackled the 
human genome. The nih had already 
begun its sequencing project, but Ven¬ 
ter believed his methods and tools— 
supercomputers, expressed sequence 
tags, mathematical algorithms and 
shotgun splicing—coidd do it faster. 
The race was on. 
Ultimately the two teams realized 
the value of working together and 
in February 2001, in a tentative and at 
times testy collaboration, they pub¬ 
lished their results simultaneously in 
the pages of Science and Nature. 
For his last appearance at the medi¬ 
cal school at grand rounds, Venter 
discussed the genome’s impact on 
medicine. “Within 10 years,” he told a 
resident, “the medicine you practice 
will be based on knowing the genetic 
code of your patients. This information 
can give individuals power and more 
control over their own lives. If you 
know what is likely to affect you, 
you can do something about it early 
enough to make a difference.” 
For the next generation 
of students, Hope 110 will be 
known as “Rosenberg" 
When former Dean Leon E. Rosenberg, 
m.d., hs ’63, returned to Yale in May 
for the dedication of a lecture hall in his 
honor, it was very much a family affair. 
He was joined by his wife, brother, chil¬ 
dren and grandchildren, along with 
dozens of former colleagues, mentors 
and students. The family members 
traveled a distance, one of his sons sug¬ 
gested, because the family itself had 
come a long way. 
Robert L. Rosenberg, ph.d., pointed 
to the new sign above the door to Hope 
no bearing his father’s name. ‘‘Back 
in Waunakee, Wis., there was another 
sign that said ‘Rosenberg.’ It hung over 
the door of the general store my grand¬ 
father owned,” said the younger Rosen¬ 
berg, who earned his doctorate at Yale 
in 1985 and is an associate professor 
of pharmacology at the University 
of North Carolina. “Coming here today, 
I thought about what makes this one 
here as important and significant as 
that big one in Wisconsin. The answer, 
I think, comes down to the three 
most important words in real estate: 
location, location, location.” 
It was an observation that provoked 
laughter as well as the realization that 
for others in the room, too, location 
was indeed key. Hope no—where gen¬ 
erations of medical students have 
attended countless lectures—is now 
The Leon E. Rosenberg, m.d., Lecture 
Room. “Within these walls, students 
will have their first classes, drink their 
coffee, read their newspapers and even 
fall asleep,” Dean David A. Kessler, 
m.d., said during the dedication. “Most 
importantly, they will establish friend¬ 
ships that will last a lifetime.” 
Rosenberg joined the Yale faculty 
in 1965 and served as dean of the medi¬ 
cal school from 1984 to 1991, when 
he left academia to head Bristol-Myers 
Squibb’s Pharmaceutical Research 
Institute. In 1998, he joined the faculty 
at Princeton. 
The former dean said he was “grate¬ 
ful beyond words” for the tribute and 
particularly touched by the location cho¬ 
sen for the honor. “I’ve been on both 
sides of tire podium in no, many times, 
and I know what it means to the school 
and the thousands of students who have 
passed through it.” 
He closed by recounting a com¬ 
ment that his son David made upon 
hearing that the room would be 
renamed in his father’s honor: “David 
said, ‘Just think, in 10 years, two Yale 
medical students will be passing in the 
hall and one will say, “I’ve got to get to 
class at 11 o’clock in Rosenberg.” ’ ” 
The former dean paused and smiled. 
“I wouldn’t have thought of it myself,” 
he said. “But it has a nice ring to it.” 
Former Dean Leon Rosenberg returned to 
the medical school in May for the dedication 
of a lecture hall in his name. 
SURGICAL RESIDENCY REVAMPED 
The days of surgery “boot camp” may be 
over. To avoid reaccreditation problems, 
Yale-New Haven Hospital is shifting to a 
maximum work week of 80 hours for its 48 
general surgery residents. The Chicago- 
based Accreditation Council for Graduate 
Medical Education warned the hospital in 
March that it must reduce work weeks; 
end every-other-night, in-house call; and 
improve documentation of procedures 
done by residents. (The general surgery resi¬ 
dency, one of 28 at Yale-New Haven, has 
had provisional accreditation since obtain¬ 
ing new-program status when combining 
with Bridgeport Hospital’s general surgery 
program in 1995.) The hospital plans to 
hire physician assistants and part-time doc¬ 
tors to reduce overnights for residents. 
Chair of Surgery Robert Udelsman, m.d., pre¬ 
dicted that the “standard practice” of ioo- 
hour workweeks would end nationwide. “We 
must develop techniques to teach an ever- 
increasing wealth of both information and 
skills, and we must do this in an efficient and 
humane environment.” The accreditation 
group will check in again on August 7. 
BIOTECH BOOMLET 
The end of 2001 was less than spectacular 
when it came to investment in startup 
companies nationally, including those in the 
biotech sector. Despite this, according to a 
survey by PriceWaterhouseCoopers, Yale- 
founded firms managed to raise $92.8 mil¬ 
lion in venture capital in the fourth quarter, 
or 38 percent of the $246 million raised in 
New England’s biotech industry.The Yale 
total is actually higher when other deals not 
included in the survey are counted. Achillion 
Pharmaceuticals led the list with $45 mil¬ 
lion, followed by Agilix Corp. with $20.8 mil¬ 
lion, Rib-X Pharmaceuticals with $20.5 
million and Archemix Corp. with $6.5 million. 
All but Cambridge, Mass.-based Archemix 
are located in New Haven. According to 
Alfred “Buz” Brown, ph.d., director of coop¬ 
erative research, three additional transac¬ 
tions—initial funding for Asilas, Aureon and 
Protomoetrix—added $24 million to the 
fourth-quarter total. Half a dozen more Yale- 
founded companies are in the pipeline. 
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S ROUnds MEDICINE AND HEALTH AT YALE 
Ralph Hoffman has alleviated some of the 
symptoms of schizophrenia using magnetic 
stimulation that targets areas of the brain. 
Quieting the voices 
of schizophrenia 
In early trials, magnetic stimulation 
is shown effective in halting 
or reducing auditory hallucinations. 
Nearly 20 years ago when Stan W. was 
- out on the high seas, menacing voices 
|< 
u began to torment him. They told him 
> that his commanding officer was the 
r devil and that he should dive off the 
boat. Soon thereafter, he was discharged 
from the Coast Guard and diagnosed 
with schizophrenia, a form of psycho¬ 
sis that affects about 1 percent of the 
world’s population. Plagued by voices 
and at times unable to distinguish 
reality from illusion, Stan W. could not 
hold a job and was intermittently hos¬ 
pitalized. Doctors tried to control his 
symptoms with antipsychotic drugs, 
but to no avail. When the 48-year-old 
man arrived at Yale’s Schizophrenia 
Research Clinic about a year ago, he 
was experiencing some 400 auditory 
hallucinations a day, voices that told 
him, “Go slit your throat with a razor,” 
“Go get drunk” and “You are stupid.” 
A year later, following an experi¬ 
mental treatment that uses electromag¬ 
netic waves to reduce brain activity 
in the area thought to produce auditory 
hallucinations, Stan W.’s voices have 
been quieted and he plans to be mar¬ 
ried. “He’s not cured, but he feels much 
better,” said Ralph E. Hoffman, m.d., 
assistant medical director of the Yale- 
New Haven Psychiatric Hospital and 
an associate professor of psychiatry. 
(The names and some of the details of 
the patients’ stories have been changed 
to protect their privacy.) 
Schizophrenia, one of the most 
complex and puzzling mental ill¬ 
nesses, as yet has no cure. The delu¬ 
sions, hallucinations and disordered 
thinking that often accompany the 
disease prompt one in 10 people with 
schizophrenia to commit suicide; 
hundreds of thousands are perma¬ 
nently debilitated by the disorder. 
While many patients have been able 
to suppress their symptoms with 
drugs, a quarter of all schizophrenics 
who hear voices don’t respond well, 
or at all, to medication. 
At Yale, Hoffman has designed 
treatments using repetitive transcranial 
HEARING SOUNDS, NOT WORDS 
In a recent experiment conducted by Yale scientists, bird songs, 
a dog’s bark and snowflakes stuck in the memories of people 
with schizophrenia, while simple words did not. In other words, 
verbal memories posed a greater difficulty to people with 
schizophrenia than did nonverbal memories. This could have a 
profound effect on cognitive function, said Bruce Wexler, m.d., 
associate professor of psychiatry and principal investigator 
on the study published earlier this year in Schizophrenia Research. 
“The use of internal language mechanisms to enhance cogni¬ 
tion,” said Wexler, “is an essential aspect of a wide range of nor¬ 
mal human brain functions.” 
magnetic stimulation (ttms), a therapy 
used since the mid-1990s to help 
patients with severe depression. The 
procedure uses a high-powered electro¬ 
magnet to target the speech-processing 
areas of the brain from which audi¬ 
tory hallucinations are thought to arise. 
Previous research had shown that 
ttms, when delivered to the scalp, pro¬ 
duces an electrical current in the 
brain itself and, if given once per sec¬ 
ond for 15 minutes, can selectively 
reduce brain reactivity. The region of 
the cerebral cortex that is altered is 
relatively small, from 2 to 4 centime¬ 
ters in diameter. Studies in animal 
models have suggested that these 
results can be sustained weeks after 
ttms is applied. Building on this infor¬ 
mation, as well as on experiments 
suggesting that auditory hallucinations 
may be generated, at least in part, by 
the activation of neurocircuitry under¬ 
lying speech perception, Hoffman set 
out to see if ttms could calm the voices 
inside schizophrenic patients’ heads. 
While his research is in the early 
stages, findings have indicated that 
ttms may be able to silence, or at least 
quiet, the hallucinations in some 
patients by reducing neural activity in 
the left temporoparietal cortex or 
other targeted speech-processing areas. 
“There’s some evidence suggesting 
perhaps that what we are doing is selec¬ 
tively eliminating abnormal brain 
activation, while leaving normal brain 
processes unimpaired,” he said. 
Hoffman’s experiments using ttms 
to treat schizophrenics made head¬ 
lines in March 2000, following publi¬ 
cation of his initial findings in The 
Lancet. His study showed that eight of 
12 patients treated with 40 minutes of 
magnetic stimulation above the left ear 
had the severity and frequency of their 
voices drop by half. Most patients ex¬ 
perienced relief that lasted from one day 
to two weeks. These results were found 
to be statistically significant compared 
to those for a placebo control group. In 
a follow-up trial, Hoffman increased 
the length of the magnetic stimulation 
threefold and found that the degree 
and duration of improvement in 
patients rose dramatically. About three- 
quarters of the 24 patients showed 
significant benefit from the treatment 
and half had their voices quieted or 
silenced for at least four months. For 
some patients these improvements 
have lasted more than one year. 
During the procedure, a small 
electromagnetic coil is placed on the 
scalp and pulses roughly the strength 
of an mri scan pass through the skull. 
While most of his studies have focused 
on the left temporoparietal cortex, Hoff¬ 
man is also using neuroimaging studies 
of hallucinating patients to find other 
parts of the brain, such as the prefrontal 
cortex, Wernicke’s area and Broca’s area, 
that may be targeted in particular indi¬ 
viduals to stop their hallucinations more 
effectively. Robert). Buchanan, m.d., 
and Kun Wu, m.d., ph.d., in the 
Department of Neurosurgery, are help¬ 
ing to develop a computer imaging 
system for visualizing the scalp loca¬ 
tions corresponding to these brain areas 
that in certain cases are also pathologi¬ 
cally active during hallucinations. 
While Hoffman emphasizes that 
more research needs to be done to 
determine whether itms can be used 
safely and effectively as an alternative 
treatment, many of his patients have 
reported significant relief. Victor B., a 
50-year-old business owner and father, 
has suffered from schizophrenia since 
his mid-30s. “I became so paranoid 
and dysfunctional that 1 was afraid to 
leave home.” Medication had failed to 
help him and he said that many times 
suicide seemed the only escape from 
the terrifying voices. 
The first ttms study at Yale pro¬ 
vided significant relief for Victor B., 
reducing the severity of his hallu¬ 
cinations from about 500 per day to 
about 70 a day for several months. 
Since his second trial a few months 
ago using a higher dosage of ttms 
that was positioned using neuroimag¬ 
ing data, he says his voices have 
disappeared entirely. 
A DEFINITE LINK TO DIABETES 
For the past decade, pediatricians have 
noticed an upswing in the number of young 
patients presenting with type 2, or adult- 
onset, diabetes—a diagnosis almost unheard 
of in children until recently. Now the anec¬ 
dotal evidence has been quantified and 
linked to the rise in childhood obesity. In 
an article published in March in The New 
England Journal of Medicine, Yale pediatric 
endocrinologist Sonia Caprio, m.d., and 
colleagues reported that of 167 severely 
obese children and adolescents a quarter of 
the children and 21 percent of the adoles¬ 
cents exhibited glucose intolerance, an indi¬ 
cator of diabetes. That intolerance was 
as prevalent among Caucasians as it was 
among Hispanics and African-Americans. 
Long-term complications of diabetes include 
premature atherosclerosis, early coronary 
artery disease, kidney disorders, eye disor¬ 
ders and nerve problems. 
SCHWANN CELLS TRANSPLANTED AGAIN 
A second patient at Yale has received a trans¬ 
plant of cells in an ongoing clinical trial that 
is attempting to treat multiple sclerosis by 
repairing myelin in the brain and spinal cord. 
“The patient is doing fine,” said Timothy L. 
Vollmer, m.d., hs ’83, associate professor of 
neurology. “He has a high level of disability 
because of the location of the lesions in his 
brain, but he is otherwise healthy.” 
Vollmer and his team performed the sur¬ 
gery in two stages in early March, and the 
29-year-old patient was discharged a few 
days later. The team harvested Schwann cells 
found in peripheral nerves of the patient’s 
ankle and transplanted them into his brain. 
Their goal is to determine whether the 
Schwann cells survive in the brain and are 
able to restore myelin, a protective sheath¬ 
ing that is destroyed by multiple sclerosis. 
Five patients are scheduled to participate 
in this clinical trial. The first was a woman 
who received a transplant last July. The trial 
is supported by the Myelin Project. 
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IO Findings from the bench 
top A section of a human rectum stained with 
immunofluorescent antibodies. Yellow-stained 
cells express both the receptor molecule ccr5 
(in red) and dc-SIGN (in green), the dendritic 
cells that can not only bind to the virus but 
become infected themselves. 
above Akiko Iwasaki’s research suggests that 
anatomical differences between the vagina 
and the rectum play a role in hiv infections. 
Men, women and 
the risk of aids 
The adhesion molecule that protects 
hiv from degradation is expressed 
differently in the rectum and vagina. 
A difference in the anatomy of the rec¬ 
tum and vagina may explain, in part, 
why anal intercourse is up to 10 times 
more likely than vaginal intercourse 
to result in hiv infection. This finding 
by investigators at the School of Public 
Health could help in the develop¬ 
ment of new microbicides against hiv. 
The higher risk of hiv transmis¬ 
sion among men who have sex with 
men has long perplexed physicians and 
researchers. They have been looking for 
answers since the aids epidemic began 
more than 20 years ago. "We decided 
to look at the cells that could be medi¬ 
ating this transmission on the mucosal 
surface,” said Akiko Iwasaki, ph.d., 
assistant professor of epidemiology. 
The key to viral entry, she found, lies 
in the location of the dendritic cells 
that express a protein called dc-sign 
in the vaginal and rectal mucosa. 
“The barrier between the outside world 
and the inside of the rectum is one 
single cell deep, whereas in the vaginal 
tract the barrier is 20 to 25 cells thick, 
depending on the stage of the men¬ 
strual cycle,” Iwasaki said. “We think 
that this difference, together with the 
abundance of DC-siGN-expressing 
cells in the rectum, might explain the 
differences in risk.” 
That 25-cell barrier is a daunting 
challenge to hiv, which must cross it 
to reach dendritic cells and begin 
its infectious process. Dendritic cells 
typically act as sentinels, alerting the 
immune system to the presence of 
microbial invaders. In the normal 
course of events, dendritic cells take 
microbial prisoners and present them 
to T lymphocytes, which then learn to 
recognize and repel them, hiv exploits 
that process by binding to dc-sign, 
then turning the dendritic cells into 
Trojan horses that carry the virus to 
the lymph nodes, where it replicates. 
“The clever thing about this is that 
when the virus binds to the dc-sign 
molecule, it is protected from degra¬ 
dation," Iwasaki said. 
dc-sign is highly expressed on 
dendritic cells near the surface of the 
rectum. In the vagina, however, the 
only dendritic cells that express dc- 
sign are underneath the skin covering 
the vaginal tract—25 cells away from 
the outside world. 
Women with sexually transmitted 
infections such as herpes simplex or 
syphilis are also at higher risk of hiv 
infection, Iwasaki said, because the 
resulting inflammation brings T cells 
to the surface, where they can be tar¬ 
geted by the virus. 
Iwasaki, who came to Yale two 
years ago from the National Institute 
of Allergies and Infectious Diseases, 
has long been interested in the mech¬ 
anisms of viral transmission and 
their relevance to sexually transmitted 
disease. Her findings raise the possi¬ 
bility of a mechanism for a microbi- 
cide that would thwart the binding of 
hiv to dc-sign. The dc-sign mole¬ 
cule recognizes and binds to a sugar 
molecule on the viral envelope protein. 
A microbicide could act by binding 
another sugar to dc-sign, thereby 
blocking hiv, Iwasaki said. 
The study was published in the 
February issue of the Journal of Virology. 
The research was conducted in collabo¬ 
ration with Robert Dorns, m.d., ph.d., 
at the University of Pennsylvania. 
ffi ® ® Link between cocaine 
and self-control emerges 
from primate study 
Cocaine users have trouble with self- 
control and decision making, even 
after they’ve given up the drug, accord¬ 
ing to a study by researchers at the 
School of Medicine. “It’s thought that 
this impairment in inhibitory control 
may contribute to certain aspects of 
drug abuse, such as craving, bingeing 
and risky behaviors,” said Jane R. 
Taylor, ph.d., associate professor in 
the division of molecular psychiatry 
and senior author of the study, 
published in the February issue of 
Neuropsychopharmacology. 
In a study of primates funded by 
the National Institute on Drug Abuse, 
Taylor and colleagues investigated 
whether an impairment in the orbito- 
frontal cortex leads to drug abuse, or 
whether it develops as a consequence 
of drug abuse. 
The primates were trained to rec¬ 
ognize that food was available under 
only one of three objects. Then the 
food was placed under a different 
object. The primates had to inhibit 
their learned response and choose 
the other object. Unlike the control 
animals, primates injected with 
cocaine were not able to inhibit their 
initial response and continued to 
reach for the original object. “While 
these deficits could be interpreted 
as indicating that addicts have an 
underlying orbitofrontal dysfunction 
that predisposes them to drug abuse, 
our results indicate that prior cocaine 
exposure is sufficient to produce 
cognitive defects reminiscent of orbi¬ 
tofrontal cortical dysfunction,” the 
researchers wrote. “The frontal-lobe 
impairments in drug abusers may 
be a consequence of, as well as a pre¬ 
disposing factor to, addiction.” 
Deficits in the orbitofrontal cortex, a brain 
region associated with self-control and 
decision-making, are thought to be pre¬ 
disposing factors for cocaine abuse. Now 
Yale scientists, working with primates, 
have shown that cocaine use may also be 
a cause of impairment in orbitofrontal 
function. The images above show pro¬ 
nounced defects in blood flow (top) and 
gray matter density (above) in cocaine¬ 
using human patients, as compared to non¬ 
using control subjects. 
et cetera 
CASE OF THE VANISHING VIRUS 
Viruses that leave no molecular fingerprints 
as they destroy brain cells may be behind 
certain psychiatric and neurological disor¬ 
ders, according to Yale investigators. In a test 
of their hypothesis they introduced a recom¬ 
binant virus, vesicular stomatitis virus, into 
an adult mouse through its nose. The virus, 
which is not dangerous to humans, traveled 
down the olfactory nerve, into the periglo- 
merular neurons, past the mitral cell layer, 
through granule cells and toward the brain’s 
subventrical zone. Then it vanished. 
“In young mice, the virus may get past 
the olfactory system and then may selec¬ 
tively infect and damage other brain regions 
such as the locus coeruleus and dorsal 
raphe that are the targets for many psychi¬ 
atric medicines,” said Anthony N. van den 
Pol, ph.d., professor of neurosurgery and lead 
author of the study, published in February 
in the Journal of Virology. “The virus can be 
eliminated by the immune system and leave 
no trace in the brain, but nerve cells in very 
specific areas of the brain are lost. This is a 
potential model for viruses that may infect 
the brain at one stage of life, and then disap¬ 
pear, but potentially cause long-lasting 
psychiatric and neurological dysfunction.” 
HOW LEGIONELLA SUBVERTS THE CELL 
Of the 35 species of Legionella bacteria, one 
is implicated in most outbreaks of Legion¬ 
naires’ disease, a severe pneumonia. Now 
researchers at Yale have revealed how that 
bacterium, L. pneumophila, subverts the 
normal functions of cells in order to replicate. 
During infection the bacterium travels to 
the lungs and invades alveolar macrophages, 
white blood cells which normally hunt down 
and destroy bacteria. L. pneumophila injects 
a protein into the macrophage that thwarts 
its transport to lysosomes, where the bac¬ 
terium would be destroyed. Instead, the 
bacterium moves to the nutrient-rich endo¬ 
plasmic reticulum, where it replicates. “These 
results show that the Legionella bacteria 
have the ability to inject a bacterial protein 
directly into macrophages during infection,” 
said Craig R. Roy, ph.d., associate professor 
of microbial pathogenesis. The results were 
published in the January 25 issue of Science. 

Eyes wide open 
The suffering of the boy who had fallen into boiling water 
was like the misery of the city’s streets: possible for 
some to ignore but searing to a medical student working 
in the hospital’s burn unit. A letter from Guatemala. 
By Monique Aurora Tello, m.d. 
Illustrations by Janis Melone 
Automatic living ...a life of comfort and achievement, accumu¬ 
lating possessions, honors, and the routine eating, mating, 
and financial habits of prosperous people, the soul sinking under 
folds of flesh, the rituals of social position; that was what the 
author of the Psalms meant when he wrote, ‘Their heart is gross 
like fat. ’ This was the contented mind that had no dealings 
with death and whose sole concern was to remain contented. ... 
It was the crushed spirit that knocked in vain, year after 
year, tapping on inanimate objects, pleading for the locked door 
to be reopened. 
—Amos Oz,from Fima 
Welcome to Guatemala City, Guatemala, where the brutal 
social dichotomy feels like a swift kick in the stomach with 
soccer cleats. Guate in December was a month of heaven, 
hell and social obligations. I ran around the pediatric burn 
unit like a frantic shadow—a shadow that fell in love with 
a three-year-old and came to life. Javier, Javier, soft and 
small, eyes wide and black; I will never forget your hoarse 
morning screams. 
Every morning for a full month, including Christmas 
day, my job was to torture Javier. Somewhere in the Guate¬ 
malan highlands, Javier’s great-aunt was remembering the 
same screams, since she was there when Javier fell back¬ 
wards into a cauldron of scalding water. In the village, the 
day’s drinking water was boiled and thus (one hoped) decon¬ 
taminated, the pot set down on the earthen floor to cool. 
Accidents were not uncommon. 
In the Guatemalan pediatric burn unit, always full, 
the job of changing dressings fell to the med student. 
For the month of December 2000, that was me. Maria the 
burn nurse—impossibly neat, admirably practical— 
showed me how. 
Oh, Javier. The raw and oozing burn patches spread 
like a flowery rash over his penis and thighs, back and but¬ 
tocks. The wet, sticky bandages had to be changed, every day, 
gauze dipped in Silvadene, Terazol and Vaseline, spread over 
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14 Eyes wide open 
Imagine Ouema del Diablo, a day of 
purification. For about a dollar 
and change you could buy a red devil 
pihata on a rope. By 7 p.m., most 
of the good citizens of the city had 
purged their homes of all unnec¬ 
essary objects—clothes, books, 
mattresses, even old love letters— 
and had thrown them all onto piles 
in the street. And then the world 
exploded. The next morning there 
were three new children in the 
“Burn Room.” 
the wasted buttocks, wrapped around his swollen genitals. 
He screamed. He clenched his tiny fists. But he did not 
struggle. He held his legs up when asked. He stood and 
squatted for the Ace bandage wrap, even while screaming. 
And then, when he was all diapered, drinking his 
bottle, he would let me pick him up. Except for when he 
screamed during dressing changes, Javier was silent; he 
hadn’t spoken for anyone during his month-long admission. 
So 1 tried to make him laugh. I grabbed his nose and said, 
“Hey, where’s your pony? Where’s your dog? Where’s your 
cow? Over here? Under here?” and he would watch me side¬ 
ways with a sad smile, as if to say, “I forgive you.” 
I was in Guatemala City for a pediatric surgery elec¬ 
tive at a nonprofit hospital downtown, but also to celebrate 
Christmas with my aunt and cousins. In Guate, Christmas 
is celebrated the whole month. The days were hectic, the 
nights a blur of mixed traditions heralding to both the 
Catholic and the pagan. 
Imagine Qiiema del Diablo, a day of purification. For 
10 quetzales (about a dollar and change) you could buy a 
red devil pinata on a rope. At every major intersection there 
were poor boys laden with large papier-mache devils, hap¬ 
pily unburdening them to happy shoppers. By 7 p.m. on 
December 7, most of the good citizens of the city had purged 
their homes of all unnecessary objects—clothes, books, 
mattresses, even old love letters—and had thrown them all 
onto piles in the street. Everyone gathered outside at dusk. 
And then the world exploded. Each devil, stuffed to 
the brim with firecrackers, was lit and thrown mercilessly 
onto the piles. Families and neighbors gathered round the 
bonfires, and children tossed more firecrackers on top. 
We even toasted marshmallows. The next morning there 
were three new children in the “Burn Room”: a teen whose 
thigh was tattooed by the bottle rocket that had lit in his 
pocket, a 4-year-old girl whose hand was singed and bubbled 
and a 6-year-old boy with full-thickness burns on both feet. 
For me, the daily culture clash between our comfort¬ 
able family celebrations and the horrors of the government 
hospital was difficult to ignore. My family had started out 
poor. My father and aunt grew up on a finca, a ranch, where 
my grandmother taught the workers’ children and my 
grandfather was a mechanic. The fact that we are now all 
financially beyond comfortable is almost solely thanks to 
my father. Through a series of achievements and sacrifice, 
15 
he landed a U.S. residency spot in Boston, and is now a 
physician in Massachusetts. 
i felt sometimes that such humble beginnings had 
been swept under a rug. I got angry at my cousins for 
such transgressions as shopping at The Gap, eating at Pizza 
Hut and belonging to the country club. Their young chil¬ 
dren watch Disney and take swimming lessons and are com¬ 
pletely sheltered from the obvious poverty that exists all 
throughout Guate. I’m not insisting that poverty is anything 
special or poetic. I am just asking my family to see it, to 
let their children see it. How about those homeless kids, 
barefoot in traffic, begging from cars, who can barely reach 
the driver’s window? Or the public emergency rooms, 
where clotted blood attracts huge cockroaches? It strength¬ 
ens your spirit, to see and register the poverty and misery 
around you. I started to feel crazy when I realized that they 
don’t see it, that they have turned from reality. 
My cousin Lea picked me up at the hospital the day 
I discovered that (avier was infested with head lice. Ana 
Luisa, a well-meaning junior med student, had picked a nit 
out of my hair that morning. Giggling, she squished sev¬ 
eral egg cases. “Oh, by the way, did you know that Javier is 
infested with head lice?” she asked. “Thanks,” I replied. 
I bought Lindane shampoo for us both. It was a bad day. 
Between the lice, the screams, the wafting putrid-sweet smell 
of the warm, sticky bandages, the nasty ER and its one dirty 
examining table, I was heavy with disgust and helplessness. 
I dragged open the car door and collapsed. 
Lea handed me the baby, her chubby, white, blue¬ 
eyed baby who, no matter how I searched for some requisite 
compliment, always looked to me like a fat worm. 
Lea chattered on about her day: a brunch at the Hilton, 
she ate too much, then she got her hair done, but they took 
off a bit too much in front, didn’t I think? And there was no 
food at home, she had to stop at the grocery store, would I 
come and help her, because there was simply too much to do. 
Here, again, was the culture clash between home 
and hospital. Here was my cousin, an alien from an alter¬ 
nate universe of ladies’ brunches and salons. I felt frus¬ 
trated anger. Then, I remembered the morning, and calmed: 
Javier, Javier ... After the bandages, I wiped his 
face of tears. I tickled his nose, I tried playing the animal 
game: “Where’s your dog?” And then, he reached out 
and grasped my fingers, and he spoke to me. It was only a 
Swinging lanterns and beating 
gongs, the children led the proces¬ 
sion of family and neighbors on 
La Posada, a few days before Christ¬ 
mas. Old wooden carved figures 
of Mary and Joseph, sumptuously 
dressed in velvet and lace, were 
set on a small bier. We made our 
way around the neighborhood, 
singing and calling out: Mary and 
Joseph were looking for a place 
to rest, but there was no room at 
the inn. 
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Eyes wide open 
hoarse whisper, strained from screaming. I couldn’t hear 
him. I thought quickly of lice, but I bent close anyway, 
so close his dry lips and hot breath tickled my ear. The little 
voice was so quiet, almost gone, but then, there it was: 
“Tengo un chucho. Se llama Zorro.” (“I have a dog. He’s 
called Fox.”) 
I bit my lip and smiled. “Oh, you do, do you, that’s 
amazing!” And we talked, for the first time, about Zorro, 
and how Javier sometimes stole food from the kitchen to 
give to Zorro, and got in trouble with his mother. I once 
read an article about adoption in a magazine, and this quota¬ 
tion stuck with me: “Some primates are so eager to nur¬ 
ture an infant, they will kidnap one.” 1 understood fully. I 
remembered this as Lea drove us to her fancy Western-style 
supermarket, and I held her baby in my arms, and I hated 
it. This baby represented the nouveaux riches of Guatemala, 
the younger upper classes who have effectively shielded 
themselves from poverty, dirt and pain. They live an illusory 
existence, in heavily guarded homes, with fierce dogs, 
watchmen, walls topped with electrified razor wire. And Lea 
aspired to this, as do so many Guatemalans. 
I needed to escape. So I told her I had head lice. 
From Javier. It worked like a curandero charm. Lea drove 
me straight home and directed me to the shower. I was 
free from the car, the worm baby and the fancy supermarket. 
In Lea’s defense, she asked about Javier every time I saw 
her: how was he, did he eat enough, would his little penis 
ever be normal, did I think? Looking back, I realize that 
maybe she did see how different her baby was from Javier. 
Maybe that concern and curiosity was Lea’s spirit, tapping 
at her from the inside, saying, “See? See?” 
I managed to avoid Lea until La Posada, a few days 
before Christmas. This is a procession of family and 
neighbors, led by the children swinging lanterns and beat¬ 
ing gongs. Old wooden carved figures of Mary and Joseph, 
sumptuously dressed in velvet and lace, are set on a 
small bier. Lea and I and two other cousins got to carry it. 
We made our way around the neighborhood, singing 
and calling out: Mary and Joseph were looking for a place 
to rest, but there was no room at the inn. The traditional 
songs degenerated into giggles and shouts of “Lemme 
in, dammit!" until finally the last neighbor opened her 
gate, and everyone filed in for rum punch and cake, songs 
and small gifts. 
* * * 
A bunch of bananas: that was my reward for the daily torture 
routine. Javier’s parents came once a week to visit. Visit¬ 
ing hours were very strict for the burn patients. Infections 
were so common and so deadly, especially at the public hos¬ 
pitals, that parents could look at their children from the 
door, but they could never touch them. So a crowd of par¬ 
ents would gather at the glass door to the burn unit, and 
they would take turns to wave, some sobbing quietly, while 
Maria pushed the metal cribs up to the door, one by one, 
and the children screamed, “Please let me out, please take 
me home! Mama, papa, don’t leave me—’’ 
Javier’s parents were indigenous Guatemalans. His 
mother was dark and slight, her long black hair tied back, 
a worn blouse tucked into a traditional woven wraparound 
skirt. She was wringing her hands, eyes wide, horrified. His 
father was wiry, strong, stoic. It had been one full month 
since they had been able to hold Javier. What kind of 
torture was this, to know that the child they had created was 
a hostage, in pain, and they could do nothing? They were 
being kicked out; it was 4 p.m., the end of visiting hours, no 
room at the inn. Javier was screaming in his sad, hoarse 
voice: husband and wife were practically cowering, on the 
verge of tears. 
They were never there for dressing changes. They 
didn’t know that I was a torturer. They didn’t know that 
it was guilt that motivated me, right at that moment, when 
I gave Javier a cookie and he stopped screaming. They 
were so grateful for this that they brought me the bananas. 
I accepted with more guilt. 
Sometimes my soul sinks under folds of flesh. Some¬ 
times, I drown. Mine is not the complacent, contented soul 
Oz speaks of, but rather, something probably worse: hypocriti¬ 
cal. I criticize my own family for trying to be comfortable, for 
trying to raise their children in safety. Who am I to criticize? 
They have no choice but to live in Guate. I only visit. 
And since I was only there for one short month, I 
had no right to laugh, to enjoy the warm days, to escape. But 
when I was tired, I always had company: the burnt-out 
residents, so desperately sick of the daily misery of the hos¬ 
pital, and of being helpless, and of being the cause of more 
new misery for patients. 
Doctora Lorenzo, my senior resident, had the ugliest, 
most beat-up 1977 beige Datsun, so unbelievably old 
and dirty. But one day Joaquin, the chief surgery resident, 
and Pablo, the second-year, and I piled in happily. The goal 
was to get some lunch at a nearby restaurant, a break from 
work. We were tired, and we simply left. What luxury! 
I sometimes hated Dra. Lorenzo, even good-natured 
Joaquin. They didn’t use enough pain medication for the 
children. I often asked for analgesics for Javier and others, 
for dressing changes, but they would only allow Tylenol 
and Dipirona (another nonnarcotic). Throughout Central 
America, narcotics are rarely used in children, even for 
burn victims, for fear of overdose, or of causing addiction. 
Morphine was used only if the burn was so severe as to 
require debridement under general anesthesia. 
Christmas Eve was an exhausting haul. My cousins 
and I had delivered a huge bag of inexpensive plastic toys to 
the ward, probably 30 kids. Every child who could be dis¬ 
charged went home that afternoon. Then, of course, one had 
to attend the Christmas parties on all the floors and sneak 
treats to our compatriots in the OR and the ER, and then the 
party continued at home. 
The evening was a long trail of guests coming and 
going, tropical-fruit rum punch and fresh tamales until mid¬ 
night. Besides eating and drinking, people appraised our 
Nacimiento, the Nativity scene that many families spent seri¬ 
ous time creating. Ours was under the Christmas tree: a 
red and green sawdust carpet with a dried moss border, and 
the simple clay figurines of Jesus, Mary and Joseph. Of 
course, we had to hear about our neighbors, who had a run¬ 
ning water river through theirs, or my little cousins, who 
had done an entire village, complete with electric lights. 
Throughout all this, we heard occasional cracks and 
whistles, forewarnings. Then, on the stroke of midnight, 
there exploded a deafening cacophony as the whole city set 
off their Christmas Eve firecrackers. Neighbors gathered 
in knots in the streets, and kids dashed in and out of the 
clouds of smoke, high on sugar and noise and the promise 
of presents, which were opened after this midnight blast. 
Christmas Day started out so well. I went in early, 
winning the murky battle of the rum-punch hangover. 
Maria (who is truly dedicated) and I changed all the band¬ 
ages. That made me feel good. But the rest of the day was 
a headachy blur. There was a Christmas dinner at the mani¬ 
cured suburban house of rich family friends, who served a 
large stuffed turkey. I wondered the whole afternoon, where 
did they get a Butterball turkey, in Guatemala? They must 
have had it flown in. Crazy! Then we spent a long evening at 
the secluded mansion of highly valued family friends, a fam¬ 
ily previously affiliated with the United Fruit Company. Their 
palpable wealth, their spoiled grandchildren, their servants 
...I felt so frustrated by their status, their complacency. 
And then I left. Sure, this good-hearted little med 
student had worked very hard for a month, and (amazingly 
enough) maintained a bright affect through it all. I was 
bone-weary from a month of Christmas excess as much as 
from the burn unit. I had also struggled with the contrast 
between the social classes on a daily basis. But in the end, 
I turned my back on the struggle the moment I got on the 
plane for home. 
Ana Luisa sent me several e-mails about Javier. He 
had finally needed skin grafts; they took, and he healed, then 
left the hospital slightly malnourished, in the arms of his 
mother. I don’t know where he is now, and I will never know 
if I mattered in his life. 
The brutal social dichotomy does exist, and I feel 
caught in the middle. I understand why Lea wants to protect 
her own, and why just to live and live comfortably is con¬ 
sidered an achievement. But we all need to see the inequality 
of the suffering of the poor, and acknowledge injustice. 
Seeing is the first step in contact, bridging between cultures, 
between souls. When you see, you wake up and realize, 
this is what really matters, and anything else is a dream. 
I made real contact with people in all the social strata, 
moving freely between worlds. I felt like a spy, a clandes¬ 
tine revolutionary. But this is no revolution. This is every day, 
and while these social rituals are so beautiful sometimes, 
and occasional escape is necessary for one’s sanity, we can¬ 
not ignore the spirit, which taps and says, “Fight compla¬ 
cency! Make people see ...” 
And so that was the whole point of quoting Oz, to 
voice the need to fight complacency, to open the closed and 
contented mind, to wake people and help them see the harsh 
but beautiful reality around them. But how does one do this? 
How can I change even one person? If there are answers to 
these questions, if there are, among you readers, people who 
know, then please share. For the sake of many spirits, ym 
Monique Aurora Tello, M.D., is a second-year resident in medicine at Yale. 
She spent December 2000 in Guatemala City while a medical student at 
the University of Vermont. The names in this story have been changed. 
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Commencement 
20 
A large class, an inspired speaker and a tall order— 
to do some good in the world. 
During their second-year show three years ago, the Class of 
2001 sang (to the tune of “Jesus Christ Superstar"), “We’ll 
all take a fifth year before we’re done.” Meant as a joke, the 
lyric was almost prophetic. Many in the class did stay for 
a fifth year. Meanwhile, the number of students in the Class 
of 2002 who took a fifth year was lower than average. These 
two anomalies swelled the ranks of this year’s graduating 
class to 112, the largest in recent memory. 
The students’ choice of Commencement speaker was 
also a departure from the norm. Paul E. Farmer, m.d., ph.d., 
has followed an unusual path since he received a medical 
degree and a doctorate in anthropology from Harvard in 1990. 
He works in Haiti’s central plateau, tending to the rural 
poor in the poorest country in the Western Hemisphere. He 
also travels the world, defying the experts as he finds ways 
to bring medical care to tuberculosis patients in Peruvian 
slums or Russian prisons. 
“When we began to treat aids patients in rural Haiti, 
it was dismissed as neither cost-effective nor sustainable,” 
Farmer said. “In fact, some experts argued that it was down¬ 
right irresponsible to use antiretroviral drugs in a setting 
of such squalor. I underline the word experts here because 
such critiques have never, in my experience, come from 
poor patients and their families. I have never had someone 
say, ‘You know, doc, I’m very interested in treatment, but 
being a Haitian I’m really not cost-effective.’ ” 
In closing, Farmer urged the new doctors to use their 
skills to change the face of medicine. 
“Try not to constrict your borders to the confines of 
a single hospital,” he said. “The rest of the world is out 
there. This world will find you, even if you are hidden away 
in a hospital or a lab. It is my hunch and my hope that you 
will succeed in the challenge now before medicine, now 
before doctors—to rebuild modern medicine on a founda¬ 
tion of evidence and equity.” 
Dean David A. Kessler, m.d., awarded Farmer the 
Peter Parker Medal for his contributions to medicine. “You 
demonstrate that there is all the difference in the world 
between a profession and a calling,” Kessler said. “Dr. Farmer, 
you teach us what it means to have a calling.” 
—John Curtis 
Photographs by Terry Dagradi 
19 
Graduates Anita Karne, Kamyar 
Madani, Reza Vagefi and Premila 
Bhat are framed in the view panel 
of Marylanne Pol-Rodriguez’s 
digital camera on Commencement 
Day in May. They were among 112 
medical students receiving their 
Yale diplomas. 
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20 Commencement 2002 
THIS PACE 
Photography was one of the most 
popular activities at Commence¬ 
ment, where family members, 
friends and the graduates them¬ 
selves worked hard to document 
the day’s events. Among them was 
Scott Floyd (bottom right photo), 
who checked the display of his 
digital camera while photograph¬ 
ing classmates. 
OPPOSITE PACE 
More than anything, the day 
was a time to celebrate. Clockwise, 
from top left: Naomi Balamuth, 
Vasanthi L. Narayan, Rupal Badani 
and Diana Bojorquez pose enthu¬ 
siastically for the camera; Virginia 
Triant gets help with her cap 
and gown before the class photo 
on the steps of Sterling Hall of 
Medicine; Bojorquez is congratu¬ 
lated by Dean David Kessler 
during University Commencement 
exercises on the Old Campus; 
the student a cappella group 
The Ultrasounds performs under 
the tent on Harkness Lawn 
during the medical school cere¬ 
mony; an exuberant Sarah 
Rettinger shakes hands with 
classmate Deborah Smith. 
21 
v
a
le
 
M
ed
ic
in
e 
s
u
m
m
e
r
 
20
02
 
22 Commencement 2002 
BELOW 
Commencement brought family 
and friends to New Haven from 
across the United States and 
abroad. Clockwise from top left: 
Steven Song is surrounded by 
his parents and cousins after the 
medical school ceremony; Andy 
Redmond is joined by his god¬ 
daughter, Tazje Henry-Phillip, and 
her sister, Rashida Peters; Nikki 
Pinkerton receives her diploma 
accompanied by her children Nick, 
Mandy and James (from left) and 
her husband, Brett; family mem¬ 
bers applaud the new graduates as 
they receive their diplomas. They, 
in turn, were recognized by Dean 
David Kessler, who asked the grad¬ 
uating class to turn and face the 
audience. “Let’s have a round of 
applause,” he said, "for the moth¬ 
ers and fathers, grandmothers and 
grandfathers, and all the other peo¬ 
ple who made this day possible.” 
23 
BELOW 
Awards and honors went to 
Commencement speaker Paul 
Farmer (top photo, right, with 
author Tracy Kidder), who received 
the Peter Parker Medal; Richard 
Belitsky (middle photo, with grad¬ 
uate Darnita Johnson-LaBorde), 
who received the Bohmfalk Prize 
for clinical teaching; Guadalupe 
Garcia-Tsao (bottom right, 
with Dean David Kessler), who 
received the Humanism in 
Medicine Award; and Frederick 
Sigworth (bottom left), recipient 
of the Bohmfalk Prize for basic 
science teaching. 
Commencement awards 
and honors 
Bohmfalk Prize 
Frederick J. Sigworth, ph.D. 
Richard Belitsky, m.d. 
Healthcare Foundation of New Jersey 
Humanism in Medicine Award 
Guadalupe Garcia-Tsao, m.d. 
Leah M. Lowenstein Prize 
Marie E. Egan, M.D. 
Francis Gilman Blake Award 
John S. Hughes, m.d. 
Betsy Winters House Staff Award 
Haider A. Akmal, m.d. 
Parker Prize 
Michael S. Singer 
Miriam Kathleen Dasey Award 
Rocco A. lannucci 
Rebekah G. Gross 
Norma Bailey Berniker Prize 
George King-Tso Lui 
Dean’s Prize for Community Service 
K. Claire Stylianopoulos 
Emmanuelle M. Clerisme 
Healthcare Foundation of 
New Jersey Humanism in Medicine 
Student Award 
Anna Gibb Hallemeier 
Campbell Prize 
James S. Castle 
K. Claire Stylianopoulos 
Perkins Prize 
R. Griff Kelley Jr. 
Merck Book Award 
Kebba M. Jobarteh 
John A. Davis 
m.d./ph.d. Award 
Scott R. Floyd 
Nataki C. Douglas 
M.D./PH.D. Alumni Award 
Michael S. Singer 
Connecticut Society of American 
Board of Obstetricians 
and Gynecologists Prize 
Hyacinth N. Browne 
New England Pediatric Society Prize 
Elizabeth M. Bird 
Diana I. Bojorquez 
Society for Academic Emergency 
Medicine Award 
Jeanne K.Tyan 
Connecticut Chapter of American 
College of Surgeons Prize 
Prashanth Vallabhajosyula 
Connecticut Academy of Family 
Physicians Award 
R. Griff Kelley Jr. 
Dr. David and Arthur Schuman Award 
of Excellence in Family Practice 
Corey L. Martin 
Endocrinology Society Medical 
Student Achievement Award 
Daniel A. Hoit 
Peter A.T. Grannum Prize 
Nataki C. Douglas 
Lauren Weinstein Award 
F. Nikki Pinkerton 
acp-asim Internal Medicine Award 
Joyce M.S. Oen-Hsiao 
Cortlandt Van Rensselaer 
Creed Award 
Kebba M. Jobarteh 
Norman Herzig International 
Fellowship 
Marc A. Davis 
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24 Commencement 2002 
BOTH PACES 
Public health graduates celebrated 
on the Old Campus in the morning 
and at a second ceremony later in 
the day in Battell Chapel. Top row, 
from left: Shalini Kapoor, Jeanna 
Haw and Margaret Dolin huddle 
for the camera on Old Campus; 
In a changed world, the agenda for public health 
remains much the same. 
The prospects for public health altered dramatically on the 
morning that journalist Mark Schoofs left his New York 
City apartment in search of coffee “and was greeted by the 
sight of a gaping hole in the World Trade Center. 
“You are being graduated into a world that has 
changed,” the Wall Street Journal reporter told students from 
the School of Public Health at their May 26 Commence¬ 
ment ceremony at Battell Chapel. “Things are different. ... 
Some of you may find yourselves organizing vaccination or 
treatment against the deliberate infliction of disease," said 
Schoofs. “But I suspect that most of you will not work direct¬ 
ly on terrorism. And, without belittling the war on terrorism, 
that is as it should be.” 
In a single day, he said, malaria kills almost 3,000 peo¬ 
ple. Tuberculosis kills about 5,500 people, and aids another 
8,000—a toll of more than 15,000 people daily. “That’s five 
World Trade Center attacks, ten towers collapsing, every day.” 
For the 123 students graduating with degrees in pub¬ 
lic health, Schoofs said the terrorist threat should underscore 
the impact of politics on public health. “It was a political 
vision that led those 19 hijackers to mass murder. But it is 
also politics that condemns many thousands to die of pre¬ 
ventable or treatable infectious diseases every year,” said 
Schoofs, a 1985 Yale College graduate who won a Pulitzer 
Prize for his coverage of aids in Africa in 2000. Parents 
still lose their children to infections that could have been pre¬ 
vented by inexpensive vaccines. African-Americans die at 
higher rates than whites and receive inferior care, even after 
accounting for differences in socioeconomic status. “That’s 
politics,” said Schoofs. 
He rejected the argument that the terrorists were moti¬ 
vated by anger over poverty and injustice. They were not 
poor, and their attack was not a protest but rather “an act of 
pure destruction and obliteration.” To counter this, he said, 
public health graduates must “insist that every life matters ... 
Partly this is sheer pragmatism—infectious diseases do not 
stay in marginalized groups, but leak out into the general 
public, and your job is to protect the public. But insisting that 
every life matters is also a profound political statement, per¬ 
haps the most profound statement you can make.” In doing 
so, he told the graduates, “you are putting forth a philosophy 
that is the exact opposite of callousness and nihilism.” 
The Rev. Thomas Gariepy, the student speaker, 
also emphasized “the political determinants” of health. He 
said that while the diseases afflicting people may have 
changed little over time, the political forces that influence 
disease are unique to our era. “Social justice is born in 
political engagement,” said Gariepy, a Catholic priest who 
was among the graduates. “If public health is social justice, 
then for us, public health will be political engagement.” 
—Cathy Shufro 
Terry Dagradi is a photographer with Med Media Services at the 
School of Medicine. 
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25 
Ferhat Kassamali, Jigar Shah and 
Toshio Kimura pass the time while 
waiting for Commencement exer¬ 
cises to begin; Commencement 
speaker Mark Schoofs addresses 
the graduates in Battell Chapel. 
Middle photo: Megan Leaderer, 
Katherine Van Loon, Jigar Shah 
and Edward Huang gather for 
the morning procession. Bottom 
photo: Among the recipients 
of honorary Yale degrees at the 
University Commencement were 
women’s advocate Ela Ramesh 
Bhatt, director Steven Spielberg 
and civil rights attorney Robert 
Carter, who successfully argued 
the Brown vs. Board of Education 
case before the Supreme Court 
a half century ago. Schoofs cited 
Carter in his speech. 
Commencement awards 
and honors 
The School of Public Health awarded 
114 master’s degrees and nine doctor¬ 
ates at Commencement exercises at 
Battell Chapel on May 26. 
Dean’s Prize for Outstanding 
m.p.h. Thesis 
Michael Chan 
Inhibited hiv & siv Replication by 
Polymorphic vif Sequences 
Shalini Kapoor 
A Needs Assessment of Orphan 
Children and Their Caregivers 
in the KwaZulu Natal Province in 
South Africa 
Karen Sautter 
Protecting Children in Times of Terror: 
Lessons From the Cold War 
Katherine Van Loon 
Informed Consent: A Study of 
the Experiences of Clinical Trial 
Researchers in South Africa 
Award for Excellence in Teaching 
Robert Dubrow, M.D., ph.d. 
The Henry J. (Sam) Chauncey Jr. 
Inspiration Award 
Chanda Cashen 
The Cortlandt Van Rensselaer 
Creed Award 
Eric Ashton 
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26 students 
Shalini Kapoor (right) presented her research 
on the impact of hiv/aids on households in 
South Africa. 
top Nobel laureate Paul Creengard, who 
began his groundbreaking research in a lab at 
Yale, visited New Haven on Student Research 
Day in May. 
middle During the poster session, Julie Jaffe 
described her research into the characteristics 
of prostate tumors. 
ottom Bonnie Kerker examined the factors 
that determined whether health care providers 
screened pregnant women for cocaine abuse. 
Excursions with 
Paul Greengard 
Nobel laureate, an expert on the 
neuron’s "inner world,” returns to 
where the work began. 
The visit of Paul Greengard, ph.d., 
to Yale in May was a homecoming of 
sorts for the Nobel laureate. 
Greengard, who gave the 15th annual 
Farr Lecture on Student Research 
Day, spent 15 years working in a lab on 
the third floor of Sterling Hall of 
Medicine’s B wing before moving to 
Rockefeller University in 1983. 
“The work which formed the foun¬ 
dation for the Nobel Prize was all 
carried out here at Yale,” said Green¬ 
gard, who shared the 2000 Nobel 
Prize in physiology or medicine for his 
research into how nerve cells in the 
brain communicate. In a joking aside, 
he added, “Don’t tell the president 
of Rockefeller I said that.” 
Greengard said that when he start¬ 
ed the work shortly after coming to 
Yale, “one of the things that our research 
was most interested in was to try to 
elucidate the mechanism by which 
neurotransmitters activate receptors.” 
One school of thought argued that 
electrical impulses drove communica¬ 
tions among neurons. An opposing 
view held that neuronal communica¬ 
tions were mediated by a chemical 
process. The chemical view eventually 
won out, and Greengard’s research 
led to his discovery of the role of phos¬ 
phorylation in the mechanism of 
action of neurotransmitters. 
While at Yale, he came close to 
making a serious error. In 1978 
a young scientist wrote and asked 
for a position in his lab as a postdoc. 
“I wrote back and said no,” Greengard 
said. “It was probably the dumbest 
thing I had ever done.” Five days later 
Greengard had a visit from cell bio¬ 
logy Chair George Palade, m.d., who 
had won the Nobel in 1974. “He came 
into my office and said, ‘You made a 
big mistake.’ He was God at that time. 
He told me how bad the mistake was, 
and I reversed my decision.” 
The young postdoc was Pietro 
De Camilli, m.d., now a professor and 
former chair of cell biology himself, 
who introduced Greengard to a stand¬ 
ing-room-only crowd in the audito¬ 
rium of the Jane Ellen Hope Building. 
“He discovered the inner world of 
the neuron,” De Camilli said of his 
former mentor. 
Greengard’s talk capped a day of 
poster and oral presentations by stu¬ 
dents. Five students made oral presen¬ 
tations and 65 had posters on the 
walls of the Hope Building. While 
slightly more than half of the posters 
described the results of laboratory 
work, the range of research questions 
was quite broad, delving into the basis 
of absolute pitch, conflicts of inter¬ 
est in medical research, the risk of 
injury to children in Pakistan and sup¬ 
ports and barriers to the use of health 
care interpreters for patients with 
limited English. 
27 
The science behind AIDS 
and prevention 
About 250 people attended aids Science 
Day at the School of Public Health 
on April 12 for discussions of a wide 
range of medical, preventive, social 
and political aspects of the disease. 
“In simple terms,” said public health 
Dean Michael Merson, “the pandemic 
now rivals in size and dimension the 
bubonic plague of the Middle Ages.” 
Three panels discussed sex, drugs and 
politics; therapeutic and preventive 
interventions; and risk factors among 
vulnerable populations. The 18 posters 
on display examined topics including 
the Tijuana sex industry, syringe access 
in Hartford and links between sub¬ 
stance abuse and domestic violence. 
Among the presenters was Shalini 
Kapoor, m.p.h. ’02, who received the 
student poster award for her research 
into the impact of aids on households 
in South Africa. (She also received the 
Dean’s Prize for Outstanding m.p.h. 
Thesis; see page 25.) Kapoor found 
many of them overwhelmed by the loss 
of productive family members and 
an increase in the number of orphans. 
Many households in the KwaZulu Natal 
province, she said, were unaware of 
government assistance programs. She 
also observed obstacles to obtaining 
that assistance, missing birth certifi¬ 
cates being high on the list. “Most 
children are in need of food, clothing, 
shoes, school uniforms, blankets and 
mattresses,” said Kapoor, who spent 
last summer in South Africa. “The 
information in this assessment is 
intended to assist in designing pro¬ 
grams targeted to the needs of young 
orphans and their families.” 
For budding scientists, 
the road ahead holds both 
promise and pitfalls 
At a biotech job fair in February, a pan¬ 
elist on alternative careers offered 
a sobering statistic. “Only one in five 
of your peers is going to have their 
own lab,” Laurie Dempsey, ph.d., told 
the crowd of graduate students and 
postdocs in the Harris Auditorium at 
the Child Study Center. The implica¬ 
tion was clear. The other four would 
have to consider alternatives. Dempsey 
herself traded pipettes and Western 
blots for an editor’s green eyeshade at 
Nature Immunology. 
And that is only one decision facing 
scientists, according to members of 
the two panels at this year’s Graduate 
Student Research Symposium. If they 
remain at the bench, will it be an 
academic or corporate lab? If the lure 
of the corporate world is stronger, 
should a scientist go for big pharma 
or an unknown biotech startup? 
Two panels, which divided neatly 
along gender lines as it happened— 
men discussing traditional career paths, 
women considering alternatives— 
offered the advice and experience of 
scientists who have been out of school 
for a few years. Whether in traditional 
or unusual careers, all managed to 
keep their hand in science. 
“I do a lot of writing, a lot of finan¬ 
cial modeling, and I talk to investors 
constantly,” said Hailey Xuereb, ph.d., 
who now does equities research in 
biotechnology at the financial giant 
Bear Stearns. Dempsey said she takes 
satisfaction in helping scientists 
communicate their work to a larger 
audience. “You have to write well 
and enjoy being challenged all the 
time,” she said. 
Karen Mangasarian, ph.d., spent 
five years as a postdoc before becom¬ 
ing a technical advisor at a law firm by 
day, while getting a law degree at night. 
Small biotech companies make up a 
large part of her client base. “You can 
help bring those companies from a 
middling company to something of 
substance,” she said. 
All agreed that an m.b.a. is not 
essential to their careers. “It’s helpful, 
but you really learn once you're on 
the job,” said Xuereb. 
Students wishing to pursue more 
traditional careers were warned of 
the trade-offs inherent in choosing 
among established firms, startups and 
academic research. 
“There are high risks involved 
and you have to determine whether it’s 
worth that risk,” said Timothy S. 
McConnell, ph.d., who chose a start¬ 
up—Rib-X Pharmaceuticals, founded 
in New Haven last July. 
“There’s a big misconception out 
there that big companies equal stability 
and small companies equal instabil¬ 
ity,” said Vic Myer, ph.d., a founding 
scientist at Akceli, a 12-person Cam¬ 
bridge, Mass., company that works on 
high-throughput, cell-based assays. 
Picking up on Myer’s thought, Mark R. 
Miglarese, ph.d., a senior research 
scientist at Bayer, added, “A big com¬ 
pany is probably not going to go 
down, but your research area might.” 
And, the panel noted, working at 
small companies allows scientists 
to develop skills in other areas, such as 
business, marketing and public rela¬ 
tions, while corporations offer another 
kind of flexibility. “In large companies 
there’s a fair bit of opportunity to move 
around, because big companies do a 
lot of different things,” said Miglarese. 
Panel members also warned students 
about the difference between science 
in academia and in industry. Academic 
researchers have the luxury of pursu¬ 
ing projects for no other reason than 
that they find them interesting. “Let’s 
face it, these are money-making ven¬ 
tures,” Miglarese said of corporate 
research. “You’ve got to sell it. It’s got 
to make some sense for the company.” 
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28 students 
top Anna Gibb Hallemeier celebrated her 
match in pediatrics at Yale-New Haven Hospital 
with a hug and a glass of champagne. 
middle Aaron Covey and Seth Goldbarg 
congratulated each other on their successful 
matches. Covey is staying in New Haven to 
pursue orthopaedics. Goldbarg is heading for 
Boston to start a residency in internal medi¬ 
cine at Brigham and Women’s Hospital. 
bottom Yee-Bun (Ben) Lui, who is entering an 
internal medicine residency at UC-San Francisco, 
shares the good news with a fellow student. 
A good year to 
be matching 
Nationally, a record number of seniors 
make the grade; for two Yale students, 
it’s on to Hopkins and ucsf. 
By 11:30 a.m. on March 21, students 
were gathering in the Marigolds 
dining hall to wait for the doors to the 
Harkness Lounge to open. As the 
crowd grew it was seized by the giddi¬ 
ness that often accompanies high anxi¬ 
ety. This was, of course, Match Day, 
and in a few minutes the 109 students, 
along with 14,227 others around 
the country, would open the letters that 
would determine the course of their 
medical careers. 
Jordan Prutkin, one of the first to 
arrive, appeared sanguine. “I think I 
matched at one of my top three or four 
choices and I would be happy at any 
of them,” he said. “But talk to me in 25 
minutes.” What Prutkin couldn’t know 
at that time was that he had good rea¬ 
son to be calm. Not only did he fare 
well but 2002 was the best year ever 
for medical school seniors, according 
to the National Resident Matching 
Program—94.1 percent matched, up 
from 93.7 percent last year. 
The Office of Student Affairs tried 
to reduce the anxiety with a new 
system for getting the letters to their 
recipients. In years past Nancy R. 
Angoff, M.P.H. ’81, M.D. ’90, HS ’93, 
associate dean for student affairs, 
and Cynthia Andrien, m.s., assistant 
dean for student affairs, trekked 
through the milling crowd, smiles on 
their faces and letters in their hands, 
closeted themselves in the mail 
room, inserted letters in boxes, then 
opened the door to the waiting throng. 
No more. 
“The anxiety was just too much, 
with some people trying to get into the 
mail room and others not being able 
to get out,” Angoff said. 
This year the letters were divided 
into alphabetical groupings and were 
waiting at tables in the lounge. Students 
appeared to welcome the new system. 
“I thought it gave us enough space,” 
Anna Gibb Hallemeier said. “You hear 
screams, but it isn’t in your face." 
Indeed, screams and squeals of joy 
filled the room as students learned 
their fates. 
Outside the lounge, Prutkin sat 
with his classmate Jennifer Wang, a 
good friend since they met at Yale 
College nine years ago. Prutkin is 
headed for Johns Hopkins Hospital— 
his first choice—and a residency in 
internal medicine. Wang’s match will 
take her to the University of Califor- 
nia-San Francisco for general surgery. 
“Since freshman year of college 
we’ve been friends,” Prutkin said. “Now 
we’re on opposite coasts.” 
“I’ll be sure to call you at 11 p.m. 
my time,” Wang joked. 
With 109 students involved, this 
year’s match was larger than usual— 
many of those in the Class of 2001 took 
a fifth year, while most of the students 
in the Class of 2002 finished their 
studies in four years. More than half 
the Yale students chose a generalist 
discipline: 26 percent went into internal 
medicine, another 6 percent chose 
internal medicine/primary, 6 percent 
opted for family practice and 14 percent 
chose some form of pediatrics. 
The results of this year’s match at 
Yale appear on the opposite page. 
2002 residency placements for 
Yale medical students 
The Office of Student Affairs has pro¬ 
vided the following list, which outlines 
the results of the National Resident 
Matching Program for Yale's medical 
graduates. Some names appear twice 
because the graduate is entering a one- 
year program before beginning a spe¬ 
cialty residency. The transitional designa¬ 
tion is a one-year program with three- 
month rotations in different specialties. 
California 
Cedars-Sinai Medical Center, 
Los Angeles 
Rupal Badani, pediatrics 
Contra Costa Regional Medical 
Center, Martinez 
Kinari Webb, family practice 
Harbor-UCLA Medical Center, 
Los Angeles 
Marc Davis, emergency medicine 
Scripps Mercy Hospital, San Diego 
Jeffrey Bush, transitional 
Stanford University Programs 
Shannon Sheu, dermatology, medicine 
Scott Sutherland, pediatrics 
Jeanne Tyan, emergency medicine 
M. Reza Vagefi, medicine 
University of California, Irvine 
Kier Ecklund, orthopaedic surgery 
Hung Nguyen, obstetrics and 
gynecology 
University of California Medical 
Center, Los Angeles 
Trac Duong, internal medicine 
Amit Jha, internal medicine 
Nara Shin, emergency medicine 
University of California, San Diego 
Jeffrey Bush, emergency medicine 
University of California, San Francisco 
Felix Adler, diagnostic radiology 
Diana Bojorquez, pediatrics/primary 
Jon Boone, psychiatry 
Karen Kim, internal medicine/primary 
Brian Lee, radiation oncology 
Yee-Bun (Ben) Lui, internal 
medicine/primary 
Kamyar Madani, internal medicine 
Sarah Rettinger, internal medicine 
M. Reza Vagefi, ophthalmology 
Jennifer Wang, general surgery 
VA Greater Los Angeles Health System 
Nara Shin, medicine 
Colorado 
University of Colorado School of 
Medicine, Denver 
David Larson, pediatrics 
Connecticut 
Greenwich Hospital 
Brian Lee, medicine 
Patricia Pahk, medicine 
Hospital of Saint Raphael, New Haven 
Michael Dutka, transitional 
Scott Floyd, medicine 
Joyce Oen-Hsiao, internal medicine 
Marlyanne Pol-Rodriguez, medicine 
Neesha Rodrigues, medicine 
Middlesex Hospital Program, 
Middletown 
F. Nikki Pinkerton,family practice 
Norwalk Hospital 
Afari Arash, medicine 
Yale-New Haven Hospital 
Hyacinth Browne, obstetrics and 
gynecology 
Anita Chandrasena, internal medicine 
Jen Chow, otolarnygology, surgery 
Emmanuelle Clerisme, internal 
medicine/primary 
Aaron Covey, orthopaedic surgery 
Michelle Diu, internal medicine 
Monique Grey, orthopaedic surgery 
Anna Hallemeier, medicine/pediatrics 
Heather Heimerdinger, psychiatry 
Joshua Horenstein, internal medicine 
Darnita Johnson-LaBorde, psychiatry 
Vasanthi L. Narayan, 
internal medicine 
Susan Lee, ophthalmology 
Vivian Lombillo, medicine/primary 
Louis Marotti Jr., neurosurgery, surgery 
Leo Otake, plastic surgery 
Patricia Pahk, ophthalmology 
Andy Redmond, neurosurgery, surgery 
Jennifer Sharp, internal medicine 
Kiriaki Stylianopoulos, pediatrics 
Bayan Takizawa, surgery, urology 
Karen Tie, internal medicine 
District of Columbia 
Georgetown University Hospital 
James Castle, medicine 
Georgia 
Eisenhower Army Medical Center, 
Augusta 
Jose Miranda, orthopaedic surgery 
Louisiana 
Tulane University, New Orleans 
Roya Vakili, ophthalmology 
Maryland 
Johns Hopkins University, Baltimore 
James Castle, neurology 
Jordan Prutkin, internal medicine 
Prashanth Vallabhajosyula, 
general surgery 
Massachusetts 
Beth Israel Deaconess Medical 
Center, Boston 
Amy Herman, internal medicine 
Brigham and Women’s 
Hospital, Boston 
Sandeep Bansal, internal medicine 
Wendy Garrett, internal medicine 
Seth Goldbarg, internal medicine 
Dawn Harris, internal medicine/ 
primary 
Julie Jaffe, internal medicine 
Biren Modi, general surgery 
Virginia (Jeanne) Triant, internal 
medicine 
Brigham/Faulkner Hospital, Boston 
Felix Adler, medicine 
Andrew Norden, medicine 
Michael Sherling, medicine 
Michael Singer, medicine 
Luke Yoon, medicine 
Children’s Hospital of Boston 
Amy Fahrenkopf, pediatrics 
Melissa McKirdy, pediatrics 
Harvard Combined Program, Boston 
Michael Fehm, orthopaedic surgery 
George Lui, medicine/pediatrics 
Harvard Medical School 
Andrew Norden, neurology 
Joint Center for Radiation 
Therapy, Boston 
Scott Floyd, radiation oncology 
Massachusetts Eye and Ear 
Infirmary, Boston 
Michael Singer, ophthalmology 
Massachusetts General 
Hospital, Boston 
Brooke Bailey, pediatrics 
John Davis, internal medicine 
Rebekah Gross, internal medicine/ 
primary 
Eric Hazen, pediatrics/psychiatry 
Neesha Rodrigues, radiation oncology 
Michael Sherling, dermatology 
Karen Thomas, internal medicine 
Luke Yoon, diagnostic radiology 
Massachusetts General 
Hospital/McLean, Boston 
Rocco lannucci, psychiatry 
Tufts-New England Medical 
Center, Boston 
Daniel Hoit, neurosurgery 
Michigan 
University of Michigan Hospitals, 
Ann Arbor 
Elizabeth Bird, pediatrics 
Nathan Siegel, emergency medicine 
Deborah Smith, internal medicine 
New York 
Einstein/Montefiore Medical 
Center, Bronx 
Monica Lopez, general surgery 
Mount Sinai Hospital, New York 
Stephen Krieger, neurology 
Rashida N’Gouamba, obstetrics and 
gynecology 
New York Presbyterian Hospital- 
Columbia 
Premila Bhat, internal medicine 
Nataki Douglas, obstetrics and 
gynecology 
Kebba Jobarteh, pediatrics 
Jeffrey Miller, psychiatry 
Jacqueline Park, internal medicine 
Marlyanne Pol-Rodriguez, 
dermatology 
New York Presbyterian Hospital- 
Cornell 
Charles Stowell, psychiatry 
New York University School of 
Medicine, New York 
Anita Karne, internal medicine/primary 
St. Vincent’s Hospital, New York 
Stephen Krieger, medicine 
Susan Lee, transitional 
South Nassau Community Hospital, 
Oceanside 
Jennifer Hammerstein,family practice 
suny Health Science Center- 
Brooklyn 
Afari Arash, diagnostic radiology 
Westchester Medical Center, Valhalla 
Jennifer Kreshak, orthopaedic surgery 
North Dakota 
University of North Dakota School of 
Medicine, Bismarck 
Corey Martin,family practice 
Oregon 
Oregon Health Sciences University, 
Portland 
Analene Pentopoulos, obstetrics and 
gynecology 
Pennsylvania 
Children’s Hospital of Philadelphia 
Naomi Balamuth, pediatrics 
Hospital of the University of 
Pennsylvania, Philadelphia 
Antony Chu, internal medicine 
Kate Lally, internal medicine 
Ingi Lee, internal medicine 
Thomas Jefferson University, 
Philadelphia 
Michael Dutka, diagnostic radiology 
University Health Center of 
Pittsburgh 
Hany Bedair, orthopaedic surgery 
Karl Lozanne, neurosurgery, surgery 
Washington Hospital, Washington 
R. Griff Kelley Jr., family practice 
Rhode Island 
Rhode Island Hospital/Brown 
University, Providence 
Tara Lagu, internal medicine/primary 
Steven Song, pediatrics 
Virginia 
Medical College of Virginia, Richmond 
Sandra Scott, emergency medicine 
Washington 
Tacoma Family Medicine Program 
Rebecca Holmes,family practice 
University of Washington Affiliated 
Hospitals, Seattle 
Vivian Lombillo, dermatology 
Wisconsin 
University of Wisconsin Hospital and 
Clinics, Madison 
Frederick (Frecky) Lewis, 
anesthesiology 
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Past President 
Executive Committee 
Cynthia B. Aten, m.d. '81 
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1950S 
Louis R.M. Del Cuercio, M.D. '53, 
of Larchmont, N.Y., was appoint¬ 
ed Emeritus Professor of Surgery 
at New York Medical College. 
Del Guercio retired at the end of 
2000 after 25 years as professor 
and chair of surgery. He is also 
a retired colonel from the Army 
Reserve Medical Corps. 
Donald P. Feeney, M.D., HS ’57, 
of LaGrange, III., has retired from 
the practice of urology and as 
assistant professor of urology at 
the University of Illinois College 
of Medicine. Feeney is now 
assistant medical director at the 
Unicre Division of WellPoint 
Health Corporation in suburban 
Chicago. 
Marcia Kraft Coin, M.D. '58, clini¬ 
cal professor 
of psychiatry 
and behav¬ 
ioral sciences 
at the Keck 
School of 
Medicine of 
the Univer¬ 
sity of Southern California, was 
elected president of the Ameri¬ 
can Psychiatric Association in 
February. She will serve a one- 
year term as president-elect 
that began in May, followed by 
a one-year term as president 
starting in May 2003. As presi¬ 
dent, Goin will head the govern¬ 
ing board of the organization 
and help guide policy and finan¬ 
cial decision making. Her goals 
include decreasing the stigma 
associated with mental illness, 
increasing public education and 
research funding for mental 
health, getting businesses to 
offer greater mental health 
insurance benefits and improv¬ 
ing government mental health 
Harry O. Kendall, m.d. ’55, retired 
in 1995 after a long career as 
an internist and later as a pul¬ 
monologist. His wife, a regis¬ 
tered nurse and operating room 
supervisor, has also retired. They 
are traveling, gardening and 
studying languages, genealogy 
and western U.S. history. 
They are also involved in social 
causes, through the aclu, 
Amnesty International and the 
Southern Poverty Law Center. 
Jerome O. Klein, M.D. ’56, profes¬ 
sor of pedi- 
r \ atriesand 
vice chair for 
academic 
affairs at 
Boston Medi¬ 
cal Center, 
received the 
20C2 Maxwell Finland Award 
for Scientific Achievement from 
the National Foundation for 
Infectious Diseases at a dinner 
in March at the Capital Hilton 
Hotel in Washington. Klein is a 
leader in research on otitis media 
and has helped define the treat¬ 
ment standards and protocols 
for ear infections in children. 
He has been active in studies of 
vaccines and antibiotic efficacy 
and infections of the fetus 
and newborn infant. Only two 
awards were presented at the 
event, the other going to Bill 
and Melinda Gates. Honorary 
co-chairs for the dinner were 
former Presidents and First 
Ladies Clinton, Carter and Ford. 
Ifr) 
I96OS 
Leon G. Smith Sr., M.D., FW ’60, 
hs ’62, chair of medicine at 
Saint Michael’s Medical Center 
in Newark, N.J., was awarded 
services. 
a Mastership from the American 
College of Physicians-American 
Society of Internal Medicine in 
recognition of his career accom¬ 
plishments and service to the 
college. He is also co-chair of the 
bioterrorism task force for the 
Medical Society of New Jersey. 
Smith has received a grant to 
build a bioterrorism lab to iso¬ 
late potential pathogens, which 
he says will be run by his son, 
Stephen M. Smith, m.d. ’89. Four 
of his children are physicians; 
two graduated from Yale School 
of Medicine. Smith also estab¬ 
lished the Infectious Disease 
Hall of Fame at Saint Michael's. 
Augustus A, White III, M.D., HS 
'66, professor of orthopaedics 
at Beth Israel Deaconess Medical 
Center, master of the Oliver 
Wendell Holmes Society and an 
orthopaedic spine surgeon, 
was named the Ellen and Melvin 
Gordon Professor of Medical 
Education in 2001 at Harvard 
Medical School. White is also 
director of the Daniel E. Hogan 
Spine Fellowship Program. His 
research focuses on the clinical 
biomechanics of the spine. 
197OS 
Robert A. Brodner, M.D., FW ’76, 
a neurosur¬ 
geon in pri¬ 
vate practice 
in Palm 
Beach, Fla., 
co-authored 
a play enti¬ 
tled Hand¬ 
shake, about a patient who 
undergoes a surgical pallidoto¬ 
my for Parkinson’s disease and 
the interrelationships between 
the patient, his family and the 
surgeon.The play had several 
readings in New York and Palm 
Beach, as well as a workshop 
production at the Cherry Lane 
Theatre in New York and an 
Off-Broadway world premiere 
last year at the Miranda Theater, 
where it enjoyed a successful 
six-week run. 
Bruce D. Cummings, M.P.H. ’77, 
writes to say that he spent 
“11 eventful years as the ceo at 
Blue Hill Memorial Hospital, 
Maine’s first integrated primary 
care system (a nonprofit medi¬ 
cal group practice with five 
rural health clinics, a Medicare- 
certified home health agency 
and Hospice provider, New 
England’s first critical access 
hospital and Parker Ridge, a 
retirement community). Now I 
am leaving ‘Downeast’ Maine 
to become president and ceo of 
the Clean General Hospital in 
Oiean, N.Y.” He began his new 
duties April 1. 
Donald L. Kent, M.D. ’72, HS ’78, 
reports that he has moved 
to Palm Harbor, Fla. "My closest 
friends and family convinced 
me not to totally retire at age 
55, and accordingly, a position 
‘fell in my lap’ through a Yale 
Med connection. As of May 20 
I am to become chief of oto¬ 
laryngology at Bay Pines VA 
Hospital in St. Petersburg, Fla.” 
1980s 
David A. Cottrell, D.M.D., HS ’88, 
director of the oral and max¬ 
illofacial surgery (oms) residen¬ 
cy program and director of 
oms resident research at Boston 
University School of Dental 
Medicine, became chair of the 
department of oms in January. 
He has been on the faculty 
since 1993. Cottrell specializes in 
orthognathic surgery, temporo¬ 
mandibular joint reconstruction, 
and bone grafting for implants 
and has authored numerous 
textbook chapters and scientific 
publications. 
David Fassler, M.D. ’82, clinical 
associate 
professor of 
psychiatry 
at the Uni¬ 
versity of 
Vermont 
College of 
Medicine, 
received the 2002 Braceland 
Award for Public Service from 
the American Psychiatric Asso¬ 
ciation (apa) in May during the 
apa annua! meeting in Philadel¬ 
phia. Fassler, also clinical direc¬ 
tor of Otter Creek Associates, a 
psychiatric and substance abuse 
treatment practice, was hon¬ 
ored for his contributions as an 
author, spokesperson and pub¬ 
licist in the service of the men¬ 
tally ill, the disabled and the art 
and science of helping. 
Blackford Middleton, M.P.H. ’81, 
writes,“1 have returned to 
the world of academic medicine 
after leaving MedicaLogic/ 
Medscape (now owned by GE 
Medical Systems). In early 2001, 
I joined the faculty in general 
medicine at the Brigham and 
Women’s Hospital/Harvard 
Medical School, and I am also 
serving as director for clinical 
information systems research 
and development at Partners 
Healthcare System. Having fun 
with students and research, 
and still building clinical sys¬ 
tems. Daughters Julia, 9, and 
Lillian, 5, are wondering ‘Where 
is the snow?’Wife Ursula King is 
making our new home and 
considering work... eventually.” 
Rock G. Positano, D.P.M., M.SC., 
M.P.H. ’89, co-director of The 
Foot Center of the Combined 
Orthopaedic Trauma and Frac¬ 
ture Service, New York-Presby- 
terian Hospital/Weill Medical 
College of Cornell University, 
received a letter of commenda¬ 
tion in January from the New 
York City Office of the Chief 
Medical Examiner for his assist¬ 
ance in their efforts to locate 
and identify the dead from 
the World Trade Center attack 
of September 11. 
David S. Weiss, M.D. ’81, was 
inaugurated 
as president 
of the Inter¬ 
national 
Association 
for Dance 
Medicine 
and Science 
(iadms) following the organiza¬ 
tion’s nth annual meeting in 
Madrid last November. Weiss is 
clinical assistant professor of 
orthopaedic surgery at New York 
University School of Medicine 
and senior orthopaedic consult¬ 
ant to the Harkness Center for 
Dance Injuries of the Hospital 
for Joint Diseases, iadms was 
founded in 1990 by an interna¬ 
tional group of dancers and 
dance medicine practitioners, 
educators and scientists. 
SEND ALUMNI NEWS TO 
Claire Bessinger, Yale Medicine, 
P.O. Box 7612, New Haven, CT 
06519-0612, or via e-mail 
to claire.bessinger@yale.edu. 
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32 on campus 
DAVID COREY 
Attacking a tumor’s longevity 
via telomerase 
Telomerase, the protein that 
keeps cells alive by adding new 
bits of dna to chromosomes, 
may be a target for treatment 
against cancer, according to 
David R. Corey, ph.d., an associ¬ 
ate professor of pharmacology 
and biochemistry at the Uni¬ 
versity of Texas Southwestern 
Medical Center in Dallas. At 
Cancer Center grand rounds in 
March, Corey suggested that 
oligonucleotides could inhibit 
telomerase, which is found in 
80 percent of solid tumors. 
Although its normal job is to 
repair telomeres, which main¬ 
tain chromosomes, telomerase 
confers a kind of immortality 
on tumors. Corey found that cer¬ 
tain oligonucleotides, small 
clusters of nucleic acids, caused 
tumor cells to grow more slowly 
and eventually die. When the 
oligonucleotides were with¬ 
drawn, the tumor cell grew at a 
normal rate. 
"You would not ever think 
about giving a telomerase 
inhibitor as a primary treatment 
to try to shrink the tumor,” 
Corey said. “Instead, after initial 
chemotherapy and radiation, 
you would remove most of the 
tumor volume and then start 
treating with telomerase 
inhibitors and hope that, in com¬ 
bination with other drugs, 
they would help keep the tumor 
from recurring.” 
JOHN NEFF 
Smallpox an unlikely threat, 
says Horstmann lecturer 
When smallpox reached the 
New World, it quickly decimated 
the indigenous population, 
said John M. Neff, M.D., professor 
of pediatrics at the University 
of Washington and the Child¬ 
ren’s Hospital in Seattle. A simi¬ 
lar, devastating outbreak is 
unlikely today, Neff told an audi¬ 
ence in April for the Dorothy 
Horstmann Lecture at pediatric 
grand rounds. 
With the disease eradicated 
since the 1970s, Neff said, the 
threat would come from misuse 
of stores of smallpox under 
guard in Russia and the United 
States or from rogue countries 
that might have obtained the 
virus. The possibility that these 
nations or groups have the 
virus is circumstantial, said Neff, 
who studied smallpox for the 
U.S. Public Health Service in 
the 1960s and ’70s. Furthermore, 
he said, its use as a bioterror¬ 
ist agent would backfire. "It 
won’t be contained in any one 
country.” Neff expressed a 
greater concern over the risks 
of vaccination. 
Neff called for destroying all 
remaining samples of the 
virus. “I don’t think the gains of 
keeping it around outweigh 
the gains of getting rid of it, and 
to destroy it makes a very posi¬ 
tive statement to the rest of the 
world," he said. 
SALLY SATEL 
From the right, a different take 
on bias in medicine 
The same day that Saliy Satel, 
hs ’88, spoke on political cor¬ 
rectness at the medical school, 
an Institute of Medicine (iom) 
report alleging racial and ethnic 
bias in medicine hit the news. 
The report was, for Satel, a prac¬ 
ticing psychiatrist and a fellow 
of the American Enterprise 
Institute, a perfect example of 
what she feels is going wrong 
with medicine. “I worry that resi¬ 
dents,” she said, "are sometimes 
being taught to see patients as 
members of victim groups 
rather than individuals.” Political 
agendas, from both the right 
and left, she said, are fueling 
misperceptions about medicine. 
"No one is debating that 
there are health disparities or, in 
certain situations, different uses 
of certain procedures,” Satel 
told an audience at a Program 
for Humanities in Medicine 
lecture in March. “But the iom 
report managed to leave out 
some studies that showed com¬ 
parable outcomes in blacks and 
whites.” More important, there 
are almost no data comparing 
the treatment of minorities 
by minority doctors and white 
doctors, she said. 
"Alleging prejudice on the 
part of doctors with so little evi¬ 
dence is inflammatory and 
engenders distrust of the medi¬ 
cal profession,” said Satel, 
author of pc, m.d.: How Politi¬ 
cal Correctness is Corrupting 
Medicine. 
ROBERT LANCER 
Technology as a weapon 
against suffering 
During his 28 years as a biomedi¬ 
cal engineer, Robert S. Langer, 
sc.d., has received four hono¬ 
rary doctorates, published 700 
articles and is the only active 
member of all three national 
academies: the Institute of 
Medicine, the National Academy 
of Engineering and the National 
Academy of Sciences. Yet the 
acknowledgement of his work 
that reached the widest 
audience came not from the 
academy, but from a popular 
television show—ER. 
An episode two years ago 
featured a “chemotherapy 
wafer” that was implanted into 
a character’s brain to treat a 
tumor. The device is one of many 
to come out of Langer’s lab 
at MIT, where he develops drug 
delivery devices and polymer 
scaffolds on which to build 
replacement tissue. 
"Drug delivery and tissue 
engineering are still at an 
embryonic stage,” he told an 
audience in April at the Yale 
Engineering Sesquicentennial 
Distinguished Lecture Series. 
"There are so many things we 
don’t know. It is my hope that 
scientists, engineers and clini¬ 
cians will be able to develop 
new principles to try to create 
new technologies and entities 
that will relieve suffering and 
prolong life.” 
Yale Medicine can help you stay connected with fellow alumni of the School of 
Medicine and its programs in Epidemiology and Public Health, the Graduate School 
of Arts and Sciences, and residency, fellowship and physician associate training. 
Share your personal and professional news for publication in the Alumni Notes 
department of Yale Medicine, using the online form at info.med.yale.edu/ayam. 
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